{"attribute_content":[],"alternate_symbols":["MC1DN31"],"keywords":[],"medgen_id":"C4748838","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032634\"}","{\"db\":\"OMIM\",\"id\":\"618251\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"615534.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31\"}","{\"db\":\"OMIM\",\"id\":\"618251\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31\"}","{\"db\":\"OMIM\",\"id\":\"618251\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN31\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032634\",\"ref_field\":\"name\"}"],"id":"40907","name":"Mitochondrial complex 1 deficiency, nuclear type 31"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1720779","type":"Disease","alternate_names":["APOC2 DEFICIENCY","C-II ANAPOLIPOPROTEINEMIA","HYPERLIPOPROTEINEMIA, TYPE IB"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"207750\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"309020\"}","{\"db\":\"Orphanet\",\"id\":\"444490\"}","{\"db\":\"OMIM\",\"id\":\"207750\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"APOC2 DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"207750\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"C-II ANAPOLIPOPROTEINEMIA\"}","{\"db\":\"OMIM\",\"id\":\"207750\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLIPOPROTEINEMIA, TYPE IB\"}","{\"db\":\"OMIM\",\"id\":\"608083.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLIPOPROTEINEMIA, TYPE IB\"}","{\"db\":\"OMIM\",\"id\":\"608083.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLIPOPROTEINEMIA, TYPE IB\"}","{\"db\":\"OMIM\",\"id\":\"608083.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLIPOPROTEINEMIA, TYPE IB\"}","{\"db\":\"OMIM\",\"id\":\"608083.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLIPOPROTEINEMIA, TYPE IB\"}","{\"db\":\"OMIM\",\"id\":\"608083.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLIPOPROTEINEMIA, TYPE IB\"}","{\"db\":\"OMIM\",\"id\":\"608083.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLIPOPROTEINEMIA, TYPE IB\"}","{\"db\":\"OMIM\",\"id\":\"608083.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLIPOPROTEINEMIA, TYPE IB\"}","{\"db\":\"OMIM\",\"id\":\"608083.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLIPOPROTEINEMIA, TYPE IB\"}","{\"db\":\"OMIM\",\"id\":\"608083.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLIPOPROTEINEMIA, TYPE IB\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Apolipoprotein+C2+deficiency/7704\",\"ref_field\":\"name\"}"],"id":"323","name":"Apolipoprotein C2 deficiency"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0023195","type":"Disease","alternate_names":["Lecithin Acyltransferase Deficiency"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"245900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"650\"}","{\"db\":\"Orphanet\",\"id\":\"79293\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Norum+disease/5271\",\"ref_field\":\"name\"}"],"id":"2544","name":"Norum disease"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"8549","medgen_id":"C0221060","type":"Disease","symbol":"MBS","alternate_names":["Absence or underdevelopment of the 6th and 7th cranial nerves","Congenital facial diplegia syndrome","Congenital oculofacial paralysis","Moebius Sequence","MÃ¶bius Syndrome"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008006\"}","{\"db\":\"OMIM\",\"id\":\"157900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"570\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"8549\",\"ref_field\":\"gard_id\"}","{\"db\":\"SNOMED CT\",\"id\":\"89444000\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"157900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3034","name":"Oromandibular-limb hypogenesis spectrum"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1853392","type":"Disease","symbol":"IMD41","alternate_names":["CD25 DEFICIENCY","IL2RA DEFICIENCY","IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"606367\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"169100\"}","{\"db\":\"OMIM\",\"id\":\"606367\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CD25 DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"606367\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IL2RA DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"147730.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY\"}","{\"db\":\"OMIM\",\"id\":\"147730.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY\"}","{\"db\":\"OMIM\",\"id\":\"147730.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY\"}","{\"db\":\"OMIM\",\"id\":\"147730.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY\"}","{\"db\":\"OMIM\",\"id\":\"147730.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY\"}","{\"db\":\"OMIM\",\"id\":\"606367\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Interleukin+2+receptor%2C+alpha%2C+deficiency+of/8676\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606367\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2315","name":"Interleukin 2 receptor, alpha, deficiency of"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258272","type":"Disease","symbol":"MRX108","alternate_names":["MENTAL RETARDATION, X-LINKED 108"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0026723\"}","{\"db\":\"OMIM\",\"id\":\"301024\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"301024\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED 108\"}","{\"db\":\"OMIM\",\"id\":\"300368.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301024\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301024\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41568","name":"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4749003","type":"Disease","symbol":"SMALED2B","alternate_names":["Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032660\"}","{\"db\":\"OMIM\",\"id\":\"618291\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"609797.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609797.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609797.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618291\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618291\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41333","name":"SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0266573","type":"Finding","alternate_names":["Congenital drooping upper eyelid"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007970\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007970\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital drooping upper eyelid\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007970\",\"ref_field\":\"name\"}"],"id":"26519","name":"Congenital ptosis"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263387","type":"Disease","symbol":"PHRINL","alternate_names":["PHRINL SYNDROME"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032931\"}","{\"db\":\"OMIM\",\"id\":\"618810\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618810\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PHRINL SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"612316.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612316.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612316.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618810\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618810\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43781","name":"PONTOCEREBELLAR HYPOPLASIA, HYPOTONIA, AND RESPIRATORY INSUFFICIENCY SYNDROME, NEONATAL LETHAL"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"9495","disease_mechanism_id":"273","medgen_id":"C2673922","type":"Disease","symbol":"AI2A1","alternate_names":["AMELOGENESIS IMPERFECTA, PIGMENTED HYPOMATURATION TYPE, 1","Amelogenesis imperfecta, type IIA1"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008772\"}","{\"db\":\"OMIM\",\"id\":\"204700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"88661\"}","{\"db\":\"OMIM\",\"id\":\"204700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AMELOGENESIS IMPERFECTA, PIGMENTED HYPOMATURATION TYPE, 1\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000324333\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000331776\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500805\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508588\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9495\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Amelogenesis+imperfecta%2C+hypomaturation+type%2C+IIA1/7676\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"204700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"229","disease_mechanism":"loss of function","name":"Amelogenesis imperfecta, hypomaturation type, IIA1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0151699","type":"Finding","alternate_names":["Bleeding within the skull","Intracranial Hemorrhages","Intracranial bleed"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002170\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0005049\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002170\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Bleeding within the skull\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002170\",\"ref_field\":\"name\"}"],"id":"34679","name":"Intracranial hemorrhage"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1839988","type":"Disease","alternate_names":["BRESHECK SYNDROME","ICHTHYOSIS FOLLICULARIS, ATRICHIA, AND PHOTOPHOBIA WITH OR WITHOUT BRAIN ANOMALIES, RETARDATION, ECTODERMAL DYSPLASIA, SKELETAL MALFORMATIONS, HIRSCHSPRUNG DISEASE, EAR/EYE ANOMALIES, CLEFT PALATE/CRYPTORCHIDISM, AND KIDNEY DYSPLASIA/HYPOPLASIA","IFAP SYNDROME WITH BRESHECK SYNDROME","Ichthyosis follicularis atrichia photophobia syndrome"],"xrefs":["{\"db\":\"Gene\",\"id\":\"266959\"}","{\"db\":\"OMIM\",\"id\":\"308205\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2273\"}","{\"db\":\"Orphanet\",\"id\":\"85284\"}","{\"db\":\"OMIM\",\"id\":\"300404\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRESHECK SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"308205\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ICHTHYOSIS FOLLICULARIS, ATRICHIA, AND PHOTOPHOBIA WITH OR WITHOUT BRAIN ANOMALIES, RETARDATION, ECTODERMAL DYSPLASIA, SKELETAL MALFORMATIONS, HIRSCHSPRUNG DISEASE, EAR/EYE ANOMALIES, CLEFT PALATE/CRYPTORCHIDISM, AND KIDNEY DYSPLASIA/HYPOPLASIA\"}","{\"db\":\"OMIM\",\"id\":\"300294.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IFAP SYNDROME WITH BRESHECK SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"300294.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IFAP SYNDROME WITH BRESHECK SYNDROME\"}","{\"db\":\"Genetic Alliance\",\"id\":\"IFAP+syndrome+with+or+without+BRESHECK+syndrome/8639\",\"ref_field\":\"name\"}"],"id":"1769","name":"IFAP syndrome with or without BRESHECK syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260726","type":"Disease","symbol":"MRT71","alternate_names":["MENTAL RETARDATION, AUTOSOMAL RECESSIVE 71"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032789\"}","{\"db\":\"OMIM\",\"id\":\"618504\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618504\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 71\"}","{\"db\":\"OMIM\",\"id\":\"613306.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613306.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618504\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618504\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42240","name":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"29792621\",\"@Source\":\"PubMed\"},{\"$\":\"NBK500456\",\"@Source\":\"BookShelf\"}]}}","gard_id":"10659","medgen_id":"C1833382","type":"Disease","symbol":"MODY4","alternate_names":["Diabetes mellitus MODY type 4","MODY insulin promoter factor-1 related","MODY type 4","MODY, type IV","Maturity-onset diabetes of the young, type IV"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011667\"}","{\"db\":\"OMIM\",\"id\":\"606392\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"552\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10659\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011667\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606392\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2867","name":"Maturity-onset diabetes of the young type 4"}
{"attribute_content":[],"alternate_symbols":["MC1DN8"],"keywords":[],"medgen_id":"C4748766","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032613\"}","{\"db\":\"OMIM\",\"id\":\"618230\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603846.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8\"}","{\"db\":\"OMIM\",\"id\":\"603846.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8\"}","{\"db\":\"OMIM\",\"id\":\"618230\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8\"}","{\"db\":\"OMIM\",\"id\":\"618230\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN8\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032613\",\"ref_field\":\"name\"}"],"id":"40882","name":"Mitochondrial complex 1 deficiency, nuclear type 8"}
{"attribute_content":[],"alternate_symbols":["MC1DN13"],"keywords":[],"medgen_id":"C4748770","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032618\"}","{\"db\":\"OMIM\",\"id\":\"618235\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618235\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13\"}","{\"db\":\"OMIM\",\"id\":\"618235\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN13\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032618\",\"ref_field\":\"name\"}"],"id":"40886","name":"Mitochondrial complex 1 deficiency, nuclear type 13"}
{"attribute_content":[],"alternate_symbols":["AOMS4"],"keywords":[],"gard_id":"13126","medgen_id":"C4014869","type":"Disease","symbol":"FPLD6","alternate_names":["Abdominal obesity-metabolic syndrome 4","LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH LIPE MUTATIONS"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615980\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"435660\"}","{\"db\":\"OMIM\",\"id\":\"615980\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH LIPE MUTATIONS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"13126\",\"ref_field\":\"gard_id\"}","{\"db\":\"OMIM\",\"id\":\"615980\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"31859","name":"Familial partial lipodystrophy 6"}
{"attribute_content":[],"alternate_symbols":["CTRCT18"],"keywords":[],"gard_id":"9892","medgen_id":"C1864908","type":"Disease","symbol":"CATC2","alternate_names":["CATARACT 18, AUTOSOMAL RECESSIVE","Cataract, autosomal recessive congenital 2"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012395\"}","{\"db\":\"OMIM\",\"id\":\"610019\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"91492\"}","{\"db\":\"Orphanet\",\"id\":\"98991\"}","{\"db\":\"Orphanet\",\"id\":\"98992\"}","{\"db\":\"Orphanet\",\"id\":\"98995\"}","{\"db\":\"OMIM\",\"id\":\"607182.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 18, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"607182.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 18, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"607182.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 18, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"607182.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 18, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"607182.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 18, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"607182.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 18, AUTOSOMAL RECESSIVE\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cataract%2C+Autosomal+Recessive+Congenital+2/1153\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cataract, autosomal recessive congenital 2\"}","{\"db\":\"OMIM\",\"id\":\"610019\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CTRCT18\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9892\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012395\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610019\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4745","name":"Cataract 18"}
{"attribute_content":[],"alternate_symbols":["MRXS36"],"keywords":[],"medgen_id":"CN262328","type":"Disease","symbol":"MRXSBA","alternate_names":["MENTAL RETARDATION, X-LINKED, SYNDROMIC, BASILICATA-AKHTAR TYPE"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0026730\"}","{\"db\":\"OMIM\",\"id\":\"301032\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"301032\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, SYNDROMIC, BASILICATA-AKHTAR TYPE\"}","{\"db\":\"OMIM\",\"id\":\"301032\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRXS36\"}","{\"db\":\"OMIM\",\"id\":\"300609.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300609.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300609.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300609.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300609.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301032\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301032\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42934","name":"BASILICATA-AKHTAR SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258822","type":"Disease","symbol":"3KS","alternate_names":["3K SYNDROME"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032764\"}","{\"db\":\"OMIM\",\"id\":\"618460\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618460\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"3K SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"608532.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608532.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608532.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618460\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618460\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41789","name":"KHAN-KHAN-KATSANIS SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0393818","type":"Disease","symbol":"CHN","alternate_names":["Neuropathy, congenital hypomelinating"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0033352\"}","{\"db\":\"OMIM\",\"id\":\"PS605253\",\"type\":\"Phenotypic series\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0033352\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Neuropathy, congenital hypomelinating\"}","{\"db\":\"SNOMED CT\",\"id\":\"230562000\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529452\",\"ref_field\":\"symbol\"}"],"id":"40848","name":"Congenital hypomyelinating neuropathy"}
{"attribute_content":[],"alternate_symbols":["MC1DN26"],"keywords":[],"medgen_id":"C4748809","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032630\"}","{\"db\":\"OMIM\",\"id\":\"618247\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603834.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26\"}","{\"db\":\"OMIM\",\"id\":\"603834.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26\"}","{\"db\":\"OMIM\",\"id\":\"618247\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26\"}","{\"db\":\"OMIM\",\"id\":\"618247\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN26\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032630\",\"ref_field\":\"name\"}"],"id":"40903","name":"Mitochondrial complex 1 deficiency, nuclear type 26"}
{"attribute_content":[],"alternate_symbols":["MC1DN21"],"keywords":[],"medgen_id":"C4748792","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032625\"}","{\"db\":\"OMIM\",\"id\":\"618242\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"613621.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21\"}","{\"db\":\"OMIM\",\"id\":\"613621.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21\"}","{\"db\":\"OMIM\",\"id\":\"613621.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21\"}","{\"db\":\"OMIM\",\"id\":\"613621.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21\"}","{\"db\":\"OMIM\",\"id\":\"613621.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21\"}","{\"db\":\"OMIM\",\"id\":\"613621.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21\"}","{\"db\":\"OMIM\",\"id\":\"613621.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21\"}","{\"db\":\"OMIM\",\"id\":\"618242\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21\"}","{\"db\":\"OMIM\",\"id\":\"618242\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN21\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032625\",\"ref_field\":\"name\"}"],"id":"40898","name":"Mitochondrial complex 1 deficiency, nuclear type 21"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"3020","medgen_id":"C0917804","type":"Disease","symbol":"BAVM","alternate_names":["Arteriovenous malformations of the brain","CEREBRAL ARTERIOVENOUS MALFORMATIONS","Cerebral AV malformation"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002408\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"108010\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"46724\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007154\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Arteriovenous malformations of the brain\"}","{\"db\":\"OMIM\",\"id\":\"108010\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBRAL ARTERIOVENOUS MALFORMATIONS\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002408\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cerebral AV malformation\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3020\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Intracranial+arteriovenous+malformation/3852\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002408\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"234142008\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"108010\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4617","name":"Cerebral arteriovenous malformation"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263147","type":"Disease","symbol":"NEDMCMS","alternate_names":["VANDERVORE-SCHOT SYNDROME"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032887\"}","{\"db\":\"OMIM\",\"id\":\"618730\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618730\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"VANDERVORE-SCHOT SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"616715.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616715.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616715.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616715.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616715.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616715.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616715.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618730\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618730\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43273","name":"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CORTICAL MALFORMATIONS, AND SPASTICITY"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"type":"Disease","symbol":"ARCL3A","alternate_names":["DE BARSY SYNDROME A"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009053\"}","{\"db\":\"OMIM\",\"id\":\"219150\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2962\"}","{\"db\":\"Orphanet\",\"id\":\"35664\"}","{\"db\":\"OMIM\",\"id\":\"219150\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DE BARSY SYNDROME A\"}","{\"db\":\"OMIM\",\"id\":\"219150\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"917","name":"Cutis laxa, autosomal recessive IIIA"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748841","type":"Disease","symbol":"CILD39","alternate_names":["CILIARY DYSKINESIA, PRIMARY, 39, WITH OR WITHOUT SITUS INVERSUS"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032637\"}","{\"db\":\"OMIM\",\"id\":\"618254\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618254\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CILIARY DYSKINESIA, PRIMARY, 39, WITH OR WITHOUT SITUS INVERSUS\"}","{\"db\":\"OMIM\",\"id\":\"618227.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618227.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618227.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618227.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618254\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618254\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40923","name":"CILIARY DYSKINESIA, PRIMARY, 39"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301337\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1158\",\"@Source\":\"BookShelf\"}]}}","gard_id":"10202","medgen_id":"C1838126","type":"Disease","symbol":"BDMR","alternate_names":["Albright hereditary osteodystrophy-like syndrome"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"600430\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1001\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10202\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Brachydactyly-Mental+Retardation+syndrome/1525\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600430\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1058","name":"Brachydactyly-Mental Retardation syndrome"}
{"attribute_content":[],"alternate_symbols":["MC1DN23"],"keywords":[],"medgen_id":"C4748799","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032627\"}","{\"db\":\"OMIM\",\"id\":\"618244\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618244\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23\"}","{\"db\":\"OMIM\",\"id\":\"618244\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN23\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032627\",\"ref_field\":\"name\"}"],"id":"40900","name":"Mitochondrial complex 1 deficiency, nuclear type 23"}
{"attribute_content":[],"alternate_symbols":["ABDS","BSAS"],"keywords":[],"gard_id":"8333","medgen_id":"C1832215","type":"Disease","alternate_names":["Athabaskan brainstem dysgenesis","Bosley Salih Alorainy syndrome","Navajo brainstem syndrome"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011099\"}","{\"db\":\"OMIM\",\"id\":\"601536\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"69737\"}","{\"db\":\"Orphanet\",\"id\":\"69739\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Athabaskan+Brainstem+Dysgenesis/643\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Athabaskan brainstem dysgenesis\"}","{\"db\":\"OMIM\",\"id\":\"601536\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ABDS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"8333\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011099\",\"ref_field\":\"name\"}"],"id":"4636","name":"Human HOXA1 syndromes"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"9987","medgen_id":"C1865370","type":"Disease","symbol":"RS-SCID","alternate_names":["SCID, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive, with sensitivity to ionizing radiation","Severe combined immunodeficiency with sensitivity to ionizing radiation"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011225\"}","{\"db\":\"OMIM\",\"id\":\"602450\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"275\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Severe+combined+immunodeficiency+with+sensitivity+to+ionizing+radiation/6524\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Severe combined immunodeficiency with sensitivity to ionizing radiation\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9987\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011225\",\"ref_field\":\"name\"}"],"id":"4388","name":"Severe combined immunodeficiency due to DCLRE1C deficiency"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0240912","type":"Disease","symbol":"CVT","alternate_names":["Pes valgus, congenital convex","Rocker-bottom foot deformity"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"192950\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"178382\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Vertical+talus%2C+congenital/7388\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"192950\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4490","name":"Vertical talus, congenital"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0268603","type":"Disease","symbol":"Acetyl-CoA","alternate_names":["ACACA DEFICIENCY","ACACAD","ACC1 DEFICIENCY","Acetyl-CoA carboxylase deficiency"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0013493\"}","{\"db\":\"OMIM\",\"id\":\"613933\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"613933\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACACA DEFICIENCY\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0013493\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACACAD\"}","{\"db\":\"OMIM\",\"id\":\"613933\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACACAD\"}","{\"db\":\"OMIM\",\"id\":\"613933\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACC1 DEFICIENCY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Acetyl-CoA%3A+carboxylase+deficiency/7621\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"4920001\",\"ref_field\":\"name\"}"],"id":"16014","name":"Acetyl-CoA: carboxylase deficiency"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263370","type":"Disease","symbol":"MRXSHD","alternate_names":["MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS, 2"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0026733\"}","{\"db\":\"OMIM\",\"id\":\"301039\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"301039\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS, 2\"}","{\"db\":\"OMIM\",\"id\":\"300766.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300766.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300766.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300766.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300766.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301039\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301039\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43770","name":"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HACKMANN-DI DONATO TYPE"}
{"attribute_content":[],"alternate_symbols":["IGE"],"keywords":[],"medgen_id":"C0270850","type":"Disease","alternate_names":["EIG"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"600669\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"PS600669\",\"type\":\"Phenotypic series\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010918\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EIG\"}","{\"db\":\"OMIM\",\"id\":\"600669\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EIG\"}","{\"db\":\"OMIM\",\"id\":\"600669\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IGE\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Idiopathic+generalized+epilepsy/8637\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"36803009\",\"ref_field\":\"name\"}"],"id":"1168","name":"Idiopathic generalized epilepsy"}
{"attribute_content":[],"alternate_symbols":["SMMCI"],"keywords":[],"gard_id":"4877","medgen_id":"C1840235","type":"Disease","alternate_names":["Fused incisors","SMMCI SYNDROME","Single Central Incisor Syndrome","Single central incisor","Single central upper incisor","Single maxillary central incisor","Single median incisor","Single median maxillary central incisor","Single median maxillary incisor","Single midline maxillary incisor","Single midline upper front tooth","Solitary median maxillary central incisor","Solitary midline maxillary central incisor"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001568\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001573\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006315\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006356\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007819\"}","{\"db\":\"OMIM\",\"id\":\"147250\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"147250\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SMMCI SYNDROME\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006315\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Single central incisor\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006315\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Single central upper incisor\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006315\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Single maxillary central incisor\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006315\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Single median incisor\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006315\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Single median maxillary central incisor\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006315\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Single median maxillary incisor\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006315\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Single midline maxillary incisor\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006315\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Single midline upper front tooth\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006315\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Solitary median maxillary central incisor\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006315\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Solitary midline maxillary central incisor\"}","{\"db\":\"OMIM\",\"id\":\"147250\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SMMCI\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4877\",\"ref_field\":\"gard_id\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006315\",\"ref_field\":\"name\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007819\",\"ref_field\":\"name\"}"],"id":"4154","name":"Solitary median maxillary central incisor syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"10128","medgen_id":"C1856716","type":"Disease","symbol":"HH24","alternate_names":["Follicle-stimulating hormone deficiency, isolated","Isolated FSH deficiency","Isolated follicle-stimulating hormone (FSH) deficiency"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009239\"}","{\"db\":\"OMIM\",\"id\":\"229070\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"52901\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Follicle-Stimulating+Hormone+Deficiency%2C+Isolated/2892\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Follicle-stimulating hormone deficiency, isolated\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10128\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009239\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"229070\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1295","name":"Hypogonadotropic hypogonadism 24 without anosmia"}
{"attribute_content":[],"alternate_symbols":["BRIDA"],"keywords":[],"medgen_id":"CN258291","type":"Disease","symbol":"IMD60","alternate_names":["IMMUNODEFICIENCY AND AUTOIMMUNITY, BACH2-RELATED"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032723\"}","{\"db\":\"OMIM\",\"id\":\"618394\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618394\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY AND AUTOIMMUNITY, BACH2-RELATED\"}","{\"db\":\"OMIM\",\"id\":\"618394\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"BRIDA\"}","{\"db\":\"OMIM\",\"id\":\"605394.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605394.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618394\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618394\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41591","name":"IMMUNODEFICIENCY 60"}
{"attribute_content":[],"alternate_symbols":["ICL"],"keywords":[],"gard_id":"12375","medgen_id":"C3809768","type":"Disease","symbol":"IMD13","alternate_names":["IDIOPATHIC CD4 LYMPHOPENIA"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615518\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"228000\"}","{\"db\":\"OMIM\",\"id\":\"615518\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IDIOPATHIC CD4 LYMPHOPENIA\"}","{\"db\":\"OMIM\",\"id\":\"615518\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ICL\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"12375\",\"ref_field\":\"gard_id\"}","{\"db\":\"OMIM\",\"id\":\"615518\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18377","name":"Immunodeficiency 13"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3810053","type":"Disease","symbol":"IMD16","alternate_names":["OX40 DEFICIENCY"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615593\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"431149\"}","{\"db\":\"OMIM\",\"id\":\"615593\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OX40 DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"615593\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18522","name":"Immunodeficiency 16"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1862151","type":"Disease","symbol":"BDA1","alternate_names":["Brachydactyly Farabee type"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009371\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"112500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"93388\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009371\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"112500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4700","name":"Type A1 brachydactyly"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262532","type":"Disease","symbol":"SIDDIS","alternate_names":["DEAFNESS, DYSTONIA, DEVELOPMENTAL DELAY, AND POOR GROWTH"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032842\"}","{\"db\":\"OMIM\",\"id\":\"618635\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618635\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DEAFNESS, DYSTONIA, DEVELOPMENTAL DELAY, AND POOR GROWTH\"}","{\"db\":\"OMIM\",\"id\":\"612029.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612029.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612029.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612029.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618635\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618635\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43025","name":"SIDDIQI SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3151898","type":"Disease","symbol":"MMIT","alternate_names":["COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT","MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAIN DEFICIENCY","RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"500009\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"254864\"}","{\"db\":\"OMIM\",\"id\":\"500009\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT\"}","{\"db\":\"OMIM\",\"id\":\"500009\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAIN DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"500009\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT\"}","{\"db\":\"OMIM\",\"id\":\"500009\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"6802","name":"Mitochondrial myopathy, infantile, transient"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4749028","type":"Disease","symbol":"CILD40","alternate_names":["CILIARY DYSKINESIA, PRIMARY, 40, WITH OR WITHOUT SITUS INVERSUS"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032664\"}","{\"db\":\"OMIM\",\"id\":\"618300\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618300\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CILIARY DYSKINESIA, PRIMARY, 40, WITH OR WITHOUT SITUS INVERSUS\"}","{\"db\":\"OMIM\",\"id\":\"618300\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618300\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41334","name":"CILIARY DYSKINESIA, PRIMARY, 40"}
{"attribute_content":[],"alternate_symbols":["CMT6C"],"keywords":[],"medgen_id":"CN260727","type":"Disease","symbol":"HMSN6C","alternate_names":["CHARCOT-MARIE-TOOTH DISEASE, TYPE 6C","HMSN VIC"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032792\"}","{\"db\":\"OMIM\",\"id\":\"618511\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618511\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH DISEASE, TYPE 6C\"}","{\"db\":\"OMIM\",\"id\":\"618511\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HMSN VIC\"}","{\"db\":\"OMIM\",\"id\":\"618511\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CMT6C\"}","{\"db\":\"OMIM\",\"id\":\"179020.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"179020.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618511\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618511\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42241","name":"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY"}
{"attribute_content":[],"alternate_symbols":["JUVAR"],"keywords":[],"medgen_id":"C3495559","type":"Disease","alternate_names":["JUVENILE ARTHRITIS"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032920\"}","{\"db\":\"OMIM\",\"id\":\"618795\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"613409.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"JUVENILE ARTHRITIS\"}","{\"db\":\"OMIM\",\"id\":\"613409.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"JUVENILE ARTHRITIS\"}","{\"db\":\"OMIM\",\"id\":\"613409.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"JUVENILE ARTHRITIS\"}","{\"db\":\"OMIM\",\"id\":\"613409.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"JUVENILE ARTHRITIS\"}","{\"db\":\"OMIM\",\"id\":\"613409.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"JUVENILE ARTHRITIS\"}","{\"db\":\"OMIM\",\"id\":\"613409.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"JUVENILE ARTHRITIS\"}","{\"db\":\"OMIM\",\"id\":\"618795\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"JUVENILE ARTHRITIS\"}","{\"db\":\"OMIM\",\"id\":\"618795\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"JUVAR\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032920\",\"ref_field\":\"name\"}"],"id":"43721","name":"Juvenile arthritis due to defect in LACC1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748993","type":"Disease","symbol":"MACID","alternate_names":["MACROCEPHALY, ACQUIRED, WITH MENTAL RETARDATION"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032658\"}","{\"db\":\"OMIM\",\"id\":\"618286\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618286\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MACROCEPHALY, ACQUIRED, WITH MENTAL RETARDATION\"}","{\"db\":\"OMIM\",\"id\":\"600728.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600728.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600728.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600728.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600728.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600728.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600728.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618286\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618286\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41319","name":"MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4225155","type":"Disease","symbol":"SIDBA3","alternate_names":["ANEMIA, SIDEROBLASTIC, 3"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0014804\"}","{\"db\":\"OMIM\",\"id\":\"616860\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"255132\"}","{\"db\":\"OMIM\",\"id\":\"609588.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANEMIA, SIDEROBLASTIC, 3\"}","{\"db\":\"OMIM\",\"id\":\"609588.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANEMIA, SIDEROBLASTIC, 3\"}","{\"db\":\"OMIM\",\"id\":\"609588.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANEMIA, SIDEROBLASTIC, 3\"}","{\"db\":\"OMIM\",\"id\":\"609588.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANEMIA, SIDEROBLASTIC, 3\"}","{\"db\":\"OMIM\",\"id\":\"609588.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANEMIA, SIDEROBLASTIC, 3\"}","{\"db\":\"OMIM\",\"id\":\"616860\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"34841","name":"Sideroblastic anemia 3, pyridoxine-refractory"}
{"attribute_content":[],"alternate_symbols":["IDIS"],"keywords":[],"medgen_id":"CN262701","type":"Disease","symbol":"DIAR11","alternate_names":["INTRACTABLE DIARRHEA OF INFANCY SYNDROME"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032857\"}","{\"db\":\"OMIM\",\"id\":\"618662\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618662\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTRACTABLE DIARRHEA OF INFANCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"618662\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IDIS\"}","{\"db\":\"OMIM\",\"id\":\"618656.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618656.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618662\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618662\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43081","name":"DIARRHEA 11, MALABSORPTIVE, CONGENITAL"}
{"attribute_content":[],"alternate_symbols":["EMA","GA2"],"keywords":[],"gard_id":"6523","medgen_id":"C0268596","type":"Disease","symbol":"MADD","alternate_names":["Ethylmalonic-adipicaciduria","GA 2","GA II","Glutaric acidemia type 2","Glutaric acidemia type II","Glutaric aciduria, type 2"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009282\"}","{\"db\":\"OMIM\",\"id\":\"231680\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"26791\"}","{\"db\":\"OMIM\",\"id\":\"231680\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GA II\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Glutaric+Acidemia+II/3111\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Glutaric aciduria, type 2\"}","{\"db\":\"SNOMED CT\",\"id\":\"22886006\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Glutaric aciduria, type 2\"}","{\"db\":\"OMIM\",\"id\":\"231680\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EMA\"}","{\"db\":\"OMIM\",\"id\":\"231680\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"GA2\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6523\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009282\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"231680\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5563","name":"Multiple acyl-CoA dehydrogenase deficiency"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263223","type":"Disease","symbol":"CATIFA","alternate_names":["CLEFT LIP, CATARACT, TOOTH ABNORMALITY, IMPAIRED INTELLECTUAL DEVELOPMENT, FACIAL DYSMORPHISM, AND ATTENTION-DEFICIT HYPERACTIVITY DISORDER"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032901\"}","{\"db\":\"OMIM\",\"id\":\"618761\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618761\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CLEFT LIP, CATARACT, TOOTH ABNORMALITY, IMPAIRED INTELLECTUAL DEVELOPMENT, FACIAL DYSMORPHISM, AND ATTENTION-DEFICIT HYPERACTIVITY DISORDER\"}","{\"db\":\"OMIM\",\"id\":\"610354.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618761\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618761\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43460","name":"CATIFA SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3550963","type":"Disease","symbol":"CHTE","alternate_names":["HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"300888\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"329235\"}","{\"db\":\"OMIM\",\"id\":\"300137.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT\"}","{\"db\":\"OMIM\",\"id\":\"300137.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT\"}","{\"db\":\"OMIM\",\"id\":\"300137.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT\"}","{\"db\":\"OMIM\",\"id\":\"300137.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT\"}","{\"db\":\"OMIM\",\"id\":\"300137.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT\"}","{\"db\":\"OMIM\",\"id\":\"300137.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT\"}","{\"db\":\"OMIM\",\"id\":\"300137.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT\"}","{\"db\":\"OMIM\",\"id\":\"300888\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT\"}","{\"db\":\"OMIM\",\"id\":\"300888\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17515","name":"Hypothyroidism, central, and testicular enlargement"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4749033","type":"Disease","symbol":"MRT68","alternate_names":["MENTAL RETARDATION, AUTOSOMAL RECESSIVE 68"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032665\"}","{\"db\":\"OMIM\",\"id\":\"618302\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618302\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 68\"}","{\"db\":\"OMIM\",\"id\":\"611669.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611669.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611669.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618302\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618302\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41335","name":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"9521","medgen_id":"C3810107","type":"Disease","symbol":"IMD17","alternate_names":["CD3-GAMMA DEFICIENCY","SCID-LIKE IMMUNODEFICIENCY, T CELL-PARTIAL, B CELL-POSITIVE, NK CELL-POSITIVE"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615607\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"169082\"}","{\"db\":\"OMIM\",\"id\":\"615607\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CD3-GAMMA DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"615607\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SCID-LIKE IMMUNODEFICIENCY, T CELL-PARTIAL, B CELL-POSITIVE, NK CELL-POSITIVE\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9521\",\"ref_field\":\"gard_id\"}","{\"db\":\"OMIM\",\"id\":\"615607\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18548","name":"Immunodeficiency 17"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262318","type":"Disease","symbol":"MRD60","alternate_names":["MENTAL RETARDATION, AUTOSOMAL DOMINANT 60, WITH SEIZURES"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032823\"}","{\"db\":\"OMIM\",\"id\":\"618587\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618587\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL DOMINANT 60, WITH SEIZURES\"}","{\"db\":\"OMIM\",\"id\":\"601024.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618587\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618587\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42927","name":"INTELLECTUAL DEVELOPMENTAL DISORDER 60 WITH SEIZURES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"3885","medgen_id":"C1838103","type":"Disease","symbol":"MLASA","alternate_names":["Myopathy with lactic acidosis and sideroblastic anemia","Myopathy, lactic acidosis and sideroblastic anemia"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0000863\"}","{\"db\":\"OMIM\",\"id\":\"PS600462\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2598\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3885\",\"ref_field\":\"gard_id\"}","{\"db\":\"Orphanet\",\"id\":\"2598\",\"ref_field\":\"name\"}"],"id":"32104","name":"Mitochondrial myopathy and sideroblastic anemia"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"EGAPP, 2009\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"2743612\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"AMA/NCHPEG, 2012\",\"@Type\":\"Suggested Reading\",\"URL\":{\"$\":\"http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf\"}}]}","disease_mechanism_id":"273","medgen_id":"CN280943","type":"Disease","symbol":"CRC","alternate_names":["COLON CANCER","Familial colorectal cancer"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"114500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"COLON CANCER\"}","{\"db\":\"OMIM\",\"id\":\"191170.0021\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"COLON CANCER\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Familial+Colorectal+Cancer/2734\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Familial colorectal cancer\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000321103\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000330058\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000333054\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501399\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501400\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501401\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501402\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501424\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508787\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508788\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508789\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508790\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508791\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508792\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508793\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508794\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508795\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508796\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508797\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508798\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508803\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509789\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510423\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512828\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515534\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515774\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519254\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519256\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519258\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519260\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519489\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519490\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520069\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520080\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520394\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522383\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522559\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527981\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527982\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527983\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527984\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528534\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528654\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530028\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530120\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530202\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552183\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552245\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552303\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558503\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000562230\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569958\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570011\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"OMIM\",\"id\":\"191170.0038\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"516030.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"516030.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"516030.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"986","disease_mechanism":"loss of function","name":"COLORECTAL CANCER"}
{"attribute_content":[],"alternate_symbols":["MC1DN33"],"keywords":[],"medgen_id":"C4748840","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032636\"}","{\"db\":\"OMIM\",\"id\":\"618253\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602138.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33\"}","{\"db\":\"OMIM\",\"id\":\"602138.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33\"}","{\"db\":\"OMIM\",\"id\":\"602138.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33\"}","{\"db\":\"OMIM\",\"id\":\"602138.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33\"}","{\"db\":\"OMIM\",\"id\":\"602138.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33\"}","{\"db\":\"OMIM\",\"id\":\"602138.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33\"}","{\"db\":\"OMIM\",\"id\":\"618253\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33\"}","{\"db\":\"OMIM\",\"id\":\"618253\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN33\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032636\",\"ref_field\":\"name\"}"],"id":"40909","name":"Mitochondrial complex 1 deficiency, nuclear type 33"}
{"attribute_content":[],"alternate_symbols":["MC1DN16"],"keywords":[],"medgen_id":"C4748785","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032621\"}","{\"db\":\"OMIM\",\"id\":\"618238\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"612360.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16\"}","{\"db\":\"OMIM\",\"id\":\"612360.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16\"}","{\"db\":\"OMIM\",\"id\":\"612360.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16\"}","{\"db\":\"OMIM\",\"id\":\"618238\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16\"}","{\"db\":\"OMIM\",\"id\":\"618238\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN16\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032621\",\"ref_field\":\"name\"}"],"id":"40894","name":"Mitochondrial complex 1 deficiency, nuclear type 16"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263303","type":"Disease","symbol":"CILD44","alternate_names":["CILIARY DYSKINESIA, PRIMARY, 44, WITHOUT SITUS INVERSUS"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032914\"}","{\"db\":\"OMIM\",\"id\":\"618781\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618781\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CILIARY DYSKINESIA, PRIMARY, 44, WITHOUT SITUS INVERSUS\"}","{\"db\":\"OMIM\",\"id\":\"618726.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618726.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618726.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618726.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618726.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618781\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618781\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43669","name":"CILIARY DYSKINESIA, PRIMARY, 44"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260600","type":"Disease","symbol":"IMD63","alternate_names":["CD122 DEFICIENCY","IL2RB DEFICIENCY","INTERLEUKIN 2 RECEPTOR, BETA, DEFICIENCY OF"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032782\"}","{\"db\":\"OMIM\",\"id\":\"618495\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618495\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CD122 DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"618495\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IL2RB DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"618495\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTERLEUKIN 2 RECEPTOR, BETA, DEFICIENCY OF\"}","{\"db\":\"OMIM\",\"id\":\"146710.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"146710.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"146710.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"146710.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618495\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618495\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42213","name":"IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"10025","medgen_id":"C1862839","type":"Disease","symbol":"ASGD1","alternate_names":["Anterior chamber cleavage defect","Anterior chamber cleavage disorder","Anterior chamber malformation","Anterior chamber mesodermal anomalies","Anterior segment mesencyhmal dysgenesis","Anterior segment ocular dysgenesis"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007696\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007699\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008040\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0019503\"}","{\"db\":\"OMIM\",\"id\":\"PS107250\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"88632\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anterior chamber cleavage defect\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anterior chamber cleavage disorder\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anterior chamber malformation\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anterior chamber mesodermal anomalies\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anterior segment mesencyhmal dysgenesis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anterior segment ocular dysgenesis\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10025\",\"ref_field\":\"gard_id\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS107250\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000553865\",\"ref_field\":\"symbol\"}"],"id":"26347","name":"Anterior segment dysgenesis"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301601\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1428\",\"@Source\":\"BookShelf\"}]}}","gard_id":"3045","medgen_id":"C1876161","type":"Disease","symbol":"CLN2","alternate_names":["Jansky-Bielschowsky disease","TPP1-Related Neuronal Ceroid-Lipofuscinosis"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008769\"}","{\"db\":\"OMIM\",\"id\":\"204500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"168491\"}","{\"db\":\"Orphanet\",\"id\":\"228349\"}","{\"db\":\"Orphanet\",\"id\":\"79264\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3045\",\"ref_field\":\"gard_id\"}","{\"db\":\"OMIM\",\"id\":\"204500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"874","name":"Ceroid lipofuscinosis neuronal 2"}
{"attribute_content":[],"alternate_symbols":["MRD47"],"keywords":[],"medgen_id":"C4539951","type":"Disease","alternate_names":["MENTAL RETARDATION, AUTOSOMAL DOMINANT 47"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0030912\"}","{\"db\":\"OMIM\",\"id\":\"617635\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"502434\"}","{\"db\":\"OMIM\",\"id\":\"604358.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL DOMINANT 47\"}","{\"db\":\"OMIM\",\"id\":\"604358.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL DOMINANT 47\"}","{\"db\":\"OMIM\",\"id\":\"604358.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL DOMINANT 47\"}","{\"db\":\"OMIM\",\"id\":\"604358.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL DOMINANT 47\"}","{\"db\":\"OMIM\",\"id\":\"604358.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL DOMINANT 47\"}","{\"db\":\"OMIM\",\"id\":\"604358.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL DOMINANT 47\"}","{\"db\":\"OMIM\",\"id\":\"617635\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL DOMINANT 47\"}","{\"db\":\"OMIM\",\"id\":\"617635\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRD47\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0030912\",\"ref_field\":\"name\"}"],"id":"38072","name":"Intellectual disability, autosomal dominant 47"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3151062","type":"Disease","alternate_names":["FADD DEFICIENCY"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"613759\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"306550\"}","{\"db\":\"OMIM\",\"id\":\"613759\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FADD DEFICIENCY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Infections%2C+recurrent%2C+with+encephalopathy%2C+hepatic+dysfunction%2C+and+cardiovascular+malformations/8662\",\"ref_field\":\"name\"}"],"id":"15775","name":"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0026848","type":"Disease","alternate_names":["Myopathic changes"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003198\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003569\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003705\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003742\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003802\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0005336\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003198\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Myopathic changes\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003198\",\"ref_field\":\"name\"}"],"id":"9536","name":"Myopathy"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0158761","type":"Disease","symbol":"RUS","alternate_names":["Fused forearm bones","RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002974\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003962\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0017985\"}","{\"db\":\"OMIM\",\"id\":\"179300\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3269\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002974\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fused forearm bones\"}","{\"db\":\"OMIM\",\"id\":\"179300\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"602931.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"602931.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"602931.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"602931.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Congenital+radio-ulnar+synostosis/9645\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002974\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"33313004\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"179300\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3573","name":"Radioulnar synostosis"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3280799","type":"Disease","symbol":"ARCL3B","alternate_names":["CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB","DE BARSY SYNDROME B","PYCR1-related de Barsy syndrome"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0013755\"}","{\"db\":\"OMIM\",\"id\":\"614438\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"293633\"}","{\"db\":\"Orphanet\",\"id\":\"2962\"}","{\"db\":\"OMIM\",\"id\":\"179035.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB\"}","{\"db\":\"OMIM\",\"id\":\"179035.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB\"}","{\"db\":\"OMIM\",\"id\":\"179035.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB\"}","{\"db\":\"OMIM\",\"id\":\"179035.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB\"}","{\"db\":\"OMIM\",\"id\":\"614438\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB\"}","{\"db\":\"OMIM\",\"id\":\"614438\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DE BARSY SYNDROME B\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0013755\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PYCR1-related de Barsy syndrome\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Autosomal+recessive+cutis+laxa+type+3B/7791\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614438\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"16806","name":"Autosomal recessive cutis laxa type 3B"}
{"attribute_content":[],"alternate_symbols":["IGHD5"],"keywords":[],"medgen_id":"C4748435","type":"Disease","alternate_names":["ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032569\"}","{\"db\":\"OMIM\",\"id\":\"618160\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618160\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V\"}","{\"db\":\"OMIM\",\"id\":\"618160\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IGHD5\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032569\",\"ref_field\":\"name\"}"],"id":"40741","name":"Isolated growth hormone deficiency, type 5"}
{"attribute_content":[],"alternate_symbols":["MC1DN2"],"keywords":[],"medgen_id":"C4748737","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032606\"}","{\"db\":\"OMIM\",\"id\":\"618222\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602141.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"602141.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"602141.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"602141.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"602141.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"602141.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"602141.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"618222\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"618222\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN2\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032606\",\"ref_field\":\"name\"}"],"id":"40887","name":"Mitochondrial complex 1 deficiency, nuclear type 2"}
{"attribute_content":[],"alternate_symbols":["OI20"],"keywords":[],"medgen_id":"CN262534","type":"Disease","alternate_names":["OSTEOGENESIS IMPERFECTA, TYPE XX"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032846\"}","{\"db\":\"OMIM\",\"id\":\"618644\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"607783.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OSTEOGENESIS IMPERFECTA, TYPE XX\"}","{\"db\":\"OMIM\",\"id\":\"607783.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OSTEOGENESIS IMPERFECTA, TYPE XX\"}","{\"db\":\"OMIM\",\"id\":\"607783.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OSTEOGENESIS IMPERFECTA, TYPE XX\"}","{\"db\":\"OMIM\",\"id\":\"607783.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OSTEOGENESIS IMPERFECTA, TYPE XX\"}","{\"db\":\"OMIM\",\"id\":\"618644\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OSTEOGENESIS IMPERFECTA, TYPE XX\"}","{\"db\":\"OMIM\",\"id\":\"618644\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"OI20\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032846\",\"ref_field\":\"name\"}"],"id":"43032","name":"Osteogenesis imperfecta, type 20"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258821","type":"Disease","symbol":"MRXSPM","alternate_names":["MENTAL RETARDATION, X-LINKED, SYNDROMIC, PAGANINI-MIOZZO TYPE"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0026724\"}","{\"db\":\"OMIM\",\"id\":\"301025\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"301025\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, SYNDROMIC, PAGANINI-MIOZZO TYPE\"}","{\"db\":\"OMIM\",\"id\":\"301025\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301025\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41788","name":"PAGANINI-MIOZZO SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0008489","type":"Finding","alternate_names":["Choreatic disease","Choreic movements","Choreiform movements"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002072\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002397\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0001595\"}","{\"db\":\"Orphanet\",\"id\":\"1429\"}","{\"db\":\"Orphanet\",\"id\":\"306715\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002072\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Choreatic disease\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0001595\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Choreatic disease\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002072\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Choreic movements\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002072\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Choreiform movements\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002072\",\"ref_field\":\"name\"}"],"id":"22827","name":"Chorea"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262442","type":"Disease","symbol":"RTS1","alternate_names":["POIKILODERMA ATROPHICANS AND CATARACT"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"618625\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"221008\"}","{\"db\":\"OMIM\",\"id\":\"618625\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"POIKILODERMA ATROPHICANS AND CATARACT\"}","{\"db\":\"OMIM\",\"id\":\"618625\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43000","name":"Rothmund-Thomson syndrome type 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263351","type":"Disease","symbol":"CILD45","alternate_names":["CILIARY DYSKINESIA, PRIMARY, 45, WITHOUT SITUS INVERSUS"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032924\"}","{\"db\":\"OMIM\",\"id\":\"618801\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618801\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CILIARY DYSKINESIA, PRIMARY, 45, WITHOUT SITUS INVERSUS\"}","{\"db\":\"OMIM\",\"id\":\"610732.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610732.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610732.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610732.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618801\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618801\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43742","name":"CILIARY DYSKINESIA, PRIMARY, 45"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21368913\",\"@Source\":\"PubMed\"}}}","medgen_id":"C1970161","type":"Disease","symbol":"MKS4","alternate_names":["MECKEL-GRUBER SYNDROME, TYPE 4"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012626\"}","{\"db\":\"OMIM\",\"id\":\"611134\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"564\"}","{\"db\":\"OMIM\",\"id\":\"611134\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MECKEL-GRUBER SYNDROME, TYPE 4\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012626\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611134\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2833","name":"Meckel syndrome, type 4"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1291386","type":"Disease","alternate_names":["D-GLYCERIC ACIDURIA","D-Glycerate kinase deficiency","GLYCERATE KINASE DEFICIENCY","Non ketotic hyperglycinemia syndrome"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"220120\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"941\"}","{\"db\":\"OMIM\",\"id\":\"220120\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"D-GLYCERIC ACIDURIA\"}","{\"db\":\"OMIM\",\"id\":\"610516.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"D-GLYCERIC ACIDURIA\"}","{\"db\":\"OMIM\",\"id\":\"610516.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"D-GLYCERIC ACIDURIA\"}","{\"db\":\"OMIM\",\"id\":\"610516.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"D-GLYCERIC ACIDURIA\"}","{\"db\":\"OMIM\",\"id\":\"220120\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GLYCERATE KINASE DEFICIENCY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Deficiency+of+glycerate+kinase/8199\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"124323007\",\"ref_field\":\"name\"}"],"id":"925","name":"Deficiency of glycerate kinase"}
{"attribute_content":[],"alternate_symbols":["IDDMSF"],"keywords":[],"medgen_id":"C4748701","type":"Disease","symbol":"SNIBCPS","alternate_names":["INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SPEECH DELAY, AND DYSMORPHIC FACIES"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032600\"}","{\"db\":\"OMIM\",\"id\":\"618205\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618205\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SPEECH DELAY, AND DYSMORPHIC FACIES\"}","{\"db\":\"OMIM\",\"id\":\"618205\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IDDMSF\"}","{\"db\":\"OMIM\",\"id\":\"602120.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602120.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602120.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602120.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602120.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618205\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618205\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40849","name":"SNIJDERS BLOK-CAMPEAU SYNDROME"}
{"attribute_content":[],"alternate_symbols":["CDG2S","CDGIIs"],"keywords":[],"medgen_id":"C4310819","type":"Disease","symbol":"IMD47","alternate_names":["CDG IIs","CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIs","IMMUNODEFICIENCY AND HEPATOPATHY WITH OR WITHOUT NEUROLOGIC FEATURES"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010504\"}","{\"db\":\"OMIM\",\"id\":\"300972\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"300972\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CDG IIs\"}","{\"db\":\"OMIM\",\"id\":\"300972\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIs\"}","{\"db\":\"OMIM\",\"id\":\"300972\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY AND HEPATOPATHY WITH OR WITHOUT NEUROLOGIC FEATURES\"}","{\"db\":\"OMIM\",\"id\":\"300972\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CDG2S\"}","{\"db\":\"OMIM\",\"id\":\"300972\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CDGIIs\"}","{\"db\":\"OMIM\",\"id\":\"300972\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"35686","name":"Immunodeficiency 47"}
{"attribute_content":[],"alternate_symbols":["NEDMIDF","NSDVS1"],"keywords":[],"medgen_id":"CN272909","type":"Disease","alternate_names":["NABAIS SA-DE VRIES SYNDROME, TYPE 1"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032942\"}","{\"db\":\"OMIM\",\"id\":\"618828\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602650.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"602650.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"618828\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"618828\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NEDMIDF\"}","{\"db\":\"OMIM\",\"id\":\"618828\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NSDVS1\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032942\",\"ref_field\":\"name\"}"],"id":"43806","name":"Neurodevelopmental disorder with microcephaly and dysmorphic facies"}
{"attribute_content":[],"alternate_symbols":["LCAPD2"],"keywords":[],"medgen_id":"C3151085","type":"Disease","alternate_names":["LECTIN COMPLEMENT ACTIVATION PATHWAY, DEFECT IN, 2"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"613791\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"331187\"}","{\"db\":\"OMIM\",\"id\":\"613791\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LECTIN COMPLEMENT ACTIVATION PATHWAY, DEFECT IN, 2\"}","{\"db\":\"OMIM\",\"id\":\"613791\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"LCAPD2\"}"],"id":"10145","name":"MASP2 deficiency"}
{"attribute_content":[],"alternate_symbols":["MC1DN30"],"keywords":[],"medgen_id":"C4746985","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0026721\"}","{\"db\":\"OMIM\",\"id\":\"301021\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"301021\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30\"}","{\"db\":\"OMIM\",\"id\":\"301021\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN30\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0026721\",\"ref_field\":\"name\"}"],"id":"40879","name":"Mitochondrial complex 1 deficiency, nuclear type 30"}
{"attribute_content":[],"alternate_symbols":["MCS","MRXS4","WWS"],"keywords":[],"medgen_id":"C0796200","type":"Disease","symbol":"WRWF","alternate_names":["Apraxia, oculomotor, with congenital contractures and muscle atrophy","Contractures of feet, muscle atrophy, and oculomotor apraxia","Wieacker Wolff syndrome","Wieacker syndrome"],"xrefs":["{\"db\":\"Gene\",\"id\":\"4183\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010758\"}","{\"db\":\"OMIM\",\"id\":\"314580\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3454\"}","{\"db\":\"Orphanet\",\"id\":\"85283\"}","{\"db\":\"SNOMED CT\",\"id\":\"722456001\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Wieacker Wolff syndrome\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Wieacker+syndrome/7492\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Wieacker syndrome\"}","{\"db\":\"OMIM\",\"id\":\"314580\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MCS\"}","{\"db\":\"OMIM\",\"id\":\"314580\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRXS4\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010758 \",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"314580\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"6123","name":"Intellectual disability-developmental delay-contractures syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"9744","medgen_id":"C0263429","type":"Disease","symbol":"AVA","alternate_names":["Atrophodermia reticulata","Folliculitis ulerythematosa","Folliculitis ulerythematosa reticulata","Honeycomb atrophy","Keratosis pilaris affecting the follicles of the eyebrow hairs","Type of genodermatosis","Vermiculata atrophoderma"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100837\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008849\"}","{\"db\":\"OMIM\",\"id\":\"209700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"79100\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100837\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Vermiculata atrophoderma\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9744\",\"ref_field\":\"gard_id\"}","{\"db\":\"SNOMED CT\",\"id\":\"2736005\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"209700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"568","name":"Atrophoderma vermiculatum"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258288","type":"Disease","symbol":"SEDKF","alternate_names":["SED WITH ELEVATED BLOOD LYSOSOMAL ENZYMES"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032721\"}","{\"db\":\"OMIM\",\"id\":\"618392\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618392\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SED WITH ELEVATED BLOOD LYSOSOMAL ENZYMES\"}","{\"db\":\"OMIM\",\"id\":\"618392\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618392\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41583","name":"SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C2676767","type":"Disease","symbol":"HACD59","alternate_names":["Cd59 deficiency","HEMOLYTIC ANEMIA, CD59-MEDIATED"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"612300\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"169464\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cd59+deficiency/7929\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cd59 deficiency\"}","{\"db\":\"OMIM\",\"id\":\"107271.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HEMOLYTIC ANEMIA, CD59-MEDIATED\"}","{\"db\":\"OMIM\",\"id\":\"612300\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"749","name":"CD59-mediated hemolytic anemia with or without immune-mediated polyneuropathy"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1838604","type":"Disease","symbol":"ECA1","alternate_names":["EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020759\"}","{\"db\":\"OMIM\",\"id\":\"600131\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"64280\"}","{\"db\":\"OMIM\",\"id\":\"600131\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"600131\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1166","name":"Epilepsy, childhood absence 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0544855","type":"Disease","symbol":"NDNC3","alternate_names":["Hereditary white nails","LEUKONYCHIA TOTALIS AND/OR PARTIALIS","NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3","Porcelain nails"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"151600\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"151600\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKONYCHIA TOTALIS AND/OR PARTIALIS\"}","{\"db\":\"OMIM\",\"id\":\"151600\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3\"}","{\"db\":\"OMIM\",\"id\":\"602142.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3\"}","{\"db\":\"OMIM\",\"id\":\"602142.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3\"}","{\"db\":\"OMIM\",\"id\":\"602142.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3\"}","{\"db\":\"OMIM\",\"id\":\"602142.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Leukonychia+totalis/4208\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"151600\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2685","name":"Leukonychia totalis"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C2751855","type":"Disease","symbol":"EIEE39","alternate_names":["EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"612949\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"353217\"}","{\"db\":\"OMIM\",\"id\":\"603667.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39\"}","{\"db\":\"OMIM\",\"id\":\"603667.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39\"}","{\"db\":\"OMIM\",\"id\":\"612949\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hypomyelination%2C+global+cerebral/8618\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612949\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"6770","name":"Hypomyelination, global cerebral"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263317","type":"Disease","symbol":"EIEE84","alternate_names":["JAMUAR SYNDROME"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032918\"}","{\"db\":\"OMIM\",\"id\":\"618792\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618792\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"JAMUAR SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"603370.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603370.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603370.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603370.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603370.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603370.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603370.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618792\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618792\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43698","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 84"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748876","type":"Disease","symbol":"EV3","alternate_names":["Epidermodysplasia verruciformis 3"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032644\"}","{\"db\":\"OMIM\",\"id\":\"618267\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602293.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602293.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602293.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602293.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602293.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618267\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618267\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40928","name":"EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0023520","type":"Disease","alternate_names":["Degeneration of white matter of brain"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002415\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0019046\"}","{\"db\":\"Orphanet\",\"id\":\"68356\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002415\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Degeneration of white matter of brain\"}","{\"db\":\"GeneTests\",\"id\":\"319799\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Leukodystrophy/4198\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002415\",\"ref_field\":\"name\"}"],"id":"14617","name":"Leukodystrophy"}
{"attribute_content":[],"alternate_symbols":["IDDRP"],"keywords":[],"medgen_id":"C4748658","type":"Disease","alternate_names":["INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032594\"}","{\"db\":\"OMIM\",\"id\":\"618195\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"611611.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA\"}","{\"db\":\"OMIM\",\"id\":\"611611.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA\"}","{\"db\":\"OMIM\",\"id\":\"611611.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA\"}","{\"db\":\"OMIM\",\"id\":\"611611.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA\"}","{\"db\":\"OMIM\",\"id\":\"618195\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA\"}","{\"db\":\"OMIM\",\"id\":\"618195\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IDDRP\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032594\",\"ref_field\":\"name\"}"],"id":"40831","name":"Intellectual developmental disorder and retinitis pigmentosa; IDDRP"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3888417","type":"Disease","symbol":"CTRCT5","alternate_names":["CATARACT 5, LAMELLAR","CATARACT, MARNER TYPE","Cataract, zonular","Congenital lamellar cataracts","Lamellar cataract","Perinuclear cataract"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007971\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007290\"}","{\"db\":\"OMIM\",\"id\":\"116800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"91492\"}","{\"db\":\"OMIM\",\"id\":\"602438.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 5, LAMELLAR\"}","{\"db\":\"OMIM\",\"id\":\"602438.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 5, LAMELLAR\"}","{\"db\":\"OMIM\",\"id\":\"602438.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 5, LAMELLAR\"}","{\"db\":\"OMIM\",\"id\":\"116800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT, MARNER TYPE\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cataract%2C+Zonular/1162\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cataract, zonular\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007971\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital lamellar cataracts\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007971\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lamellar cataract\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007290\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"116800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4749","name":"Cataract 5 multiple types"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258213","type":"Disease","symbol":"IMAGEI","alternate_names":["IMAGEI SYNDROME"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032684\"}","{\"db\":\"OMIM\",\"id\":\"618336\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618336\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMAGEI SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"174762.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"174762.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"174762.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"174762.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"174762.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618336\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618336\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41419","name":"INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"12550","medgen_id":"C1852150","type":"Finding","symbol":"ADERM","alternate_names":["FINGERPRINTS, ABSENCE OF"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007455\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"136000\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"289465\"}","{\"db\":\"OMIM\",\"id\":\"136000\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FINGERPRINTS, ABSENCE OF\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"12550\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"adermatoglyphia\",\"ref_field\":\"ghr_links\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Adermatoglyphia/7635\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007455\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"136000\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"26191","name":"Adermatoglyphia","ghr_links":"adermatoglyphia"}
{"attribute_content":[],"alternate_symbols":["MC1DM1"],"keywords":[],"medgen_id":"C4746992","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 1"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0027068\"}","{\"db\":\"OMIM\",\"id\":\"500014\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"500014\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"516002.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"516002.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"516002.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"500014\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DM1\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0027068\",\"ref_field\":\"name\"}"],"id":"40880","name":"Mitochondrial complex 1 deficiency, mitochondrial type 1"}
{"attribute_content":[],"alternate_symbols":["IMD11"],"keywords":[],"medgen_id":"C3554686","type":"Disease","symbol":"IMD11A","alternate_names":["IMMUNODEFICIENCY 11A"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615206\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"357237\"}","{\"db\":\"OMIM\",\"id\":\"607210.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 11A\"}","{\"db\":\"OMIM\",\"id\":\"607210.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 11A\"}","{\"db\":\"OMIM\",\"id\":\"615206\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IMD11\"}","{\"db\":\"OMIM\",\"id\":\"615206\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17786","name":"Immunodeficiency 11"}
{"attribute_content":[],"alternate_symbols":["NEDXCF"],"keywords":[],"medgen_id":"CN258252","type":"Disease","symbol":"MKMS","alternate_names":["NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0026722\"}","{\"db\":\"OMIM\",\"id\":\"301022\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"301022\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES\"}","{\"db\":\"OMIM\",\"id\":\"301022\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NEDXCF\"}","{\"db\":\"OMIM\",\"id\":\"300826.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300826.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300826.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300826.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300826.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300826.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300826.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301022\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301022\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41548","name":"MULLEGAMA-KLEIN-MARTINEZ SYNDROME"}
{"attribute_content":[],"alternate_symbols":["MC1DN24"],"keywords":[],"medgen_id":"C4748803","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032628\"}","{\"db\":\"OMIM\",\"id\":\"618245\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618245\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24\"}","{\"db\":\"OMIM\",\"id\":\"618245\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN24\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032628\",\"ref_field\":\"name\"}"],"id":"40901","name":"Mitochondrial complex 1 deficiency, nuclear type 24"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN069573","type":"Disease","symbol":"EDMD","alternate_names":["Muscular dystrophy, tardive Emery-Dreifuss type, with contractures"],"xrefs":["{\"db\":\"Orphanet\",\"id\":\"98863\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Emery-Dreifuss+Muscular+Dystrophy%2C+X-Linked/2512\",\"ref_field\":\"name\"}"],"id":"10875","name":"Emery-Dreifuss muscular dystrophy, X-linked"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C2750220","type":"Disease","alternate_names":["Early-onset progressive cerebellar ataxia dystonia spasticity and intellectual decline"],"xrefs":["{\"db\":\"Genetic Alliance\",\"id\":\"Karak+syndrome/3956\",\"ref_field\":\"name\"}"],"id":"6470","name":"Karak syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3150701","type":"Disease","symbol":"BMIQ16","alternate_names":["BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 16"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"613444\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"261222\"}","{\"db\":\"OMIM\",\"id\":\"613444\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 16\"}","{\"db\":\"OMIM\",\"id\":\"613444\",\"ref_field\":\"symbol\"}"],"id":"6658","name":"Chromosome 16p11.2 deletion syndrome, 220 kb"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262579","type":"Disease","symbol":"DMJDS2","alternate_names":["SPASTIC TETRAPARESIS, DYSTONIA, DEVELOPMENTAL DELAY, AND STRUCTURAL ABNORMALITIES OF THE BASAL GANGLIA"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020762\"}","{\"db\":\"OMIM\",\"id\":\"618646\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618646\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC TETRAPARESIS, DYSTONIA, DEVELOPMENTAL DELAY, AND STRUCTURAL ABNORMALITIES OF THE BASAL GANGLIA\"}","{\"db\":\"OMIM\",\"id\":\"616253.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616253.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618646\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618646\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43037","name":"DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3809008","type":"Disease","symbol":"HBSL","alternate_names":["ASPARTYL-tRNA SYNTHETASE DEFICIENCY"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615281\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"363412\"}","{\"db\":\"OMIM\",\"id\":\"615281\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ASPARTYL-tRNA SYNTHETASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"615281\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17945","name":"Hypomyelination with brainstem and spinal cord involvement and leg spasticity"}
{"attribute_content":[],"alternate_symbols":["GPIBD20"],"keywords":[],"medgen_id":"CN262313","type":"Disease","symbol":"EIEE80","alternate_names":["GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 20"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032822\"}","{\"db\":\"OMIM\",\"id\":\"618580\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618580\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 20\"}","{\"db\":\"OMIM\",\"id\":\"618580\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"GPIBD20\"}","{\"db\":\"OMIM\",\"id\":\"604122.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604122.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604122.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604122.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604122.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604122.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618580\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618580\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42919","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 80"}
{"attribute_content":[],"alternate_symbols":["MC1DN12"],"keywords":[],"medgen_id":"C4746984","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0026720\"}","{\"db\":\"OMIM\",\"id\":\"301020\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"300078.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12\"}","{\"db\":\"OMIM\",\"id\":\"300078.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12\"}","{\"db\":\"OMIM\",\"id\":\"301020\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12\"}","{\"db\":\"OMIM\",\"id\":\"301020\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN12\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0026720\",\"ref_field\":\"name\"}"],"id":"40878","name":"Mitochondrial complex 1 deficiency, nuclear type 12"}
{"attribute_content":[],"alternate_symbols":["PSAPD"],"keywords":[],"gard_id":"12505","medgen_id":"C2673635","type":"Disease","alternate_names":["COMBINED SAP DEFICIENCY","PROSAPOSIN DEFICIENCY"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"611721\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"139406\"}","{\"db\":\"OMIM\",\"id\":\"611721\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"COMBINED SAP DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"611721\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PROSAPOSIN DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"611721\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PSAPD\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"12505\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Combined+saposin+deficiency/8022\",\"ref_field\":\"name\"}"],"id":"4831","name":"Combined saposin deficiency"}
{"attribute_content":[],"alternate_symbols":["MC1DN4"],"keywords":[],"medgen_id":"C4748753","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032609\"}","{\"db\":\"OMIM\",\"id\":\"618225\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"161015.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4\"}","{\"db\":\"OMIM\",\"id\":\"161015.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4\"}","{\"db\":\"OMIM\",\"id\":\"161015.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4\"}","{\"db\":\"OMIM\",\"id\":\"161015.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4\"}","{\"db\":\"OMIM\",\"id\":\"618225\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4\"}","{\"db\":\"OMIM\",\"id\":\"618225\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN4\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032609\",\"ref_field\":\"name\"}"],"id":"40889","name":"Mitochondrial complex 1 deficiency, nuclear type 4"}
{"attribute_content":[],"alternate_symbols":["CDPD1"],"keywords":[],"gard_id":"1529","medgen_id":"C1857572","type":"Disease","symbol":"CDPD","alternate_names":["Congenital corneal dystrophy, progressive sensorineural deafness","Corneal dystrophy and perceptive deafness","Corneal dystrophy and sensorineural deafness","Harboyan syndrome"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009015\"}","{\"db\":\"OMIM\",\"id\":\"217400\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1490\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Corneal+Dystrophy+and+Perceptive+Deafness/1905\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Corneal dystrophy and perceptive deafness\"}","{\"db\":\"OMIM\",\"id\":\"217400\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CDPD1\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1529\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009015\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"217400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1559","name":"Corneal dystrophy-perceptive deafness syndrome"}
{"attribute_content":[],"alternate_symbols":["GEFS+10"],"keywords":[],"medgen_id":"CN260572","type":"Disease","symbol":"GEFSP10","alternate_names":["GEFS+, TYPE 10"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032777\"}","{\"db\":\"OMIM\",\"id\":\"618482\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618482\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GEFS+, TYPE 10\"}","{\"db\":\"OMIM\",\"id\":\"618482\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"GEFS+10\"}","{\"db\":\"OMIM\",\"id\":\"602780.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602780.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602780.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602780.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602780.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602780.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618482\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618482\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42150","name":"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10"}
{"attribute_content":[],"alternate_symbols":["CDGIu"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301507\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1332\",\"@Source\":\"BookShelf\"}]}}","gard_id":"12416","medgen_id":"C3554385","type":"Disease","symbol":"CDG1U","alternate_names":["CDG Iu"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615042\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"329178\"}","{\"db\":\"OMIM\",\"id\":\"615042\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CDG Iu\"}","{\"db\":\"OMIM\",\"id\":\"615042\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CDGIu\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"12416\",\"ref_field\":\"gard_id\"}","{\"db\":\"OMIM\",\"id\":\"615042\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17567","name":"Congenital disorder of glycosylation type 1u"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3810043","type":"Disease","symbol":"IMD15B","alternate_names":["IMMUNODEFICIENCY 15B"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615592\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"397787\"}","{\"db\":\"OMIM\",\"id\":\"603258.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 15B\"}","{\"db\":\"OMIM\",\"id\":\"603258.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 15B\"}","{\"db\":\"OMIM\",\"id\":\"615592\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 15B\"}","{\"db\":\"OMIM\",\"id\":\"615592\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18501","name":"Immunodeficiency 15"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0220722","type":"Disease","symbol":"COFS1","alternate_names":["Cerebro-oculo-facio-skeletal syndrome 1"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008955\"}","{\"db\":\"OMIM\",\"id\":\"214150\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"214150\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1348","name":"Cerebrooculofacioskeletal syndrome 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"6569","medgen_id":"C0018609","type":"Disease","symbol":"HND","alternate_names":["Hartnup disease","Hartnup disorder"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009324\"}","{\"db\":\"OMIM\",\"id\":\"234500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2116\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hartnup+Disease/3246\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hartnup disease\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009324\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hartnup disease\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6569\",\"ref_field\":\"gard_id\"}","{\"db\":\"SNOMED CT\",\"id\":\"80902009\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"234500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2259","name":"Neutral 1 amino acid transport defect"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258276","type":"Disease","symbol":"MRT69","alternate_names":["MENTAL RETARDATION, AUTOSOMAL RECESSIVE 69"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032715\"}","{\"db\":\"OMIM\",\"id\":\"618383\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618383\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 69\"}","{\"db\":\"OMIM\",\"id\":\"618181.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618181.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618383\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618383\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41573","name":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69"}
{"attribute_content":[],"alternate_symbols":["DECAM"],"keywords":[],"medgen_id":"CN260164","type":"Disease","symbol":"EIEE76","alternate_names":["DEVELOPMENTAL DELAY, EPILEPTIC ENCEPHALOPATHY, CEREBRAL ATROPHY, AND ABNORMAL MYELINATION"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032768\"}","{\"db\":\"OMIM\",\"id\":\"618468\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618468\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DEVELOPMENTAL DELAY, EPILEPTIC ENCEPHALOPATHY, CEREBRAL ATROPHY, AND ABNORMAL MYELINATION\"}","{\"db\":\"OMIM\",\"id\":\"618468\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"DECAM\"}","{\"db\":\"OMIM\",\"id\":\"612458.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612458.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612458.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612458.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612458.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612458.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612458.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612458.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618468\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618468\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42118","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 76"}
{"attribute_content":[],"alternate_symbols":["MRX102"],"keywords":[],"medgen_id":"C4085582","type":"Disease","symbol":"MRXSSB","alternate_names":["INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"300958\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"457260\"}","{\"db\":\"OMIM\",\"id\":\"300160.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300958\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300958\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRX102\"}","{\"db\":\"OMIM\",\"id\":\"300958\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"34131","name":"Mental retardation, X-linked 102"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C2748515","type":"Disease","symbol":"BCYM4","alternate_names":["BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES","SEMD, PAKISTANI TYPE","Spondyloepimetaphyseal dysplasia, PAPSS2 type"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0019666\"}","{\"db\":\"OMIM\",\"id\":\"612847\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"93282\"}","{\"db\":\"OMIM\",\"id\":\"603005.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"603005.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"603005.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"603005.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"603005.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"603005.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"603005.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"603005.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"612847\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"612847\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SEMD, PAKISTANI TYPE\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0019666\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Spondyloepimetaphyseal dysplasia, PAPSS2 type\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Spondyloepimetaphyseal+dysplasia%2C+pakistani+type/9350\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612847\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"6840","name":"Spondyloepimetaphyseal dysplasia, pakistani type"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3280113","type":"Disease","symbol":"NPHS5","alternate_names":["NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES","NEPHROTIC SYNDROME, TYPE 5, WITHOUT OCULAR ABNORMALITIES"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614199\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"306507\"}","{\"db\":\"OMIM\",\"id\":\"150325.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES\"}","{\"db\":\"OMIM\",\"id\":\"150325.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES\"}","{\"db\":\"OMIM\",\"id\":\"150325.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES\"}","{\"db\":\"OMIM\",\"id\":\"150325.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES\"}","{\"db\":\"OMIM\",\"id\":\"150325.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES\"}","{\"db\":\"OMIM\",\"id\":\"150325.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEPHROTIC SYNDROME, TYPE 5, WITHOUT OCULAR ABNORMALITIES\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Nephrotic+syndrome%2C+type+5%2C+with+or+without+ocular+abnormalities/8989\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614199\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"16538","name":"Nephrotic syndrome, type 5, with or without ocular abnormalities"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258336","type":"Disease","symbol":"MRT70","alternate_names":["MENTAL RETARDATION, AUTOSOMAL RECESSIVE 70"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032729\"}","{\"db\":\"OMIM\",\"id\":\"618402\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618402\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 70\"}","{\"db\":\"OMIM\",\"id\":\"613352.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613352.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618402\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618402\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41599","name":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3266076","type":"Disease","alternate_names":["Orofacial clefting"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0000358\"}","{\"db\":\"OMIM\",\"id\":\"PS119530\",\"type\":\"Phenotypic series\"}","{\"db\":\"CSER _CC_NCGL, University of Washington\",\"id\":\"UWMG_3343104\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Orofacial clefting\"}","{\"db\":\"OMIM\",\"id\":\"PS119530\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"],"id":"16696","name":"Orofacial cleft"}
{"attribute_content":[],"alternate_symbols":["NEDBSS"],"keywords":[],"medgen_id":"CN262319","type":"Disease","alternate_names":["NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032824\"}","{\"db\":\"OMIM\",\"id\":\"618590\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608528.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS\"}","{\"db\":\"OMIM\",\"id\":\"608528.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS\"}","{\"db\":\"OMIM\",\"id\":\"618590\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS\"}","{\"db\":\"OMIM\",\"id\":\"618590\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NEDBSS\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032824\",\"ref_field\":\"name\"}"],"id":"42928","name":"Glycosylphosphatidylinositol biosynthesis defect 21"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262194","type":"Disease","alternate_names":["HIGH DENSITY LIPOPROTEIN DEFICIENCY"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032766\"}","{\"db\":\"OMIM\",\"id\":\"618463\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618463\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIGH DENSITY LIPOPROTEIN DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"107680.0023\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618463\",\"type\":\"MIM\",\"ref_field\":\"name\"}"],"id":"42319","name":"HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263332","type":"Disease","symbol":"MRD62","alternate_names":["MENTAL RETARDATION, AUTOSOMAL DOMINANT 62"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032919\"}","{\"db\":\"OMIM\",\"id\":\"618793\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618793\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL DOMINANT 62\"}","{\"db\":\"OMIM\",\"id\":\"602887.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602887.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602887.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602887.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602887.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602887.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618793\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618793\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43719","name":"INTELLECTUAL DEVELOPMENTAL DISORDER 62"}
{"attribute_content":[],"alternate_symbols":["MC1DN5"],"keywords":[],"medgen_id":"C4748754","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032610\"}","{\"db\":\"OMIM\",\"id\":\"618226\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"157655.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5\"}","{\"db\":\"OMIM\",\"id\":\"157655.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5\"}","{\"db\":\"OMIM\",\"id\":\"157655.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5\"}","{\"db\":\"OMIM\",\"id\":\"157655.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5\"}","{\"db\":\"OMIM\",\"id\":\"157655.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5\"}","{\"db\":\"OMIM\",\"id\":\"157655.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5\"}","{\"db\":\"OMIM\",\"id\":\"157655.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5\"}","{\"db\":\"OMIM\",\"id\":\"157655.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5\"}","{\"db\":\"OMIM\",\"id\":\"618226\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5\"}","{\"db\":\"OMIM\",\"id\":\"618226\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN5\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032610\",\"ref_field\":\"name\"}"],"id":"40890","name":"Mitochondrial complex 1 deficiency, nuclear type 5"}
{"attribute_content":[],"alternate_symbols":["JAE1"],"keywords":[],"medgen_id":"C2750892","type":"Disease","symbol":"EJA1","alternate_names":["Epilepsy, Absence"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020772\"}","{\"db\":\"OMIM\",\"id\":\"607631\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1941\"}","{\"db\":\"OMIM\",\"id\":\"607631\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"JAE1\"}","{\"db\":\"OMIM\",\"id\":\"607631\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1610","name":"Epilepsy, juvenile absence, susceptibility to, 1"}
{"attribute_content":[],"alternate_symbols":["AI3C"],"keywords":[],"medgen_id":"CN258278","type":"Disease","alternate_names":["AMELOGENESIS IMPERFECTA, HYPOCALCIFICATION TYPE, AUTOSOMAL RECESSIVE","AMELOGENESIS IMPERFECTA, TYPE IIIC"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032717\"}","{\"db\":\"OMIM\",\"id\":\"618386\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618386\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AMELOGENESIS IMPERFECTA, HYPOCALCIFICATION TYPE, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"611211.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AMELOGENESIS IMPERFECTA, TYPE IIIC\"}","{\"db\":\"OMIM\",\"id\":\"611211.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AMELOGENESIS IMPERFECTA, TYPE IIIC\"}","{\"db\":\"OMIM\",\"id\":\"611211.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AMELOGENESIS IMPERFECTA, TYPE IIIC\"}","{\"db\":\"OMIM\",\"id\":\"618386\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AMELOGENESIS IMPERFECTA, TYPE IIIC\"}","{\"db\":\"OMIM\",\"id\":\"618386\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AI3C\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032717\",\"ref_field\":\"name\"}"],"id":"41577","name":"Amelogenesis imperfecta, type 3c"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"5258","medgen_id":"C1857276","type":"Disease","alternate_names":["Syndromic diarrhea","THE SYNDROME","Tricho-hepato-enteric syndrome"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009105\"}","{\"db\":\"OMIM\",\"id\":\"PS222470\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"84064\"}","{\"db\":\"Orphanet\",\"id\":\"84064\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Syndromic diarrhea\"}","{\"db\":\"OMIM\",\"id\":\"222470\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THE SYNDROME\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009105\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Tricho-hepato-enteric syndrome\"}","{\"db\":\"Orphanet\",\"id\":\"84064\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Tricho-hepato-enteric syndrome\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5258\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Tricho-hepato-enteric+syndrome/7191\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS222470\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"],"id":"36272","name":"Trichohepatoenteric syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"4835","medgen_id":"C0432197","type":"Disease","alternate_names":["SRPS, TYPE III","Short rib-polydactyly syndrome, Verma-Naumoff type"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0019664\"}","{\"db\":\"Orphanet\",\"id\":\"93271\"}","{\"db\":\"OMIM\",\"id\":\"263510\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SRPS, TYPE III\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0019664\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Short rib-polydactyly syndrome, Verma-Naumoff type\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4835\",\"ref_field\":\"gard_id\"}"],"id":"38405","name":"Short-rib polydactyly syndrome type III"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0011854","type":"Disease","symbol":"IDDM","alternate_names":["Insulin-dependent diabetes mellitus","Juvenile diabetes mellitus","Type I diabetes","Type I diabetes mellitus"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100651\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"222100\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"181371\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100651\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Insulin-dependent diabetes mellitus\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100651\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Juvenile diabetes mellitus\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100651\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Type I diabetes\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100651\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Type I diabetes mellitus\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Diabetes+mellitus+type+1/8214\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"46635009\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"222100\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1089","name":"Diabetes mellitus type 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"AAN/CNS, 2011\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"21956720\",\"@Source\":\"PubMed\"}}}","gard_id":"11963","medgen_id":"C1843367","type":"Finding","alternate_names":["Dull intelligence","Low intelligence","Mental deficiency","Mental retardation, nonspecific","Mental-retardation","Nonprogressive intellectual disability","Nonprogressive mental retardation","Poor school performance"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000730\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001249\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001267\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001286\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002122\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002192\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002316\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002382\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002386\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002402\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002458\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002482\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002499\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002543\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003767\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006833\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007154\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007176\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007180\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0001071\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001249\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Dull intelligence\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001249\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Low intelligence\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001249\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mental deficiency\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001249\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mental retardation, nonspecific\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001249\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mental-retardation\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001249\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Nonprogressive intellectual disability\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001249\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Nonprogressive mental retardation\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001249\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Poor school performance\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"11963\",\"ref_field\":\"gard_id\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001249\",\"ref_field\":\"name\"}"],"id":"22261","name":"Intellectual disability"}
{"attribute_content":[],"alternate_symbols":["MC1DN14"],"keywords":[],"medgen_id":"C4748777","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032619\"}","{\"db\":\"OMIM\",\"id\":\"618236\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"612638.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14\"}","{\"db\":\"OMIM\",\"id\":\"618236\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14\"}","{\"db\":\"OMIM\",\"id\":\"618236\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN14\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032619\",\"ref_field\":\"name\"}"],"id":"40892","name":"Mitochondrial complex 1 deficiency, nuclear type 14"}
{"attribute_content":[],"alternate_symbols":["HED"],"keywords":[],"medgen_id":"C0265331","type":"Disease","alternate_names":["Autosomal dominant hypohidrotic ectodermal dysplasia syndrome"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0015884\"}","{\"db\":\"Orphanet\",\"id\":\"1810\"}","{\"db\":\"NCBI for submitter\",\"id\":\"40541338\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Autosomal dominant hypohidrotic ectodermal dysplasia syndrome\"}","{\"db\":\"OMIM\",\"id\":\"129490\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HED\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hypohidrotic+ectodermal+dysplasia+autosomal+dominant/3655\",\"ref_field\":\"name\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0015884\",\"ref_field\":\"name\"}"],"id":"42473","name":"Autosomal dominant hypohidrotic ectodermal dysplasia"}
{"attribute_content":[],"alternate_symbols":["COFS"],"keywords":[],"gard_id":"6027","medgen_id":"CN239231","type":"Disease","alternate_names":["Cerebro-oculo-facio-skeletal syndrome","Cerebrooculofacioskeletal Syndrome","PENA-SHOKEIR SYNDROME, TYPE II"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008926\"}","{\"db\":\"OMIM\",\"id\":\"PS214150\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"1466\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cerebro-Oculo-Facio-Skeletal+Syndrome/1246\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cerebro-oculo-facio-skeletal syndrome\"}","{\"db\":\"SNOMED CT\",\"id\":\"41283003\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cerebro-oculo-facio-skeletal syndrome\"}","{\"db\":\"OMIM\",\"id\":\"214150\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PENA-SHOKEIR SYNDROME, TYPE II\"}","{\"db\":\"OMIM\",\"id\":\"214150\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"COFS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6027\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008926\",\"ref_field\":\"name\"}"],"id":"36428","name":"COFS syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262331","type":"Disease","symbol":"STAHP","alternate_names":["SOD1 DEFICIENCY, AUTOSOMAL RECESSIVE"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032828\"}","{\"db\":\"OMIM\",\"id\":\"618598\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618598\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SOD1 DEFICIENCY, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"147450.0036\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618598\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618598\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42942","name":"SPASTIC TETRAPLEGIA AND AXIAL HYPOTONIA, PROGRESSIVE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"4475","medgen_id":"C0342549","type":"Disease","alternate_names":["Familial Testotoxicosis (subtype)","Pubertas Praecox","TESTOTOXICOSIS, FAMILIAL","Testotoxicosis"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"176410\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3000\"}","{\"db\":\"OMIM\",\"id\":\"176410\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"TESTOTOXICOSIS, FAMILIAL\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4475\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Testotoxicosis/7032\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"237818003\",\"ref_field\":\"name\"}"],"id":"3529","name":"Gonadotropin-independent familial sexual precocity"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263060","type":"Disease","symbol":"NEDALVS","alternate_names":["ITO-RAYMOND SYNDROME"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032876\"}","{\"db\":\"OMIM\",\"id\":\"618707\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618707\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ITO-RAYMOND SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"605035.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605035.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605035.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618707\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618707\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43130","name":"NEURODEVELOPMENTAL DISORDER WITH ABSENT LANGUAGE AND VARIABLE SEIZURES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"29792621\",\"@Source\":\"PubMed\"},{\"$\":\"NBK500456\",\"@Source\":\"BookShelf\"}]}}","gard_id":"10663","medgen_id":"C2677132","type":"Disease","symbol":"MODY9","alternate_names":["Diabetes mellitus MODY type 9","MODY PAX4 related","MODY type 9"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012818\"}","{\"db\":\"OMIM\",\"id\":\"612225\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"552\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10663\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012818\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612225\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2871","name":"Maturity-onset diabetes of the young type 9"}
{"attribute_content":[],"alternate_symbols":["MC1DN27"],"keywords":[],"medgen_id":"C4748826","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032631\"}","{\"db\":\"OMIM\",\"id\":\"618248\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"611766.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27\"}","{\"db\":\"OMIM\",\"id\":\"611766.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27\"}","{\"db\":\"OMIM\",\"id\":\"618248\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27\"}","{\"db\":\"OMIM\",\"id\":\"618248\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN27\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032631\",\"ref_field\":\"name\"}"],"id":"40904","name":"Mitochondrial complex 1 deficiency, nuclear type 27"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748455","type":"Disease","symbol":"SEMDK","alternate_names":["IMMUNOOSSEOUS DYSPLASIA, KRAKOW TYPE"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032571\"}","{\"db\":\"OMIM\",\"id\":\"618162\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618162\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNOOSSEOUS DYSPLASIA, KRAKOW TYPE\"}","{\"db\":\"OMIM\",\"id\":\"618162\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618162\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40742","name":"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"1120","medgen_id":"C1829703","type":"Disease","alternate_names":["CPT1A deficiency","Carnitine palmitoyl transferase 1 deficiency","Hepatic CPT1","Hepatic carnitine palmitoyltransferase 1 deficiency","L-CPT 1 deficiency"],"xrefs":["{\"db\":\"Orphanet\",\"id\":\"156\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1120\",\"ref_field\":\"gard_id\"}"],"id":"8237","name":"Carnitine palmitoyltransferase 1A deficiency"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0025281","type":"Disease","alternate_names":["Meniere disease"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007972\"}","{\"db\":\"OMIM\",\"id\":\"156000\",\"type\":\"MIM\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007972\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Meniere disease\"}","{\"db\":\"SNOMED CT\",\"id\":\"13445001\",\"ref_field\":\"name\"}"],"id":"5474","name":"MÃ©niÃ¨re's disease"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258210","type":"Disease","symbol":"EIEE71","alternate_names":["GLUTAMINASE DEFICIENCY WITH NEONATAL EPILEPTIC ENCEPHALOPATHY"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032678\"}","{\"db\":\"OMIM\",\"id\":\"618328\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618328\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GLUTAMINASE DEFICIENCY WITH NEONATAL EPILEPTIC ENCEPHALOPATHY\"}","{\"db\":\"OMIM\",\"id\":\"138280.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"138280.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"138280.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618328\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618328\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41411","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258346","type":"Disease","symbol":"GDPAG","alternate_names":["GLUTAMINASE DEFICIENCY WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND PROGRESSIVE ATAXIA"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032733\"}","{\"db\":\"OMIM\",\"id\":\"618412\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618412\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GLUTAMINASE DEFICIENCY WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND PROGRESSIVE ATAXIA\"}","{\"db\":\"OMIM\",\"id\":\"138280.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"138280.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"138280.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618412\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618412\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41607","name":"GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262196","type":"Disease","symbol":"MYOTREM","alternate_names":["MYOGENIC TREMOR"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032797\"}","{\"db\":\"OMIM\",\"id\":\"618524\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618524\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYOGENIC TREMOR\"}","{\"db\":\"OMIM\",\"id\":\"160794.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"160794.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"160794.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"160794.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618524\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618524\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42439","name":"MYOPATHY, CONGENITAL, WITH TREMOR"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3554225","type":"Disease","symbol":"LEPRD","alternate_names":["OBESITY, MORBID"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614963\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"179494\"}","{\"db\":\"OMIM\",\"id\":\"614963\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OBESITY, MORBID\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Leptin+receptor+deficiency/8736\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614963\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"16778","name":"Leptin receptor deficiency"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301772\",\"@Source\":\"PubMed\"},{\"$\":\"NBK9587\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C4551474","type":"Disease","symbol":"SCKL1","alternate_names":["MICROCEPHALIC PRIMORDIAL DWARFISM I"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008869\"}","{\"db\":\"OMIM\",\"id\":\"210600\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"808\"}","{\"db\":\"OMIM\",\"id\":\"210600\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MICROCEPHALIC PRIMORDIAL DWARFISM I\"}","{\"db\":\"OMIM\",\"id\":\"210600\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4382","name":"Seckel syndrome 1"}
{"attribute_content":[],"alternate_symbols":["MSA1"],"keywords":[],"medgen_id":"C3714927","type":"Disease","symbol":"MSA","alternate_names":["MSA1, SUSCEPTIBILITY TO","Multiple system atrophy (MSA) with orthostatic hypotension","Multiple system atrophy with autonomic failure","Orthostatic hypotension, bladder and bowel incontinence, anhidrosis, iris atrophy, amyotrophy, ataxia, rigidity and tremor","Shy-Drager syndrome"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"146500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"102\"}","{\"db\":\"OMIM\",\"id\":\"146500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MSA1, SUSCEPTIBILITY TO\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Shy-Drager+syndrome/6584\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Shy-Drager syndrome\"}","{\"db\":\"SNOMED CT\",\"id\":\"16576004\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Shy-Drager syndrome\"}","{\"db\":\"OMIM\",\"id\":\"146500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MSA1\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007803\",\"ref_field\":\"name\"}"],"id":"3052","name":"Multiple system atrophy"}
{"attribute_content":[],"alternate_symbols":["MC3DN10"],"keywords":[],"medgen_id":"CN263279","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032909\"}","{\"db\":\"OMIM\",\"id\":\"618775\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"191327.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10\"}","{\"db\":\"OMIM\",\"id\":\"191327.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10\"}","{\"db\":\"OMIM\",\"id\":\"191327.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10\"}","{\"db\":\"OMIM\",\"id\":\"618775\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10\"}","{\"db\":\"OMIM\",\"id\":\"618775\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC3DN10\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032909\",\"ref_field\":\"name\"}"],"id":"43637","name":"Mitochondrial complex 3 deficiency, nuclear type 10"}
{"attribute_content":[],"alternate_symbols":["MC1DN9"],"keywords":[],"medgen_id":"C4748767","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032615\"}","{\"db\":\"OMIM\",\"id\":\"618232\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603848.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9\"}","{\"db\":\"OMIM\",\"id\":\"603848.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9\"}","{\"db\":\"OMIM\",\"id\":\"603848.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9\"}","{\"db\":\"OMIM\",\"id\":\"618232\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9\"}","{\"db\":\"OMIM\",\"id\":\"618232\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN9\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032615\",\"ref_field\":\"name\"}"],"id":"40883","name":"Mitochondrial complex 1 deficiency, nuclear type 9"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"9711","medgen_id":"C1846421","type":"Disease","symbol":"LATHOS","alternate_names":["SC5D deficiency","Sterol c5-desaturase deficiency"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011816\"}","{\"db\":\"OMIM\",\"id\":\"607330\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"46059\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9711\",\"ref_field\":\"gard_id\"}","{\"db\":\"GeneTests\",\"id\":\"317090\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Lathosterolosis/4115\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607330\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2667","name":"Lathosterolosis"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1851936","type":"Finding","alternate_names":["Choreoathetosis, episodic","Choreoathetosis, intermittent"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002351\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007098\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007098\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Choreoathetosis, episodic\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007098\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Choreoathetosis, intermittent\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007098\",\"ref_field\":\"name\"}"],"id":"25997","name":"Paroxysmal choreoathetosis"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4310675","type":"Disease","symbol":"PEBEL1","alternate_names":["NAD(P)HX epimerase deficiency"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020781\"}","{\"db\":\"OMIM\",\"id\":\"617186\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"555407\"}","{\"db\":\"Orphanet\",\"id\":\"555407\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAD(P)HX epimerase deficiency\"}","{\"db\":\"OMIM\",\"id\":\"617186\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"36315","name":"Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263231","type":"Disease","symbol":"MRD61","alternate_names":["MENTAL RETARDATION, AUTOSOMAL DOMINANT 61"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032485\"}","{\"db\":\"OMIM\",\"id\":\"618009\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618009\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL DOMINANT 61\"}","{\"db\":\"OMIM\",\"id\":\"603808.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603808.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603808.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603808.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603808.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618009\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618009\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43466","name":"INTELLECTUAL DEVELOPMENTAL DISORDER 61"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263209","type":"Disease","symbol":"EIEE83","alternate_names":["BARAKAT-PERENTHALER SYNDROME"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032895\"}","{\"db\":\"OMIM\",\"id\":\"618744\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618744\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BARAKAT-PERENTHALER SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"191760.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618744\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618744\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43443","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 83"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0025500","type":"Disease","alternate_names":["Mesothelioma, somatic"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0005065\"}","{\"db\":\"Orphanet\",\"id\":\"50251\"}"],"id":"10230","name":"Mesothelioma"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"29792621\",\"@Source\":\"PubMed\"},{\"$\":\"NBK500456\",\"@Source\":\"BookShelf\"}]}}","gard_id":"10661","medgen_id":"C1864839","type":"Disease","symbol":"MODY7","alternate_names":["Diabetes mellitus MODY type 7","MODY KLF11 related","MODY type 7"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012513\"}","{\"db\":\"OMIM\",\"id\":\"610508\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"552\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10661\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012513\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610508\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2869","name":"Maturity-onset diabetes of the young type 7"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"29792621\",\"@Source\":\"PubMed\"},{\"$\":\"NBK500456\",\"@Source\":\"BookShelf\"}]}}","gard_id":"10660","medgen_id":"C1853371","type":"Disease","symbol":"MODY6","alternate_names":["Diabetes mellitus MODY type 6","MODY NEUROD1 related","MODY type 6"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011668\"}","{\"db\":\"OMIM\",\"id\":\"606394\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"552\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10660\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011668\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606394\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2868","name":"Maturity-onset diabetes of the young type 6"}
{"attribute_content":[],"alternate_symbols":["PAX3"],"keywords":[],"gard_id":"1571","medgen_id":"C1852510","type":"Disease","symbol":"CDHS","alternate_names":["Features of flat facial profile, hypertelorism, hypoplastic nose with slitlike nares, and a sensorineural hearing loss"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007395\"}","{\"db\":\"OMIM\",\"id\":\"122880\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1529\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1571\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007395\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"122880\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4869","name":"Craniofacial-deafness-hand syndrome"}
{"attribute_content":[],"alternate_symbols":["MC1DN17"],"keywords":[],"medgen_id":"C4748786","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032622\"}","{\"db\":\"OMIM\",\"id\":\"618239\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"612392.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17\"}","{\"db\":\"OMIM\",\"id\":\"612392.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17\"}","{\"db\":\"OMIM\",\"id\":\"612392.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17\"}","{\"db\":\"OMIM\",\"id\":\"612392.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17\"}","{\"db\":\"OMIM\",\"id\":\"612392.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17\"}","{\"db\":\"OMIM\",\"id\":\"612392.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17\"}","{\"db\":\"OMIM\",\"id\":\"612392.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17\"}","{\"db\":\"OMIM\",\"id\":\"618239\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17\"}","{\"db\":\"OMIM\",\"id\":\"618239\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN17\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032622\",\"ref_field\":\"name\"}"],"id":"40895","name":"Mitochondrial complex 1 deficiency, nuclear type 17"}
{"attribute_content":[],"alternate_symbols":["ADH"],"keywords":[],"medgen_id":"C1832648","type":"Disease","symbol":"FIH1","alternate_names":["HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 1"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"146200\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2238\"}","{\"db\":\"OMIM\",\"id\":\"146200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 1\"}","{\"db\":\"OMIM\",\"id\":\"168450.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 1\"}","{\"db\":\"OMIM\",\"id\":\"168450.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 1\"}","{\"db\":\"Orphanet\",\"id\":\"2238\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"146200\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2273","name":"Familial isolated hypoparathyroidism"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301628\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1455\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3111019\",\"@Source\":\"pmc\"}}]}","gard_id":"7380","medgen_id":"C0220658","type":"Disease","symbol":"ACS5","alternate_names":["ACS V","Acrocephalosyndactyly, type 5","Pfeiffer type acrocephalosyndactyly"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007043\"}","{\"db\":\"OMIM\",\"id\":\"101600\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"710\"}","{\"db\":\"OMIM\",\"id\":\"101600\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACS V\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7380\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pfeiffer+syndrome/5702\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"pfeiffer-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"101600\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3791","name":"Pfeiffer syndrome"}
{"attribute_content":[],"alternate_symbols":["MC1DN7"],"keywords":[],"medgen_id":"C4748760","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032612\"}","{\"db\":\"OMIM\",\"id\":\"618229\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600532.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7\"}","{\"db\":\"OMIM\",\"id\":\"600532.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7\"}","{\"db\":\"OMIM\",\"id\":\"618229\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7\"}","{\"db\":\"OMIM\",\"id\":\"618229\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN7\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032612\",\"ref_field\":\"name\"}"],"id":"40881","name":"Mitochondrial complex 1 deficiency, nuclear type 7"}
{"attribute_content":[],"alternate_symbols":["SDSL"],"keywords":[],"medgen_id":"CN263232","type":"Disease","symbol":"SCN8","alternate_names":["NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT, WITH OR WITHOUT PANCREATIC DYSFUNCTION AND/OR NEUROLOGIC ABNORMALITIES","SHWACHMAN-DIAMOND SYNDROME-LIKE"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032899\"}","{\"db\":\"OMIM\",\"id\":\"618752\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618752\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT, WITH OR WITHOUT PANCREATIC DYSFUNCTION AND/OR NEUROLOGIC ABNORMALITIES\"}","{\"db\":\"OMIM\",\"id\":\"618752\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHWACHMAN-DIAMOND SYNDROME-LIKE\"}","{\"db\":\"OMIM\",\"id\":\"618752\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SDSL\"}","{\"db\":\"OMIM\",\"id\":\"604857.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604857.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604857.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604857.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604857.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604857.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618752\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618752\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43467","name":"NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263464","type":"Disease","symbol":"MRD63","alternate_names":["MENTAL RETARDATION, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032939\"}","{\"db\":\"OMIM\",\"id\":\"618825\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618825\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY\"}","{\"db\":\"OMIM\",\"id\":\"601893.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601893.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601893.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601893.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618825\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618825\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43804","name":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY"}
{"attribute_content":[],"alternate_symbols":[],"keywords":["Hereditary cancer syndrome"],"gard_id":"7026","medgen_id":"C0345967","type":"Disease","symbol":"MESOM","alternate_names":["Malignant mesothelioma (disease)"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100001\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0006292\"}","{\"db\":\"OMIM\",\"id\":\"156240\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"50251\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0006292\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Malignant mesothelioma (disease)\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7026\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mesothelioma%2C+malignant/8859\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"62064005\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"156240\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2924","name":"Mesothelioma, malignant"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"10320","medgen_id":"C1837974","type":"Disease","symbol":"CDL3A","alternate_names":["Lattice corneal dystrophy type III A"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012044\"}","{\"db\":\"OMIM\",\"id\":\"608471\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"98964\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10320\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012044\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608471\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"842","name":"Corneal dystrophy, lattice type 3A"}
{"attribute_content":[],"alternate_symbols":["CPP3","CTPP3"],"keywords":[],"gard_id":"10227","medgen_id":"C1854311","type":"Disease","symbol":"CTRCT31","alternate_names":["CATARACT 31, POSTERIOR POLAR","Cataract, posterior polar, 3"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011547\"}","{\"db\":\"OMIM\",\"id\":\"605387\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"91492\"}","{\"db\":\"OMIM\",\"id\":\"610897.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 31, POSTERIOR POLAR\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cataract%2C+Posterior+Polar%2C+3/1158\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cataract, posterior polar, 3\"}","{\"db\":\"OMIM\",\"id\":\"605387\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CPP3\"}","{\"db\":\"OMIM\",\"id\":\"605387\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CTPP3\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10227\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011547\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605387\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"742","name":"Cataract 31 multiple types"}
{"attribute_content":[],"alternate_symbols":["MC1DN28"],"keywords":[],"medgen_id":"C4748827","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032632\"}","{\"db\":\"OMIM\",\"id\":\"618249\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618249\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28\"}","{\"db\":\"OMIM\",\"id\":\"618249\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN28\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032632\",\"ref_field\":\"name\"}"],"id":"40905","name":"Mitochondrial complex 1 deficiency, nuclear type 28"}
{"attribute_content":[],"alternate_symbols":["GPIBD19"],"keywords":[],"medgen_id":"CN262219","type":"Disease","symbol":"EIEE77","alternate_names":["GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 19"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032808\"}","{\"db\":\"OMIM\",\"id\":\"618548\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618548\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 19\"}","{\"db\":\"OMIM\",\"id\":\"618548\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"GPIBD19\"}","{\"db\":\"OMIM\",\"id\":\"605754.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605754.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605754.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605754.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618548\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618548\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42467","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 77"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3805410","type":"Disease","symbol":"CTRCT20","alternate_names":["Membranous cataract"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010922\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007284\"}","{\"db\":\"OMIM\",\"id\":\"116100\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"91492\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010922\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Membranous cataract\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007284\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"116100\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4751","name":"Cataract 20 multiple types"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"4612","medgen_id":"C0265294","type":"Disease","symbol":"PYL","alternate_names":["Metaphyseal dysplasia","Pyle disease","Pyle's disease"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000948\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005002\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005636\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005704\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006427\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100255\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009943\"}","{\"db\":\"OMIM\",\"id\":\"265900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3005\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100255\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Metaphyseal dysplasia\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009943\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Pyle disease\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4612\",\"ref_field\":\"gard_id\"}","{\"db\":\"SNOMED CT\",\"id\":\"27837003\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"265900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3585","name":"Pyle metaphyseal dysplasia"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0021847","type":"Disease","symbol":"CSBS","alternate_names":["Congenital short bowel syndrome","Hollow visceral myopathy","Intestinal pseudoobstruction"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004389\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"615237\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2301\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004389\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Intestinal pseudoobstruction\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004389\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615237\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17848","name":"Intestinal pseudo-obstruction"}
{"attribute_content":[],"alternate_symbols":["ABCB6"],"keywords":[],"medgen_id":"C1836705","type":"Disease","symbol":"PSHK2","alternate_names":["CRYOHYDROCYTOSIS, MILD","PSEUDOHYPERKALEMIA EAST LONDON","PSEUDOHYPERKALEMIA LILLE","Pseudohyperkalemia Chiswick","Pseudohyperkalemia Falkirk"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"609153\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"90044\"}","{\"db\":\"OMIM\",\"id\":\"609153\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CRYOHYDROCYTOSIS, MILD\"}","{\"db\":\"OMIM\",\"id\":\"609153\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PSEUDOHYPERKALEMIA EAST LONDON\"}","{\"db\":\"OMIM\",\"id\":\"609153\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PSEUDOHYPERKALEMIA LILLE\"}","{\"db\":\"OMIM\",\"id\":\"609153\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4055","name":"Pseudohyperkalemia, familial, 2, due to red cell leak"}
{"attribute_content":[],"alternate_symbols":["GOUT5","UAQTL7"],"keywords":[],"medgen_id":"C1855552","type":"Disease","symbol":"DLACD","alternate_names":["D-LACTIC ACIDURIA WITH GOUT","GOUT, SUSCEPTIBILITY TO, 5","URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 7"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009505\"}","{\"db\":\"OMIM\",\"id\":\"245450\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"245450\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"D-LACTIC ACIDURIA WITH GOUT\"}","{\"db\":\"OMIM\",\"id\":\"245450\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GOUT, SUSCEPTIBILITY TO, 5\"}","{\"db\":\"OMIM\",\"id\":\"245450\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 7\"}","{\"db\":\"OMIM\",\"id\":\"245450\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"GOUT5\"}","{\"db\":\"OMIM\",\"id\":\"245450\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"UAQTL7\"}","{\"db\":\"OMIM\",\"id\":\"245450\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2451","name":"Lactic aciduria due to d-lactic acid"}
{"attribute_content":[],"alternate_symbols":["PCD"],"keywords":[],"disease_mechanism_id":"273","medgen_id":"C2674321","type":"Disease","symbol":"THPH3","alternate_names":["PROC DEFICIENCY, AUTOSOMAL DOMINANT","PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT","THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008316\"}","{\"db\":\"OMIM\",\"id\":\"176860\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"745\"}","{\"db\":\"OMIM\",\"id\":\"176860\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PROC DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"176860\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"176860\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"612283.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"612283.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"612283.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"612283.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"612283.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"612283.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"612283.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"612283.0017\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"612283.0018\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"612283.0019\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"612283.0022\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"612283.0023\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"612283.0024\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"612283.0025\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000503185\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PCD\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000202257\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000320550\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000503185\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512308\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515785\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521658\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000523364\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000576178\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Thrombophilia%2C+hereditary%2C+due+to+protein+c+deficiency%2C+autosomal+dominant/9396\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"176860\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"6050","disease_mechanism":"loss of function","name":"Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant"}
{"attribute_content":[],"alternate_symbols":["CHDTHP"],"keywords":[],"medgen_id":"C1857587","type":"Disease","alternate_names":["Orstavik Lindemann Solberg syndrome"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"217085\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1338\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Orstavik+Lindemann+Solberg+syndrome/5435\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Orstavik Lindemann Solberg syndrome\"}","{\"db\":\"OMIM\",\"id\":\"217085\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CHDTHP\"}"],"id":"838","name":"Congenital heart defects, hamartomas of tongue, and polysyndactyly"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263051","type":"Disease","symbol":"CILD42","alternate_names":["CILIARY DYSKINESIA, PRIMARY, 42, WITHOUT SITUS INVERSUS"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032872\"}","{\"db\":\"OMIM\",\"id\":\"618695\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618695\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CILIARY DYSKINESIA, PRIMARY, 42, WITHOUT SITUS INVERSUS\"}","{\"db\":\"OMIM\",\"id\":\"614086.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614086.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614086.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614086.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618695\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618695\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43127","name":"CILIARY DYSKINESIA, PRIMARY, 42"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1864843","type":"Disease","symbol":"COXPD2","alternate_names":["CORPUS CALLOSUM, AGENESIS OF, WITH DYSMORPHISM AND FATAL LACTIC ACIDOSIS"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"610498\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"254920\"}","{\"db\":\"OMIM\",\"id\":\"610498\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CORPUS CALLOSUM, AGENESIS OF, WITH DYSMORPHISM AND FATAL LACTIC ACIDOSIS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Combined+oxidative+phosphorylation+deficiency+2/8014\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610498\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1538","name":"Combined oxidative phosphorylation deficiency 2"}
{"attribute_content":[],"alternate_symbols":["MC1DN25"],"keywords":[],"medgen_id":"C4748806","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032629\"}","{\"db\":\"OMIM\",\"id\":\"618246\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603839.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25\"}","{\"db\":\"OMIM\",\"id\":\"603839.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25\"}","{\"db\":\"OMIM\",\"id\":\"618246\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25\"}","{\"db\":\"OMIM\",\"id\":\"618246\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN25\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032629\",\"ref_field\":\"name\"}"],"id":"40902","name":"Mitochondrial complex 1 deficiency, nuclear type 25"}
{"attribute_content":[],"alternate_symbols":["MC1DN11"],"keywords":[],"medgen_id":"C4748769","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032617\"}","{\"db\":\"OMIM\",\"id\":\"618234\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606934.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11\"}","{\"db\":\"OMIM\",\"id\":\"606934.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11\"}","{\"db\":\"OMIM\",\"id\":\"606934.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11\"}","{\"db\":\"OMIM\",\"id\":\"606934.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11\"}","{\"db\":\"OMIM\",\"id\":\"618234\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11\"}","{\"db\":\"OMIM\",\"id\":\"618234\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN11\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032617\",\"ref_field\":\"name\"}"],"id":"40885","name":"Mitochondrial complex 1 deficiency, nuclear type 11"}
{"attribute_content":[],"alternate_symbols":["MC1DN29"],"keywords":[],"medgen_id":"C4748830","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032633\"}","{\"db\":\"OMIM\",\"id\":\"618250\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"615533.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29\"}","{\"db\":\"OMIM\",\"id\":\"615533.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29\"}","{\"db\":\"OMIM\",\"id\":\"615533.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29\"}","{\"db\":\"OMIM\",\"id\":\"615533.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29\"}","{\"db\":\"OMIM\",\"id\":\"618250\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29\"}","{\"db\":\"OMIM\",\"id\":\"618250\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN29\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032633\",\"ref_field\":\"name\"}"],"id":"40906","name":"Mitochondrial complex 1 deficiency, nuclear type 29"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0795940","type":"Disease","symbol":"FLPIS","alternate_names":["Craniodigital syndrome with mental retardation","Craniodigital syndrome-mental retardation, Scott type","Scott Bryant Graham syndrome","Scott craniodigital syndrome with mental retardation","Syndactyly type I with microcephaly and mental retardation","Unusual facial appearance, microcephaly, growth and mental retardation and syndactyly"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"272440\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3255\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Scott+Bryant+Graham+syndrome/6469\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Scott Bryant Graham syndrome\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Filippi+Syndrome/2864\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"272440\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4481","name":"Filippi syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263278","type":"Disease","symbol":"CEBALID","alternate_names":["CRANIOFACIAL DEFECTS, DYSMORPHIC EARS, STRUCTURAL BRAIN ABNORMALITIES, EXPRESSIVE LANGUAGE DELAY, AND IMPAIRED INTELLECTUAL DEVELOPMENT"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032908\"}","{\"db\":\"OMIM\",\"id\":\"618774\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618774\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CRANIOFACIAL DEFECTS, DYSMORPHIC EARS, STRUCTURAL BRAIN ABNORMALITIES, EXPRESSIVE LANGUAGE DELAY, AND IMPAIRED INTELLECTUAL DEVELOPMENT\"}","{\"db\":\"OMIM\",\"id\":\"156100.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"156100.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"156100.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"156100.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"156100.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"156100.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"156100.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618774\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618774\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43636","name":"CEBALID SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260596","type":"Disease","symbol":"HIDEA","alternate_names":["HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032780\"}","{\"db\":\"OMIM\",\"id\":\"618493\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"614584.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES\"}","{\"db\":\"OMIM\",\"id\":\"614584.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES\"}","{\"db\":\"OMIM\",\"id\":\"614584.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES\"}","{\"db\":\"OMIM\",\"id\":\"614584.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES\"}","{\"db\":\"OMIM\",\"id\":\"614584.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES\"}","{\"db\":\"OMIM\",\"id\":\"618493\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618493\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42211","name":"HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES"}
{"attribute_content":[],"alternate_symbols":["MC1DN15"],"keywords":[],"medgen_id":"C4748778","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032620\"}","{\"db\":\"OMIM\",\"id\":\"618237\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"611776.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15\"}","{\"db\":\"OMIM\",\"id\":\"618237\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15\"}","{\"db\":\"OMIM\",\"id\":\"618237\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN15\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032620\",\"ref_field\":\"name\"}"],"id":"40893","name":"Mitochondrial complex 1 deficiency, nuclear type 15"}
{"attribute_content":[],"alternate_symbols":["MC1DN19"],"keywords":[],"medgen_id":"C4748791","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032624\"}","{\"db\":\"OMIM\",\"id\":\"618241\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"613622.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19\"}","{\"db\":\"OMIM\",\"id\":\"613622.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19\"}","{\"db\":\"OMIM\",\"id\":\"613622.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19\"}","{\"db\":\"OMIM\",\"id\":\"618241\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19\"}","{\"db\":\"OMIM\",\"id\":\"618241\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN19\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032624\",\"ref_field\":\"name\"}"],"id":"40897","name":"Mitochondrial complex 1 deficiency, nuclear type 19"}
{"attribute_content":[],"alternate_symbols":["MC1DN6"],"keywords":[],"medgen_id":"C4748759","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032611\"}","{\"db\":\"OMIM\",\"id\":\"618228\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602985.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6\"}","{\"db\":\"OMIM\",\"id\":\"602985.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6\"}","{\"db\":\"OMIM\",\"id\":\"602985.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6\"}","{\"db\":\"OMIM\",\"id\":\"618228\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6\"}","{\"db\":\"OMIM\",\"id\":\"618228\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN6\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032611\",\"ref_field\":\"name\"}"],"id":"40891","name":"Mitochondrial complex 1 deficiency, nuclear type 6"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258309","type":"Disease","symbol":"CMT2EE","alternate_names":["CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2EE"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032728\"}","{\"db\":\"OMIM\",\"id\":\"618400\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2EE\"}","{\"db\":\"OMIM\",\"id\":\"137960.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137960.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137960.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618400\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41598","name":"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"2906","medgen_id":"C0151723","type":"Finding","alternate_names":["Low blood magnesium levels"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002917\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003284\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS602014\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"34526\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002917\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Low blood magnesium levels\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2906\",\"ref_field\":\"gard_id\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002917\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS602014\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"],"id":"23417","name":"Hypomagnesemia"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"1195","medgen_id":"C1859301","type":"Disease","alternate_names":["Endosteal sclerosis-cerebellar hypoplasia syndrome"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008940\"}","{\"db\":\"OMIM\",\"id\":\"213002\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"85186\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008940\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Endosteal sclerosis-cerebellar hypoplasia syndrome\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1195\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cerebellar+Hypoplasia+with+Endosteal+Sclerosis/1213\",\"ref_field\":\"name\"}"],"id":"4766","name":"Cerebellar hypoplasia with endosteal sclerosis"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C2242577","type":"Finding","alternate_names":["Cranial dystonia"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001494\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012048\",\"type\":\"primary\"}","{\"db\":\"Orphanet\",\"id\":\"93958\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012048\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cranial dystonia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012048\",\"ref_field\":\"name\"}"],"id":"29934","name":"Oromandibular dystonia"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263250","type":"Disease","symbol":"AMCNACC","alternate_names":["ZAIN SYNDROME"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032903\"}","{\"db\":\"OMIM\",\"id\":\"618766\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618766\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ZAIN SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"616365.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616365.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618766\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618766\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43487","name":"ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH AGENESIS OF THE CORPUS CALLOSUM"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"3066","medgen_id":"C1832162","type":"Disease","symbol":"HJMD","alternate_names":["HYPOTRICHOSIS WITH CONE-ROD DYSTROPHY","Juvenile macular degeneration and hypotrichosis","Juvenile macular dystrophy and congenital hypotrichosis"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011107\"}","{\"db\":\"OMIM\",\"id\":\"601553\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1573\"}","{\"db\":\"OMIM\",\"id\":\"601553\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTRICHOSIS WITH CONE-ROD DYSTROPHY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Juvenile+macular+degeneration+and+hypotrichosis/3933\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Juvenile macular degeneration and hypotrichosis\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3066\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011107\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601553\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2396","name":"Congenital hypotrichosis with juvenile macular dystrophy"}
{"attribute_content":[],"alternate_symbols":["MGA1"],"keywords":[],"gard_id":"7006","medgen_id":"C4551825","type":"Disease","alternate_names":["Enterocyte cobalamin malabsorption","Enterocyte intrinsic factor receptor, defect of","Imerslund-Grasbeck syndrome","MEGALOBLASTIC ANEMIA, FINNISH TYPE","Pernicious anemia, juvenile, due to selective intestinal malabsorption of vitamin b12, with proteinuria"],"xrefs":["{\"db\":\"Orphanet\",\"id\":\"35858\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009853\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Imerslund-Grasbeck syndrome\"}","{\"db\":\"OMIM\",\"id\":\"261100\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MEGALOBLASTIC ANEMIA, FINNISH TYPE\"}","{\"db\":\"OMIM\",\"id\":\"250950\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MGA1\"}","{\"db\":\"OMIM\",\"id\":\"261100\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MGA1\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7006\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Megaloblastic+anemia+due+to+inborn+errors+of+metabolism/8803\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"34925000\",\"ref_field\":\"name\"}"],"id":"2837","name":"Megaloblastic anemia due to inborn errors of metabolism"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262875","type":"Disease","symbol":"MRT72","alternate_names":["MENTAL RETARDATION, AUTOSOMAL RECESSIVE 72"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032860\"}","{\"db\":\"OMIM\",\"id\":\"618665\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618665\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 72\"}","{\"db\":\"OMIM\",\"id\":\"618628.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618628.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618665\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618665\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43094","name":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 72"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3151753","type":"Disease","symbol":"COXPD6","alternate_names":["ENCEPHALOMYOPATHY, MITOCHONDRIAL, X-LINKED"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"300816\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"238329\"}","{\"db\":\"OMIM\",\"id\":\"300816\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ENCEPHALOMYOPATHY, MITOCHONDRIAL, X-LINKED\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Combined+oxidative+phosphorylation+deficiency+6/8018\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300816\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"6671","name":"Combined oxidative phosphorylation deficiency 6"}
{"attribute_content":[],"alternate_symbols":["MC1DN34"],"keywords":[],"medgen_id":"CN263285","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032910\"}","{\"db\":\"OMIM\",\"id\":\"618776\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618461.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34\"}","{\"db\":\"OMIM\",\"id\":\"618461.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34\"}","{\"db\":\"OMIM\",\"id\":\"618461.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34\"}","{\"db\":\"OMIM\",\"id\":\"618461.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34\"}","{\"db\":\"OMIM\",\"id\":\"618776\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34\"}","{\"db\":\"OMIM\",\"id\":\"618776\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN34\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032910\",\"ref_field\":\"name\"}"],"id":"43645","name":"Mitochondrial complex 1 deficiency, nuclear type 34"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4020893","type":"Finding","alternate_names":["Cheiloschisis of upper lip","Cleft of upper lip","Harelip"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000204\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0016043\"}","{\"db\":\"Orphanet\",\"id\":\"199302\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000204\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cheiloschisis of upper lip\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000204\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cleft of upper lip\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000204\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Harelip\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000204\",\"ref_field\":\"name\"}"],"id":"17048","name":"Cleft upper lip"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4749019","type":"Disease","symbol":"MRT67","alternate_names":["MENTAL RETARDATION, AUTOSOMAL RECESSIVE 67"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032662\"}","{\"db\":\"OMIM\",\"id\":\"618295\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618295\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 67\"}","{\"db\":\"OMIM\",\"id\":\"603914.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618295\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618295\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41321","name":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1833053","type":"Disease","alternate_names":["OBESITY AND ENDOCRINOPATHY DUE TO IMPAIRED PROCESSING OF PROHORMONES"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"600955\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"71528\"}","{\"db\":\"OMIM\",\"id\":\"600955\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OBESITY AND ENDOCRINOPATHY DUE TO IMPAIRED PROCESSING OF PROHORMONES\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Proprotein+convertase+1-3+deficiency/9174\",\"ref_field\":\"name\"}"],"id":"3538","name":"Proprotein convertase 1/3 deficiency"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1867968","type":"Disease","alternate_names":["PCT, ''SPORADIC'' TYPE","PCT, TYPE I"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"176090\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"101330\"}","{\"db\":\"Orphanet\",\"id\":\"443057\"}","{\"db\":\"OMIM\",\"id\":\"176090\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PCT, ''SPORADIC'' TYPE\"}","{\"db\":\"OMIM\",\"id\":\"176090\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PCT, TYPE I\"}"],"id":"4010","name":"Porphyria cutanea tarda, type I"}
{"attribute_content":[],"alternate_symbols":["MC1DN32"],"keywords":[],"medgen_id":"C4748839","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032635\"}","{\"db\":\"OMIM\",\"id\":\"618252\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602140.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32\"}","{\"db\":\"OMIM\",\"id\":\"602140.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32\"}","{\"db\":\"OMIM\",\"id\":\"602140.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32\"}","{\"db\":\"OMIM\",\"id\":\"602140.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32\"}","{\"db\":\"OMIM\",\"id\":\"618252\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32\"}","{\"db\":\"OMIM\",\"id\":\"618252\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN32\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032635\",\"ref_field\":\"name\"}"],"id":"40908","name":"Mitochondrial complex 1 deficiency, nuclear type 32"}
{"attribute_content":[],"alternate_symbols":["CILD31"],"keywords":[],"medgen_id":"C1855705","type":"Disease","symbol":"STROMS","alternate_names":["APPLE PEEL SYNDROME WITH MICROCEPHALY AND OCULAR ANOMALIES","Ciliary dyskinesia, primary, 31"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009477\"}","{\"db\":\"OMIM\",\"id\":\"243605\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"444069\"}","{\"db\":\"Orphanet\",\"id\":\"506307\"}","{\"db\":\"OMIM\",\"id\":\"243605\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"APPLE PEEL SYNDROME WITH MICROCEPHALY AND OCULAR ANOMALIES\"}","{\"db\":\"OMIM\",\"id\":\"243605\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CILD31\"}","{\"db\":\"OMIM\",\"id\":\"243605\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5348","name":"Stromme syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262231","type":"Disease","symbol":"PADMAL","alternate_names":["DEMENTIA, HEREDITARY MULTI-INFARCT, SWEDISH TYPE"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032814\"}","{\"db\":\"OMIM\",\"id\":\"618564\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618564\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DEMENTIA, HEREDITARY MULTI-INFARCT, SWEDISH TYPE\"}","{\"db\":\"OMIM\",\"id\":\"120130.0025\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"120130.0026\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"120130.0027\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"120130.0028\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618564\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618564\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42899","name":"MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT"}
{"attribute_content":[],"alternate_symbols":["MC5DN6"],"keywords":[],"medgen_id":"CN262927","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032869\"}","{\"db\":\"OMIM\",\"id\":\"618683\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"615204.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6\"}","{\"db\":\"OMIM\",\"id\":\"618683\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6\"}","{\"db\":\"OMIM\",\"id\":\"618683\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC5DN6\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032869\",\"ref_field\":\"name\"}"],"id":"43114","name":"Mitochondrial complex 5 (atp synthase) deficiency, nuclear type 6"}
{"attribute_content":[],"alternate_symbols":["ACDC"],"keywords":[],"gard_id":"10762","medgen_id":"C1859372","type":"Disease","symbol":"CALJA","alternate_names":["ARTERIAL CALCIFICATION DUE TO DEFICIENCY OF CD73"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"211800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"289601\"}","{\"db\":\"OMIM\",\"id\":\"211800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ARTERIAL CALCIFICATION DUE TO DEFICIENCY OF CD73\"}","{\"db\":\"OMIM\",\"id\":\"211800\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ACDC\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10762\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Calcification+of+joints+and+arteries/7882\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"211800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"643","name":"Calcification of joints and arteries"}
{"attribute_content":[],"alternate_symbols":["OTX2"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301552\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1378\",\"@Source\":\"BookShelf\"}]}}","gard_id":"3692","medgen_id":"C1864690","type":"Disease","symbol":"MCOPS5","alternate_names":["RETINAL DYSTROPHY, EARLY-ONSET, WITH PITUITARY DYSFUNCTION","RETINAL DYSTROPHY, EARLY-ONSET, WITHOUT PITUITARY DYSFUNCTION"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012413\"}","{\"db\":\"OMIM\",\"id\":\"610125\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"178364\"}","{\"db\":\"OMIM\",\"id\":\"600037.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RETINAL DYSTROPHY, EARLY-ONSET, WITH PITUITARY DYSFUNCTION\"}","{\"db\":\"OMIM\",\"id\":\"600037.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RETINAL DYSTROPHY, EARLY-ONSET, WITHOUT PITUITARY DYSFUNCTION\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3692\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012413\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610125\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2946","name":"Syndromic microphthalmia type 5"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3279614","type":"Disease","symbol":"BDPLT13","alternate_names":["BLEEDING DISORDER, SUSCEPTIBILITY TO, DUE TO DEFECTIVE PLATELET THROMBOXANE A2 RECEPTOR"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614009\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"220443\"}","{\"db\":\"OMIM\",\"id\":\"614009\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BLEEDING DISORDER, SUSCEPTIBILITY TO, DUE TO DEFECTIVE PLATELET THROMBOXANE A2 RECEPTOR\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Bleeding+disorder%2C+platelet-type%2C+13%2C+susceptibility+to/7824\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614009\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"16543","name":"Platelet-type bleeding disorder 13, susceptibility to"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4225333","type":"Disease","symbol":"HOMGSMR1","alternate_names":["Hypomagnesemia, seizures, and intellectual disability 1"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020787\"}","{\"db\":\"OMIM\",\"id\":\"616418\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"34527\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0020787\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypomagnesemia, seizures, and intellectual disability 1\"}","{\"db\":\"OMIM\",\"id\":\"616418\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"33528","name":"Hypomagnesemia, seizures, and mental retardation 1"}
{"attribute_content":[],"alternate_symbols":["IMD57"],"keywords":[],"medgen_id":"C4748212","type":"Disease","alternate_names":["IMMUNODEFICIENCY 57 WITH AUTOINFLAMMATION"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020849\"}","{\"db\":\"OMIM\",\"id\":\"618108\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603453.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 57 WITH AUTOINFLAMMATION\"}","{\"db\":\"OMIM\",\"id\":\"603453.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 57 WITH AUTOINFLAMMATION\"}","{\"db\":\"OMIM\",\"id\":\"618108\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 57 WITH AUTOINFLAMMATION\"}","{\"db\":\"OMIM\",\"id\":\"618108\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IMD57\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0020849\",\"ref_field\":\"name\"}"],"id":"40636","name":"Immunodeficiency 57"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263052","type":"Disease","symbol":"CILD43","alternate_names":["CILIARY DYSKINESIA, PRIMARY, 43, WITH OR WITHOUT SITUS INVERSUS"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032874\"}","{\"db\":\"OMIM\",\"id\":\"618699\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602291.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CILIARY DYSKINESIA, PRIMARY, 43, WITH OR WITHOUT SITUS INVERSUS\"}","{\"db\":\"OMIM\",\"id\":\"618699\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CILIARY DYSKINESIA, PRIMARY, 43, WITH OR WITHOUT SITUS INVERSUS\"}","{\"db\":\"OMIM\",\"id\":\"618699\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618699\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43128","name":"CILIARY DYSKINESIA, PRIMARY, 43"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3275684","type":"Disease","alternate_names":["Mitochondrial complex 5 (atp synthase) deficiency, mitochondrial type 1"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0027069\"}","{\"db\":\"OMIM\",\"id\":\"500015\",\"type\":\"MIM\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0027069\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mitochondrial complex 5 (atp synthase) deficiency, mitochondrial type 1\"}"],"id":"16265","name":"Mitochondrial complex v (atp synthase) deficiency, mitochondrial type 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1970109","type":"Disease","symbol":"AEXS","alternate_names":["AROMATASE ACTIVITY, INCREASED","Familial gynecomastia, due to increased aromatase activity","GYNECOMASTIA, HEREDITARY"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007690\"}","{\"db\":\"OMIM\",\"id\":\"139300\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"178345\"}","{\"db\":\"OMIM\",\"id\":\"139300\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AROMATASE ACTIVITY, INCREASED\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Aromatase+Deficiency/581\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Familial gynecomastia, due to increased aromatase activity\"}","{\"db\":\"OMIM\",\"id\":\"139300\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GYNECOMASTIA, HEREDITARY\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007690\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"139300\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"442","name":"Aromatase excess syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3275406","type":"Disease","symbol":"MRXSR","alternate_names":["INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE","ZDHHC9-Related X-linked Mental Retardation"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010427\"}","{\"db\":\"OMIM\",\"id\":\"300799\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"300646.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300646.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300646.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300646.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300646.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300799\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE\"}","{\"db\":\"Genetic Alliance\",\"id\":\"MENTAL+RETARDATION%2C+X-LINKED%2C+SYNDROMIC%2C+RAYMOND+TYPE/8856\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300799\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"6793","name":"Mental retardation, X-linked, syndromic, Raymond type"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C2676285","type":"Disease","alternate_names":["LH3 DEFICIENCY","LYSYL HYDROXYLASE 3 DEFICIENCY"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"612394\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"300284\"}","{\"db\":\"OMIM\",\"id\":\"612394\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LH3 DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"603066.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LYSYL HYDROXYLASE 3 DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"603066.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LYSYL HYDROXYLASE 3 DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"612394\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LYSYL HYDROXYLASE 3 DEFICIENCY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Bone+fragility+with+contractures%2C+arterial+rupture%2C+and+deafness/7852\",\"ref_field\":\"name\"}"],"id":"507","name":"Bone fragility with contractures, arterial rupture, and deafness"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301552\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1378\",\"@Source\":\"BookShelf\"}]}}","gard_id":"3645","medgen_id":"C1864689","type":"Disease","symbol":"MCOPS6","alternate_names":["Anophthalmia clinical with micrognathia malformed ears digital anomalies and abnormal external genitalia","Microphthalmia and pituitary anomalies","Microphthalmia syndromic 6","Microphthalmia with brain and digit developmental anomalies"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011936\"}","{\"db\":\"OMIM\",\"id\":\"607932\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"139471\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Microphthalmia+syndromic+6/4790\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Microphthalmia syndromic 6\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3645\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011936\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607932\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3196","name":"Microphthalmia with brain and digit anomalies"}
{"attribute_content":[],"alternate_symbols":["IGDS","IHGA","IRID2"],"keywords":[],"gard_id":"3026","medgen_id":"C1842031","type":"Disease","symbol":"ASGD4","alternate_names":["Iridogoniodysgenesis syndrome","Iridogoniodysgenesis type 2","Iridogoniodysgenesis, dominant type","Iris hypoplasia with early onset glaucoma, autosomal dominant"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007662\"}","{\"db\":\"OMIM\",\"id\":\"137600\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"91483\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Iridogoniodysgenesis%2C+dominant+type/3869\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Iridogoniodysgenesis, dominant type\"}","{\"db\":\"OMIM\",\"id\":\"137600\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IGDS\"}","{\"db\":\"OMIM\",\"id\":\"137600\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IHGA\"}","{\"db\":\"OMIM\",\"id\":\"137600\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IRID2\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3026\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007662\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137600\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2421","name":"Anterior segment dysgenesis 4"}
{"attribute_content":[],"alternate_symbols":["PPPP"],"keywords":[],"gard_id":"4439","medgen_id":"C1867982","type":"Disease","symbol":"PPKP2","alternate_names":["PALMOPLANTAR KERATODERMA, PUNCTATE TYPE II"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008292\"}","{\"db\":\"OMIM\",\"id\":\"175860\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"79502\"}","{\"db\":\"OMIM\",\"id\":\"175860\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PALMOPLANTAR KERATODERMA, PUNCTATE TYPE II\"}","{\"db\":\"OMIM\",\"id\":\"175860\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PPPP\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4439\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008292\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"175860\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1888","name":"Punctate palmoplantar keratoderma type 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C2751090","type":"Disease","symbol":"THPH11","alternate_names":["THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"613116\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"217467\"}","{\"db\":\"OMIM\",\"id\":\"142640.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"142640.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"142640.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"613116\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Thrombophilia%2C+histidine-rich+glycoprotein-related/9398\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613116\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"11424","name":"Thrombophilia, histidine-rich glycoprotein-related"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"5680","disease_mechanism_id":"273","medgen_id":"C0268297","type":"Disease","symbol":"PPSH","alternate_names":["Familial incomplete male pseudohermaphroditism, type 2","Male pseudohermaphroditism due to 5-alpha-reductase deficiency","Pseudovaginal perineoscrotal hypospadias"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009923\"}","{\"db\":\"OMIM\",\"id\":\"264600\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"753\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508993\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520059\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5680\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"3-Oxo-5+alpha-steroid+delta+4-dehydrogenase+deficiency/7608\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"57514000\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"264600\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5821","disease_mechanism":"loss of function","name":"3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency"}
{"attribute_content":[],"alternate_symbols":["MC1DN10"],"keywords":[],"medgen_id":"C4748768","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032616\"}","{\"db\":\"OMIM\",\"id\":\"618233\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"609653.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10\"}","{\"db\":\"OMIM\",\"id\":\"609653.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10\"}","{\"db\":\"OMIM\",\"id\":\"609653.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10\"}","{\"db\":\"OMIM\",\"id\":\"609653.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10\"}","{\"db\":\"OMIM\",\"id\":\"609653.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10\"}","{\"db\":\"OMIM\",\"id\":\"618233\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10\"}","{\"db\":\"OMIM\",\"id\":\"618233\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN10\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032616\",\"ref_field\":\"name\"}"],"id":"40884","name":"Mitochondrial complex 1 deficiency, nuclear type 10"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4722258","type":"Disease","symbol":"EV2","alternate_names":["Epidermodysplasia verruciformis 2"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032614\"}","{\"db\":\"OMIM\",\"id\":\"618231\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"605829.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605829.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605829.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618231\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618231\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40861","name":"EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0685889","type":"Disease","symbol":"ICAS","alternate_names":["ASPLENIA, FAMILIAL","HYPOSPLENIA, ISOLATED CONGENITAL"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"271400\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"101351\"}","{\"db\":\"OMIM\",\"id\":\"271400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ASPLENIA, FAMILIAL\"}","{\"db\":\"OMIM\",\"id\":\"271400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOSPLENIA, ISOLATED CONGENITAL\"}","{\"db\":\"OMIM\",\"id\":\"271400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3827","name":"Asplenia, isolated congenital"}
{"attribute_content":[],"alternate_symbols":["NEDMACE","NSDVS2"],"keywords":[],"medgen_id":"CN272910","type":"Disease","alternate_names":["NABAIS SA-DE VRIES SYNDROME, TYPE 2"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032943\"}","{\"db\":\"OMIM\",\"id\":\"618829\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602650.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"602650.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"602650.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"602650.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"618829\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"618829\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NEDMACE\"}","{\"db\":\"OMIM\",\"id\":\"618829\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NSDVS2\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032943\",\"ref_field\":\"name\"}"],"id":"43807","name":"Neurodevelopmental disorder with relative macrocephaly and with or without cardiac or endocrine anomalies"}
{"attribute_content":[],"alternate_symbols":["PDHLD"],"keywords":[],"gard_id":"12678","medgen_id":"C3280887","type":"Disease","symbol":"HGCLAS","alternate_names":["HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614462\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"401859\"}","{\"db\":\"OMIM\",\"id\":\"607031.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES\"}","{\"db\":\"OMIM\",\"id\":\"607031.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES\"}","{\"db\":\"OMIM\",\"id\":\"607031.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES\"}","{\"db\":\"OMIM\",\"id\":\"614462\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES\"}","{\"db\":\"OMIM\",\"id\":\"614462\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PDHLD\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"12678\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"PYRUVATE+DEHYDROGENASE+LIPOIC+ACID+SYNTHETASE+DEFICIENCY/9203\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614462\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"16815","name":"Pyruvate dehydrogenase lipoic acid synthetase deficiency"}
{"attribute_content":[],"alternate_symbols":[],"keywords":["Neoplasm"],"medgen_id":"C3152204","type":"Disease","symbol":"CMM8","alternate_names":["MELANOMA AND RENAL CELL CARCINOMA, SUSCEPTIBILITY TO","MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614456\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"293822\"}","{\"db\":\"OMIM\",\"id\":\"614456\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MELANOMA AND RENAL CELL CARCINOMA, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"156845.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8\"}","{\"db\":\"OMIM\",\"id\":\"601800\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8\"}","{\"db\":\"OMIM\",\"id\":\"606933.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8\"}","{\"db\":\"OMIM\",\"id\":\"614456\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8\"}","{\"db\":\"OMIM\",\"id\":\"614456\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"10004","name":"Cutaneous malignant melanoma 8"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4317151","type":"Disease","symbol":"HLTRS","alternate_names":["Telangiectatic membranoproliferative glomerulonephritis"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"137940\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"69735\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Glomerulonephritis+with+Sparse+Hair+and+Telangiectases/3082\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137940\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1379","name":"Glomerulonephritis with sparse hair and telangiectases"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3809877","type":"Disease","symbol":"SHFYNG","alternate_names":["CHITAYAT-HALL SYNDROME","Prader-Willi syndrome due to point mutation"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0014243\"}","{\"db\":\"OMIM\",\"id\":\"615547\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"398073\"}","{\"db\":\"OMIM\",\"id\":\"615547\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHITAYAT-HALL SYNDROME\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0014243\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Prader-Willi syndrome due to point mutation\"}","{\"db\":\"OMIM\",\"id\":\"615547\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18442","name":"Schaaf-Yang syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4021030","type":"Finding","alternate_names":["Lissencephaly type 3"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0045028\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0015148\"}","{\"db\":\"Orphanet\",\"id\":\"102011\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0015148\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lissencephaly type 3\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0045028\",\"ref_field\":\"name\"}"],"id":"32670","name":"Type III lissencephaly"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C5193023","type":"Disease","symbol":"HOMGSMR2","alternate_names":["Hypomagnesemia, seizures, and intellectual disability 2"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020788\"}","{\"db\":\"OMIM\",\"id\":\"618314\",\"type\":\"MIM\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0020788\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypomagnesemia, seizures, and intellectual disability 2\"}","{\"db\":\"OMIM\",\"id\":\"618314\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41351","name":"Hypomagnesemia, seizures, and mental retardation 2"}
{"attribute_content":[],"alternate_symbols":["PSD","THPH5"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"ACOG, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20027064\",\"@Source\":\"PubMed\"}}}","disease_mechanism_id":"273","medgen_id":"C3278211","type":"Disease","alternate_names":["Protein S deficiency"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012868\"}","{\"db\":\"OMIM\",\"id\":\"612336\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"26349\"}","{\"db\":\"Orphanet\",\"id\":\"743\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Protein+S+deficiency/6003\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Protein S deficiency\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000503187\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PSD\"}","{\"db\":\"OMIM\",\"id\":\"612336\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"THPH5\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000503187\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511112\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512307\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521659\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000576178\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012868\",\"ref_field\":\"name\"}"],"id":"4263","disease_mechanism":"loss of function","name":"Thrombophilia due to protein S deficiency, autosomal dominant"}
{"attribute_content":[],"alternate_symbols":["MSCD"],"keywords":[],"medgen_id":"CN262665","type":"Disease","symbol":"MYOCOZ","alternate_names":["MULTIPLE STRUCTURED CORE DISEASE"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032852\"}","{\"db\":\"OMIM\",\"id\":\"618654\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618654\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MULTIPLE STRUCTURED CORE DISEASE\"}","{\"db\":\"OMIM\",\"id\":\"618654\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MSCD\"}","{\"db\":\"OMIM\",\"id\":\"102573.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"102573.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618654\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618654\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43055","name":"MYOPATHY, CONGENITAL, WITH STRUCTURED CORES AND Z-LINE ABNORMALITIES"}
{"attribute_content":[],"alternate_symbols":["IGHD4"],"keywords":[],"medgen_id":"C4722273","type":"Disease","alternate_names":["DWARFISM OF SINDH","ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032567\"}","{\"db\":\"OMIM\",\"id\":\"618157\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618157\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DWARFISM OF SINDH\"}","{\"db\":\"OMIM\",\"id\":\"139191.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV\"}","{\"db\":\"OMIM\",\"id\":\"139191.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV\"}","{\"db\":\"OMIM\",\"id\":\"139191.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV\"}","{\"db\":\"OMIM\",\"id\":\"139191.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV\"}","{\"db\":\"OMIM\",\"id\":\"139191.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV\"}","{\"db\":\"OMIM\",\"id\":\"139191.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV\"}","{\"db\":\"OMIM\",\"id\":\"139191.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV\"}","{\"db\":\"OMIM\",\"id\":\"618157\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV\"}","{\"db\":\"OMIM\",\"id\":\"618157\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IGHD4\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032567\",\"ref_field\":\"name\"}"],"id":"40740","name":"Isolated growth hormone deficiency, type 4"}
{"attribute_content":[],"alternate_symbols":["CTSD"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301601\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1428\",\"@Source\":\"BookShelf\"}]}}","gard_id":"1218","medgen_id":"C1864669","type":"Disease","symbol":"CLN10","alternate_names":["CTSD-Related Neuronal Ceroid-Lipofuscinosis","Ceroid lipofuscinosis neuronal Cathepsin D-deficient","Neuronal ceroid lipofuscinosis due to Cathepsin D deficiency"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012414\"}","{\"db\":\"OMIM\",\"id\":\"610127\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"228337\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1218\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012414\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610127\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1352","name":"Neuronal ceroid lipofuscinosis 10"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"10120","medgen_id":"C4551953","type":"Disease","symbol":"VMD1","alternate_names":["Macular dystrophy, atypical vitelliform"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007933\"}","{\"db\":\"OMIM\",\"id\":\"153840\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"99000\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Macular+dystrophy%2C+atypical+vitelliform/4404\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Macular dystrophy, atypical vitelliform\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10120\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007933\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"153840\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2588","name":"Vitelliform macular dystrophy 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4225177","type":"Disease","symbol":"SMABF1","alternate_names":["SMA1 with congenital bone fractures"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"616866\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"616866\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"34870","name":"Spinal muscular atrophy with congenital bone fractures 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258267","type":"Disease","symbol":"TPFS","alternate_names":["NEUROCARDIOSKELETAL SYNDROME"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032707\"}","{\"db\":\"OMIM\",\"id\":\"618371\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618371\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEUROCARDIOSKELETAL SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"600346.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600346.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618371\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618371\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41561","name":"TURNPENNY-FRY SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263103","type":"Disease","symbol":"HESJAS","alternate_names":["MICROCEPHALY, SHORT STATURE, AND IMPAIRED INTELLECTUAL DEVELOPMENT"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032882\"}","{\"db\":\"OMIM\",\"id\":\"618724\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618724\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MICROCEPHALY, SHORT STATURE, AND IMPAIRED INTELLECTUAL DEVELOPMENT\"}","{\"db\":\"OMIM\",\"id\":\"602769.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602769.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618724\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618724\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43214","name":"HEYN-SPROUL-JACKSON SYNDROME"}
{"attribute_content":[],"alternate_symbols":["ACS"],"keywords":[],"gard_id":"9798","medgen_id":"C1865295","type":"Disease","alternate_names":["Auriculo-condylar syndrome","Ears prominent and constricted","QUESTION MARK EARS SYNDROME"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0000107\"}","{\"db\":\"OMIM\",\"id\":\"PS602483\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"137888\"}","{\"db\":\"OMIM\",\"id\":\"602483\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"QUESTION MARK EARS SYNDROME\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9798\",\"ref_field\":\"gard_id\"}","{\"db\":\"OMIM\",\"id\":\"PS602483\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"],"id":"17461","name":"Auriculocondylar syndrome"}
{"attribute_content":[],"alternate_symbols":["MC1DN18"],"keywords":[],"medgen_id":"C4748790","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032623\"}","{\"db\":\"OMIM\",\"id\":\"618240\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"612911.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18\"}","{\"db\":\"OMIM\",\"id\":\"612911.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18\"}","{\"db\":\"OMIM\",\"id\":\"612911.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18\"}","{\"db\":\"OMIM\",\"id\":\"618240\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18\"}","{\"db\":\"OMIM\",\"id\":\"618240\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN18\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032623\",\"ref_field\":\"name\"}"],"id":"40896","name":"Mitochondrial complex 1 deficiency, nuclear type 18"}
{"attribute_content":[],"alternate_symbols":["PFD"],"keywords":[],"medgen_id":"C1839454","type":"Disease","symbol":"CFPD","alternate_names":["COMPLEMENT FACTOR PROPERDIN DEFICIENCY","PROPERDIN DEFICIENCY, TYPE I","Properdin P factor deficiency","Properdin deficiency, type 1"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"312060\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"312060\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"COMPLEMENT FACTOR PROPERDIN DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"300383.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PROPERDIN DEFICIENCY, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"300383.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PROPERDIN DEFICIENCY, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"300383.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PROPERDIN DEFICIENCY, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"312060\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PROPERDIN DEFICIENCY, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"312060\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PFD\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Properdin+deficiency%2C+X-linked/5993\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"312060\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5804","name":"Properdin deficiency, X-linked"}
{"attribute_content":[],"alternate_symbols":["BLS"],"keywords":[],"gard_id":"824","medgen_id":"C2931418","type":"Disease","alternate_names":["BARE LYMPHOCYTE SYNDROME, TYPE II","BLS 2","BLS, TYPE II","Bare Lymphocyte Syndrome","MHC class II deficiency","SCID, HLA CLASS II-NEGATIVE","SCID, HLA Class 2-Negative","Severe combined immunodeficiency, HLA class II negative"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008855\"}","{\"db\":\"OMIM\",\"id\":\"209920\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"572\"}","{\"db\":\"OMIM\",\"id\":\"209920\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BARE LYMPHOCYTE SYNDROME, TYPE II\"}","{\"db\":\"OMIM\",\"id\":\"209920\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BLS, TYPE II\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008855\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MHC class II deficiency\"}","{\"db\":\"OMIM\",\"id\":\"209920\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SCID, HLA CLASS II-NEGATIVE\"}","{\"db\":\"OMIM\",\"id\":\"209920\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"BLS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"824\",\"ref_field\":\"gard_id\"}","{\"db\":\"MeSH\",\"id\":\"C537079\",\"ref_field\":\"name\"}"],"id":"486","name":"Bare lymphocyte syndrome 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"10775","medgen_id":"C3150649","type":"Disease","symbol":"ADMFD","alternate_names":["AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"613385\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"228426\"}","{\"db\":\"OMIM\",\"id\":\"606409.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM\"}","{\"db\":\"OMIM\",\"id\":\"613385\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10775\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Autoimmune+disease%2C+syndromic+multisystem/7775\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613385\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"6641","name":"Autoimmune disease, syndromic multisystem"}
{"attribute_content":[],"alternate_symbols":["MC1DN22"],"keywords":[],"medgen_id":"C4748796","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032626\"}","{\"db\":\"OMIM\",\"id\":\"618243\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603835.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22\"}","{\"db\":\"OMIM\",\"id\":\"603835.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22\"}","{\"db\":\"OMIM\",\"id\":\"603835.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22\"}","{\"db\":\"OMIM\",\"id\":\"603835.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22\"}","{\"db\":\"OMIM\",\"id\":\"618243\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22\"}","{\"db\":\"OMIM\",\"id\":\"618243\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN22\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032626\",\"ref_field\":\"name\"}"],"id":"40899","name":"Mitochondrial complex 1 deficiency, nuclear type 22"}
{"attribute_content":[],"alternate_symbols":["HED-ID","HEDID","XHMED"],"keywords":[],"medgen_id":"C1846006","type":"Disease","symbol":"EDAID1","alternate_names":["ECTODERMAL DYSPLASIA AND IMMUNE DEFICIENCY 1","ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNE DEFICIENCY","Hypohidrotic ectodermal dysplasia with immune deficiency"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020740\"}","{\"db\":\"OMIM\",\"id\":\"300291\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"238468\"}","{\"db\":\"Orphanet\",\"id\":\"98813\"}","{\"db\":\"OMIM\",\"id\":\"300248.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ECTODERMAL DYSPLASIA AND IMMUNE DEFICIENCY 1\"}","{\"db\":\"OMIM\",\"id\":\"300291\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNE DEFICIENCY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hypohidrotic+ectodermal+dysplasia+with+immune+deficiency/3657\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypohidrotic ectodermal dysplasia with immune deficiency\"}","{\"db\":\"OMIM\",\"id\":\"300291\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HEDID\"}","{\"db\":\"OMIM\",\"id\":\"300291\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"XHMED\"}","{\"db\":\"OMIM\",\"id\":\"300291\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1582","name":"Ectodermal dysplasia and immunodeficiency 1"}
{"attribute_content":[],"alternate_symbols":["MC1DN3"],"keywords":[],"medgen_id":"C4748752","type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032608\"}","{\"db\":\"OMIM\",\"id\":\"618224\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"601825.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3\"}","{\"db\":\"OMIM\",\"id\":\"601825.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3\"}","{\"db\":\"OMIM\",\"id\":\"601825.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3\"}","{\"db\":\"OMIM\",\"id\":\"618224\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3\"}","{\"db\":\"OMIM\",\"id\":\"618224\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN3\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032608\",\"ref_field\":\"name\"}"],"id":"40888","name":"Mitochondrial complex 1 deficiency, nuclear type 3"}
{"attribute_content":[],"alternate_symbols":["CDH","DDH"],"keywords":[],"medgen_id":"C1840555","type":"Disease","alternate_names":["Congenital dislocation of the hip","Congenital dislocation of the hips","Congenital hip anomaly","Congenital hip dislocations","Dislocated hip since birth","Dysplasia of acetabulum"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001374\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0000158\"}","{\"db\":\"OMIM\",\"id\":\"PS142700\",\"type\":\"Phenotypic series\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001374\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital dislocation of the hip\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001374\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital dislocation of the hips\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001374\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital hip anomaly\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001374\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital hip dislocations\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001374\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Dislocated hip since birth\"}","{\"db\":\"SNOMED CT\",\"id\":\"52781008\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Dysplasia of acetabulum\"}","{\"db\":\"OMIM\",\"id\":\"142700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CDH\"}","{\"db\":\"OMIM\",\"id\":\"142700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"DDH\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0000158\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS142700\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"],"id":"36162","name":"Developmental dysplasia of the hip"}
{"attribute_content":[],"alternate_symbols":["NEDBA"],"keywords":[],"medgen_id":"CN258765","type":"Disease","alternate_names":["NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032755\"}","{\"db\":\"OMIM\",\"id\":\"618443\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618443\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES\"}","{\"db\":\"OMIM\",\"id\":\"618443\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NEDBA\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032755\",\"ref_field\":\"name\"}"],"id":"41773","name":"Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263109","type":"Disease","symbol":"EIEE82","alternate_names":["GLUTAMATE OXALOACETATE TRANSAMINASE, MITOCHONDRIAL, DEFICIENCY OF","GOT2 DEFICIENCY"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032880\"}","{\"db\":\"OMIM\",\"id\":\"618721\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618721\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GLUTAMATE OXALOACETATE TRANSAMINASE, MITOCHONDRIAL, DEFICIENCY OF\"}","{\"db\":\"OMIM\",\"id\":\"618721\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GOT2 DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"138150.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"138150.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"138150.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"138150.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618721\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618721\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43192","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 82"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301771\",\"@Source\":\"PubMed\"},{\"$\":\"NBK8828\",\"@Source\":\"BookShelf\"}]}}","gard_id":"4973","medgen_id":"C1853296","public_definition":"Spondylocostal dysostosis (SCDO), defined radiographically as multiple segmentation defects of the vertebrae (M-SDV) in combination with abnormalities of the ribs, is characterized clinically by: a short trunk in proportion to height; short neck; non-progressive mild scoliosis in most affected individuals, and occasionally, more significant scoliosis. Respiratory function in neonates may be compromised by reduced size of the thorax. By age two years lung growth may improve sufficiently to support relatively normal growth and development; however, even then life-threatening complications can occur, especially pulmonary hypertension in children with severely restricted lung capacity from birth. Males with SCDO appear to be at increased risk for inguinal hernia.","type":"Disease","symbol":"SCDO3","alternate_names":["Spondylocostal dysostosis 3"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012349\"}","{\"db\":\"OMIM\",\"id\":\"609813\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2311\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Spondylocostal+dysostosis+3/6804\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Spondylocostal dysostosis 3\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4973\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012349\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK8828\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"609813\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5978","name":"Spondylocostal dysostosis 3, autosomal recessive"}
{"attribute_content":[],"alternate_symbols":["COL11A1"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301479\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1302\",\"@Source\":\"BookShelf\"}]}}","gard_id":"5020","medgen_id":"C1858084","public_definition":"Stickler syndrome is a connective tissue disorder that can include ocular findings of myopia, cataract, and retinal detachment; hearing loss that is both conductive and sensorineural; midfacial underdevelopment and cleft palate (either alone or as part of the Robin sequence); and mild spondyloepiphyseal dysplasia and/or precocious arthritis. Variable phenotypic expression of Stickler syndrome occurs both within and among families; interfamilial variability is in part explained by locus and allelic heterogeneity.","type":"Disease","symbol":"STL2","alternate_names":["STICKLER SYNDROME, TYPE II","STL 2","Stickler syndrome, beaded vitreous type","Stickler syndrome, vitreous type 2"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011493\"}","{\"db\":\"OMIM\",\"id\":\"604841\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"828\"}","{\"db\":\"Orphanet\",\"id\":\"90654\"}","{\"db\":\"OMIM\",\"id\":\"120280.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"STICKLER SYNDROME, TYPE II\"}","{\"db\":\"OMIM\",\"id\":\"120280.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"STICKLER SYNDROME, TYPE II\"}","{\"db\":\"OMIM\",\"id\":\"604841\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"STICKLER SYNDROME, TYPE II\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5020\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011493\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1302\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"604841\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4464","name":"Stickler syndrome type 2"}
{"attribute_content":[],"alternate_symbols":["PEO"],"keywords":[],"gard_id":"4503","medgen_id":"C0162674","public_definition":"Progressive external ophthalmoplegia is a condition characterized by weakness of the eye muscles. The condition typically appears in adults between ages 18 and 40 and slowly worsens over time. The first sign of progressive external ophthalmoplegia is typically drooping eyelids (ptosis), which can affect one or both eyelids. As ptosis worsens, affected individuals may use the forehead muscles to try to lift the eyelids, or they may lift up their chin in order to see. Another characteristic feature of progressive external ophthalmoplegia is weakness or paralysis of the muscles that move the eye (ophthalmoplegia). Affected individuals have to turn their head to see in different directions, especially as the ophthalmoplegia worsens. People with progressive external ophthalmoplegia may also have general weakness of the muscles used for movement (myopathy), particularly those in the neck, arms, or legs. The weakness may be especially noticeable during exercise (exercise intolerance). Muscle weakness may also cause difficulty swallowing (dysphagia).When the muscle cells of affected individuals are stained and viewed under a microscope, these cells usually appear abnormal. These abnormal muscle cells contain an excess of cell structures called mitochondria and are known as ragged-red fibers.Although muscle weakness is the primary symptom of progressive external ophthalmoplegia, this condition can be accompanied by other signs and symptoms. In these instances, the condition is referred to as progressive external ophthalmoplegia plus (PEO+). Additional signs and symptoms can include hearing loss caused by nerve damage in the inner ear (sensorineural hearing loss), weakness and loss of sensation in the limbs due to nerve damage (neuropathy), impaired muscle coordination (ataxia), a pattern of movement abnormalities known as parkinsonism, and depression.Progressive external ophthalmoplegia is part of a spectrum of disorders with overlapping signs and symptoms. Similar disorders include ataxia neuropathy spectrum and Kearns-Sayre syndrome. Like progressive external ophthalmoplegia, the other conditions in this spectrum can involve weakness of the eye muscles. However, these conditions have many additional features not shared by most people with progressive external ophthalmoplegia.","type":"Disease","symbol":"CPEO","alternate_names":["Ophthalmoplegia, Chronic Progressive External"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000562\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000590\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0005181\"}","{\"db\":\"Orphanet\",\"id\":\"520820\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4503\",\"ref_field\":\"gard_id\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000590\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"46252003\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"progressive-external-ophthalmoplegia\",\"ref_field\":\"public_definition\"}"],"id":"6479","name":"Progressive external ophthalmoplegia"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301382\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1203\",\"@Source\":\"BookShelf\"}]}}","gard_id":"7343","medgen_id":"C0342784","public_definition":"Mitochondrial DNA (mtDNA) deletion syndromes predominantly comprise three overlapping phenotypes that are usually simplex (i.e., a single occurrence in a family), but rarely may be observed in different members of the same family or may evolve from one clinical syndrome to another in a given individual over time. The three classic phenotypes caused by mtDNA deletions are Kearns-Sayre syndrome (KSS), Pearson syndrome, and progressive external ophthalmoplegia (PEO). KSS is a progressive multisystem disorder defined by onset before age 20 years, pigmentary retinopathy, and PEO; additional features include cerebellar ataxia, impaired intellect (intellectual disability, dementia, or both), sensorineural hearing loss, ptosis, oropharyngeal and esophageal dysfunction, exercise intolerance, muscle weakness, cardiac conduction block, and endocrinopathy. Pearson syndrome is characterized by sideroblastic anemia and exocrine pancreas dysfunction and may be fatal in infancy without appropriate hematologic management. PEO is characterized by ptosis, impaired eye movements due to paralysis of the extraocular muscles (ophthalmoplegia), oropharyngeal weakness, and variably severe proximal limb weakness with exercise intolerance. Rarely, a mtDNA deletion can manifest as Leigh syndrome.","type":"Disease","alternate_names":["Pearson marrow-pancreas syndrome","Pearson's marrow/pancreas syndrome","Pearson's syndrome","Sideroblastic anemia with marrow cell vacuolization and exocrine pancreatic dysfunction"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010797\"}","{\"db\":\"OMIM\",\"id\":\"557000\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"699\"}","{\"db\":\"SNOMED CT\",\"id\":\"237985009\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Pearson's syndrome\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7343\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010797\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1203\",\"ref_field\":\"public_definition\"}"],"id":"3283","name":"Pearson syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301291\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1112\",\"@Source\":\"BookShelf\"}]}}","gard_id":"2048","medgen_id":"C3888065","public_definition":"Hypohidrotic ectodermal dysplasia (HED) is characterized by hypotrichosis (sparseness of scalp and body hair), hypohidrosis (reduced ability to sweat), and hypodontia (congenital absence of teeth). The cardinal features of classic HED become obvious during childhood. The scalp hair is thin, lightly pigmented, and slow-growing. Sweating, although present, is greatly deficient, leading to episodes of hyperthermia until the affected individual or family acquires experience with environmental modifications to control temperature. Only a few abnormally formed teeth erupt, and at a later-than-average age. Physical growth and psychomotor development are otherwise within normal limits. Mild HED is characterized by mild manifestations of any or all the characteristic features.","type":"Disease","symbol":"ECTD10A","alternate_names":["Ectodermal Dysplasia 3, Anhidrotic"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007509\"}","{\"db\":\"OMIM\",\"id\":\"129490\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1810\"}","{\"db\":\"Orphanet\",\"id\":\"238468\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2048\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007509\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1112\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"129490\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2064","name":"Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant"}
{"attribute_content":[],"alternate_symbols":["CDPXD","CPXD"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"21634086\",\"@Source\":\"PubMed\"},{\"$\":\"NBK55062\",\"@Source\":\"BookShelf\"}]}}","gard_id":"6189","medgen_id":"C0282102","public_definition":"The findings in X-linked chondrodysplasia punctata 2 (CDPX2) range from fetal demise with multiple malformations and severe growth retardation to much milder manifestations, including females with no recognizable physical abnormalities. At least 95% of liveborn individuals with CDPX2 are female. Characteristic features include growth deficiency; distinctive craniofacial appearance; chondrodysplasia punctata (stippling of the epiphyses of the long bones, vertebrae, trachea, and distal ends of the ribs); often asymmetric rhizomelic shortening of limbs; scoliosis; linear or blotchy scaling ichthyosis in the newborn; later appearance of linear or whorled atrophic patches involving hair follicles (follicular atrophoderma); coarse hair with scarring alopecia; and cataracts.","type":"Disease","symbol":"CDPX2","alternate_names":["CONRADI-HUNERMANN-HAPPLE SYNDROME","Chondrodysplasia punctata, X-linked dominant","Conrad Hunermann Happle syndrome","Happle syndrome","Hunermann-Conradi Syndrome"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"302960\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"35173\"}","{\"db\":\"OMIM\",\"id\":\"302960\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CONRADI-HUNERMANN-HAPPLE SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"302960\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CDPXD\"}","{\"db\":\"OMIM\",\"id\":\"302960\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CPXD\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6189\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Chondrodysplasia+Punctata+2+X-Linked+Dominant/1368\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK55062\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"302960\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"800","name":"Chondrodysplasia punctata 2 X-linked dominant"}
{"attribute_content":["{\"Attribute\":{\"$\":\"loss of function\",\"@Type\":\"disease mechanism\",\"@integerValue\":\"273\"},\"XRef\":[{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528516\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000551442\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000505068\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000507480\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000507942\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000522527\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000568367\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000514924\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520414\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000246735\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000260631\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520063\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520447\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528528\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000552214\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000556520\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000558532\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000325415\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000512526\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528276\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528500\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528536\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000556501\"}]}"],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"3009617\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301469\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1292\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"HFSA, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20610207\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2002\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"12735292\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Eng et al., 2006\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"16980809\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Salviati et al, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"2869001\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"EuroGentest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21934708\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"AHA/ASA, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25355838\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23860966\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ESC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25173338\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]}]}","gard_id":"6400","medgen_id":"C0002986","public_definition":"Fabry disease results from deficient activity of the enzyme alpha-galactosidase A (a-Gal A) and progressive lysosomal deposition of globotriaosylceramide (GL-3) in cells throughout the body. The classic form, occurring in males with less than 1% a-Gal A enzyme activity, usually has its onset in childhood or adolescence with periodic crises of severe pain in the extremities (acroparesthesia), the appearance of vascular cutaneous lesions (angiokeratomas), sweating abnormalities (anhidrosis, hypohidrosis, and rarely hyperhidrosis), characteristic corneal and lenticular opacities, and proteinuria. Gradual deterioration of renal function to end-stage renal disease (ESRD) usually occurs in men in the third to fifth decade. In middle age, most males successfully treated for ESRD develop cardiac and/or cerebrovascular disease, a major cause of morbidity and mortality. Heterozygous females typically have milder symptoms at a later age of onset than males. Rarely, they may be relatively asymptomatic throughout a normal life span or may have symptoms as severe as those observed in males with the classic phenotype. In contrast, males with greater than 1% a-Gal A activity may have: (1) a cardiac variant phenotype that usually presents in the sixth to eighth decade with left ventricular hypertrophy, cardiomyopathy and arrhythmia, and proteinuria, but without ESRD; or (2) a renal variant phenotype, associated with ESRD but without the skin lesions or pain; or (3) cerebrovascular disease presenting as stroke or transient ischemic attack.","type":"Disease","alternate_names":["Alpha-galactosidase A deficiency","Anderson-Fabry disease","Angiokeratoma corporis diffusum","Angiokeratoma, diffuse","Ceramide trihexosidase deficiency","Ceramide trihexosidosis","Fabry syndrome","Fabry's disease","GLA deficiency","Hereditary dystopic lipidosis"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001071\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010526\"}","{\"db\":\"OMIM\",\"id\":\"301500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"324\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001071\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Angiokeratoma corporis diffusum\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001071\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fabry syndrome\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Fabry+Disease/2690\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fabry's disease\"}","{\"db\":\"SNOMED CT\",\"id\":\"16652001\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fabry's disease\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500007\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6400\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"fabry-disease\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1292\",\"ref_field\":\"public_definition\"}"],"id":"1790","disease_mechanism":"Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.","name":"Fabry disease"}
{"attribute_content":[],"alternate_symbols":["JHF"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301698\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1525\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C2745948","public_definition":"Inherited systemic hyalinosis is characterized by hyaline deposits in the papillary dermis and other tissues. It typically presents at birth or in infancy with severe pain with movement, progressive joint contractures, and often with severe motor disability, thickened skin, and hyperpigmented macules/patches over bony prominences of the joints. Gingival hypertrophy, skin nodules, pearly papules of the face and neck, and perianal masses are common. Complications of protein-losing enteropathy and failure to thrive can be life threatening. Cognitive development is normal. Many children with the severe form (previously called infantile systemic hyalinosis) die in early childhood; some with a milder phenotype (previously called juvenile hyaline fibromatosis) survive into adulthood.","type":"Disease","symbol":"HFS","alternate_names":["HYALINOSIS, SYSTEMIC","Hyalinosis, systemic juvenile","Juvenile hyaline fibromatosis","Puretic syndrome"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009229\"}","{\"db\":\"OMIM\",\"id\":\"228600\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2028\"}","{\"db\":\"OMIM\",\"id\":\"228600\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYALINOSIS, SYSTEMIC\"}","{\"db\":\"SNOMED CT\",\"id\":\"238861002\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Juvenile hyaline fibromatosis\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Fibromatosis+Juvenile+Hyaline/2851\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1525\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"228600\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"9509","name":"Hyaline fibromatosis syndrome"}
{"attribute_content":[],"alternate_symbols":["CASK","MRXSNA"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"24278995\",\"@Source\":\"PubMed\"},{\"$\":\"NBK169825\",\"@Source\":\"BookShelf\"}]}}","gard_id":"12669","medgen_id":"C2677903","public_definition":"CASK disorders include a spectrum of phenotypes in both females and males. Two main types of clinical presentation are seen: Microcephaly with pontine and cerebellar hypoplasia (MICPCH), generally associated with pathogenic loss-of-function variants in CASK. X-linked intellectual disability (XLID) with or without nystagmus, generally associated with hypomorphic CASK pathogenic variants. MICPCH is typically seen in females with moderate-to-severe intellectual disability, progressive microcephaly with or without ophthalmologic anomalies, and sensorineural hearing loss. Most are able to sit independently; 20%-25% attain the ability to walk; language is nearly absent in most. Neurologic features may include axial hypotonia, hypertonia/spasticity of the extremities, and dystonia or other movement disorders. Nearly 40% have seizures by age ten years. Behaviors may include sleep disturbances, hand stereotypies, and self biting. MICPCH in males may occur with or without severe epileptic encephalopathy in addition to severe-to-profound developmental delay. When seizures are present they occur early and may be intractable. In individuals and families with milder (i.e., hypomorphic) pathogenic variants, the clinical phenotype is usually that of XLID with or without nystagmus and additional clinical features. Males have mild-to-severe intellectual disability, with or without nystagmus and other ocular features. Females typically have normal intelligence with some displaying mild-to-severe intellectual disability with or without ocular features.","type":"Disease","symbol":"MICPCH","alternate_names":["Intellectual Disability and Microcephaly with Pontine and Cerebellar Hypoplasia","MENTAL RETARDATION, X-LINKED, SYNDROMIC, NAJM TYPE","MICPCH SYNDROME"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010417\"}","{\"db\":\"OMIM\",\"id\":\"300749\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"163937\"}","{\"db\":\"OMIM\",\"id\":\"300749\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, SYNDROMIC, NAJM TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300749\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MICPCH SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"300749\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRXSNA\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"12669\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mental+retardation+and+microcephaly+with+pontine+and+cerebellar+hypoplasia/8814\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK169825\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"300749\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2748","name":"Mental retardation and microcephaly with pontine and cerebellar hypoplasia"}
{"attribute_content":[],"alternate_symbols":["CASK"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"24278995\",\"@Source\":\"PubMed\"},{\"$\":\"NBK169825\",\"@Source\":\"BookShelf\"}]}}","gard_id":"9925","medgen_id":"C1845546","public_definition":"CASK disorders include a spectrum of phenotypes in both females and males. Two main types of clinical presentation are seen: Microcephaly with pontine and cerebellar hypoplasia (MICPCH), generally associated with pathogenic loss-of-function variants in CASK. X-linked intellectual disability (XLID) with or without nystagmus, generally associated with hypomorphic CASK pathogenic variants. MICPCH is typically seen in females with moderate-to-severe intellectual disability, progressive microcephaly with or without ophthalmologic anomalies, and sensorineural hearing loss. Most are able to sit independently; 20%-25% attain the ability to walk; language is nearly absent in most. Neurologic features may include axial hypotonia, hypertonia/spasticity of the extremities, and dystonia or other movement disorders. Nearly 40% have seizures by age ten years. Behaviors may include sleep disturbances, hand stereotypies, and self biting. MICPCH in males may occur with or without severe epileptic encephalopathy in addition to severe-to-profound developmental delay. When seizures are present they occur early and may be intractable. In individuals and families with milder (i.e., hypomorphic) pathogenic variants, the clinical phenotype is usually that of XLID with or without nystagmus and additional clinical features. Males have mild-to-severe intellectual disability, with or without nystagmus and other ocular features. Females typically have normal intelligence with some displaying mild-to-severe intellectual disability with or without ocular features.","type":"Disease","symbol":"FGS4","alternate_names":["MENTAL RETARDATION, X-LINKED, WITH NYSTAGMUS","MENTAL RETARDATION, X-LINKED, WITHOUT NYSTAGMUS","X-Linked Intellectual Disability with or without Nystagmus"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010318\"}","{\"db\":\"OMIM\",\"id\":\"300422\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"300172.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, WITH NYSTAGMUS\"}","{\"db\":\"OMIM\",\"id\":\"300172.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, WITH NYSTAGMUS\"}","{\"db\":\"OMIM\",\"id\":\"300172.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, WITH NYSTAGMUS\"}","{\"db\":\"OMIM\",\"id\":\"300172.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, WITH NYSTAGMUS\"}","{\"db\":\"OMIM\",\"id\":\"300172.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, WITH NYSTAGMUS\"}","{\"db\":\"OMIM\",\"id\":\"300172.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, WITHOUT NYSTAGMUS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9925\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"FG+Syndrome+4/2845\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK169825\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"300422\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5151","name":"FG syndrome 4"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301619\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1446\",\"@Source\":\"BookShelf\"}]}}","gard_id":"6550","medgen_id":"C0265306","public_definition":"Typical Greig cephalopolysyndactyly syndrome (GCPS) is characterized by macrocephaly, widely spaced eyes associated with increased interpupillary distance, preaxial polydactyly with or without postaxial polydactyly, and cutaneous syndactyly. Developmental delay, intellectual disability, or seizures appear to be uncommon manifestations (~\u003c10%) of GCPS and may be more common in individuals with large (\u003e300-kb) deletions that encompass GLI3. Approximately 20% of individuals with GCPS have hypoplasia or agenesis of the corpus callosum.","type":"Disease","symbol":"GCPS","alternate_names":["Greig syndrome","Polysyndactyly with peculiar skull shape"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008287\"}","{\"db\":\"OMIM\",\"id\":\"175700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"380\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6550\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Greig+Cephalopolysyndactyly+Syndrome/3182\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"greig-cephalopolysyndactyly-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"32985001\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1446\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"175700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2006","name":"Greig cephalopolysyndactyly syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0015503","public_definition":"Factor VII deficiency is an autosomal recessive bleeding disorder showing variable severity (summary by Millar et al., 2000).\r\nPerry (2002) provided a comprehensive review of factor VII deficiency with a description of F7 polymorphisms, gene structure, and a summary of 120 mutations.","type":"Disease","alternate_names":["F7 deficiency","Factor 7 deficiency","Hypoproconvertinemia"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"227500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"327\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Factor+VII+Deficiency/2711\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"37193007\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"227500\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}"],"id":"10942","name":"Factor VII deficiency"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301623\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1450\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"25577942\",\"@Source\":\"PubMed\"},{\"$\":\"NBK268647\",\"@Source\":\"BookShelf\"}]}]}","medgen_id":"C3888102","public_definition":"C9orf72-related amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is characterized by: Motor neuron disease, including upper or lower motor neuron dysfunction (or both) that may or may not fulfill criteria for the ALS phenotype; Frontotemporal lobar degeneration (FTLD), including progressive changes in behavior, executive dysfunction, and/or language impairment; and Some degree of parkinsonism (typically of the akinetic-rigid type without tremor that is levodopa unresponsive). Age at onset is usually 30-70 years (range: 27-85 years) irrespective of the presenting symptoms. Initial manifestations may be pure FTLD or pure ALS; additional symptoms may appear during the disease course. Life expectancy is highly variable and mainly associated with the clinical manifestations.","type":"Disease","symbol":"FTDALS1","alternate_names":["Frontotemporal dementia with motor neuron disease 1"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007105\"}","{\"db\":\"OMIM\",\"id\":\"105550\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"275872\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007105\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Frontotemporal dementia with motor neuron disease 1\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK268647\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"105550\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1898","name":"Amyotrophic lateral sclerosis and/or frontotemporal dementia 1"}
{"attribute_content":[],"alternate_symbols":["FHM","MHP1"],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301562\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1388\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EFNS, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20298421\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Orphanet, 2013\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"Orphanet, Hemiplegic Migraine (HM), 2013\"},\"URL\":{\"$\":\"https://www.orpha.net/data/patho/Pro/en/Emergency_HemiplegicMigraine-enPro1031.pdf\"}}]}","gard_id":"2638","medgen_id":"C1832884","public_definition":"Familial hemiplegic migraine (FHM) falls within the category of migraine with aura. In migraine with aura (including familial hemiplegic migraine) the neurologic symptoms of aura are unequivocally localizable to the cerebral cortex or brain stem and include visual disturbance (most common), sensory loss (e.g., numbness or paresthesias of the face or an extremity), and dysphasia (difficulty with speech); FHM must include motor involvement, i.e., hemiparesis (weakness of an extremity). Hemiparesis occurs with at least one other symptom during FHM aura. Neurologic deficits with FHM attacks can be prolonged for hours to days and may outlast the associated migrainous headache. FHM is often earlier in onset than typical migraine, frequently beginning in the first or second decade; the frequency of attacks tends to decrease with age. Approximately 40%-50% of families with FHM1 have cerebellar signs ranging from nystagmus to progressive, usually late-onset mild ataxia. Cerebral infarction and death have rarely been associated with hemiplegic migraine.","type":"Disease","symbol":"FHM1","alternate_names":["Migraine, familial hemiplegic 1, with progressive cerebellar ataxia"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007714\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0020756\"}","{\"db\":\"OMIM\",\"id\":\"141500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"569\"}","{\"db\":\"OMIM\",\"id\":\"141500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"FHM\"}","{\"db\":\"OMIM\",\"id\":\"141500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MHP1\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2638\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hemiplegic+migraine%2C+familial+type+1/3286\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1388\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"141500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5542","name":"Familial hemiplegic migraine type 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301360\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1181\",\"@Source\":\"BookShelf\"}]}}","gard_id":"10214","medgen_id":"C1853942","public_definition":"Citrin deficiency can manifest in newborns or infants as neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD), in older children as failure to thrive and dyslipidemia caused by citrin deficiency (FTTDCD), and in adults as recurrent hyperammonemia with neuropsychiatric symptoms in citrullinemia type II (CTLN2). Often citrin deficiency is characterized by strong preference for protein-rich and/or lipid-rich foods and aversion to carbohydrate-rich foods. NICCD. Children younger than age one year have a history of low birth weight with growth restriction and transient intrahepatic cholestasis, hepatomegaly, diffuse fatty liver, and parenchymal cellular infiltration associated with hepatic fibrosis, variable liver dysfunction, hypoproteinemia, decreased coagulation factors, hemolytic anemia, and/or hypoglycemia. NICCD is generally not severe and symptoms often resolve by age one year with appropriate treatment, although liver transplantation has been required in rare instances. FTTDCD. Beyond age one year, many children with citrin deficiency develop a protein-rich and/or lipid-rich food preference and aversion to carbohydrate-rich foods. Clinical abnormalities may include growth restriction, hypoglycemia, pancreatitis, severe fatigue, anorexia, and impaired quality of life. Laboratory changes are dyslipidemia, increased lactate-to-pyruvate ratio, higher levels of urinary oxidative stress markers, and considerable deviation in tricarboxylic acid (TCA) cycle metabolites. One or more decades later, some individuals with NICCD or FTTDCD develop CTLN2. CTLN2. Presentation is sudden and usually between ages 20 and 50 years. Manifestations are recurrent hyperammonemia with neuropsychiatric symptoms including nocturnal delirium, aggression, irritability, hyperactivity, delusions, disorientation, restlessness, drowsiness, loss of memory, flapping tremor, convulsive seizures, and coma. Symptoms are often provoked by alcohol and sugar intake, medication, and/or surgery. Affected individuals may or may not have a prior history of NICCD or FTTDCD.","type":"Disease","symbol":"NICCD","alternate_names":["CITRULLINEMIA, TYPE II, NEONATAL-ONSET, WITH OR WITHOUT FAILURE TO THRIVE AND DYSLIPIDEMIA","Neonatal-onset citrullinemia type 2","Neonatal-onset citrullinemia type II"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"605814\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"247598\"}","{\"db\":\"OMIM\",\"id\":\"605814\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CITRULLINEMIA, TYPE II, NEONATAL-ONSET, WITH OR WITHOUT FAILURE TO THRIVE AND DYSLIPIDEMIA\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10214\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Citrin+Deficiency/1648\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1181\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"605814\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4809","name":"Neonatal intrahepatic cholestasis caused by citrin deficiency"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301338\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1159\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301396\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1217\",\"@Source\":\"BookShelf\"}]}]}","gard_id":"5840","medgen_id":"C0268548","public_definition":"Arginase deficiency in untreated individuals is characterized by episodic hyperammonemia of variable degree that is infrequently severe enough to be life threatening or to cause death. Most commonly, birth and early childhood are normal. Untreated individuals have slowing of linear growth at age one to three years, followed by development of spasticity, plateauing of cognitive development, and subsequent loss of developmental milestones. If untreated, arginase deficiency usually progresses to severe spasticity, loss of ambulation, complete loss of bowel and bladder control, and severe intellectual disability. Seizures are common and are usually controlled easily. Individuals treated from birth, either as a result of newborn screening or having an affected older sib, appear to have minimal symptoms.","type":"Disease","alternate_names":["ARG1 deficiency","Argininemia","Hyperargininemia"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008814\"}","{\"db\":\"OMIM\",\"id\":\"207800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"90\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008814\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hyperargininemia\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5840\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Arginase+Deficiency/574\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"23501004\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1159\",\"ref_field\":\"public_definition\"}"],"id":"4607","name":"Arginase deficiency"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301457\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1280\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C3810394","public_definition":"Pachyonychia congenita (PC) is characterized by hypertrophic nail dystrophy, painful palmoplantar keratoderma and blistering, oral leukokeratosis, pilosebaceous cysts (including steatocystoma and vellus hair cysts), palmoplantar hyperhydrosis, and follicular keratoses on the trunk and extremities.","type":"Disease","symbol":"PPKNEFD","alternate_names":["PALMOPLANTAR KERATODERMA, FOCAL OR DIFFUSE"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615735\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"402003\"}","{\"db\":\"OMIM\",\"id\":\"612315.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PALMOPLANTAR KERATODERMA, FOCAL OR DIFFUSE\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1280\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"615735\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18675","name":"Palmoplantar keratoderma, nonepidermolytic, focal or diffuse"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301458\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1281\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EFNS/ENS, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24418350\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ESC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25173338\",\"@Source\":\"PubMed\"}}]}","medgen_id":"C0016719","public_definition":"Friedreich ataxia (FRDA) is characterized by slowly progressive ataxia with onset usually before age 25 years (mean age at onset: 10-15 yrs). FRDA is typically associated with dysarthria, muscle weakness, spasticity particularly in the lower limbs, scoliosis, bladder dysfunction, absent lower-limb reflexes, and loss of position and vibration sense. Approximately two thirds of individuals with FRDA have cardiomyopathy, up to 30% have diabetes mellitus, and approximately 25% have an \"atypical\" presentation with later onset or retained tendon reflexes.","type":"Disease","symbol":"FRDA","alternate_names":["Friedreich ataxia","Hereditary spinal ataxia","Hereditary spinal sclerosis","Spinocerebellar ataxia, Friedreich"],"xrefs":["{\"db\":\"Orphanet\",\"id\":\"95\"}","{\"db\":\"SNOMED CT\",\"id\":\"10394003\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1281\",\"ref_field\":\"public_definition\"}"],"id":"10029","name":"Friedreich's ataxia"}
{"attribute_content":[],"alternate_symbols":["LFS1","LFS3"],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301471\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1294\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301488\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1311\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACS, 2007\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"17392385\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO, 2010\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"20065170\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO, 2003\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"12692171\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO, 2009\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"2668639\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ASHG/ACMG, 1995\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"1801355\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"NSGC, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15604628\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24493721\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG/NSGC, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25394175\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]}]}","medgen_id":"C1835398","public_definition":"Li-Fraumeni syndrome (LFS) is a cancer predisposition syndrome associated with high risks for a diverse spectrum of childhood- and adult-onset malignancies. The lifetime risk of cancer in individuals with LFS is =70% for men and =90% for women. Five cancer types account for the majority of LFS tumors: adrenocortical carcinomas, breast cancer, central nervous system tumors, osteosarcomas, and soft-tissue sarcomas. LFS is associated with an increased risk of several additional cancers including leukemia, lymphoma, gastrointestinal cancers, cancers of head and neck, kidney, larynx, lung, skin (e.g., melanoma), ovary, pancreas, prostate, testis, and thyroid. Individuals with LFS are at increased risk for cancer in childhood and young adulthood; survivors are at increased risk for multiple primary cancers.","type":"Disease","symbol":"LFS","alternate_names":["Li-Fraumeni syndrome 3"],"xrefs":["{\"db\":\"Gene\",\"id\":\"553989\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007903\"}","{\"db\":\"OMIM\",\"id\":\"151623\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"524\"}","{\"db\":\"OMIM\",\"id\":\"609266\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"LFS3\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Li-Fraumeni+syndrome+1/8745\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1311\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"151623\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5406","name":"Li-Fraumeni syndrome 1"}
{"attribute_content":[],"alternate_symbols":["PDMI","PNDM1"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301620\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1447\",\"@Source\":\"BookShelf\"}]}}","gard_id":"10457","disease_mechanism_id":"274","medgen_id":"C1833104","public_definition":"Permanent neonatal diabetes mellitus (PNDM) is characterized by the onset of hyperglycemia within the first six months of life (mean age: 7 weeks; range: birth to 26 weeks). The diabetes mellitus is associated with partial or complete insulin deficiency. Clinical manifestations at the time of diagnosis include intrauterine growth retardation, hyperglycemia, glycosuria, osmotic polyuria, severe dehydration, and failure to thrive. Therapy with insulin corrects the hyperglycemia and results in dramatic catch-up growth. The course of PNDM varies by genotype.","type":"Disease","alternate_names":["DIABETES MELLITUS, PERMANENT NEONATAL 1","Permanent diabetes mellitus of infancy"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011643\"}","{\"db\":\"OMIM\",\"id\":\"606176\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"99885\"}","{\"db\":\"OMIM\",\"id\":\"138079.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIABETES MELLITUS, PERMANENT NEONATAL 1\"}","{\"db\":\"OMIM\",\"id\":\"138079.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIABETES MELLITUS, PERMANENT NEONATAL 1\"}","{\"db\":\"OMIM\",\"id\":\"606176\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIABETES MELLITUS, PERMANENT NEONATAL 1\"}","{\"db\":\"OMIM\",\"id\":\"606176\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PDMI\"}","{\"db\":\"OMIM\",\"id\":\"606176\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PNDM1\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000284792\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500516\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500517\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000506518\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000506519\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000506524\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508859\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514676\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514677\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514687\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514688\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514689\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552542\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552543\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552544\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552549\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556820\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556824\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556831\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556834\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000557910\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558434\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000559250\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10457\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Permanent+neonatal+diabetes+mellitus/5681\",\"ref_field\":\"name\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011643\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1447\",\"ref_field\":\"public_definition\"}"],"id":"1095","disease_mechanism":"gain of function","name":"Permanent neonatal diabetes mellitus"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"22797890\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301558\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1384\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACMG, 2001\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3110344\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3111012\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ACMG, 2005\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3110946\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3111547\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21540884\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23519317\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"EMQN, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25227148\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23765048\",\"@Source\":\"PubMed\"}}]}","gard_id":"6464","disease_mechanism_id":"273","medgen_id":"C0016667","public_definition":"FMR1 disorders include fragile X syndrome (FXS), fragile X-associated tremor/ataxia syndrome (FXTAS), and fragile X-associated primary ovarian insufficiency (FXPOI). Fragile X syndrome occurs in individuals with an FMR1 full mutation or other loss-of-function variant and is nearly always characterized in affected males by developmental delay and intellectual disability along with a variety of behavioral issues. Autism spectrum disorder is present in 50%-70% of individuals with FXS. Affected males may have characteristic craniofacial features (which become more obvious with age) and medical problems including hypotonia, gastroesophageal reflux, strabismus, seizures, sleep disorders, joint laxity, pes planus, scoliosis, and recurrent otitis media. Adults may have mitral valve prolapse or aortic root dilatation. The physical and behavioral features seen in males with FXS have been reported in females heterozygous for the FMR1 full mutation, but with lower frequency and milder involvement. FXTAS occurs in individuals who have an FMR1 premutation and is characterized by late-onset, progressive cerebellar ataxia and intention tremor followed by cognitive impairment. Psychiatric disorders are common. Age of onset is typically between 60 and 65 years and is more common among males who are hemizygous for the premutation (40%) than among females who are heterozygous for the premutation (16%-20%). FXPOI, defined as hypergonadotropic hypogonadism before age 40 years, has been observed in 20% of women who carry a premutation allele compared to 1% in the general population.","type":"Disease","symbol":"FXS","alternate_names":["FRAGILE X MENTAL RETARDATION SYNDROME","Fra(X) syndrome","Fragile X syndrome, type A","MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28","Marker X syndrome","Martin-Bell syndrome","X-linked mental retardation and macroorchidism"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010383\"}","{\"db\":\"OMIM\",\"id\":\"300624\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"449291\"}","{\"db\":\"Orphanet\",\"id\":\"908\"}","{\"db\":\"OMIM\",\"id\":\"300624\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRAGILE X MENTAL RETARDATION SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"300624\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000264966\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552393\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000553203\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556541\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558914\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000560955\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561923\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568029\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568236\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568277\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569189\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569426\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569960\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570010\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000571198\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000576178\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6464\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Fragile+X+Syndrome/2906\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"613003\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1384\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"300624\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1302","disease_mechanism":"loss of function","name":"Fragile X syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":["Neoplasm"],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"24761742\",\"@Source\":\"PubMed\"},{\"$\":\"NBK196157\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C0018022","public_definition":"DICER1 tumor predisposition (DICER1) is characterized by an increased risk for pleuropulmonary blastoma (PPB), pulmonary cysts, thyroid gland neoplasia (multinodular goiter, adenomas, and/or thyroid cancer), ovarian tumors (Sertoli-Leydig cell tumor, gynandroblastoma, and sarcoma), and cystic nephroma. Less commonly observed tumors include ciliary body medulloepithelioma, nasal chondromesenchymal hamartoma, embryonal rhabdomyosarcoma, pituitary blastoma, pineoblastoma, central nervous system (CNS) sarcoma, other CNS tumors, and presacral malignant teratoid tumor. The majority of tumors occur in individuals younger than age 40 years. PPB typically presents in infants and children younger than age six years. Ovarian sex cord-stromal tumors are most often diagnosed before age 40 years. Cystic nephroma generally presents in young children but has also been reported in adolescents. Additional clinical features that may be seen include macrocephaly, ocular abnormalities, structural anomalies of the kidney and collecting system, and dental anomalies (bulbous crowns).","type":"Disease","symbol":"MNG1","alternate_names":["GOITER, NONTOXIC, WITH INTRATHYROIDAL CALCIFICATION","Goiter, Endemic","MULTINODULAR GOITER, ADOLESCENT","SIMPLE GOITER"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"138800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"276399\"}","{\"db\":\"OMIM\",\"id\":\"138800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GOITER, NONTOXIC, WITH INTRATHYROIDAL CALCIFICATION\"}","{\"db\":\"OMIM\",\"id\":\"138800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MULTINODULAR GOITER, ADOLESCENT\"}","{\"db\":\"OMIM\",\"id\":\"138800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SIMPLE GOITER\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Goiter%2C+multinodular+1%2C+with+or+without+sertoli-leydig+cell+tumors/8492\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK196157\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"138800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1940","name":"Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors"}
{"attribute_content":[],"alternate_symbols":[],"keywords":["Hereditary cancer syndrome"],"medgen_id":"C0005684","public_definition":"Bladder cancer is a disease in which certain cells in the bladder become abnormal and multiply uncontrollably to form a tumor. The bladder is a muscular organ in the lower abdomen that stores urine until it can be removed (excreted) from the body.Bladder cancer may cause blood in the urine, pain during urination, frequent urination, the feeling of needing to urinate without being able to, or lower back pain. Many of these signs and symptoms are nonspecific, which means they may occur in multiple disorders. People who have one or more of these nonspecific health problems often do not have bladder cancer, but another condition such as an infection.The most common type of bladder cancer, called non-muscle invasive bladder cancer (NMIBC), involves cells lining the inside of the bladder. NMIBC generally does not spread to other tissues (metastasize), but it often does recur after it has been treated. The other type, called muscle-invasive bladder cancer (MIBC), involves cells of the muscle wall of the bladder. MIBC generally does metastasize and is often life-threatening.","type":"Disease","alternate_names":["Bladder cancer","Malignant tumor of urinary bladder","Urinary Bladder Neoplasms"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0001187\"}","{\"db\":\"OMIM\",\"id\":\"109800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"157980\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Bladder+cancer/7822\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Malignant tumor of urinary bladder\"}","{\"db\":\"SNOMED CT\",\"id\":\"399326009\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Malignant tumor of urinary bladder\"}","{\"db\":\"MeSH\",\"id\":\"D001749\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Urinary Bladder Neoplasms\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0001187\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"bladder-cancer\",\"ref_field\":\"public_definition\"}"],"id":"4675","name":"Urinary bladder cancer"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301696\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1523\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"Int'l 22q11.2 Del Syndrome Consortium, 2011\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3197829\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"EuroGenetest, 2010\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"2987430\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"Fung et al., 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25569435\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"27467454\",\"@Source\":\"PubMed\"}}]}","disease_mechanism_id":"273","medgen_id":"C0220704","public_definition":"Individuals with 22q11.2 deletion syndrome (22q11.2DS) can present with a wide range of features that are highly variable, even within families. The major clinical manifestations of 22q11.2DS include congenital heart disease, particularly conotruncal malformations (ventricular septal defect, tetralogy of Fallot, interrupted aortic arch, and truncus arteriosus), palatal abnormalities (velopharyngeal incompetence, submucosal cleft palate, bifid uvula, and cleft palate), immune deficiency, characteristic facial features, and learning difficulties. Hearing loss can be sensorineural and/or conductive. Laryngotracheoesophageal, gastrointestinal, ophthalmologic, central nervous system, skeletal, and genitourinary anomalies also occur. Psychiatric illness and autoimmune disorders are more common in individuals with 22q11.2DS.","type":"Disease","symbol":"VCFS","alternate_names":["CHROMOSOME 22q11.2 DELETION SYNDROME","Shprintzen VCF syndrome","Takao vcf syndrome","VCF SYNDROME","VCF syndome","Velocardiofacial syndrome"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008644\"}","{\"db\":\"OMIM\",\"id\":\"192430\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"567\"}","{\"db\":\"OMIM\",\"id\":\"192430\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHROMOSOME 22q11.2 DELETION SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"192430\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"VCF SYNDROME\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008644\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Velocardiofacial syndrome\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000013538\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000332446\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000335344\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501119\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520911\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529038\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000531722\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556723\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"SNOMED CT\",\"id\":\"83092002\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1523\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"192430\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4485","disease_mechanism":"loss of function","name":"Shprintzen syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"31600044\",\"@Source\":\"PubMed\"},{\"$\":\"NBK547595\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C1864498","public_definition":"Individuals with hereditary distal renal tubular acidosis (dRTA) typically present in infancy with failure to thrive, although later presentations can occur, especially in individuals with autosomal dominant SLC4A1-dRTA. Initial clinical manifestations can also include emesis, polyuria, polydipsia, constipation, diarrhea, decreased appetite, and episodes of dehydration. Electrolyte manifestations include hyperchloremic non-anion gap metabolic acidosis and hypokalemia. Renal complications of dRTA include nephrocalcinosis, nephrolithiasis, medullary cysts, and impaired renal function. Additional manifestations include bone demineralization (rickets, osteomalacia), growth deficiency, sensorineural hearing loss (in ATP6V0A4-, ATP6V1B1-, and FOXI1-dRTA), and hereditary hemolytic anemia (in some individuals with SLC4A1-dRTA).","type":"Disease","symbol":"RTADR","alternate_names":["RTA, distal, autosomal recessive","Renal tubular acidosis, autosomal recessive with preserved hearing"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"602722\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"402041\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Renal+tubular+acidosis%2C+distal%2C+autosomal+recessive/6215\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK547595\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"602722\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4322","name":"Renal tubular acidosis, distal, autosomal recessive"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301384\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1205\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"MDA Consensus document - CMT testing, 2011\",\"@Type\":\"general\",\"ID\":{\"$\":\"3058597\",\"@Source\":\"pmc\"}}]}","gard_id":"9190","medgen_id":"C3495591","public_definition":"Charcot-Marie-Tooth disease encompasses a group of disorders called hereditary sensory and motor neuropathies that damage the peripheral nerves. Peripheral nerves connect the brain and spinal cord to muscles and to sensory cells that detect sensations such as touch, pain, heat, and sound. Damage to the peripheral nerves that worsens over time can result in alteration or loss of sensation and wasting (atrophy) of muscles in the feet, legs, and hands.Charcot-Marie-Tooth disease usually becomes apparent in adolescence or early adulthood, but onset may occur anytime from early childhood through late adulthood. Symptoms of Charcot-Marie-Tooth disease vary in severity and age of onset even among members of the same family. Some people never realize they have the disorder because their symptoms are so mild, but most have a moderate amount of physical disability. A small percentage of people experience severe weakness or other problems which, in very rare cases, can be life-threatening. In most affected individuals, however, Charcot-Marie-Tooth disease does not affect life expectancy.Typically, the earliest symptoms of Charcot-Marie-Tooth disease result from muscle atrophy in the feet. Affected individuals may have foot abnormalities such as high arches (pes cavus), flat feet (pes planus), or curled toes (hammer toes). They often have difficulty flexing the foot or walking on the heel of the foot. These difficulties may cause a higher than normal step (steppage gait) and increase the risk of ankle injuries and tripping. As the disease worsens, muscles in the lower legs usually weaken, but leg and foot problems rarely require the use of a wheelchair.Affected individuals may also develop weakness in the hands, causing difficulty with daily activities such as writing, fastening buttons, and turning doorknobs. People with Charcot-Marie-Tooth disease typically experience a decreased sensitivity to touch, heat, and cold in the feet and lower legs, but occasionally feel aching or burning sensations. In rare cases, affected individuals have loss of vision or gradual hearing loss that sometimes leads to deafness.There are several types of Charcot-Marie-Tooth disease, which are differentiated by their effects on nerve cells and patterns of inheritance. Type 1 (CMT1) is characterized by abnormalities in myelin, the fatty substance that covers nerve cells, protecting them and helping to transmit nerve impulses. These abnormalities slow the transmission of nerve impulses and can affect the health of the nerve fiber. Type 2 (CMT2) is characterized by abnormalities in the fiber, or axon, that extends from a nerve cell body to muscles or to sense organs. These abnormalities reduce the strength of the nerve impulse. In forms of Charcot-Marie-Tooth disease classified as intermediate type, the nerve impulses are both slowed and reduced in strength, probably due to abnormalities in both myelin and axons. Type 4 (CMT4) is distinguished from the other types by its pattern of inheritance; it can affect either the axons or the myelin. Type X Charcot-Marie-Tooth disease (CMTX) is caused by mutations in genes on the X chromosome, one of the two sex chromosomes. Within the various types of Charcot-Marie-Tooth disease, subtypes (such as CMT1A, CMT1B, CMT2A, CMT4A, and CMTX1) indicate different genetic causes.Sometimes other, historical names are used to refer to particular forms of Charcot-Marie-Tooth disease. For example, Roussy-Levy syndrome is a form of CMT11 with the additional feature of rhythmic shaking (tremors). Dejerine-Sottas syndrome is a term sometimes used to describe a severe, early childhood form of Charcot-Marie-Tooth disease; it is also sometimes called type 3 (CMT3). Depending on the specific gene that is altered, this severe, early-onset form of the disorder may also be classified as CMT1 or CMT4. CMTX5 is also known as Rosenberg-Chutorian syndrome.","type":"Disease","symbol":"CMT1E","alternate_names":["CMT 1E","Charcot-Marie-Tooth Neuropathy Type 1E","Charcot-Marie-Tooth disease, demyelinating, Type 1E","Charcot-Marie-Tooth disease, type 1E","Charcot-Marie-Tooth neuropathy and deafness, autosomal dominant"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"118300\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"90658\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Charcot-Marie-Tooth+Disease+Type+1E/1288\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Charcot-Marie-Tooth disease, type 1E\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9190\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"charcot-marie-tooth-disease\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"118300\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4778","name":"Charcot-Marie-Tooth disease and deafness"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301532\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1358\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C1843183","public_definition":"Charcot-Marie-Tooth disease encompasses a group of disorders called hereditary sensory and motor neuropathies that damage the peripheral nerves. Peripheral nerves connect the brain and spinal cord to muscles and to sensory cells that detect sensations such as touch, pain, heat, and sound. Damage to the peripheral nerves that worsens over time can result in alteration or loss of sensation and wasting (atrophy) of muscles in the feet, legs, and hands.Charcot-Marie-Tooth disease usually becomes apparent in adolescence or early adulthood, but onset may occur anytime from early childhood through late adulthood. Symptoms of Charcot-Marie-Tooth disease vary in severity and age of onset even among members of the same family. Some people never realize they have the disorder because their symptoms are so mild, but most have a moderate amount of physical disability. A small percentage of people experience severe weakness or other problems which, in very rare cases, can be life-threatening. In most affected individuals, however, Charcot-Marie-Tooth disease does not affect life expectancy.Typically, the earliest symptoms of Charcot-Marie-Tooth disease result from muscle atrophy in the feet. Affected individuals may have foot abnormalities such as high arches (pes cavus), flat feet (pes planus), or curled toes (hammer toes). They often have difficulty flexing the foot or walking on the heel of the foot. These difficulties may cause a higher than normal step (steppage gait) and increase the risk of ankle injuries and tripping. As the disease worsens, muscles in the lower legs usually weaken, but leg and foot problems rarely require the use of a wheelchair.Affected individuals may also develop weakness in the hands, causing difficulty with daily activities such as writing, fastening buttons, and turning doorknobs. People with Charcot-Marie-Tooth disease typically experience a decreased sensitivity to touch, heat, and cold in the feet and lower legs, but occasionally feel aching or burning sensations. In rare cases, affected individuals have loss of vision or gradual hearing loss that sometimes leads to deafness.There are several types of Charcot-Marie-Tooth disease, which are differentiated by their effects on nerve cells and patterns of inheritance. Type 1 (CMT1) is characterized by abnormalities in myelin, the fatty substance that covers nerve cells, protecting them and helping to transmit nerve impulses. These abnormalities slow the transmission of nerve impulses and can affect the health of the nerve fiber. Type 2 (CMT2) is characterized by abnormalities in the fiber, or axon, that extends from a nerve cell body to muscles or to sense organs. These abnormalities reduce the strength of the nerve impulse. In forms of Charcot-Marie-Tooth disease classified as intermediate type, the nerve impulses are both slowed and reduced in strength, probably due to abnormalities in both myelin and axons. Type 4 (CMT4) is distinguished from the other types by its pattern of inheritance; it can affect either the axons or the myelin. Type X Charcot-Marie-Tooth disease (CMTX) is caused by mutations in genes on the X chromosome, one of the two sex chromosomes. Within the various types of Charcot-Marie-Tooth disease, subtypes (such as CMT1A, CMT1B, CMT2A, CMT4A, and CMTX1) indicate different genetic causes.Sometimes other, historical names are used to refer to particular forms of Charcot-Marie-Tooth disease. For example, Roussy-Levy syndrome is a form of CMT11 with the additional feature of rhythmic shaking (tremors). Dejerine-Sottas syndrome is a term sometimes used to describe a severe, early childhood form of Charcot-Marie-Tooth disease; it is also sometimes called type 3 (CMT3). Depending on the specific gene that is altered, this severe, early-onset form of the disorder may also be classified as CMT1 or CMT4. CMTX5 is also known as Rosenberg-Chutorian syndrome.","type":"Disease","alternate_names":["CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE","CMT2 WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE","Charcot-Marie-Tooth disease, Type 4A, axonal form"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011898\"}","{\"db\":\"OMIM\",\"id\":\"607706\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"101097\"}","{\"db\":\"OMIM\",\"id\":\"607706\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"607706\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CMT2 WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Charcot-Marie-Tooth+disease%2C+axonal%2C+with+vocal+cord+paresis%2C+autosomal+recessive/7952\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"charcot-marie-tooth-disease\",\"ref_field\":\"public_definition\"}"],"id":"1418","name":"Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive"}
{"attribute_content":[],"alternate_symbols":["SPG8"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301727\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1827\",\"@Source\":\"BookShelf\"}]}}","gard_id":"9591","medgen_id":"C1863704","public_definition":"Hereditary spastic paraplegia 8 (SPG8) is a slowly progressive pure spastic paraplegia of the lower limbs (i.e., pyramidal signs including hyperreflexia, spasticity, and occasionally clonus without other neurologic findings). Some affected individuals have urinary urgency that usually becomes apparent at the same time as the spasticity. Onset is between ages ten and 59 years. Affected individuals often become wheelchair dependent. While intra- and interfamilial phenotypic variability is high, SPG8 is typically more severe than other types of hereditary spastic paraplegia.","type":"Disease","alternate_names":["SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT","Spastic paraplegia 8"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011339\"}","{\"db\":\"OMIM\",\"id\":\"603563\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"100989\"}","{\"db\":\"OMIM\",\"id\":\"603563\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"610657.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"610657.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"610657.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"610657.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Spastic+paraplegia+8/6700\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Spastic paraplegia 8\"}","{\"db\":\"OMIM\",\"id\":\"603563\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SPG8\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9591\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011339\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1827\",\"ref_field\":\"public_definition\"}"],"id":"4416","name":"Hereditary spastic paraplegia 8"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3553943","public_definition":"STK4 deficiency results in a primary T-cell immunodeficiency syndrome characterized by progressive loss of naive T cells, recurrent bacterial, viral, and fungal infections, warts, and abscesses, autoimmune manifestations, and cardiac malformations, including atrial septal defect (Abdollahpour et al., 2012; Nehme et al., 2012).","type":"Disease","symbol":"TIIAC","alternate_names":["MST1 DEFICIENCY","STK4 DEFICIENCY","T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AUTOIMMUNITY, AND CARDIAC MALFORMATIONS"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614868\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"314689\"}","{\"db\":\"OMIM\",\"id\":\"614868\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MST1 DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"614868\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"STK4 DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"604965.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AUTOIMMUNITY, AND CARDIAC MALFORMATIONS\"}","{\"db\":\"OMIM\",\"id\":\"604965.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AUTOIMMUNITY, AND CARDIAC MALFORMATIONS\"}","{\"db\":\"OMIM\",\"id\":\"604965.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AUTOIMMUNITY, AND CARDIAC MALFORMATIONS\"}","{\"db\":\"OMIM\",\"id\":\"614868\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614868\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17416","name":"T-cell immunodeficiency, recurrent infections, and autoimmunity with or without cardiac malformations"}
{"attribute_content":[],"alternate_symbols":["MRXSL"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301461\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1284\",\"@Source\":\"BookShelf\"}]}}","gard_id":"9781","medgen_id":"C1846058","public_definition":"MECP2 duplication syndrome is a severe neurodevelopmental disorder characterized by early-onset hypotonia, feeding difficulty, gastrointestinal manifestations including gastroesophageal reflux and constipation, delayed psychomotor development leading to severe intellectual disability, poor speech development, progressive spasticity, recurrent respiratory infections (in ~75% of affected individuals), and seizures (in ~50%). MECP2 duplication syndrome is 100% penetrant in males. Occasionally females have been described with a MECP2 duplication and a range of findings from mild intellectual disability to a phenotype similar to that seen in males. In addition to the core features, autistic behaviors, nonspecific neuroradiologic findings on brain MRI, mottled skin, and urogenital anomalies have been observed in several affected boys.","type":"Disease","alternate_names":["Lubs X-linked mental retardation syndrome","MECP2 duplication syndrome","MENTAL RETARDATION, X-LINKED, SYNDROMIC, LUBS TYPE","MENTAL RETARDATION, X-LINKED, WITH RECURRENT RESPIRATORY INFECTIONS","Mental retardation, X-linked, Lubs type","XLMR syndrome, Lubs type"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010283\"}","{\"db\":\"OMIM\",\"id\":\"300260\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1762\"}","{\"db\":\"Genetic Alliance\",\"id\":\"MECP2+duplication+syndrome/4540\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MECP2 duplication syndrome\"}","{\"db\":\"OMIM\",\"id\":\"300260\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, SYNDROMIC, LUBS TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300260\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, WITH RECURRENT RESPIRATORY INFECTIONS\"}","{\"db\":\"OMIM\",\"id\":\"300260\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRXSL\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9781\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010283\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1284\",\"ref_field\":\"public_definition\"}"],"id":"2613","name":"Syndromic X-linked intellectual disability Lubs type"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301471\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1294\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301534\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1360\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"NSGC, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15604628\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"32352694\",\"@Source\":\"PubMed\"},{\"$\":\"NBK556455\",\"@Source\":\"BookShelf\"}]}]}","medgen_id":"CN033288","public_definition":"PAX6-related aniridia occurs either as an isolated ocular abnormality or as part of the Wilms tumor-aniridia-genital anomalies-retardation (WAGR) syndrome. Aniridia is a pan ocular disorder affecting the cornea, iris, intraocular pressure (resulting in glaucoma), lens (cataract and lens subluxation), fovea (foveal hypoplasia), and optic nerve (optic nerve coloboma and hypoplasia). Individuals with aniridia characteristically show nystagmus and impaired visual acuity (usually 20/100 - 20/200); however, milder forms of aniridia with subtle iris architecture changes, good vision, and normal foveal structure do occur. Other ocular involvement may include strabismus and occasionally microphthalmia. Although the severity of aniridia can vary between and within families, little variability is usually observed in the two eyes of an affected individual. WAGR syndrome. The risk for Wilms tumor is 42.5%-77%; of those who develop Wilms tumor, 90% do so by age four years and 98% by age seven years. Genital anomalies in males can include cryptorchidism and hypospadias (sometimes resulting in ambiguous genitalia), urethral strictures, ureteric abnormalities, and gonadoblastoma. While females typically have normal external genitalia, they may have uterine abnormalities and streak ovaries. Intellectual disability (defined as IQ \u003c74) is observed in 70%; behavioral abnormalities include attention deficit hyperactivity disorder (ADHD), autism spectrum disorder, anxiety, depression, and obsessive-compulsive disorder. Other individuals with WAGR syndrome can have normal intellect without behavioral problems.","type":"Disease","symbol":"WT1","alternate_names":["Bilateral Wilms tumor","Familial Wilms tumor 2","Wilms tumor, somatic","Wilms' tumor"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008679\"}","{\"db\":\"OMIM\",\"id\":\"194070\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"654\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Wilms%27+tumor/7505\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Wilms' tumor\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1360\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"194070\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4506","name":"Wilms tumor 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3279722","public_definition":"Williams distal myopathy is an autosomal dominant slowly progressive muscular disorder characterized by distal muscle weakness and atrophy affecting the upper and lower limbs. Onset occurs around the third to fourth decades of life, and patients remain ambulatory even after long disease duration. Muscle biopsy shows nonspecific changes with no evidence of rods, necrosis, or inflammation (summary by Duff et al., 2011).\r\nMutation in the FLNC gene can also cause myofibrillar myopathy-5 (MFM5; 609524), which shows a different pattern of muscle involvement and different histologic changes.","type":"Disease","symbol":"MPD4","alternate_names":["WILLIAMS DISTAL MYOPATHY"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614065\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"63273\"}","{\"db\":\"OMIM\",\"id\":\"614065\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"WILLIAMS DISTAL MYOPATHY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Myopathy%2C+distal%2C+4/8952\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614065\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614065\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"16113","name":"Myopathy, distal, 4"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301403\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1224\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"MMS, 2014\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"25503498\",\"@Source\":\"PubMed\"}}]}","medgen_id":"C0751651","public_definition":"Mitochondrial diseases are a clinically heterogeneous group of disorders that arise as a result of dysfunction of the mitochondrial respiratory chain. They can be caused by mutation of genes encoded by either nuclear DNA or mitochondrial DNA (mtDNA). While some mitochondrial disorders only affect a single organ (e.g., the eye in Leber hereditary optic neuropathy [LHON]), many involve multiple organ systems and often present with prominent neurologic and myopathic features. Mitochondrial disorders may present at any age. Many individuals with a mutation of mtDNA display a cluster of clinical features that fall into a discrete clinical syndrome, such as the Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia (CPEO), mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), myoclonic epilepsy with ragged-red fibers (MERRF), neurogenic weakness with ataxia and retinitis pigmentosa (NARP), or Leigh syndrome (LS). However, considerable clinical variability exists and many individuals do not fit neatly into one particular category, which is well-illustrated by the overlapping spectrum of disease phenotypes (including mitochondrial recessive ataxia syndrome (MIRAS) resulting from mutation of the nuclear gene POLG, which has emerged as a major cause of mitochondrial disease. Common clinical features of mitochondrial disease â whether involving a mitochondrial or nuclear gene â include ptosis, external ophthalmoplegia, proximal myopathy and exercise intolerance, cardiomyopathy, sensorineural deafness, optic atrophy, pigmentary retinopathy, and diabetes mellitus. Common central nervous system findings are fluctuating encephalopathy, seizures, dementia, migraine, stroke-like episodes, ataxia, and spasticity. A high incidence of mid- and late pregnancy loss is a common occurrence that often goes unrecognized.","type":"Disease","alternate_names":["Mitochondrial disease"],"xrefs":["{\"db\":\"Orphanet\",\"id\":\"68380\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mitochondrial+Disorders/4830\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1224\",\"ref_field\":\"public_definition\"}"],"id":"9530","name":"Mitochondrial diseases"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301304\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1125\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301481\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1304\",\"@Source\":\"BookShelf\"}]}]}","medgen_id":"C0268374","public_definition":"Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.","type":"Disease","symbol":"GABEB","alternate_names":["Adult junctional epidermolysis bullosa","EPIDERMOLYSIS BULLOSA JUNCTIONALIS, NON-HERLITZ TYPE","Epidermolysis bullosa junctionalis, disentis type","Epidermolysis bullosa junctionalis, progressive","Epidermolysis bullosa junctionalis, severe nonlethal","Epidermolysis bullosa, generalized atrophic benign","Epidermolysis bullosa, junctional, non-herlitz type, somatic mosaic revertant"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"226650\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"251393\"}","{\"db\":\"Orphanet\",\"id\":\"79402\"}","{\"db\":\"Orphanet\",\"id\":\"79405\"}","{\"db\":\"Orphanet\",\"id\":\"89840\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Adult+junctional+epidermolysis+bullosa/7640\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Adult junctional epidermolysis bullosa\"}","{\"db\":\"SNOMED CT\",\"id\":\"33662006\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Adult junctional epidermolysis bullosa\"}","{\"db\":\"OMIM\",\"id\":\"226650\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EPIDERMOLYSIS BULLOSA JUNCTIONALIS, NON-HERLITZ TYPE\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009180\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1125\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"226650\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5023","name":"Junctional epidermolysis bullosa, non-Herlitz type"}
{"attribute_content":[],"alternate_symbols":[],"keywords":["Hereditary cancer syndrome"],"gard_id":"3108","medgen_id":"C0022603","public_definition":"Seborrheic keratoses are common benign epidermal lesion that can develop on any part of the body.","type":"Disease","alternate_names":["Keratosis Seborrheica","Keratosis, seborrheic, somatic","Seborrheic keratoses"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008420\"}","{\"db\":\"OMIM\",\"id\":\"182000\",\"type\":\"MIM\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3108\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Keratosis%2C+seborrheic/3987\",\"ref_field\":\"name\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008420\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"182000\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}"],"id":"5363","name":"Seborrheic keratosis"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"23230576\",\"@Source\":\"PubMed\"},{\"$\":\"NBK114628\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C3149750","public_definition":"TK2-related mitochondrial DNA (mtDNA) maintenance defect is a phenotypic continuum that ranges from severe to mild. To date, approximately 107 individuals with a molecularly confirmed diagnosis have been reported. Three main subtypes of presentation have been described: Infantile-onset myopathy with neurologic involvement and rapid progression to early death. Affected individuals experience progressive muscle weakness leading to respiratory failure. Some individuals develop dysarthria, dysphagia, and/or hearing loss. Cognitive function is typically spared. Juvenile/childhood onset with generalized proximal weakness and survival to at least 13 years. Late-/adult-onset myopathy with facial and limb weakness and mtDNA deletions. Some affected individuals develop respiratory insufficiency, chronic progressive external ophthalmoplegia, dysphagia, and dysarthria.","type":"Disease","symbol":"MTDPS2","alternate_names":["MITOCHONDRIAL DNA DEPLETION MYOPATHY, TK2-RELATED","MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)","TK2-Related Mitochondrial DNA Depletion Syndrome, Myopathic Form"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"609560\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"254875\"}","{\"db\":\"OMIM\",\"id\":\"609560\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION MYOPATHY, TK2-RELATED\"}","{\"db\":\"OMIM\",\"id\":\"188250.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)\"}","{\"db\":\"OMIM\",\"id\":\"188250.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)\"}","{\"db\":\"OMIM\",\"id\":\"188250.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)\"}","{\"db\":\"OMIM\",\"id\":\"188250.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)\"}","{\"db\":\"OMIM\",\"id\":\"188250.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)\"}","{\"db\":\"OMIM\",\"id\":\"188250.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)\"}","{\"db\":\"OMIM\",\"id\":\"609560\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK114628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"TK2-Related Mitochondrial DNA Depletion Syndrome, Myopathic Form\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mitochondrial+DNA+depletion+syndrome+2/8897\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK114628\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"609560\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2956","name":"Mitochondrial DNA depletion syndrome 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301597\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1424\",\"@Source\":\"BookShelf\"}]}}","gard_id":"540","medgen_id":"C0220710","public_definition":"Medium-chain acyl-coenzyme A dehydrogenase (MCAD) is one of the enzymes involved in mitochondrial fatty acid Ã-oxidation. Fatty acid Ã-oxidation fuels hepatic ketogenesis, which provides a major source of energy once hepatic glycogen stores become depleted during prolonged fasting and periods of higher energy demands. MCAD deficiency is the most common disorder of fatty acid Ã-oxidation and one of the most common inborn errors of metabolism. Most children are now diagnosed through newborn screening. Clinical symptoms in a previously apparently healthy child with MCAD deficiency include hypoketotic hypoglycemia and vomiting that may progress to lethargy, seizures, and coma triggered by a common illness. Hepatomegaly and liver disease are often present during an acute episode. Children appear normal at birth and â if not identified through newborn screening â typically present between age three and 24 months, although presentation even as late as adulthood is possible. The prognosis is excellent once the diagnosis is established and frequent feedings are instituted to avoid any prolonged periods of fasting.","type":"Disease","symbol":"ACADMD","alternate_names":["CARNITINE DEFICIENCY SECONDARY TO MEDIUM-CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY","MCADD","Medium chain acyl-CoA dehydrogenase deficiency"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008721\"}","{\"db\":\"OMIM\",\"id\":\"201450\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"42\"}","{\"db\":\"OMIM\",\"id\":\"201450\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CARNITINE DEFICIENCY SECONDARY TO MEDIUM-CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008721\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Medium chain acyl-CoA dehydrogenase deficiency\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"540\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Medium-chain+acyl-coenzyme+A+dehydrogenase+deficiency/4547\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"128596003\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1424\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"201450\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"81","name":"Medium-chain acyl-coenzyme A dehydrogenase deficiency"}
{"attribute_content":[],"alternate_symbols":["TCOF","TCS"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301704\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1532\",\"@Source\":\"BookShelf\"}]}}","gard_id":"9124","medgen_id":"C0242387","public_definition":"Treacher Collins syndrome (TCS) is characterized by bilateral and symmetric downslanting palpebral fissures, malar hypoplasia, micrognathia, and external ear abnormalities. Hypoplasia of the zygomatic bones and mandible can cause significant feeding and respiratory difficulties. About 40%-50% of individuals have conductive hearing loss attributed most commonly to malformation of the ossicles and hypoplasia of the middle ear cavities. Inner ear structures tend to be normal. Other, less common abnormalities include cleft palate and unilateral or bilateral choanal stenosis or atresia. Typically intellect is normal.","type":"Disease","alternate_names":["Treacher Collins-Franceschetti syndrome"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005321\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0002457\"}","{\"db\":\"OMIM\",\"id\":\"PS154500\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"861\"}","{\"db\":\"OMIM\",\"id\":\"154500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"TCOF\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9124\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"treacher-collins-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS154500\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"82203000\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1532\",\"ref_field\":\"public_definition\"}"],"id":"6070","name":"Treacher Collins syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301622\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1449\",\"@Source\":\"BookShelf\"}]}}","gard_id":"5864","medgen_id":"C1845055","public_definition":"Alpha-thalassemia X-linked intellectual disability (ATR-X) syndrome is characterized by distinctive craniofacial features, genital anomalies, hypotonia, and mild-to-profound developmental delay / intellectual disability (DD/ID). Craniofacial abnormalities include small head circumference, telecanthus or widely spaced eyes, short triangular nose, tented upper lip, and thick or everted lower lip with coarsening of the facial features over time. While all affected individuals have a normal 46,XY karyotype, genital anomalies comprise a range from hypospadias and undescended testicles, to severe hypospadias and ambiguous genitalia, to normal-appearing female external genitalia. Alpha-thalassemia, observed in about 75% of affected individuals, is mild and typically does not require treatment. Osteosarcoma has been reported in a few males with germline pathogenic variants.","type":"Disease","symbol":"ATRX","alternate_names":["ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED","ATR, nondeletion type","ATR-X syndrome","Alpha thalassemia mental retardation syndrome, nondeletion type, X-linked","Alpha-Thalassemia X-Linked Intellectual Disability  Syndrome","XLMR hypotonic face syndrome"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010519\"}","{\"db\":\"OMIM\",\"id\":\"301040\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"847\"}","{\"db\":\"OMIM\",\"id\":\"300032.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300032.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300032.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300032.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300032.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300032.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300032.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300032.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300032.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300032.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300032.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300032.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300032.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300032.0018\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300032.0019\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"301040\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED\"}","{\"db\":\"Genetic Alliance\",\"id\":\"ATR-X+Syndrome/647\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ATR-X syndrome\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5864\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010519\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1449\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"301040\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"281","name":"Alpha thalassemia-X-linked intellectual disability syndrome"}
{"attribute_content":[],"alternate_symbols":["SFM1","SFMS"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301622\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1449\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C0796003","public_definition":"Alpha-thalassemia X-linked intellectual disability (ATR-X) syndrome is characterized by distinctive craniofacial features, genital anomalies, hypotonia, and mild-to-profound developmental delay / intellectual disability (DD/ID). Craniofacial abnormalities include small head circumference, telecanthus or widely spaced eyes, short triangular nose, tented upper lip, and thick or everted lower lip with coarsening of the facial features over time. While all affected individuals have a normal 46,XY karyotype, genital anomalies comprise a range from hypospadias and undescended testicles, to severe hypospadias and ambiguous genitalia, to normal-appearing female external genitalia. Alpha-thalassemia, observed in about 75% of affected individuals, is mild and typically does not require treatment. Osteosarcoma has been reported in a few males with germline pathogenic variants.","type":"Disease","symbol":"MRXHF1","alternate_names":["CHUDLEY-LOWRY SYNDROME","Carpenter-Waziri syndrome","Chudley Lowry Hoar syndrome","Chudley mental retardation syndrome","Chudley syndrome 1","Holmes-Gang syndrome","Juberg-Marsidi syndrome","Mental retardation, X-linked, with growth retardation, deafness, and microgenitalism","Smith Fineman Myers syndrome 1","XLMR-HYPOTONIC FACIES SYNDROME"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"309580\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"73220\"}","{\"db\":\"Orphanet\",\"id\":\"93970\"}","{\"db\":\"Orphanet\",\"id\":\"93971\"}","{\"db\":\"Orphanet\",\"id\":\"93972\"}","{\"db\":\"Orphanet\",\"id\":\"93973\"}","{\"db\":\"Orphanet\",\"id\":\"93974\"}","{\"db\":\"Orphanet\",\"id\":\"93975\"}","{\"db\":\"OMIM\",\"id\":\"309580\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHUDLEY-LOWRY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"309580\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"XLMR-HYPOTONIC FACIES SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"309580\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SFM1\"}","{\"db\":\"OMIM\",\"id\":\"309580\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SFMS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mental+retardation-hypotonic+facies+syndrome+X-linked%2C+1/4666\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1449\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"309580\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5503","name":"Mental retardation-hypotonic facies syndrome X-linked, 1"}
{"attribute_content":[],"alternate_symbols":["LISX","XLIS"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301364\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1185\",\"@Source\":\"BookShelf\"}]}}","gard_id":"6914","medgen_id":"C4551968","public_definition":"DCX-related disorders include the neuronal migration disorders: Classic thick lissencephaly (more severe anteriorly), usually in males. Subcortical band heterotopia (SBH), primarily in females. Males with classic DCX-related lissencephaly typically have early and profound cognitive and language impairment, cerebral palsy, and epileptic seizures. The clinical phenotype in females with SBH varies widely with cognitive abilities that range from average or mild cognitive impairment to severe intellectual disability and language impairment. Seizures, which frequently are refractory to antiepileptic medication, may be either focal or generalized and behavioral problems may also be observed. In DCX-related lissencephaly and SBH the severity of the clinical manifestation correlates roughly with the degree of the underlying brain malformation as observed in cerebral imaging.","type":"Disease","symbol":"LISX1","alternate_names":["LISSENCEPHALY, X-LINKED, 1","Lissencephaly and agenesis of corpus callosum"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"300067\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2148\"}","{\"db\":\"OMIM\",\"id\":\"300067\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LISSENCEPHALY, X-LINKED, 1\"}","{\"db\":\"OMIM\",\"id\":\"300121.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LISSENCEPHALY, X-LINKED, 1\"}","{\"db\":\"OMIM\",\"id\":\"300121.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LISSENCEPHALY, X-LINKED, 1\"}","{\"db\":\"OMIM\",\"id\":\"300121.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LISSENCEPHALY, X-LINKED, 1\"}","{\"db\":\"OMIM\",\"id\":\"300121.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LISSENCEPHALY, X-LINKED, 1\"}","{\"db\":\"OMIM\",\"id\":\"300121.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LISSENCEPHALY, X-LINKED, 1\"}","{\"db\":\"OMIM\",\"id\":\"300121.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LISSENCEPHALY, X-LINKED, 1\"}","{\"db\":\"OMIM\",\"id\":\"300121.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LISSENCEPHALY, X-LINKED, 1\"}","{\"db\":\"OMIM\",\"id\":\"300121.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LISSENCEPHALY, X-LINKED, 1\"}","{\"db\":\"OMIM\",\"id\":\"300067\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"XLIS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6914\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Lissencephaly+X-linked/4273\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1185\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"300067\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2610","name":"Lissencephaly, X-linked"}
{"attribute_content":[],"alternate_symbols":["RYR1-CMD","RYR1-RM"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301467\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1290\",\"@Source\":\"BookShelf\"}]}}","gard_id":"9130","medgen_id":"C2673970","public_definition":"Multiminicore disease is a disorder that primarily affects muscles used for movement (skeletal muscles). This condition causes muscle weakness and related health problems that range from mild to life-threatening.Researchers have identified at least four forms of multiminicore disease, which can be distinguished by their characteristic signs and symptoms. The forms of multiminicore disease are the classic form, the progressive form with hand involvement, the antenatal form with arthrogryposis, and the ophthalmoplegic form.The classic form accounts for about 75 percent of cases of multiminicore disease. This form causes muscle weakness beginning in infancy or early childhood. The muscles of the torso and neck (axial muscles) are most affected with arm and leg muscles less so. Muscle weakness causes affected infants to appear \"floppy\" (hypotonic) and they may have feeding problems early in life. Muscle weakness can delay the development of motor skills such as sitting, standing, and walking. In this form, the muscles of the ribcage and spine become stiff. In addition, the muscles needed for breathing are weak. This combination of muscle weakness and stiffness leads to severe or life-threatening respiratory problems. Almost all children with the classic form develop an abnormal curvature of the spine (scoliosis), which appears during childhood and steadily worsens over time.The progressive form with hand involvement causes muscle weakness and looseness of the joints (joint laxity) in the arms and hands. Individuals with this form may experience muscle pain (myalgia) or extreme fatigue in response to physical activity (exercise intolerance). This form accounts for about 10 percent of cases of multiminicore disease.The antenatal form with arthrogryposis is characterized by stiff, rigid joints throughout the body (arthrogryposis) and distinctive facial features. Weakness in the muscles needed for breathing can result in breathing problems for affected individuals. This form also accounts for about 10 percent of cases of multiminicore disease.The ophthalmoplegic form of multiminicore disease is characterized by paralysis of the eye muscles (external ophthalmoplegia). This can lead to abnormal eye movements and droopy eyelids (ptosis). This form of the condition can also cause weakness in the muscles close to the center of the body (proximal muscles), such as those of the upper arms and legs. The ophthalmoplegic form accounts for 5 to 10 percent of cases of multiminicore disease.Many people with multiminicore disease also have an increased risk of developing a severe reaction to certain drugs used during surgery and other invasive procedures. This reaction is called malignant hyperthermia. Malignant hyperthermia occurs in response to some anesthetic gases, which are used to block the sensation of pain, either given alone or in combination with a muscle relaxant that is used to temporarily paralyze a person during a surgical procedure. If given these drugs, people at risk of malignant hyperthermia may experience a rapid increase in heart rate (tachycardia) and body temperature (hyperthermia), abnormally fast breathing (tachypnea), muscle rigidity, breakdown of muscle fibers (rhabdomyolysis), and increased acid levels in the blood and other tissues (acidosis). The complications of malignant hyperthermia can be life-threatening unless they are treated promptly.Multiminicore disease gets its name from small, disorganized areas called minicores, which are found in skeletal muscle cells of many affected individuals. These abnormal regions can only been seen when muscle tissue is viewed under a microscope. Minicores are often present in cells with few or no mitochondria, which are the energy-producing centers within cells. Although the presence of minicores can help doctors diagnose multiminicore disease, it is unclear how they are related to muscle weakness and the other features of this condition.","type":"Disease","symbol":"MmD","alternate_names":["Multiminicore myopathy","RYR1-related multiminicore disease","RYR1-related myopathy"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0018948\"}","{\"db\":\"Orphanet\",\"id\":\"598\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0018948\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Multiminicore myopathy\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9130\",\"ref_field\":\"gard_id\"}","{\"db\":\"GeneTests\",\"id\":\"3129\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"multiminicore-disease\",\"ref_field\":\"public_definition\"}"],"id":"9533","name":"Multiminicore Disease"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301787\",\"@Source\":\"PubMed\"},{\"$\":\"NBK25565\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C1858726","public_definition":"Congenital cataracts, facial dysmorphism, and neuropathy (CCFDN) is characterized by abnormalities of the eye (bilateral congenital cataracts, microcornea, microphthalmia, micropupils); mildly dysmorphic facial features apparent in late childhood; and a hypo/demyelinating, symmetric, distal peripheral neuropathy. The neuropathy is predominantly motor at the onset and results in delays in early motor development, progressing to severe disability by the third decade. Secondary scoliosis and foot deformities are common. Sensory neuropathy develops after age ten years. Most affected individuals have a mild non-progressive intellectual deficit and cerebellar involvement including ataxia, nystagmus, intention tremor, and dysmetria. All have short stature and subnormal weight. Adults have hypogonadotropic hypogonadism. Parainfectious rhabdomyolysis (profound muscle weakness, myoglobinuria, and excessively elevated serum concentration of creatine kinase usually following a viral infection) is a potentially life-threatening complication. To date all affected individuals and carriers identified have been from the Roma/Gypsy population.","type":"Disease","symbol":"CCFDN","alternate_names":["CATARACT, CONGENITAL, WITH FACIAL DYSMORPHISM AND NEUROPATHY","Congenital Cataracts, Facial Dysmorphism, and Neuropathy"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011402\"}","{\"db\":\"OMIM\",\"id\":\"604168\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"48431\"}","{\"db\":\"OMIM\",\"id\":\"604168\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT, CONGENITAL, WITH FACIAL DYSMORPHISM AND NEUROPATHY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Congenital+Cataracts%2C+Facial+Dysmorphism%2C+and+Neuropathy/8047\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital Cataracts, Facial Dysmorphism, and Neuropathy\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011402\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK25565\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"604168\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"832","name":"Congenital cataracts-facial dysmorphism-neuropathy syndrome"}
{"attribute_content":[],"alternate_symbols":["SCAR9"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"28125198\",\"@Source\":\"PubMed\"},{\"$\":\"NBK410087\",\"@Source\":\"BookShelf\"}]}}","gard_id":"10294","medgen_id":"C2677589","public_definition":"Primary coenzyme Q10 (CoQ10) deficiency is usually associated with multisystem involvement, including neurologic manifestations such as fatal neonatal encephalopathy with hypotonia; a late-onset slowly progressive multiple-system atrophy-like phenotype (neurodegeneration with autonomic failure and various combinations of parkinsonism and cerebellar ataxia, and pyramidal dysfunction); and dystonia, spasticity, seizures, and intellectual disability. Steroid-resistant nephrotic syndrome (SRNS), the hallmark renal manifestation, is often the initial manifestation either as isolated renal involvement that progresses to end-stage renal disease (ESRD), or associated with encephalopathy (seizures, stroke-like episodes, severe neurologic impairment) resulting in early death. Hypertrophic cardiomyopathy (HCM), retinopathy or optic atrophy, and sensorineural hearing loss can also be seen.","type":"Disease","symbol":"COQ10D4","alternate_names":["Spinocerebellar ataxia, autosomal recessive 9"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"612016\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"139485\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Spinocerebellar+ataxia%2C+autosomal+recessive+9/9342\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Spinocerebellar ataxia, autosomal recessive 9\"}","{\"db\":\"OMIM\",\"id\":\"612016\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SCAR9\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10294\",\"ref_field\":\"gard_id\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK410087\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"612016\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5960","name":"Coenzyme Q10 deficiency, primary, 4"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"28125198\",\"@Source\":\"PubMed\"},{\"$\":\"NBK410087\",\"@Source\":\"BookShelf\"}]}}","gard_id":"10423","medgen_id":"C1843920","public_definition":"Primary coenzyme Q10 (CoQ10) deficiency is usually associated with multisystem involvement, including neurologic manifestations such as fatal neonatal encephalopathy with hypotonia; a late-onset slowly progressive multiple-system atrophy-like phenotype (neurodegeneration with autonomic failure and various combinations of parkinsonism and cerebellar ataxia, and pyramidal dysfunction); and dystonia, spasticity, seizures, and intellectual disability. Steroid-resistant nephrotic syndrome (SRNS), the hallmark renal manifestation, is often the initial manifestation either as isolated renal involvement that progresses to end-stage renal disease (ESRD), or associated with encephalopathy (seizures, stroke-like episodes, severe neurologic impairment) resulting in early death. Hypertrophic cardiomyopathy (HCM), retinopathy or optic atrophy, and sensorineural hearing loss can also be seen.","type":"Disease","alternate_names":["CoQ10 deficiency","CoQ10 deficiency, primary","Coenzyme Q10 deficiency"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0018151\"}","{\"db\":\"OMIM\",\"id\":\"PS607426\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"35656\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Coenzyme+Q10+Deficiency/1707\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Coenzyme Q10 deficiency\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0018151\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Coenzyme Q10 deficiency\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10423\",\"ref_field\":\"gard_id\"}","{\"db\":\"OMIM\",\"id\":\"PS607426\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK410087\",\"ref_field\":\"public_definition\"}"],"id":"33110","name":"Coenzyme Q10 deficiency, primary"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301773\",\"@Source\":\"PubMed\"},{\"$\":\"NBK9673\",\"@Source\":\"BookShelf\"}]}}","gard_id":"343","medgen_id":"C1856974","public_definition":"TSEN54 pontocerebellar hypoplasia (TSEN54-PCH) comprises three PCH phenotypes (PCH2, 4, and 5) that share characteristic neuroradiologic and neurologic findings. The three PCH phenotypes (which differ mainly in life expectancy) were considered to be distinct entities before their molecular basis was known. PCH2. Children usually succumb before age ten years (those with PCH4 and 5 usually succumb as neonates). Children with PCH2 have generalized clonus, uncoordinated sucking and swallowing, impaired cognitive development, lack of voluntary motor development, cortical blindness, and an increased risk for rhabdomyolysis during severe infections. Epilepsy is present in approximately 50%. PCH4. Neonates often have seizures, multiple joint contractures (\"arthrogryposis\"), generalized clonus, and central respiratory impairment. PCH5 resembles PCH4 and has been described in one family.","type":"Disease","symbol":"PCH4","alternate_names":["Encephalopathy fatal infantile with olivopontocerebellar hypoplasia"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009166\"}","{\"db\":\"OMIM\",\"id\":\"225753\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"166063\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"343\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pontocerebellar+hypoplasia+type+4/5866\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK9673\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"225753\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3365","name":"Pontocerebellar hypoplasia type 4"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301773\",\"@Source\":\"PubMed\"},{\"$\":\"NBK9673\",\"@Source\":\"BookShelf\"}]}}","gard_id":"3631","medgen_id":"C1848526","public_definition":"TSEN54 pontocerebellar hypoplasia (TSEN54-PCH) comprises three PCH phenotypes (PCH2, 4, and 5) that share characteristic neuroradiologic and neurologic findings. The three PCH phenotypes (which differ mainly in life expectancy) were considered to be distinct entities before their molecular basis was known. PCH2. Children usually succumb before age ten years (those with PCH4 and 5 usually succumb as neonates). Children with PCH2 have generalized clonus, uncoordinated sucking and swallowing, impaired cognitive development, lack of voluntary motor development, cortical blindness, and an increased risk for rhabdomyolysis during severe infections. Epilepsy is present in approximately 50%. PCH4. Neonates often have seizures, multiple joint contractures (\"arthrogryposis\"), generalized clonus, and central respiratory impairment. PCH5 resembles PCH4 and has been described in one family.","type":"Disease","symbol":"PCH2A","alternate_names":["PONTOCEREBELLAR HYPOPLASIA WITH PROGRESSIVE CEREBRAL ATROPHY","VOLENDAM NEURODEGENERATIVE DISEASE"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010190\"}","{\"db\":\"OMIM\",\"id\":\"277470\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2524\"}","{\"db\":\"OMIM\",\"id\":\"277470\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PONTOCEREBELLAR HYPOPLASIA WITH PROGRESSIVE CEREBRAL ATROPHY\"}","{\"db\":\"OMIM\",\"id\":\"277470\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"VOLENDAM NEURODEGENERATIVE DISEASE\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3631\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pontocerebellar+hypoplasia+type+2A/9133\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK9673\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"277470\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3519","name":"Pontocerebellar hypoplasia type 2A"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301773\",\"@Source\":\"PubMed\"},{\"$\":\"NBK9673\",\"@Source\":\"BookShelf\"}]}}","gard_id":"10709","medgen_id":"C1857762","public_definition":"TSEN54 pontocerebellar hypoplasia (TSEN54-PCH) comprises three PCH phenotypes (PCH2, 4, and 5) that share characteristic neuroradiologic and neurologic findings. The three PCH phenotypes (which differ mainly in life expectancy) were considered to be distinct entities before their molecular basis was known. PCH2. Children usually succumb before age ten years (those with PCH4 and 5 usually succumb as neonates). Children with PCH2 have generalized clonus, uncoordinated sucking and swallowing, impaired cognitive development, lack of voluntary motor development, cortical blindness, and an increased risk for rhabdomyolysis during severe infections. Epilepsy is present in approximately 50%. PCH4. Neonates often have seizures, multiple joint contractures (\"arthrogryposis\"), generalized clonus, and central respiratory impairment. PCH5 resembles PCH4 and has been described in one family.","type":"Disease","symbol":"PCH5","alternate_names":["Olivopontocerebellar hypoplasia fetal-onset"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012438\"}","{\"db\":\"OMIM\",\"id\":\"610204\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"166068\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10709\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pontocerebellar+hypoplasia+type+5/5867\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK9673\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"610204\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3520","name":"Pontocerebellar hypoplasia type 5"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"29072892\",\"@Source\":\"PubMed\"},{\"$\":\"NBK459117\",\"@Source\":\"BookShelf\"}]}}","gard_id":"10680","medgen_id":"C1864100","public_definition":"Disorders of GNAS inactivation include the phenotypes pseudohypoparathyroidism Ia, Ib, and Ic (PHP-Ia, -Ib, -Ic), pseudopseudohypoparathyroidism (PPHP), progressive osseous heteroplasia (POH), and osteoma cutis (OC). PHP-Ia and PHP-Ic are characterized by: End-organ resistance to endocrine hormones including parathyroid hormone (PTH), thyroid-stimulating hormone (TSH), gonadotropins (LH and FSH), growth hormone-releasing hormone (GHRH), and CNS neurotransmitters (leading to obesity and variable degrees of intellectual disability and developmental delay); and The Albright hereditary osteodystrophy (AHO) phenotype (short stature, round facies, and subcutaneous ossifications) and brachydactyly type E (shortening mainly of the 4th and/or 5th metacarpals and metatarsals and distal phalanx of the thumb). Although PHP-Ib is characterized principally by PTH resistance, some individuals also have partial TSH resistance and mild features of AHO (e.g., brachydactyly). PPHP, a more limited form of PHP-Ia, is characterized by various manifestations of the AHO phenotype without the hormone resistance or obesity. POH and OC are even more restricted variants of PPHP: POH consists of dermal ossification beginning in infancy, followed by increasing and extensive bone formation in deep muscle and fascia. OC consists of extra-skeletal ossification that is limited to the dermis and subcutaneous tissues.","type":"Disease","symbol":"PHP1B","alternate_names":["PHP IB","Pseudohypoparathyroidism Type IB"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"603233\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"94089\"}","{\"db\":\"OMIM\",\"id\":\"603233\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PHP IB\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10680\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pseudohypoparathyroidism+type+1B/6036\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK459117\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"603233\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4057","name":"Pseudohypoparathyroidism type 1B"}
{"attribute_content":[],"alternate_symbols":["CRV"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"31536185\",\"@Source\":\"PubMed\"},{\"$\":\"NBK546576\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C1860518","public_definition":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is a small-vessel disease that affects highly vascularized tissues including the retina, brain, liver, and kidneys. Age of onset is often between 35 and 50 years. The most common presenting finding is decreased visual acuity and/or visual field defects. Neurologic manifestations may include hemiparesis, facial weakness, aphasia, and hemianopsia. Migraines and seizures are less frequently described. Renal manifestations may include mild-to-moderate increase in serum creatinine and mild proteinuria; progression to end-stage renal disease (ESRD) is uncommon. Hepatic manifestations frequently include mildly elevated levels of alkaline phosphatase and gamma-glutamyltransferase (GGT). Less common findings include psychiatric disorders, hypertension, mild-to-moderate anemia, and Raynaud phenomenon.","type":"Disease","symbol":"RVCL","alternate_names":["Cerebroretinal vasculopathy, hereditary","Retinopathy, vascular, with cerebral and renal involvement and Raynaud and migraine phenomena","Vasculopathy, retinal, with cerebral leukodystrophy"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008641\"}","{\"db\":\"OMIM\",\"id\":\"192315\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"247691\"}","{\"db\":\"Orphanet\",\"id\":\"3421\"}","{\"db\":\"Orphanet\",\"id\":\"63261\"}","{\"db\":\"Orphanet\",\"id\":\"71291\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Vasculopathy%2C+retinal%2C+with+cerebral+leukodystrophy/7360\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Vasculopathy, retinal, with cerebral leukodystrophy\"}","{\"db\":\"OMIM\",\"id\":\"192315\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CRV\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008641\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK546576\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"192315\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"6104","name":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"24741716\",\"@Source\":\"PubMed\"},{\"$\":\"NBK195854\",\"@Source\":\"BookShelf\"}]}}","gard_id":"13200","medgen_id":"C2749861","public_definition":"RRM2B-related mitochondrial disease can be grouped by disease pathogenesis, phenotype, and mode of inheritance into two major types: mitochondrial DNA (mtDNA) depletion and multiple mtDNA deletions. Mitochondrial DNA depletion usually manifests as severe multisystem disease (encephalomyopathy with proximal renal tubulopathy) and is often fatal in early life. Inheritance is autosomal recessive. Multiple mtDNA deletions cause tissue-specific cytochrome c oxidase (COX) deficiency. Inheritance can be either autosomal recessive (with progressive external ophthalmoplegia [PEO] and multisystem involvement manifesting during early childhood/adulthood) or autosomal dominant (with less severe, often tissue-specific manifestations [e.g., chronic PEO] developing in later adulthood). Other rarer phenotypes are Kearns-Sayre syndrome (KSS) and mitochondrial neurogastrointestinal encephalopathy (MNGIE).","type":"Disease","symbol":"MTDPS8A","alternate_names":["MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)","MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC, WITH RENAL TUBULOPATHY, AUTOSOMAL RECESSIVE","RRM2B-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form, with Renal Tubulopathy"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"612075\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"255235\"}","{\"db\":\"OMIM\",\"id\":\"604712.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)\"}","{\"db\":\"OMIM\",\"id\":\"604712.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)\"}","{\"db\":\"OMIM\",\"id\":\"604712.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)\"}","{\"db\":\"OMIM\",\"id\":\"604712.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)\"}","{\"db\":\"OMIM\",\"id\":\"604712.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)\"}","{\"db\":\"OMIM\",\"id\":\"604712.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)\"}","{\"db\":\"OMIM\",\"id\":\"612075\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)\"}","{\"db\":\"OMIM\",\"id\":\"612075\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC, WITH RENAL TUBULOPATHY, AUTOSOMAL RECESSIVE\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"13200\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mitochondrial+DNA+depletion+syndrome%2C+encephalomyopathic+form%2C+with+renal+tubulopathy/8900\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK195854\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"612075\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2810","name":"Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20437616\",\"@Source\":\"PubMed\"},{\"$\":\"NBK32534\",\"@Source\":\"BookShelf\"}]}}","gard_id":"13060","medgen_id":"C3150986","public_definition":"KCNQ2-related disorders represent a continuum of overlapping neonatal epileptic phenotypes caused by a heterozygous pathogenic variant in KCNQ2. The clinical features of KCNQ2-related disorders range from KCNQ2-related benign familial neonatal epilepsy (KCNQ2-BFNE) at the mild end to KCNQ2-related neonatal epileptic encephalopathy (KCNQ2-NEE) at the severe end. KCNQ2-BFNE is characterized by a wide spectrum of seizure types (tonic or apneic episodes, focal clonic activity, or autonomic changes) that start in otherwise healthy infants between the second and eighth day of life and spontaneously disappear between the first and the sixth to 12th month of life. Motor activity may be confined to one body part, migrate to other body regions, or generalize. Seizures are generally brief, lasting one to two minutes. Rarely, KCNQ2-BFNE may evolve into status epilepticus. About 10%-15% of individuals with BFNE develop epileptic seizures later in life. KCNQ2-NEE is characterized by multiple daily seizures beginning in the first week of life that are mostly tonic, with associated focal motor and autonomic features. Seizures generally cease between ages nine months and four years. At onset, EEG shows a burst-suppression pattern or multifocal epileptiform activity; early brain MRI can show basal ganglia and thalamic hyperintensities that later resolve. Moderate to severe developmental impairment is present.","type":"Disease","symbol":"EIEE7","alternate_names":["KCNQ2-Related Neonatal Epileptic Encephalopathy"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"613720\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"439218\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"13060\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Epileptic+encephalopathy%2C+early+infantile%2C+7/8345\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK32534\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"613720\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"15768","name":"Early infantile epileptic encephalopathy 7"}
{"attribute_content":[],"alternate_symbols":["DRAM2"],"keywords":[],"medgen_id":"C4049066","public_definition":"Cone-rod dystrophy is a group of related eye disorders that causes vision loss, which becomes more severe over time. These disorders affect the retina, which is the layer of light-sensitive tissue at the back of the eye. In people with cone-rod dystrophy, vision loss occurs as the light-sensing cells of the retina gradually deteriorate.The first signs and symptoms of cone-rod dystrophy, which often occur in childhood, are usually decreased sharpness of vision (visual acuity) and increased sensitivity to light (photophobia). These features are typically followed by impaired color vision (dyschromatopsia), blind spots (scotomas) in the center of the visual field, and partial side (peripheral) vision loss. Over time, affected individuals develop night blindness and a worsening of their peripheral vision, which can limit independent mobility. Decreasing visual acuity makes reading increasingly difficult and most affected individuals are legally blind by mid-adulthood. As the condition progresses, individuals may develop involuntary eye movements (nystagmus).There are more than 30 types of cone-rod dystrophy, which are distinguished by their genetic cause and their pattern of inheritance: autosomal recessive, autosomal dominant, and X-linked. Additionally, cone-rod dystrophy can occur alone without any other signs and symptoms or it can occur as part of a syndrome that affects multiple parts of the body.","type":"Disease","symbol":"CORD21","alternate_names":["Retinal dystrophy with early macular involvement"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0030635\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0014669\"}","{\"db\":\"OMIM\",\"id\":\"616502\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1872\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0030635\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Retinal dystrophy with early macular involvement\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"cone-rod-dystrophy\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"616502\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"33616","name":"Cone-rod dystrophy 21"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3280866","public_definition":"Episodic encephalopathy due to thiamine pyrophosphokinase deficiency is an autosomal recessive metabolic disorder due to an inborn error of thiamine metabolism. The phenotype is highly variable, but in general, affected individuals have onset in early childhood of acute encephalopathic episodes associated with increased serum and CSF lactate. These episodes result in progressive neurologic dysfunction manifest as gait disturbances, ataxia, dystonia, and spasticity, which in some cases may result in loss of ability to walk. Cognitive function is usually preserved, although mildly delayed development has been reported. These episodes are usually associated with infection and metabolic decompensation. Some patients may have recovery of some neurologic deficits (summary by Mayr et al., 2011).\r\nFor a discussion of genetic heterogeneity of disorders due to thiamine metabolism dysfunction, see THMD1 (249270).","type":"Disease","symbol":"THMD5","alternate_names":["ENCEPHALOPATHY, EPISODIC, DUE TO THIAMINE PYROPHOSPHOKINASE DEFICIENCY"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614458\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"293955\"}","{\"db\":\"OMIM\",\"id\":\"614458\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ENCEPHALOPATHY, EPISODIC, DUE TO THIAMINE PYROPHOSPHOKINASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"614458\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614458\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"16823","name":"Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)"}
{"attribute_content":[],"alternate_symbols":["ANE"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"25473726\",\"@Source\":\"PubMed\"},{\"$\":\"NBK258641\",\"@Source\":\"BookShelf\"}]}}","gard_id":"13232","medgen_id":"C2675556","public_definition":"Infection-induced acute encephalopathy 3 (IIAE3) is the susceptibility to recurrent acute necrotizing encephalopathy (ANE) caused by a heterozygous pathogenic variant in RANBP2. ANE refers to the specific neurologic presentation in which bilateral symmetric thalamic, midbrain, and/or hindbrain lesions occur within days following the onset of an acute viral illness caused by influenza A, influenza B, parainfluenza II, human herpes virus 6, coxsackie virus, or an enterovirus. Although most IIAE3 occurs before age six years, first episodes have been observed in teenagers and adults. ANE begins within 12 hours to three or four days of the first awareness of viral symptoms (fever, cough, rhinorrhea, vomiting, diarrhea, and malaise). The most common sign of ANE is lethargy that progresses to coma (which may last for weeks) and seizures (in 50%). One third of affected individuals die during the acute phase of the encephalopathy; of the survivors, one half have permanent neurologic damage and the remainder have no discernible residual symptoms. Fifty per cent of persons with IIAE3 will have at least one repeat episode and some will have multiple repeat episodes","type":"Disease","symbol":"IIAE3","alternate_names":["ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO","Susceptibility to Acute Necrotizing Encephalopathy 1"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"608033\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"88619\"}","{\"db\":\"OMIM\",\"id\":\"608033\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"608033\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ANE\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"13232\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Encephalopathy%2C+acute%2C+infection-induced%2C+3%2C+suceptibility+to/8307\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK258641\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"608033\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1591","name":"Encephalopathy, acute, infection-induced, 3, suceptibility to"}
{"attribute_content":[],"alternate_symbols":["OAS"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301552\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1378\",\"@Source\":\"BookShelf\"}]}}","gard_id":"722","medgen_id":"C0599973","public_definition":"Ophthalmo-acromelic syndrome is a condition that results in malformations of the eyes, hands, and feet. The features of this condition are present from birth. The eyes are often absent or severely underdeveloped (anophthalmia), or they may be abnormally small (microphthalmia). Usually both eyes are similarly affected in this condition, but if only one eye is small or missing, the other eye may have a defect such as a gap or split in its structures (coloboma).The most common hand and foot malformation seen in ophthalmo-acromelic syndrome is missing fingers or toes (oligodactyly). Other frequent malformations include fingers or toes that are fused together (syndactyly) or extra fingers or toes (polydactyly). These skeletal malformations are often described as acromelic, meaning that they occur in the bones that are away from the center of the body. Additional skeletal abnormalities involving the long bones of the arms and legs or the spinal bones (vertebrae) can also occur. Affected individuals may have distinctive facial features, an opening in the lip (cleft lip) with or without an opening in the roof of the mouth (cleft palate), or intellectual disability.","type":"Disease","symbol":"MLA","alternate_names":["ANOPHTHALMIA-SYNDACTYLY","Anophthalmia Waardenburg syndrome","Anophthalmos with limb anomalies","Anophthalmos-syndactyly","MICROPHTHALMIA AND LIMB ANOMALIES","Ophthalmoacromelic syndrome"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008800\"}","{\"db\":\"OMIM\",\"id\":\"206920\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1106\"}","{\"db\":\"OMIM\",\"id\":\"206920\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANOPHTHALMIA-SYNDACTYLY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Anophthalmos+with+Limb+Anomalies/503\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anophthalmos with limb anomalies\"}","{\"db\":\"OMIM\",\"id\":\"608488.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MICROPHTHALMIA AND LIMB ANOMALIES\"}","{\"db\":\"OMIM\",\"id\":\"608488.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MICROPHTHALMIA AND LIMB ANOMALIES\"}","{\"db\":\"OMIM\",\"id\":\"608488.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MICROPHTHALMIA AND LIMB ANOMALIES\"}","{\"db\":\"OMIM\",\"id\":\"206920\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"OAS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"722\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008800\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"ophthalmo-acromelic-syndrome\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"206920\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2942","name":"Microphthalmia with limb anomalies"}
{"attribute_content":[],"alternate_symbols":["BBGD","BTBGD"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"24260777\",\"@Source\":\"PubMed\"},{\"$\":\"NBK169615\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C1843807","public_definition":"Biotin-thiamine-responsive basal ganglia disease (BTBGD) may present in childhood, early infancy, or adulthood. The classic presentation of BTBGD occurs in childhood (age 3-10 years) and is characterized by recurrent subacute encephalopathy manifest as confusion, seizures, ataxia, dystonia, supranuclear facial palsy, external ophthalmoplegia, and/or dysphagia which, if left untreated, can eventually lead to coma and even death. Dystonia and cogwheel rigidity are nearly always present; hyperreflexia, ankle clonus, and Babinski responses are common. Hemiparesis or quadriparesis may be seen. Episodes are often triggered by febrile illness or mild trauma or stress. Simple partial or generalized seizures are easily controlled with antiepileptic drugs. An early-infantile Leigh-like syndrome / atypical infantile spasms presentation occurs in the first three months of life with poor feeding, vomiting, acute encephalopathy and severe lactic acidosis. An adult-onset Wernicke-like encephalopathy presentation is characterized by acute onset of status epilepticus, ataxia, nystagmus, diplopia, and ophthalmoplegia in the second decade of life. Prompt administration of biotin and thiamine early in the disease course results in partial or complete improvement within days in the childhood and adult presentations, but most with the infantile presentation have had poor outcome even after supplementation with biotin and thiamine.","type":"Disease","symbol":"THMD2","alternate_names":["Biotin-thiamine-responsive basal ganglia disease","ENCEPHALOPATHY, THIAMINE-RESPONSIVE","THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)","Thiamine Metabolism Dysfunction Syndrome 2","Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"607483\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"199348\"}","{\"db\":\"Orphanet\",\"id\":\"65284\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Basal+Ganglia+Disease%2C+Biotin-Responsive/756\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Biotin-thiamine-responsive basal ganglia disease\"}","{\"db\":\"OMIM\",\"id\":\"607483\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ENCEPHALOPATHY, THIAMINE-RESPONSIVE\"}","{\"db\":\"OMIM\",\"id\":\"606152.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)\"}","{\"db\":\"OMIM\",\"id\":\"606152.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)\"}","{\"db\":\"OMIM\",\"id\":\"606152.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)\"}","{\"db\":\"OMIM\",\"id\":\"606152.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)\"}","{\"db\":\"OMIM\",\"id\":\"606152.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)\"}","{\"db\":\"OMIM\",\"id\":\"606152.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)\"}","{\"db\":\"OMIM\",\"id\":\"606152.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)\"}","{\"db\":\"OMIM\",\"id\":\"607483\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)\"}","{\"db\":\"OMIM\",\"id\":\"607483\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"BBGD\"}","{\"db\":\"OMIM\",\"id\":\"607483\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"BTBGD\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011841\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK169615\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"607483\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"585","name":"Biotin-responsive basal ganglia disease"}
{"attribute_content":[],"alternate_symbols":["AATD"],"keywords":["Neoplasm"],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301692\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1519\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ATS/ERS, 2003\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15685488\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"EuroGentest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"3083625\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"Alpha-1 Foundation, 2014\",\"@Type\":\"general\",\"ID\":{\"$\":\"24121147\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Orphanet, 2010\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"Orphanet, Alpha-1 antitrypsin deficiency, 2010\"},\"URL\":{\"$\":\"https://www.orpha.net/data/patho/Pro/en/Emergency_Alpha1Antitrypsin-enPro194.pdf\"}}]}","gard_id":"5784","medgen_id":"C0221757","public_definition":"Alpha-1 antitrypsin deficiency (AATD) can present with hepatic dysfunction in individuals from infancy to adulthood and with chronic obstructive lung disease (emphysema and/or bronchiectasis), characteristically in individuals older than age 30 years. Individuals with AATD are also at increased risk for panniculitis (migratory, inflammatory, tender skin nodules which may ulcerate on legs and lower abdomen) and C-ANCA-positive vasculitis (granulomatosis with polyangiitis). Phenotypic expression varies within and between families. In adults, smoking is the major factor in accelerating the development of COPD; nonsmokers may have a normal life span, but can also develop lung and/or liver disease. Although reported, emphysema in children with AATD is extremely rare. AATD-associated liver disease, which is present in only a small portion of affected children, manifests as neonatal cholestasis. The incidence of liver disease increases with age. Liver disease in adults (manifesting as cirrhosis and fibrosis) may occur in the absence of a history of neonatal or childhood liver disease. The risk for hepatocellular carcinoma (HCC) is increased in individuals with AATD.","type":"Disease","symbol":"A1ATD","alternate_names":["A1AT deficiency","AAT deficiency","Alpha1-Antitrypsin Deficiency"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0013282\"}","{\"db\":\"OMIM\",\"id\":\"613490\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"60\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5784\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Alpha+1-Antitrypsin+Deficiency/325\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"30188007\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1519\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"613490\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"15742","name":"Alpha-1-antitrypsin deficiency"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"ACMG/ACOG, 2001\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"11280952\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3110945\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301428\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1250\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACOG, 2009\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"19888064\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2005\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15789152\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3110977\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"CPGPT/CF FPT Committees, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20675678\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ECFS, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20605539\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"CFF, 2009\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"19914445\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"CFF, 2009\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"19914443\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG ACT Sheets, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"21938795\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG Lab QA, 2002\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"12394352\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"CDC, 2012\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"22475884\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Accurso et al., 2010\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"3148255\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ACOG, 2011\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"21422883\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"CPIC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"4026598\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"NSGC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24014130\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"HGS Australasia, 2014\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"25431289\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Wainwright et al., 2015\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"25981758\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"CFF, 2007\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"17761616\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"DailyMed Drug Label, 2012\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"DailyMed Drug Label, KALYDECO, 2012\"},\"URL\":{\"$\":\"https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25\"}}]}","gard_id":"6233","disease_mechanism_id":"273","medgen_id":"C0010674","public_definition":"Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include progressive obstructive lung disease with bronchiectasis, frequent hospitalizations for pulmonary disease, pancreatic insufficiency and malnutrition, recurrent sinusitis and bronchitis, and male infertility. Pulmonary disease is the major cause of morbidity and mortality in CF. Meconium ileus occurs at birth in 15%-20% of newborns with CF. More than 95% of males with CF are infertile. Congenital absence of the vas deferens (CAVD) is generally identified during evaluation of infertility or as an incidental finding at the time of a surgical procedure. Hypoplasia or aplasia of the vas deferens and seminal vesicles may occur either bilaterally or unilaterally. Testicular development and function and spermatogenesis are usually normal.","type":"Disease","symbol":"CF","alternate_names":["Mucoviscidosis"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009061\"}","{\"db\":\"OMIM\",\"id\":\"219700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"586\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000004176\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000005248\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000025280\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000028916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000074114\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000209428\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000226639\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000246717\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000277984\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000320929\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000328569\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000330969\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000332363\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501120\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501918\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501920\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501921\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507003\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507006\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507010\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507864\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507950\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508782\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508810\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508811\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508812\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508889\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508890\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508893\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508894\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514611\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520059\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521905\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522527\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528606\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529460\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530118\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556535\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556536\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558875\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558928\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568279\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569406\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569426\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569602\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569639\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569790\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569791\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569946\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569960\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569982\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569983\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570010\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570019\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570054\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570317\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000571198\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000576178\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6233\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cystic+Fibrosis/2071\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"219700\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"190905008\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1250\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"219700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1695","disease_mechanism":"loss of function","name":"Cystic fibrosis"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"10604","medgen_id":"C2678408","public_definition":"Combined pituitary hormone deficiency is a condition that causes a shortage (deficiency) of several hormones produced by the pituitary gland, which is located at the base of the brain. A lack of these hormones may affect the development of many parts of the body. The first signs of this condition include a failure to grow at the expected rate and short stature that usually becomes apparent in early childhood.People with combined pituitary hormone deficiency may have hypothyroidism, which is underactivity of the butterfly-shaped thyroid gland in the lower neck. Hypothyroidism can cause many symptoms, including weight gain and fatigue. Other features of combined pituitary hormone deficiency include delayed or absent puberty and lack the ability to have biological children (infertility). The condition can also be associated with a deficiency of the hormone cortisol. Cortisol deficiency can impair the body's immune system, causing individuals to be more susceptible to infection.Rarely, people with combined pituitary hormone deficiency have intellectual disability; a short, stiff neck; or underdeveloped optic nerves, which carry visual information from the eyes to the brain.","type":"Disease","symbol":"CPHD4","alternate_names":["Pituitary hormone deficiency, combined 4","Pituitary hormone deficiency, combined with or without cerebellar defects","Short stature, pituitary and cerebellar defects and small sella turcica"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009880\"}","{\"db\":\"OMIM\",\"id\":\"262700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"85442\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pituitary+hormone+deficiency%2C+combined+4/5782\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Pituitary hormone deficiency, combined 4\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10604\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009880\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"combined-pituitary-hormone-deficiency\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"262700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3502","name":"Short stature-pituitary and cerebellar defects-small sella turcica syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3553529","public_definition":"COXPD10 is an autosomal recessive disorder resulting in variable defects of mitochondrial oxidative respiration. Affected individuals present in infancy with hypertrophic cardiomyopathy and lactic acidosis. The severity is variable, but can be fatal in the most severe cases (summary by Ghezzi et al., 2012).\r\nFor a discussion of genetic heterogeneity of combined oxidative phosphorylation deficiency, see COXPD1 (609060).","type":"Disease","symbol":"COXPD10","alternate_names":["CARDIOMYOPATHY, INFANTILE HYPERTROPHIC MITOCHONDRIAL, AND LACTIC ACIDOSIS"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614702\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"314637\"}","{\"db\":\"OMIM\",\"id\":\"614702\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CARDIOMYOPATHY, INFANTILE HYPERTROPHIC MITOCHONDRIAL, AND LACTIC ACIDOSIS\"}","{\"db\":\"OMIM\",\"id\":\"614702\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614702\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17310","name":"Combined oxidative phosphorylation deficiency 10"}
{"attribute_content":[],"alternate_symbols":["EBVS","IMD5","LYP","XLP","XLPD"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301580\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1406\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C1868674","public_definition":"X-linked lymphoproliferative disease (XLP) has two recognizable subtypes, XLP1 and XLP2. XLP1 is characterized predominantly by one of three commonly recognized phenotypes: Inappropriate immune response to Epstein-Barr virus (EBV) infection leading to hemophagocytic lymphohistiocytosis (HLH) or severe mononucleosis. Dysgammaglobulinemia. Lymphoproliferative disease (malignant lymphoma). XLP2 is most often characterized by HLH (often associated with EBV), dysgammaglobulinemia, and inflammatory bowel disease. HLH resulting from EBV infection is associated with an unregulated and exaggerated immune response with widespread proliferation of cytotoxic T cells, EBV-infected B cells, and macrophages. Dysgammaglobulinemia is typically hypogammaglobulinemia of one or more immunoglobulin subclasses. The malignant lymphomas are typically B-cell lymphomas, non-Hodgkin type, often extranodal, and in particular involving the intestine.","type":"Disease","symbol":"XLP1","alternate_names":["Duncan disease","Duncan's syndrome","EBV infection severe susceptibility to","Epstein Barr virus infection familial fatal","IMMUNODEFICIENCY 5","IMMUNODEFICIENCY, X-LINKED PROGRESSIVE COMBINED VARIABLE","INFECTIOUS MONONUCLEOSIS, SEVERE, SUSCEPTIBILITY TO","Purtilo syndrome"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"308240\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2442\"}","{\"db\":\"Orphanet\",\"id\":\"538931\"}","{\"db\":\"OMIM\",\"id\":\"308240\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 5\"}","{\"db\":\"OMIM\",\"id\":\"308240\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY, X-LINKED PROGRESSIVE COMBINED VARIABLE\"}","{\"db\":\"OMIM\",\"id\":\"308240\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INFECTIOUS MONONUCLEOSIS, SEVERE, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"308240\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EBVS\"}","{\"db\":\"OMIM\",\"id\":\"308240\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IMD5\"}","{\"db\":\"OMIM\",\"id\":\"308240\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"LYP\"}","{\"db\":\"OMIM\",\"id\":\"308240\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"XLP\"}","{\"db\":\"OMIM\",\"id\":\"308240\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"XLPD\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Lymphoproliferative+syndrome+X-linked+1/4379\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1406\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"308240\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5424","name":"Lymphoproliferative syndrome 1, X-linked"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301775\",\"@Source\":\"PubMed\"},{\"$\":\"NBK11167\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"29334453\",\"@Source\":\"PubMed\"},{\"$\":\"NBK475803\",\"@Source\":\"BookShelf\"}]}]}","gard_id":"10740","medgen_id":"C3150154","public_definition":"The 16p11.2 recurrent microdeletion phenotype is characterized by developmental delay, intellectual disability, and/or autism spectrum disorder (ASD). Developmental delays are related to diminished language, cognitive function, and motor impairments. While IQ scores range from mild intellectual disability to normal, those with IQ scores in the average range typically have other developmental issues such as language delay or ASD. Expressive language appears to be more affected than receptive language. Seizures are observed in approximately 20% of individuals with the recurrent microdeletion. Macrocephaly is common, usually becoming apparent by age two years. Chiari malformations/cerebellar ectopia are the most frequently observed structural brain abnormalities. In individuals with the 16p11.2 recurrent microdeletion the frequency of birth defects of all types is slightly increased, with vertebral anomalies appearing to be most frequent.","type":"Disease","alternate_names":["16p11.2 Microdeletion","CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB","Chromosome 16p11.2 deletion syndrome"],"xrefs":["{\"db\":\"Gene\",\"id\":\"100187724\"}","{\"db\":\"OMIM\",\"id\":\"611913\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"261197\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK11167\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"16p11.2 Microdeletion\"}","{\"db\":\"OMIM\",\"id\":\"611913\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10740\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"16p11.2+deletion+syndrome/9529\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK11167\",\"ref_field\":\"public_definition\"}"],"id":"808","name":"16p11.2 deletion syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"24027799\",\"@Source\":\"PubMed\"},{\"$\":\"NBK154653\",\"@Source\":\"BookShelf\"}]}}","gard_id":"359","medgen_id":"CN119432","public_definition":"Cranioectodermal dysplasia (CED), a ciliopathy also known as Sensenbrenner syndrome, is a multisystem disorder with skeletal involvement (narrow thorax, shortened proximal limbs, and brachydactyly), ectodermal features (widely-spaced hypoplastic teeth, hypodontia, sparse hair, skin laxity, abnormal nails), joint laxity, growth retardation, and characteristic facial features (frontal bossing, low-set simple ears, high forehead, telecanthus/epicanthus, full cheeks, everted lower lip). Most affected children develop nephronophthisis that often leads to end-stage renal disease (ESRD) in infancy or childhood, a major cause of morbidity and mortality. Hepatic fibrosis and retinal dystrophy, other manifestations of ciliopathies, are also observed. Dolichocephaly, often secondary to sagittal craniosynostosis, is a primary manifestation that distinguishes CED from most other ciliopathies. Brain malformations and developmental delay may also occur.","type":"Disease","alternate_names":["Cranioectoderma","Sensenbrenner syndrome"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009032\"}","{\"db\":\"OMIM\",\"id\":\"PS218330\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"1515\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"359\",\"ref_field\":\"gard_id\"}","{\"db\":\"OMIM\",\"id\":\"PS218330\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"254093009\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK154653\",\"ref_field\":\"public_definition\"}"],"id":"16704","name":"Cranioectodermal dysplasia"}
{"attribute_content":[],"alternate_symbols":["SOX2"],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301477\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1300\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301552\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1378\",\"@Source\":\"BookShelf\"}]}]}","gard_id":"1443","medgen_id":"C1859773","public_definition":"SOX2-related eye disorders are characterized by anophthalmia and/or microphthalmia that is usually bilateral, severe, and apparent at birth or by prenatal ultrasound examination. Other common findings include brain malformations, esophageal atresia, cryptorchidism and/or micropenis in males, and hypogonadotropic hypogonadism and/or pituitary hypoplasia. Postnatal growth failure, delayed motor development, and learning disability are common.","type":"Disease","symbol":"MCOPS3","alternate_names":["AEG syndrome","Anophthalmia clinical with associated anomalies","Anophthalmia esophageal genital syndrome","Anophthalmia microphthalmia esophageal atresia","Microphthalmia and esophageal atresia syndrome","Microphthalmia syndromic 3"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008799\"}","{\"db\":\"OMIM\",\"id\":\"206900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"77298\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Microphthalmia+syndromic+3/4787\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Microphthalmia syndromic 3\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1443\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008799\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1300\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"206900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5530","name":"Anophthalmia/microphthalmia-esophageal atresia syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"32352694\",\"@Source\":\"PubMed\"},{\"$\":\"NBK556455\",\"@Source\":\"BookShelf\"}]}}","gard_id":"5576","medgen_id":"C0950121","public_definition":"WT1 disorder is characterized by congenital/infantile- or childhood-onset of a progressive glomerulopathy that does not respond to standard steroid therapy. Additional common findings can include disorders of testicular development (with or without abnormalities of the external genitalia and/or mÃ¼llerian structures) and Wilms tumor. Less common findings are congenital anomalies of the kidney and urinary tract (CAKUT) and gonadoblastoma. While various combinations of renal and other findings associated with a WT1 pathogenic variant were designated as certain syndromes in the past, those designations are now recognized to be part of a phenotypic continuum and are no longer clinically helpful.","type":"Disease","symbol":"DDS","alternate_names":["Nephropathy associated with male pseudohermaphroditism and Wilms' tumor","Nephropathy, wilms tumor, and genital anomalies","Pseudohermaphroditism, nephron disorder and Wilms' tumor","WILMS TUMOR AND PSEUDO- OR TRUE HERMAPHRODITISM","Wilms tumor and pseudohermaphroditism"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008682\"}","{\"db\":\"OMIM\",\"id\":\"194080\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"220\"}","{\"db\":\"OMIM\",\"id\":\"194080\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"WILMS TUMOR AND PSEUDO- OR TRUE HERMAPHRODITISM\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5576\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Wilms+tumor+and+pseudohermaphroditism/7503\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"236385009\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK556455\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"194080\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"969","name":"Drash syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"32352694\",\"@Source\":\"PubMed\"},{\"$\":\"NBK556455\",\"@Source\":\"BookShelf\"}]}}","gard_id":"3547","medgen_id":"C3151568","public_definition":"WT1 disorder is characterized by congenital/infantile- or childhood-onset of a progressive glomerulopathy that does not respond to standard steroid therapy. Additional common findings can include disorders of testicular development (with or without abnormalities of the external genitalia and/or mÃ¼llerian structures) and Wilms tumor. Less common findings are congenital anomalies of the kidney and urinary tract (CAKUT) and gonadoblastoma. While various combinations of renal and other findings associated with a WT1 pathogenic variant were designated as certain syndromes in the past, those designations are now recognized to be part of a phenotypic continuum and are no longer clinically helpful.","type":"Disease","symbol":"NPHS4","alternate_names":["Familial mesangial sclerosis","Nephrotic syndrome, early onset with diffuse mesangial sclerosis"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001967\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004728\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009733\"}","{\"db\":\"OMIM\",\"id\":\"256370\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"656\"}","{\"db\":\"SNOMED CT\",\"id\":\"236383002\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Familial mesangial sclerosis\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3547\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009733\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK556455\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"256370\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3167","name":"Nephrotic syndrome, type 4"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301721\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1728\",\"@Source\":\"BookShelf\"}]}}","gard_id":"3395","medgen_id":"C1855425","public_definition":"FREM1 autosomal recessive disorders include: Manitoba oculotrichoanal (MOTA) syndrome, bifid nose with or without anorectal and renal anomalies (BNAR syndrome), and isolated congenital anomalies of kidney and urinary tract (CAKUT). MOTA syndrome is characterized by an aberrant hairline (unilateral or bilateral wedge-shaped extension of the anterior hairline from the temple region to the ipsilateral eye) and anomalies of the eyes (widely spaced eyes, anophthalmia/microphthalmia and/or cryptophthalmos, colobomas of the upper eyelid, and corneopalpebral synechiae), nose (bifid or broad nasal tip), abdominal wall (omphalocele or umbilical hernia), and anus (stenosis and/or anterior displacement of the anal opening). The manifestations and degree of severity vary even among affected members of the same family. Growth and psychomotor development are normal. BNAR syndrome is characterized by a bifid or wide nasal tip, anorectal anomalies, and renal malformations (e.g., renal agenesis, renal dysplasia). Typically the eye manifestations of MOTA syndrome are absent. FREM1-CAKUT was identified in one individual with bilateral vesicoureteral reflux (VUR) and a second individual with VUR and renal hypodysplasia.","type":"Disease","symbol":"MOTA","alternate_names":["Manitoba Trichoanal syndrome","Marles Greenberg Persaud syndrome","Marles syndrome","Unilateral upper eyelid coloboma, aberrant anterior hairline pattern, and anal anomalies"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009560\"}","{\"db\":\"OMIM\",\"id\":\"248450\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2717\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Marles+Greenberg+Persaud+syndrome/4481\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Marles Greenberg Persaud syndrome\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3395\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009560\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1728\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"248450\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2820","name":"Oculotrichoanal syndrome"}
{"attribute_content":[],"alternate_symbols":["DDP","DDS"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301395\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1216\",\"@Source\":\"BookShelf\"}]}}","gard_id":"8331","medgen_id":"C0796074","public_definition":"Males with deafness-dystonia-optic neuronopathy (DDON) syndrome have prelingual or postlingual sensorineural hearing impairment in early childhood, slowly progressive dystonia or ataxia in the teens, slowly progressive decreased visual acuity from optic atrophy beginning at approximately age 20 years, and dementia beginning at approximately age 40 years. Psychiatric symptoms such as personality change and paranoia may appear in childhood and progress. The hearing impairment appears to be consistent in age of onset and progression, whereas the neurologic, visual, and neuropsychiatric signs vary in degree of severity and rate of progression. Females may have mild hearing impairment and focal dystonia.","type":"Disease","symbol":"MTS","alternate_names":["DDON syndrome","Deafness syndrome, progressive, with blindness, dystonia, fractures, and mental deficiency","Deafness-Dystonia-Optic Neuronopathy Syndrome","Deafness-dystonia-optic atrophy syndrome","Deafness-dystonia-optic neuronopathy (DDON) syndrome","Jensen syndrome","Mohr-Tranebjaerg syndrome","Nerve deafness optic nerve atrophy, and dementia","OPTICOACOUSTIC NERVE ATROPHY WITH DEMENTIA","Opticoacustic nerve atrophy with dementia","Syndrome of opticoacoustic nerve atrophy with dementia"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010578\"}","{\"db\":\"OMIM\",\"id\":\"304700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"52368\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1216\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Deafness-Dystonia-Optic Neuronopathy Syndrome\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Jensen+syndrome/3902\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Jensen syndrome\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mohr-Tranebjaerg+syndrome/4848\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mohr-Tranebjaerg syndrome\"}","{\"db\":\"OMIM\",\"id\":\"304700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OPTICOACOUSTIC NERVE ATROPHY WITH DEMENTIA\"}","{\"db\":\"OMIM\",\"id\":\"304700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"DDP\"}","{\"db\":\"OMIM\",\"id\":\"304700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"DDS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"8331\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010578\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1216\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"304700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3213","name":"Deafness dystonia syndrome"}
{"attribute_content":[],"alternate_symbols":["SWILS"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"32078278\",\"@Source\":\"PubMed\"},{\"$\":\"NBK554080\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C1300285","public_definition":"Saul-Wilson syndrome (SWS) is a skeletal dysplasia characterized by profound short stature, distinctive craniofacial features, short distal phalanges of fingers and toes, and often clubfoot. Early development (primarily speech and motor) is delayed; cognition is normal. Other findings can include hearing loss (conductive, sensorineural, and mixed), lamellar cataracts, and/or rod-cone retinal dystrophy. To date, 16 affected individuals have been reported.","type":"Disease","alternate_names":["MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA","SAUL-WILSON SYNDROME"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0019407\"}","{\"db\":\"OMIM\",\"id\":\"618150\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"85172\"}","{\"db\":\"OMIM\",\"id\":\"618150\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA\"}","{\"db\":\"OMIM\",\"id\":\"606976.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SAUL-WILSON SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"606976.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SAUL-WILSON SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"618150\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SAUL-WILSON SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"618150\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SWILS\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0019407\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK554080\",\"ref_field\":\"public_definition\"}"],"id":"40720","name":"Microcephalic osteodysplastic dysplasia, Saul-Wilson type"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301484\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1307\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C4014700","public_definition":"The spectrum of BSCL2-related neurologic disorders includes Silver syndrome and variants of Charcot-Marie-Tooth neuropathy type 2, distal hereditary motor neuropathy (dHMN) type V, and spastic paraplegia 17. Features of these disorders include onset of symptoms ranging from the first to the seventh decade, slow disease progression, upper motor neuron involvement (gait disturbance with pyramidal signs ranging from mild to severe spasticity with hyperreflexia in the lower limbs and variable extensor plantar responses), lower motor neuron involvement (amyotrophy of the peroneal muscles and small muscles of the hand), and pes cavus and other foot deformities. Disease severity is variable among and within families.","type":"Disease","symbol":"PELD","alternate_names":["ENCEPHALOPATHY, PROGRESSIVE, WITH LIPODYSTROPHY"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615924\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"363400\"}","{\"db\":\"OMIM\",\"id\":\"606158.0018\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ENCEPHALOPATHY, PROGRESSIVE, WITH LIPODYSTROPHY\"}","{\"db\":\"OMIM\",\"id\":\"606158.0019\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ENCEPHALOPATHY, PROGRESSIVE, WITH LIPODYSTROPHY\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1307\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"615924\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"21315","name":"Encephalopathy, progressive, with or without lipodystrophy"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301641\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1468\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301711\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1539\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"MDA Consensus document - CMT testing, 2011\",\"@Type\":\"general\",\"ID\":{\"$\":\"3058597\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"EuroGenetest, 2010\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"2987431\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301532\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1358\",\"@Source\":\"BookShelf\"}]}]}","gard_id":"1252","medgen_id":"C1859198","public_definition":"GDAP1-related hereditary motor and sensory neuropathy (GDAP1-HMSN) is a peripheral neuropathy (also known as a subtype of Charcot-Marie-Tooth disease) that typically affects the lower extremities earlier and more severely than the upper extremities. As the neuropathy progresses, the distal upper extremities also become severely affected. Proximal muscles can also become weak. Age at onset ranges from infancy to early childhood. In most cases, disease progression causes disabilities within the first or second decade of life. At the end of the second decade, most individuals are wheelchair bound. Disease progression varies considerably even within the same family. The neuropathy can be either of the demyelinating type with reduced nerve conduction velocities or the axonal type with normal nerve conduction velocities. Vocal cord paresis is common. Intelligence is normal. Life expectancy is usually normal, but on occasion may be reduced because of secondary complications.","type":"Disease","symbol":"CMT4A","alternate_names":["Charcot-Marie-Tooth Neuropathy Type 4A","Charcot-Marie-Tooth disease, demyelinating, autosomal recessive","Charcot-Marie-Tooth disease, demyelinating, autosomal recessive, type 4a"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008961\"}","{\"db\":\"OMIM\",\"id\":\"214400\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"99948\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1539\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Charcot-Marie-Tooth Neuropathy Type 4A\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1252\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Charcot-Marie-Tooth+Disease+Type+4A/1303\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1539\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"214400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"785","name":"Charcot-Marie-Tooth disease, type 4A"}
{"attribute_content":[],"alternate_symbols":["XP6"],"keywords":["Neoplasm"],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301571\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1397\",\"@Source\":\"BookShelf\"}]}}","gard_id":"5628","medgen_id":"C0268140","public_definition":"Xeroderma pigmentosum (XP) is characterized by: Sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure in ~60% of affected individuals), with marked freckle-like pigmentation of the face before age two years in most affected individuals; Sunlight-induced ocular involvement (photophobia, keratitis, atrophy of the skin of the lids); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma). Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, and progressive cognitive impairment). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).","type":"Disease","symbol":"XPF","alternate_names":["XERODERMA PIGMENTOSUM VI","XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F","XERODERMA PIGMENTOSUM, TYPE F","XP, GROUP F","Xeroderma pigmentosum, type 6"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010215\"}","{\"db\":\"OMIM\",\"id\":\"278760\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"278760\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"XERODERMA PIGMENTOSUM VI\"}","{\"db\":\"OMIM\",\"id\":\"278760\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F\"}","{\"db\":\"OMIM\",\"id\":\"133520.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"XERODERMA PIGMENTOSUM, TYPE F\"}","{\"db\":\"OMIM\",\"id\":\"133520.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"XERODERMA PIGMENTOSUM, TYPE F\"}","{\"db\":\"OMIM\",\"id\":\"278760\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"XP, GROUP F\"}","{\"db\":\"OMIM\",\"id\":\"278760\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"XP6\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5628\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Xeroderma+pigmentosum%2C+group+F/9524\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"42530008\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1397\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"278760\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4031","name":"Xeroderma pigmentosum, group F"}
{"attribute_content":[],"alternate_symbols":["US1","USH1A"],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301442\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1265\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21697857\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24651602\",\"@Source\":\"PubMed\"}}]}","medgen_id":"C1568247","public_definition":"Usher syndrome type I is characterized by congenital, bilateral, profound sensorineural hearing loss, vestibular areflexia, and adolescent-onset retinitis pigmentosa. Unless fitted with a cochlear implant, individuals do not typically develop speech. Retinitis pigmentosa (RP), a progressive, bilateral, symmetric degeneration of rod and cone functions of the retina, develops in adolescence, resulting in progressively constricted visual fields and impaired visual acuity.","type":"Disease","symbol":"USH1","alternate_names":["Retinitis pigmentosa and congenital deafness","Usher syndrome, type I, French variety"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010168\"}","{\"db\":\"OMIM\",\"id\":\"276900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"231169\"}","{\"db\":\"Orphanet\",\"id\":\"886\"}","{\"db\":\"OMIM\",\"id\":\"276900\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"US1\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010168\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1265\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"276900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5091","name":"Usher syndrome type 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301442\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1265\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21697857\",\"@Source\":\"PubMed\"}}]}","gard_id":"5438","medgen_id":"C1832845","public_definition":"Usher syndrome type I is characterized by congenital, bilateral, profound sensorineural hearing loss, vestibular areflexia, and adolescent-onset retinitis pigmentosa. Unless fitted with a cochlear implant, individuals do not typically develop speech. Retinitis pigmentosa (RP), a progressive, bilateral, symmetric degeneration of rod and cone functions of the retina, develops in adolescence, resulting in progressively constricted visual fields and impaired visual acuity.","type":"Disease","symbol":"USH1D","alternate_names":["USHER SYNDROME, TYPE ID"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010984\"}","{\"db\":\"OMIM\",\"id\":\"601067\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"231169\"}","{\"db\":\"Orphanet\",\"id\":\"886\"}","{\"db\":\"OMIM\",\"id\":\"601067\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"USHER SYNDROME, TYPE ID\"}","{\"db\":\"OMIM\",\"id\":\"605516.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"USHER SYNDROME, TYPE ID\"}","{\"db\":\"OMIM\",\"id\":\"605516.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"USHER SYNDROME, TYPE ID\"}","{\"db\":\"OMIM\",\"id\":\"605516.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"USHER SYNDROME, TYPE ID\"}","{\"db\":\"OMIM\",\"id\":\"605516.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"USHER SYNDROME, TYPE ID\"}","{\"db\":\"OMIM\",\"id\":\"605516.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"USHER SYNDROME, TYPE ID\"}","{\"db\":\"OMIM\",\"id\":\"605516.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"USHER SYNDROME, TYPE ID\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5438\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010984\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1265\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"601067\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"6095","name":"Usher syndrome type 1D"}
{"attribute_content":[],"alternate_symbols":["HHCS"],"keywords":[],"gard_id":"2806","medgen_id":"C1833213","public_definition":"Hyperferritinemia-cataract syndrome is a disorder characterized by an excess of an iron storage protein called ferritin in the blood (hyperferritinemia) and tissues of the body. A buildup of this protein begins early in life, leading to clouding of the lenses of the eyes (cataracts). In affected individuals, cataracts usually develop in infancy, rather than after age 60 as typically occurs in the general population. Cataracts that are not removed surgically cause progressive dimming and blurriness of vision because the clouded lenses reduce and distort incoming light.Although the hyperferritinemia in this disorder does not usually cause any health problems other than cataracts, the elevated ferritin levels in the blood can be mistaken for a sign of certain liver disorders. These conditions result in excess iron in the body and may be treated by blood-drawing. However, individuals with hyperferritinemia-cataract syndrome do not have an excess of iron, and with repeated blood draws will develop reduced iron levels leading to a low number of red blood cells (anemia). Therefore, correct diagnosis of hyperferritinemia-cataract syndrome is important to avoid unnecessary treatments or invasive test procedures such as liver biopsies.","type":"Disease","symbol":"HRFTC","alternate_names":["Bonneau-Beaumont syndrome","HYPERFERRITINEMIA WITH OR WITHOUT CATARACT","Hereditary hyperferritinemia cataract syndrome","Hyperferritinemia cataract syndrome"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010952\"}","{\"db\":\"OMIM\",\"id\":\"600886\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"163\"}","{\"db\":\"OMIM\",\"id\":\"134790.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERFERRITINEMIA WITH OR WITHOUT CATARACT\"}","{\"db\":\"OMIM\",\"id\":\"134790.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERFERRITINEMIA WITH OR WITHOUT CATARACT\"}","{\"db\":\"OMIM\",\"id\":\"134790.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERFERRITINEMIA WITH OR WITHOUT CATARACT\"}","{\"db\":\"OMIM\",\"id\":\"134790.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERFERRITINEMIA WITH OR WITHOUT CATARACT\"}","{\"db\":\"OMIM\",\"id\":\"134790.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERFERRITINEMIA WITH OR WITHOUT CATARACT\"}","{\"db\":\"OMIM\",\"id\":\"134790.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERFERRITINEMIA WITH OR WITHOUT CATARACT\"}","{\"db\":\"OMIM\",\"id\":\"134790.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERFERRITINEMIA WITH OR WITHOUT CATARACT\"}","{\"db\":\"OMIM\",\"id\":\"134790.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERFERRITINEMIA WITH OR WITHOUT CATARACT\"}","{\"db\":\"OMIM\",\"id\":\"134790.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERFERRITINEMIA WITH OR WITHOUT CATARACT\"}","{\"db\":\"OMIM\",\"id\":\"134790.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERFERRITINEMIA WITH OR WITHOUT CATARACT\"}","{\"db\":\"OMIM\",\"id\":\"134790.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERFERRITINEMIA WITH OR WITHOUT CATARACT\"}","{\"db\":\"OMIM\",\"id\":\"134790.0017\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERFERRITINEMIA WITH OR WITHOUT CATARACT\"}","{\"db\":\"OMIM\",\"id\":\"134790.0020\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERFERRITINEMIA WITH OR WITHOUT CATARACT\"}","{\"db\":\"OMIM\",\"id\":\"600886\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERFERRITINEMIA WITH OR WITHOUT CATARACT\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hyperferritinemia+cataract+syndrome/3553\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hyperferritinemia cataract syndrome\"}","{\"db\":\"OMIM\",\"id\":\"600886\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HHCS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2806\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010952\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"hyperferritinemia-cataract-syndrome\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"600886\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2178","name":"Hereditary hyperferritinemia with congenital cataracts"}
{"attribute_content":[],"alternate_symbols":["AHCH","X-AHC"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301604\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1431\",\"@Source\":\"BookShelf\"}]}}","gard_id":"555","disease_mechanism_id":"273","medgen_id":"C0342482","public_definition":"NR0B1-related adrenal hypoplasia congenita includes both X-linked adrenal hypoplasia congenita (X-linked AHC) and Xp21 deletion (previously called complex glycerol kinase deficiency). X-linked AHC is characterized by primary adrenal insufficiency and/or hypogonadotropic hypogonadism (HH). Adrenal insufficiency is acute infantile onset (average age 3 weeks) in approximately 60% of affected males and childhood onset (ages 1-9 years) in approximately 40%. HH typically manifests in a male with adrenal insufficiency as delayed puberty (i.e., onset age \u003e14 years) and less commonly as arrested puberty at about Tanner Stage 3. Rarely, X-linked AHC manifests initially in early adulthood as delayed-onset adrenal insufficiency, partial HH, and/or infertility. Heterozygous females very occasionally have manifestations of adrenal insufficiency or hypogonadotropic hypogonadism. Xp21 deletion includes deletion of NR0B1 (causing X-linked AHC) and GK (causing glycerol kinase deficiency), and in some cases deletion of DMD (causing Duchenne muscular dystrophy). Developmental delay has been reported in males with Xp21 deletion when the deletion extends proximally to include DMD or when larger deletions extend distally to include IL1RAPL1 and DMD.","type":"Disease","symbol":"AHC","alternate_names":["ADRENAL HYPOPLASIA, CONGENITAL, WITH HYPOGONADOTROPIC HYPOGONADISM","Adrenal hypoplasia congenita","Isolated X-Linked Adrenal Hypoplasia Congenita","X-linked AHC"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010264\"}","{\"db\":\"OMIM\",\"id\":\"300200\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"95702\"}","{\"db\":\"OMIM\",\"id\":\"300200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ADRENAL HYPOPLASIA, CONGENITAL, WITH HYPOGONADOTROPIC HYPOGONADISM\"}","{\"db\":\"OMIM\",\"id\":\"300200\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AHCH\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520059\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000576178\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"555\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Congenital+adrenal+hypoplasia%2C+X-linked/7542\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"237764004\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1431\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"300200\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"87","disease_mechanism":"loss of function","name":"Congenital adrenal hypoplasia, X-linked"}
{"attribute_content":[],"alternate_symbols":["ADRESD","EPND","LKS","RESDAD"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"27683935\",\"@Source\":\"PubMed\"},{\"$\":\"NBK385627\",\"@Source\":\"BookShelf\"}]}}","gard_id":"6855","medgen_id":"C3806402","public_definition":"GRIN2A-related speech disorders and epilepsy are characterized by speech disorders in all affected individuals and a range of epilepsy syndromes present in about 90%. Severe speech disorders observed can include dysarthria and speech dyspraxia, and both receptive and expressive language delay/regression; more mildly affected individuals may display subtly impaired intelligibility of conversational speech. Epilepsy features include seizure onset usually between ages three and six years, focal epilepsy with language and/or global developmental regression, and electroencephalogram (EEG) showing continuous spike-and-wave discharges in sleep or very active centrotemporal discharges. Seizure types include seizures associated with aura of perioral paresthesia, focal or focal motor seizures (often evolving to generalized tonic-clonic), and atypical absence seizures. Epilepsy syndromes can include: Landau-Kleffner syndrome (LKS), epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS), childhood epilepsy with centrotemporal spikes (CECTS), atypical childhood epilepsy with centrotemporal spikes (ACECTS), autosomal dominant rolandic epilepsy with speech dyspraxia (ADRESD), and infantile-onset epileptic encephalopathy.","type":"Disease","symbol":"FESD","alternate_names":["APHASIA, ACQUIRED, WITH EPILEPSY","Acquired aphasia with convulsive disorder","Acquired epileptiform aphasia","Epilepsy with neurodevelopmental defects","GRIN2A-Related Disorders","Landau-Kleffner syndrome","Rolandic epilepsy, mental retardation, and speech dyspraxia, autosomal dominant"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"245570\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1945\"}","{\"db\":\"Orphanet\",\"id\":\"725\"}","{\"db\":\"Orphanet\",\"id\":\"98818\"}","{\"db\":\"OMIM\",\"id\":\"245570\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"APHASIA, ACQUIRED, WITH EPILEPSY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Epilepsy+with+neurodevelopmental+defects/8322\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Epilepsy with neurodevelopmental defects\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Landau-Kleffner+syndrome/4080\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Landau-Kleffner syndrome\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009509\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Landau-Kleffner syndrome\"}","{\"db\":\"OMIM\",\"id\":\"245570\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ADRESD\"}","{\"db\":\"OMIM\",\"id\":\"613971\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EPND\"}","{\"db\":\"OMIM\",\"id\":\"245570\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"LKS\"}","{\"db\":\"OMIM\",\"id\":\"245570\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"RESDAD\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6855\",\"ref_field\":\"gard_id\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK385627\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"245570\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5374","name":"Epilepsy, focal, with speech disorder and with or without mental retardation"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301550\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1376\",\"@Source\":\"BookShelf\"}]}}","gard_id":"4984","medgen_id":"C0877024","public_definition":"Schimke immunoosseous dysplasia (SIOD) is an autosomal recessive multisystem disorder characterized by spondyloepiphyseal dysplasia (SED) resulting in short stature, nephropathy, and T-cell deficiency. Radiographic manifestations of SED include ovoid and mildly flattened vertebral bodies, small deformed capital femoral epiphyses, and shallow dysplastic acetabular fossae. Adult height is 136-157 cm for men and 98.5-143 cm for women. Nearly all affected individuals have progressive steroid-resistant nephropathy, usually developing within five years of the diagnosis of growth failure and terminating with end-stage renal disease (ESRD). The majority of tested individuals have T-cell deficiency and an associated risk for opportunistic infection, a common cause of death. SIOD involves a spectrum that ranges from an infantile or severe early-onset form with death early in life to a juvenile or milder later-onset form with survival into adulthood if renal disease is appropriately treated.","type":"Disease","symbol":"SIOD","alternate_names":["Schimke immunoosseous dysplasia","Schimke syndrome","Spondyloepiphyseal dysplasia nephrotic syndrome"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009458\"}","{\"db\":\"OMIM\",\"id\":\"242900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1830\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Spondyloepiphyseal+dysplasia+nephrotic+syndrome/6823\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Schimke immunoosseous dysplasia\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4984\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009458\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1376\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"242900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5333","name":"Schimke immuno-osseous dysplasia"}
{"attribute_content":[],"alternate_symbols":["HMSN IIA1","HMSN2A1"],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301462\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1285\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301684\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1511\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2010\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"2987431\",\"@Source\":\"pmc\"}}]}","gard_id":"1248","medgen_id":"C1861678","public_definition":"MFN2 hereditary motor and sensory neuropathy (MFN2-HMSN) is a classic axonal peripheral sensorimotor neuropathy, inherited in either an autosomal dominant (AD) manner (~90%) or an autosomal recessive (AR) manner (~10%). MFN2-HMSN is characterized by more severe involvement of the lower extremities than the upper extremities, distal upper-extremity involvement as the neuropathy progresses, more prominent motor deficits than sensory deficits, and normal (\u003e42 m/s) or only slightly decreased nerve conduction velocities (NCVs). Postural tremor is common. Median onset is age 12 years in the AD form and age eight years in the AR form. The prevalence of optic atrophy is approximately 7% in the AD form and approximately 20% in the AR form.","type":"Disease","symbol":"CMT2A1","alternate_names":["CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A1","CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1","CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2A1","CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2A1","HEREDITARY MOTOR AND SENSORY NEUROPATHY IIA1"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007308\"}","{\"db\":\"OMIM\",\"id\":\"118210\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"99946\"}","{\"db\":\"OMIM\",\"id\":\"118210\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A1\"}","{\"db\":\"OMIM\",\"id\":\"118210\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1\"}","{\"db\":\"OMIM\",\"id\":\"118210\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2A1\"}","{\"db\":\"OMIM\",\"id\":\"118210\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2A1\"}","{\"db\":\"OMIM\",\"id\":\"118210\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HEREDITARY MOTOR AND SENSORY NEUROPATHY IIA1\"}","{\"db\":\"OMIM\",\"id\":\"118210\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HMSN IIA1\"}","{\"db\":\"OMIM\",\"id\":\"118210\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HMSN2A1\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1248\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Charcot-Marie-Tooth+disease%2C+type+2A1/7957\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1511\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"118210\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1413","name":"Charcot-Marie-Tooth disease, type 2A1"}
{"attribute_content":[],"alternate_symbols":["CMT2A2","HMSN2A2"],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301462\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1285\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301684\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1511\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"MDA Consensus document - CMT testing, 2011\",\"@Type\":\"general\",\"ID\":{\"$\":\"3058597\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"EuroGenetest, 2010\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"2987431\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301532\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1358\",\"@Source\":\"BookShelf\"}]}]}","medgen_id":"C4721887","public_definition":"MFN2 hereditary motor and sensory neuropathy (MFN2-HMSN) is a classic axonal peripheral sensorimotor neuropathy, inherited in either an autosomal dominant (AD) manner (~90%) or an autosomal recessive (AR) manner (~10%). MFN2-HMSN is characterized by more severe involvement of the lower extremities than the upper extremities, distal upper-extremity involvement as the neuropathy progresses, more prominent motor deficits than sensory deficits, and normal (\u003e42 m/s) or only slightly decreased nerve conduction velocities (NCVs). Postural tremor is common. Median onset is age 12 years in the AD form and age eight years in the AR form. The prevalence of optic atrophy is approximately 7% in the AD form and approximately 20% in the AR form.","type":"Disease","symbol":"CMT2A2A","alternate_names":["CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A","CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2","CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2A2","Charcot-Marie-Tooth Neuropathy Type 2A2","HEREDITARY MOTOR AND SENSORY NEUROPATHY IIA2","HMSN IIA2"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012231\"}","{\"db\":\"OMIM\",\"id\":\"609260\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"99947\"}","{\"db\":\"OMIM\",\"id\":\"609260\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A\"}","{\"db\":\"OMIM\",\"id\":\"609260\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2\"}","{\"db\":\"OMIM\",\"id\":\"609260\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2A2\"}","{\"db\":\"OMIM\",\"id\":\"609260\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HEREDITARY MOTOR AND SENSORY NEUROPATHY IIA2\"}","{\"db\":\"OMIM\",\"id\":\"609260\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HMSN IIA2\"}","{\"db\":\"OMIM\",\"id\":\"609260\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CMT2A2\"}","{\"db\":\"OMIM\",\"id\":\"609260\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HMSN2A2\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Charcot-Marie-Tooth+disease%2C+type+2A2/7958\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1511\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"609260\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"776","name":"Charcot-Marie-Tooth disease, type 2A2A"}
{"attribute_content":[],"alternate_symbols":["CMT6","CMT6A","HMSN6","HSMN6"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301684\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1511\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C0393807","public_definition":"MFN2 hereditary motor and sensory neuropathy (MFN2-HMSN) is a classic axonal peripheral sensorimotor neuropathy, inherited in either an autosomal dominant (AD) manner (~90%) or an autosomal recessive (AR) manner (~10%). MFN2-HMSN is characterized by more severe involvement of the lower extremities than the upper extremities, distal upper-extremity involvement as the neuropathy progresses, more prominent motor deficits than sensory deficits, and normal (\u003e42 m/s) or only slightly decreased nerve conduction velocities (NCVs). Postural tremor is common. Median onset is age 12 years in the AD form and age eight years in the AR form. The prevalence of optic atrophy is approximately 7% in the AD form and approximately 20% in the AR form.","type":"Disease","symbol":"HMSN6A","alternate_names":["CHARCOT-MARIE-TOOTH DISEASE, TYPE 6","CHARCOT-MARIE-TOOTH DISEASE, TYPE 6A","HMSN VIA","NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA","NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA, WITH OPTIC ATROPHY","PERIPHERAL NEUROPATHY AND OPTIC ATROPHY"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"601152\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"90120\"}","{\"db\":\"OMIM\",\"id\":\"601152\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH DISEASE, TYPE 6\"}","{\"db\":\"OMIM\",\"id\":\"601152\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH DISEASE, TYPE 6A\"}","{\"db\":\"OMIM\",\"id\":\"601152\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HMSN VIA\"}","{\"db\":\"OMIM\",\"id\":\"608507.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA\"}","{\"db\":\"OMIM\",\"id\":\"608507.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA\"}","{\"db\":\"OMIM\",\"id\":\"608507.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA\"}","{\"db\":\"OMIM\",\"id\":\"608507.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA\"}","{\"db\":\"OMIM\",\"id\":\"608507.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA\"}","{\"db\":\"OMIM\",\"id\":\"601152\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA, WITH OPTIC ATROPHY\"}","{\"db\":\"OMIM\",\"id\":\"601152\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PERIPHERAL NEUROPATHY AND OPTIC ATROPHY\"}","{\"db\":\"OMIM\",\"id\":\"601152\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CMT6\"}","{\"db\":\"OMIM\",\"id\":\"601152\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CMT6A\"}","{\"db\":\"OMIM\",\"id\":\"601152\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HMSN6\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hereditary+motor+and+sensory+neuropathy+with+optic+atrophy/8523\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"128203003\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1511\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"601152\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2032","name":"Hereditary motor and sensory neuropathy with optic atrophy"}
{"attribute_content":[],"alternate_symbols":["ILS"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301752\",\"@Source\":\"PubMed\"},{\"$\":\"NBK5189\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C0431375","public_definition":"PAFAH1B1-associated lissencephaly includes Miller-Dieker syndrome (MDS), isolated lissencephaly sequence (ILS), and (rarely) subcortical band heterotopia (SBH). Lissencephaly and SBH are cortical malformations caused by deficient neuronal migration during embryogenesis. Lissencephaly refers to a \"smooth brain\" with absent gyri (agyria) or abnormally wide gyri (pachygyria). SBH refers to a band of heterotopic gray matter located just beneath the cortex and separated from it by a thin zone of normal white matter. MDS is characterized by lissencephaly, typical facial features, and severe neurologic abnormalities. ILS is characterized by lissencephaly and its direct sequelae: developmental delay, intellectual disability, and seizures.","type":"Disease","symbol":"LIS1","alternate_names":["Isolated Lissencephaly Sequence","LIS1-Associated Lissencephaly/Subcortical Band Heterotopia","Lissencephaly classic","Type 1 lissencephaly","Type I lissencephaly"],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006818\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"607432\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"95232\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK5189\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LIS1-Associated Lissencephaly/Subcortical Band Heterotopia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006818\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Type 1 lissencephaly\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006818\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Type I lissencephaly\"}","{\"db\":\"OMIM\",\"id\":\"607432\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ILS\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011830\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK5189\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"607432\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2563","name":"Lissencephaly due to LIS1 mutation"}
{"attribute_content":[],"alternate_symbols":[],"keywords":["Hereditary cancer syndrome","Neoplasm"],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301425\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1247\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"NSGC, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15604628\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Stratton and Rahman, 2008\",\"@Type\":\"review\",\"ID\":{\"$\":\"18163131\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2007\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"17508274\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24366376\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2014\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"24366402\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"24432435\",\"@Source\":\"PubMed\"}}]}","disease_mechanism_id":"273","medgen_id":"C0006142","public_definition":"BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.","type":"Disease","alternate_names":["Breast cancer, familial","CHEK2-Related Breast Cancer"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0016419\"}","{\"db\":\"OMIM\",\"id\":\"114480\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"227535\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530707\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000531340\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558503\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561700\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000562228\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569423\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570011\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Familial+cancer+of+breast/8375\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"254843006\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1247\",\"ref_field\":\"public_definition\"}"],"id":"536","disease_mechanism":"loss of function","name":"Familial cancer of breast"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"27308687\",\"@Source\":\"PubMed\"},{\"$\":\"NBK367946\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C2675336","public_definition":"15q duplication syndrome and related disorders (dup15q) are caused by presence of at least one extra maternally derived copy of the Prader-Willi/Angelman critical region (PWACR) within chromosome 15q11.2-q13.1. The extra copy or copies most commonly arise by one of two mechanisms: A maternal isodicentric 15q11.2-q13.1 supernumerary chromosome â idic(15) â typically comprising two extra copies of 15q11.2-q13.1 and resulting in tetrasomy for 15q11.2-q13.1 (~80% of cases); A maternal interstitial 15q11.2-q13.1 duplication that typically includes one extra copy of 15q11.2-q13.1 within chromosome 15, resulting in trisomy for 15q11.2-q13.1 (~20% of cases). Dup15q is characterized by hypotonia and motor delays, intellectual disability, autism spectrum disorder (ASD), and epilepsy including infantile spasms. Rarely, dup15q may also be associated with psychosis or sudden unexplained death. Those with maternal idic(15) are typically more severely affected than those with an interstitial duplication.","type":"Disease","alternate_names":["15q11.2-q13.1 Duplication Syndrome","DUPLICATION 15q11-q13 SYNDROME"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"608636\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"238446\"}","{\"db\":\"OMIM\",\"id\":\"608636\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DUPLICATION 15q11-q13 SYNDROME\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK367946\",\"ref_field\":\"public_definition\"}"],"id":"903","name":"Chromosome 15q11-q13 duplication syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"27413800\",\"@Source\":\"PubMed\"},{\"$\":\"NBK373578\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C1850155","public_definition":"Multicentric osteolysis nodulosis and arthropathy (MONA) is a skeletal dysplasia characterized by progressive osteolysis (particularly of the carpal and tarsal bones), osteoporosis, subcutaneous nodules on the palms and soles, and progressive arthropathy (joint contractures, pain, swelling, and stiffness). Other manifestations include coarse facies, pigmented skin lesions, cardiac defects, and corneal opacities. Onset is usually between ages six months and six years (range: birth to 11 years).","type":"Disease","symbol":"MONA","alternate_names":["AL-AQEEL SEWAIRI SYNDROME","Al-Qeel Sewairi syndrome","NAO SYNDROME","NOA syndrome","Nodulosis arthropathy osteolysis syndrome","Osteolysis, hereditary multicentric","Torg Winchester syndrome","Torg syndrome","Winchester-Grossman syndrome"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"259600\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3460\"}","{\"db\":\"Orphanet\",\"id\":\"371428\"}","{\"db\":\"OMIM\",\"id\":\"259600\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AL-AQEEL SEWAIRI SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"259600\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAO SYNDROME\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Torg+Winchester+syndrome/7136\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Torg Winchester syndrome\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK373578\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"259600\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4566","name":"Multicentric osteolysis, nodulosis and arthropathy"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"13007","medgen_id":"C1840779","public_definition":"Methemoglobinemia, beta-globin type is a condition that affects the function of red blood cells. Specifically, it alters a molecule called hemoglobin within these cells. Hemoglobin within red blood cells attaches (binds) to oxygen molecules in the lungs, which it carries through the bloodstream, then releases in tissues throughout the body. Instead of normal hemoglobin, people with methemoglobinemia, beta-globin type have an abnormal form called methemoglobin, which is unable to efficiently deliver oxygen to the body's tissues. In methemoglobinemia, beta-globin type, the abnormal hemoglobin gives the blood a brown color. It also causes a bluish appearance of the skin, lips, and nails (cyanosis), which usually first appears around the age of 6 months. The signs and symptoms of methemoglobinemia, beta-globin type are generally limited to cyanosis, which does not cause any health problems. However, in rare cases, severe methemoglobinemia, beta-globin type can cause headaches, weakness, and fatigue.","type":"Disease","alternate_names":["METHEMOGLOBINEMIA, BETA TYPE"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"617971\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"141900.0163\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"METHEMOGLOBINEMIA, BETA TYPE\"}","{\"db\":\"OMIM\",\"id\":\"141900.0164\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"METHEMOGLOBINEMIA, BETA TYPE\"}","{\"db\":\"OMIM\",\"id\":\"617971\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"METHEMOGLOBINEMIA, BETA TYPE\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"13007\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"methemoglobinemia-beta-globin-type\",\"ref_field\":\"public_definition\"}"],"id":"16291","name":"Methemoglobinemia, beta-globin type"}
{"attribute_content":[],"alternate_symbols":["CHR"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301621\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1448\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C4721541","public_definition":"Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term \"ZSD\" is now used to refer to all individuals with a PEX gene defect regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and other long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss); neurologic involvement (ataxia, polyneuropathy, and leukodystrophy); liver dysfunction; adrenal insufficiency; and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.","type":"Disease","symbol":"PBD1A","alternate_names":["Peroxisome biogenesis disorder 1a","Zellweger leukodystrophy"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008953\"}","{\"db\":\"OMIM\",\"id\":\"214100\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"912\"}","{\"db\":\"OMIM\",\"id\":\"214100\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CHR\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1448\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"214100\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5138","name":"Peroxisome biogenesis disorder 1A (Zellweger)"}
{"attribute_content":[],"alternate_symbols":["NPH3"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"27336129\",\"@Source\":\"PubMed\"},{\"$\":\"NBK368475\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C1858392","public_definition":"The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-LÃ¸ken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).","type":"Disease","symbol":"NPHP3","alternate_names":["Adolescent nephronophthisis"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011456\"}","{\"db\":\"OMIM\",\"id\":\"604387\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"655\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Adolescent+nephronophthisis/7636\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Adolescent nephronophthisis\"}","{\"db\":\"SNOMED CT\",\"id\":\"444749006\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Adolescent nephronophthisis\"}","{\"db\":\"OMIM\",\"id\":\"604387\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NPH3\"}","{\"db\":\"GeneTests\",\"id\":\"72010\",\"ref_field\":\"name\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011456\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK368475\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"604387\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5620","name":"Nephronophthisis 3"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"32027475\",\"@Source\":\"PubMed\"},{\"$\":\"NBK553533\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C4748427","public_definition":"Squalene synthase deficiency (SQSD) is a rare inborn error of cholesterol biosynthesis with multisystem clinical manifestations similar to Smith-Lemli-Optiz syndrome. Key clinical features include facial dysmorphism, a generalized seizure disorder presenting in the neonatal period, nonspecific structural brain malformations, cortical visual impairment, optic nerve hypoplasia, profound developmental delay / intellectual disability, dry skin with photosensitivity, and genital malformations in males.","type":"Disease","symbol":"SQSD","alternate_names":["NEURODEVELOPMENTAL DISORDER WITH LOW CHOLESTEROL AND ABNORMAL URINE ORGANIC ACIDS"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032566\"}","{\"db\":\"OMIM\",\"id\":\"618156\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618156\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEURODEVELOPMENTAL DISORDER WITH LOW CHOLESTEROL AND ABNORMAL URINE ORGANIC ACIDS\"}","{\"db\":\"GeneTests\",\"id\":\"320637\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"184420.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"184420.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"184420.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618156\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK553533\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"618156\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40736","name":"SQUALENE SYNTHASE DEFICIENCY"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"NINDS Fact Sheet\",\"@Type\":\"review\",\"URL\":{\"$\":\"https://www.ninds.nih.gov/disorders/autism/detail_autism.htm\"}},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3111012\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ACMG, 2005\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3110947\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3111019\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ISCA, 2010\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"20466091\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23519317\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NCCN, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25190698\",\"@Source\":\"PubMed\"}}]}","medgen_id":"C1510586","public_definition":"Autism spectrum disorder (ASD) is a condition that appears very early in childhood development, varies in severity, and is characterized by impaired social skills, communication problems, and repetitive behaviors. These difficulties can interfere with affected individuals' ability to function in social, academic, and employment settings. People with ASD also have an increased risk of psychiatric problems such as anxiety, depression, obsessive-compulsive disorder, and eating disorders.From as early as 1 to 2 years of age, people with ASD have an impaired ability to interact with other people; they are often more comfortable dealing with objects. Affected individuals have difficulty understanding and using non-verbal social cues such as eye contact, facial expressions, gestures, and body language. Inability to recognize and use these cues makes it hard for affected individuals to understand the feelings of others or communicate their own feelings appropriately. Behavioral signs of ASD, such as reduced eye contact and social interaction, can sometimes be detected before age 2. However, the condition is usually diagnosed between ages 2 and 4, when more advanced communication and social skills, such as learning to play with others, typically begin to develop.Repetitive behaviors in ASD can include simple actions such as rocking, hand-flapping, or repetition of words or noises (echolalia). Affected individuals often dwell on or repeatedly express particular thoughts; this behavior is called perseveration. People with ASD tend to be rigid about their established routines and may strongly resist disruptions such as changes in schedule. They may also have difficulty tolerating sensory stimuli such as loud noises or bright lights.While social and communication difficulties and unusual behaviors define ASD, affected individuals can have a wide range of intellectual abilities and language skills. A majority of people with ASD have mild to moderate intellectual disability, while others have average to above-average intelligence. Some have particular cognitive abilities that greatly surpass their overall level of functioning, often in areas such as music, mathematics, or memory.Some people with ASD do not speak at all, while others use language fluently. However, fluent speakers with ASD often have problems associated with verbal communication. They might speak in a monotone voice, have unusual vocal mannerisms, or choose unusual topics of conversation.Several diagnoses that used to be classified as separate conditions are now grouped together under the diagnosis of ASD. For example, autistic disorder was a term that was used when affected individuals had limited or absent verbal communication, often in combination with intellectual disability. By contrast, Asperger syndrome was a diagnosis formerly applied to affected individuals of average or above-average intelligence who were not delayed in their language development. The broader diagnosis of ASD was established because many affected individuals fall outside of the strict definitions of the narrower diagnoses, and their intellectual and communication abilities may change over time. However, some individuals who were previously diagnosed with one of the subtypes now do not meet all the criteria of the new umbrella diagnosis.","type":"Disease","alternate_names":["Autism spectrum disorders","Autism susceptibility"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0005258\"}","{\"db\":\"OMIM\",\"id\":\"PS209850\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"106\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Autism+Spectrum+Disorders/7767\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Autism spectrum disorders\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0005258\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"autism-spectrum-disorder\",\"ref_field\":\"public_definition\"}"],"id":"9460","name":"Autism spectrum disorder"}
{"attribute_content":[],"alternate_symbols":["NPHP1"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301500\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1325\",\"@Source\":\"BookShelf\"}]}}","gard_id":"10169","medgen_id":"C1846790","public_definition":"Classic Joubert syndrome (JS) is characterized by three primary findings: A distinctive cerebellar and brain stem malformation called the molar tooth sign (MTS). Hypotonia. Developmental delays. Often these findings are accompanied by episodic tachypnea or apnea and/or atypical eye movements. In general, the breathing abnormalities improve with age, truncal ataxia develops over time, and acquisition of gross motor milestones is delayed. Cognitive abilities are variable, ranging from severe intellectual disability to normal. Additional findings can include retinal dystrophy, renal disease, ocular colobomas, occipital encephalocele, hepatic fibrosis, polydactyly, oral hamartomas, and endocrine abnormalities. Both intra- and interfamilial variation are seen.","type":"Disease","symbol":"JBTS4","alternate_names":["Joubert syndrome with renal anomalies"],"xrefs":["{\"db\":\"OMIM\",\"id\":\"609583\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"220497\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10169\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Joubert+syndrome+4/3921\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1325\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"609583\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2499","name":"Joubert syndrome 4"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"28837307\",\"@Source\":\"PubMed\"},{\"$\":\"NBK447920\",\"@Source\":\"BookShelf\"}]}}","gard_id":"10145","medgen_id":"C2931246","public_definition":"Potocki-Lupski syndrome (PTLS) is characterized by cognitive, behavioral, and medical manifestations. Cognitively, most individuals present with developmental delay, later meeting criteria for moderate intellectual disability. Behaviorally, issues with attention, hyperactivity, withdrawal, and anxiety may be seen. Some individuals meet criteria for autism spectrum disorder. Medically, hypotonia, oropharyngeal dysphagia leading to failure to thrive, congenital heart disease, hypoglycemia associated with growth hormone deficiency, and mildly dysmorphic facial features are observed. Medical manifestations typically lead to identification of PTLS in infancy; however, those with only behavioral and cognitive manifestations may be identified in later childhood.","type":"Disease","symbol":"PTLS","alternate_names":["CHROMOSOME 17p11.2 DUPLICATION SYNDROME","Chromosome 17, trisomy 17p11 2","Duplication 17p11 2","Duplication 17p11.2 syndrome","Potocki-Lupski syndrome (dup(17)(p11.2p11.2))","Trisomy 17p11 2"],"xrefs":["{\"db\":\"Gene\",\"id\":\"100038247\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012574\"}","{\"db\":\"OMIM\",\"id\":\"610883\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1713\"}","{\"db\":\"OMIM\",\"id\":\"610883\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHROMOSOME 17p11.2 DUPLICATION SYNDROME\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Chromosome+17%2C+Trisomy+17p11+2/1476\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Chromosome 17, trisomy 17p11 2\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10145\",\"ref_field\":\"gard_id\"}","{\"db\":\"GeneTests\",\"id\":\"320523\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Potocki-Lupski+syndrome/5903\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"potocki-lupski-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012574\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK447920\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"610883\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"8007","name":"Potocki-Lupski syndrome"}
{"attribute_content":[],"alternate_symbols":["NBM1"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301423\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1245\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C3495587","public_definition":"X-linked congenital stationary night blindness (CSNB) is characterized by non-progressive retinal findings of reduced visual acuity ranging from 20/30 to 20/200; defective dark adaptation; refractive error, most typically myopia ranging from low (-0.25 diopters [D] to -4.75 D) to high (=-10.00 D) but occasionally hyperopia; nystagmus; strabismus; normal color vision; and normal fundus examination. Characteristic ERG findings can help distinguish between complete X-linked CSNB and incomplete X-linked CSNB.","type":"Disease","symbol":"CSNB1A","alternate_names":["CSNB, COMPLETE, X-LINKED","Hemeralopia-myopia","Myopia-night blindness","Night blindness, congenital stationary, type 1","Night blindness, congenital stationary, with myopia","X-linked congenital stationary night blindness"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010690\"}","{\"db\":\"OMIM\",\"id\":\"310500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"215\"}","{\"db\":\"OMIM\",\"id\":\"310500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CSNB, COMPLETE, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"310500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NBM1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Congenital+stationary+night+blindness%2C+type+1A/8081\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1245\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"310500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3641","name":"Congenital stationary night blindness, type 1A"}
{"attribute_content":[],"alternate_symbols":["JOAG1"],"keywords":[],"gard_id":"9485","medgen_id":"C1842028","public_definition":"Glaucoma is a group of eye disorders in which the optic nerves connecting the eyes and the brain are progressively damaged. This damage can lead to reduction in side (peripheral) vision and eventual blindness. Other signs and symptoms may include bulging eyes, excessive tearing, and abnormal sensitivity to light (photophobia). The term \"early-onset glaucoma\" may be used when the disorder appears before the age of 40.In most people with glaucoma, the damage to the optic nerves is caused by increased pressure within the eyes (intraocular pressure). Intraocular pressure depends on a balance between fluid entering and leaving the eyes.Usually glaucoma develops in older adults, in whom the risk of developing the disorder may be affected by a variety of medical conditions including high blood pressure (hypertension) and diabetes mellitus, as well as family history. The risk of early-onset glaucoma depends mainly on heredity.Structural abnormalities that impede fluid drainage in the eye may be present at birth and usually become apparent during the first year of life. Such abnormalities may be part of a genetic disorder that affects many body systems, called a syndrome. If glaucoma appears before the age of 5 without other associated abnormalities, it is called primary congenital glaucoma.Other individuals experience early onset of primary open-angle glaucoma, the most common adult form of glaucoma. If primary open-angle glaucoma develops during childhood or early adulthood, it is called juvenile open-angle glaucoma.","type":"Disease","symbol":"GLC1A","alternate_names":["Glaucoma hereditary, juvenile","Glaucoma, Dominant (Juvenile Onset)","Primary open angle glaucoma juvenile onset 1"],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007664\"}","{\"db\":\"OMIM\",\"id\":\"137750\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"98977\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Primary+open+angle+glaucoma+juvenile+onset+1/5956\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Primary open angle glaucoma juvenile onset 1\"}","{\"db\":\"OMIM\",\"id\":\"137750\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"JOAG1\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9485\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007664\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"early-onset-glaucoma\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"137750\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1921","name":"Glaucoma 1, open angle, A"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4014291","type":"Disease","symbol":"OOMD1","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615774\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"404466\"}","{\"db\":\"OMIM\",\"id\":\"615774\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18726","name":"Oocyte maturation defect 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3279875","type":"Disease","symbol":"OCCM","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614115\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"280640\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cortical+malformations%2C+occipital/8099\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614115\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"16110","name":"Cortical malformations, occipital"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263090","type":"Disease","symbol":"POF16","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032881\"}","{\"db\":\"OMIM\",\"id\":\"618723\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618723\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618723\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43193","name":"PREMATURE OVARIAN FAILURE 16"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262871","type":"Disease","symbol":"EIEE81","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032858\"}","{\"db\":\"OMIM\",\"id\":\"618663\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"612186.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612186.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612186.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612186.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612186.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618663\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618663\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43090","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 81"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258293","type":"Disease","symbol":"EIEE74","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032725\"}","{\"db\":\"OMIM\",\"id\":\"618396\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"137164.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137164.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137164.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618396\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618396\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41594","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263374","type":"Disease","symbol":"RLSDF","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032935\"}","{\"db\":\"OMIM\",\"id\":\"618821\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"614150.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614150.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618821\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618821\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43779","name":"RHIZOMELIC LIMB SHORTENING WITH DYSMORPHIC FEATURES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4310764","type":"Disease","symbol":"SCN7","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"617014\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"420702\"}","{\"db\":\"OMIM\",\"id\":\"617014\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"35689","name":"Neutropenia, severe congenital, 7, autosomal recessive"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262332","type":"Disease","symbol":"CHNG9","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0026732\"}","{\"db\":\"OMIM\",\"id\":\"301035\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"300904.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300904.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300904.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301035\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301035\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42943","name":"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 9"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262443","type":"Disease","symbol":"USH1M","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032841\"}","{\"db\":\"OMIM\",\"id\":\"618632\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618632\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618632\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43020","name":"USHER SYNDROME, TYPE 1M"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748988","type":"Disease","symbol":"EIEE69","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032657\"}","{\"db\":\"OMIM\",\"id\":\"618285\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"601013.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601013.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601013.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601013.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601013.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618285\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618285\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41315","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748732","type":"Disease","symbol":"MRT66","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032605\"}","{\"db\":\"OMIM\",\"id\":\"618221\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"616082.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616082.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616082.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618221\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618221\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40859","name":"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN279276","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0017847\"}","{\"db\":\"Orphanet\",\"id\":\"316240\"}","{\"db\":\"NCBI for submitter\",\"id\":\"60213427\",\"ref_field\":\"name\"}"],"id":"42452","name":"Autosomal recessive spastic ataxia"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263095","type":"Disease","symbol":"IDDBCS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032883\"}","{\"db\":\"OMIM\",\"id\":\"618725\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608325.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618725\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618725\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43202","name":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT SEIZURES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258819","type":"Disease","symbol":"DFNB115","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032762\"}","{\"db\":\"OMIM\",\"id\":\"618457\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618457\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618457\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41786","name":"DEAFNESS, AUTOSOMAL RECESSIVE 115"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263366","type":"Disease","symbol":"TLIND","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032928\"}","{\"db\":\"OMIM\",\"id\":\"618806\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600838.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600838.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600838.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618806\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618806\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43763","name":"T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258245","type":"Disease","symbol":"NEDLBA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032697\"}","{\"db\":\"OMIM\",\"id\":\"618354\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618354\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618354\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41509","name":"NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258265","type":"Disease","symbol":"NEDMEHM","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032705\"}","{\"db\":\"OMIM\",\"id\":\"618367\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"604197.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604197.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604197.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618367\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618367\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41559","name":"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"10654","medgen_id":"C1845407","type":"Disease","symbol":"CORDX3","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010335\"}","{\"db\":\"OMIM\",\"id\":\"300476\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1872\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10654\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010335\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300476\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1545","name":"X-linked cone-rod dystrophy 3"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748708","type":"Disease","symbol":"IBDIMDE","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032601\"}","{\"db\":\"OMIM\",\"id\":\"618213\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"190180.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"190180.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"190180.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618213\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618213\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40856","name":"INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258762","type":"Disease","symbol":"SPAX9","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032753\"}","{\"db\":\"OMIM\",\"id\":\"618438\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618438\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618438\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41772","name":"SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748442","type":"Disease","symbol":"JBTS35","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032570\"}","{\"db\":\"OMIM\",\"id\":\"618161\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"604695.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604695.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618161\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618161\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40744","name":"JOUBERT SYNDROME 35"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"3971","medgen_id":"C1863843","type":"Disease","symbol":"NIID","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011327\"}","{\"db\":\"OMIM\",\"id\":\"603472\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2289\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3971\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Neuronal+intranuclear+inclusion+disease/5196\",\"ref_field\":\"name\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011327\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603472\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5632","name":"Neuronal intranuclear inclusion disease"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3672352","type":"Disease","symbol":"HOD","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032805\"}","{\"db\":\"OMIM\",\"id\":\"618541\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602727.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618541\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618541\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42318","name":"HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN261159","type":"Disease","symbol":"SHUVER","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0026727\"}","{\"db\":\"OMIM\",\"id\":\"301029\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"300688.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300688.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300688.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300688.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301029\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301029\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42271","name":"SHUKLA-VERNON SYNDROME"}
{"attribute_content":[],"alternate_symbols":["MSSGM"],"keywords":[],"medgen_id":"C4014997","type":"Disease","symbol":"MSSGM1","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0000208\"}","{\"db\":\"OMIM\",\"id\":\"616033\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"391408\"}","{\"db\":\"OMIM\",\"id\":\"616033\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MSSGM\"}","{\"db\":\"OMIM\",\"id\":\"616033\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"31901","name":"Microcephaly, short stature, and impaired glucose metabolism 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263108","type":"Disease","symbol":"HLD19","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032871\"}","{\"db\":\"OMIM\",\"id\":\"618688\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618685.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618685.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618685.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618688\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618688\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43124","name":"LEUKODYSTROPHY, HYPOMYELINATING, 19, TRANSIENT INFANTILE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258212","type":"Disease","symbol":"CDGF2","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020777\"}","{\"db\":\"OMIM\",\"id\":\"618324\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618324\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41416","name":"Congenital disorder of glycosylation with defective fucosylation 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748428","type":"Disease","symbol":"IDDMSSD","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032568\"}","{\"db\":\"OMIM\",\"id\":\"618158\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602590.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602590.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618158\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618158\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40743","name":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263266","type":"Disease","symbol":"LMPHM8","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032907\"}","{\"db\":\"OMIM\",\"id\":\"618773\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618773\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618773\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43625","name":"LYMPHATIC MALFORMATION 8"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262929","type":"Disease","symbol":"IDDSSBA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032870\"}","{\"db\":\"OMIM\",\"id\":\"618687\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"610166.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610166.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618687\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618687\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43122","name":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4310671","type":"Disease","symbol":"PEBAT","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0014964\"}","{\"db\":\"OMIM\",\"id\":\"617193\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"496641\"}","{\"db\":\"OMIM\",\"id\":\"617193\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"36321","name":"Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748872","type":"Disease","symbol":"ACCIID","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032642\"}","{\"db\":\"OMIM\",\"id\":\"618265\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"114105.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114105.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618265\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618265\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40926","name":"ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748930","type":"Disease","symbol":"HYPT14","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032649\"}","{\"db\":\"OMIM\",\"id\":\"618275\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600909.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600909.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600909.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618275\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618275\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40934","name":"HYPOTRICHOSIS 14"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262446","type":"Disease","symbol":"OPML1","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032843\"}","{\"db\":\"OMIM\",\"id\":\"618637\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618637\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618637\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43023","name":"OCULOPHARYNGEAL MYOPATHY WITH LEUKOENCEPHALOPATHY 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260577","type":"Disease","symbol":"NEDMIBA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032779\"}","{\"db\":\"OMIM\",\"id\":\"618492\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603331.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603331.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603331.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618492\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618492\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42185","name":"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260588","type":"Disease","symbol":"AOVD3","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032783\"}","{\"db\":\"OMIM\",\"id\":\"618496\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"607528.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607528.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618496\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618496\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42205","name":"AORTIC VALVE DISEASE 3"}
{"attribute_content":[],"alternate_symbols":["D,L-2-HGA","SLC25A1"],"keywords":[],"disease_mechanism_id":"273","medgen_id":"C2746066","type":"Disease","symbol":"D2L2AD","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0014072\"}","{\"db\":\"OMIM\",\"id\":\"615182\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"356978\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501795\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"D,L-2-HGA\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501795\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530097\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"OMIM\",\"id\":\"615182\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17743","disease_mechanism":"loss of function","name":"Combined d-2- and l-2-hydroxyglutaric aciduria"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258386","type":"Disease","symbol":"SPGF37","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032744\"}","{\"db\":\"OMIM\",\"id\":\"618429\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"611430.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611430.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611430.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611430.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611430.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618429\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618429\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41645","name":"SPERMATOGENIC FAILURE 37"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262312","type":"Disease","symbol":"MYOSCO","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032821\"}","{\"db\":\"OMIM\",\"id\":\"618578\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"167410.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"167410.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"167410.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"167410.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618578\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618578\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42918","name":"MYOPATHY, CONGENITAL, PROGRESSIVE, WITH SCOLIOSIS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3554593","type":"Disease","symbol":"RDCCAS","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615147\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"352718\"}","{\"db\":\"OMIM\",\"id\":\"615147\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17702","name":"Retinal dystrophy, iris coloboma, and comedogenic acne syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1300287","type":"Disease","symbol":"HRPTTN","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032591\"}","{\"db\":\"OMIM\",\"id\":\"618188\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606680.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606680.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606680.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606680.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606680.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606680.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618188\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618188\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40821","name":"HYPERPARATHYROIDISM, TRANSIENT NEONATAL"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C2748918","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"Orphanet\",\"id\":\"364541\"}"],"id":"9152","name":"Otopalatodigital spectrum disorder"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263365","type":"Disease","symbol":"JRRP","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032925\"}","{\"db\":\"OMIM\",\"id\":\"618803\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618803\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618803\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43762","name":"RESPIRATORY PAPILLOMATOSIS, JUVENILE RECURRENT, CONGENITAL"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260602","type":"Disease","symbol":"CSS10","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032791\"}","{\"db\":\"OMIM\",\"id\":\"618506\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"184430.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"184430.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"184430.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"184430.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618506\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618506\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42216","name":"COFFIN-SIRIS SYNDROME 10"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748626","type":"Disease","symbol":"ODG8","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032590\"}","{\"db\":\"OMIM\",\"id\":\"618187\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618187\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618187\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40824","name":"OVARIAN DYSGENESIS 8"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748721","type":"Disease","symbol":"PAPA9","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032603\"}","{\"db\":\"OMIM\",\"id\":\"618219\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618219\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618219\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40857","name":"POLYDACTYLY, POSTAXIAL, TYPE A9"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3809470","type":"Disease","symbol":"EBSB2","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615425\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"412181\"}","{\"db\":\"OMIM\",\"id\":\"615425\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18300","name":"Epidermolysis bullosa simplex, autosomal recessive 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1855860","type":"Disease","symbol":"HIHGHH","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"240900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"293964\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hypoglycemia%2C+neonatal%2C+simulating+foetopathia+diabetica/8611\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"240900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5301","name":"Hypoglycemia, neonatal, simulating foetopathia diabetica"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263281","type":"Disease","symbol":"NEDESBA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032894\"}","{\"db\":\"OMIM\",\"id\":\"618741\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"610971.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618741\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618741\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43642","name":"NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, SPASTICITY, AND BRAIN ATROPHY"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260170","type":"Disease","symbol":"BANDDOS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032772\"}","{\"db\":\"OMIM\",\"id\":\"618476\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"164770.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"164770.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"164770.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"164770.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"164770.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"164770.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618476\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618476\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42137","name":"BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262229","type":"Disease","symbol":"CHNG7","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032819\"}","{\"db\":\"OMIM\",\"id\":\"618573\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"188545.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"188545.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"188545.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"188545.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618573\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618573\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42896","name":"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0263383","type":"Disease","symbol":"KPA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0021036\"}","{\"db\":\"OMIM\",\"id\":\"604093\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3406\"}","{\"db\":\"SNOMED CT\",\"id\":\"5132005\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604093\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2653","name":"Keratosis pilaris"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"6258","medgen_id":"C0011436","type":"Finding","alternate_names":[],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000703\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0018849\"}","{\"db\":\"Orphanet\",\"id\":\"49042\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6258\",\"ref_field\":\"gard_id\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000703\",\"ref_field\":\"name\"}"],"id":"21860","name":"Dentinogenesis imperfecta"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C5193073","type":"Disease","symbol":"SEMDJL3","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032724\"}","{\"db\":\"OMIM\",\"id\":\"618395\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"607880.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607880.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618395\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618395\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41592","name":"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262580","type":"Disease","symbol":"IMD65","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032848\"}","{\"db\":\"OMIM\",\"id\":\"618648\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"147574.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"147574.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618648\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618648\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43038","name":"IMMUNODEFICIENCY 65, SUSCEPTIBILITY TO VIRAL INFECTIONS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260173","type":"Disease","symbol":"PGL7","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032771\"}","{\"db\":\"OMIM\",\"id\":\"618475\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"126063.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618475\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618475\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42138","name":"PARAGANGLIOMAS 7"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263148","type":"Disease","symbol":"BAIDCS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032892\"}","{\"db\":\"OMIM\",\"id\":\"618736\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600470.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600470.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600470.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600470.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618736\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618736\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43274","name":"STRUCTURAL BRAIN ANOMALIES WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CRANIOSYNOSTOSIS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3809583","type":"Disease","symbol":"IMD12","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615468\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"397964\"}","{\"db\":\"OMIM\",\"id\":\"615468\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18315","name":"Immunodeficiency 12"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262872","type":"Disease","symbol":"SPGF40","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032859\"}","{\"db\":\"OMIM\",\"id\":\"618664\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"614270.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614270.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614270.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614270.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614270.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618664\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618664\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43091","name":"SPERMATOGENIC FAILURE 40"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748484","type":"Disease","symbol":"CAFDADD","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032572\"}","{\"db\":\"OMIM\",\"id\":\"618164\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606692.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606692.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606692.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606692.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618164\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618164\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40764","name":"CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260601","type":"Disease","symbol":"NEDNEH","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032784\"}","{\"db\":\"OMIM\",\"id\":\"618497\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"601012.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601012.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601012.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601012.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618497\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618497\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42214","name":"NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748694","type":"Disease","symbol":"IMD15A","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032599\"}","{\"db\":\"OMIM\",\"id\":\"618204\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603258.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618204\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618204\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40841","name":"IMMUNODEFICIENCY 15A"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3810324","type":"Disease","symbol":"MOSPGF","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615703\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"397615\"}","{\"db\":\"OMIM\",\"id\":\"615703\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18640","name":"Morbid obesity and spermatogenic failure"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C2676023","type":"Disease","symbol":"HCVAD","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"115300\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"199285\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hypercarotenemia+and+vitamin+a+deficiency%2C+autosomal+dominant/8579\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"115300\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2351","name":"Hypercarotenemia and vitamin a deficiency, autosomal dominant"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263213","type":"Disease","symbol":"IDDHBA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032897\"}","{\"db\":\"OMIM\",\"id\":\"618748\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603184.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603184.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603184.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603184.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603184.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618748\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618748\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43447","name":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA AND BEHAVIORAL ABNORMALITIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262440","type":"Disease","symbol":"NS12","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032839\"}","{\"db\":\"OMIM\",\"id\":\"618624\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600098.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600098.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600098.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618624\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618624\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42982","name":"NOONAN SYNDROME 12"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260064","type":"Disease","symbol":"URCTU","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032773\"}","{\"db\":\"OMIM\",\"id\":\"618477\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606207.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606207.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606207.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618477\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618477\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41991","name":"URIDINE-CYTIDINEURIA"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262923","type":"Disease","symbol":"IDDSADF","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032864\"}","{\"db\":\"OMIM\",\"id\":\"618672\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"604910.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604910.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604910.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604910.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604910.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618672\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618672\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43108","name":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4014668","type":"Disease","symbol":"COXPD21","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615918\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"420733\"}","{\"db\":\"OMIM\",\"id\":\"615918\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"21303","name":"Combined oxidative phosphorylation deficiency 21"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"10995","medgen_id":"C3150921","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"613668\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"402364\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10995\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Microcephaly%2C+postnatal+progressive%2C+with+seizures+and+brain+atrophy/8871\",\"ref_field\":\"name\"}"],"id":"15711","name":"Microcephaly, postnatal progressive, with seizures and brain atrophy"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1850395","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"256840\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"139578\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Neuropathy%2C+hereditary+sensory%2C+with+spastic+paraplegia%2C+autosomal+recessive/9003\",\"ref_field\":\"name\"}"],"id":"5639","name":"Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748684","type":"Disease","symbol":"CMS24","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032597\"}","{\"db\":\"OMIM\",\"id\":\"618198\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618198\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618198\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40847","name":"MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258208","type":"Disease","symbol":"CMS25","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032675\"}","{\"db\":\"OMIM\",\"id\":\"618323\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"185880.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"185880.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"185880.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"185880.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"185880.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618323\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618323\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41409","name":"MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4225258","type":"Disease","symbol":"EPM10","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"616640\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"324290\"}","{\"db\":\"OMIM\",\"id\":\"616640\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"34421","name":"Epilepsy, progressive myoclonic, 10"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4225260","type":"Disease","symbol":"IMD44","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"616636\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"431166\"}","{\"db\":\"OMIM\",\"id\":\"616636\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"34432","name":"Immunodeficiency 44"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748647","type":"Disease","symbol":"CMD2C","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032592\"}","{\"db\":\"OMIM\",\"id\":\"618189\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"609853.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618189\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618189\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40823","name":"CARDIOMYOPATHY, DILATED, 2C"}
{"attribute_content":[],"alternate_symbols":["PPKNE","TYLOSIS"],"keywords":[],"medgen_id":"C1833030","type":"Disease","symbol":"NEPPK","alternate_names":[],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007404\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"600962\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2337\"}","{\"db\":\"OMIM\",\"id\":\"600962\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PPKNE\"}","{\"db\":\"OMIM\",\"id\":\"600962\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"TYLOSIS\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007404\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600962\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3754","name":"Nonepidermolytic palmoplantar keratoderma"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263280","type":"Disease","symbol":"CHTD7","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032913\"}","{\"db\":\"OMIM\",\"id\":\"618780\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"136352.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"136352.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"136352.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"136352.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"136352.0017\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618780\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618780\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43640","name":"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 7"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C5193144","type":"Disease","symbol":"EKVP6","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032801\"}","{\"db\":\"OMIM\",\"id\":\"618531\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606936.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606936.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618531\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618531\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42305","name":"ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 6"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263277","type":"Disease","symbol":"SPG82","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032906\"}","{\"db\":\"OMIM\",\"id\":\"618770\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602679.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602679.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602679.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618770\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618770\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43635","name":"SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262656","type":"Disease","symbol":"NEDSOSB","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032849\"}","{\"db\":\"OMIM\",\"id\":\"618651\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618651\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618651\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43043","name":"NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA, OPTIC ATROPHY, SEIZURES, AND STRUCTURAL BRAIN ANOMALIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258815","type":"Disease","symbol":"CILD41","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032757\"}","{\"db\":\"OMIM\",\"id\":\"618449\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618449\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618449\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41780","name":"CILIARY DYSKINESIA, PRIMARY, 41"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262197","type":"Disease","symbol":"NEDVIBA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032807\"}","{\"db\":\"OMIM\",\"id\":\"618547\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"142600.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"142600.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"142600.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"142600.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618547\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618547\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42440","name":"NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4281785","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010826\"}","{\"db\":\"OMIM\",\"id\":\"PS600131\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"64280\"}","{\"db\":\"Orphanet\",\"id\":\"64280\",\"ref_field\":\"name\"}"],"id":"38473","name":"Childhood absence epilepsy"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301628\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1455\",\"@Source\":\"BookShelf\"}]}}","gard_id":"10965","medgen_id":"C3281247","type":"Disease","symbol":"BBDS","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614592\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"313855\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10965\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"BENT+BONE+DYSPLASIA+SYNDROME/7809\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614592\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"16886","name":"Bent bone dysplasia syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"12892","medgen_id":"C3809339","type":"Disease","symbol":"COXPD16","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615395\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"352563\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"12892\",\"ref_field\":\"gard_id\"}","{\"db\":\"OMIM\",\"id\":\"615395\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18259","name":"Combined oxidative phosphorylation deficiency 16"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263398","type":"Disease","symbol":"MYP27","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032941\"}","{\"db\":\"OMIM\",\"id\":\"618827\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606027.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606027.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606027.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606027.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618827\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618827\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43794","name":"MYOPIA 27"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258211","type":"Disease","symbol":"GDDI","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032680\"}","{\"db\":\"OMIM\",\"id\":\"618330\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618330\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618330\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41412","name":"GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748678","type":"Disease","symbol":"CMS23","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032596\"}","{\"db\":\"OMIM\",\"id\":\"618197\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"190315.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618197\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618197\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40839","name":"MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263139","type":"Disease","symbol":"ANIB12","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032891\"}","{\"db\":\"OMIM\",\"id\":\"618734\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618734\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618734\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43264","name":"ANEURYSM, INTRACRANIAL BERRY, 12"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258215","type":"Disease","symbol":"COXPD37","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032679\"}","{\"db\":\"OMIM\",\"id\":\"618329\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618329\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41420","name":"Combined oxidative phosphorylation deficiency 37"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262335","type":"Disease","symbol":"NEDHIB","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032829\"}","{\"db\":\"OMIM\",\"id\":\"618603\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"180660.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"180660.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"180660.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"180660.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"180660.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618603\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618603\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42946","name":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263397","type":"Disease","symbol":"IBGC8","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032938\"}","{\"db\":\"OMIM\",\"id\":\"618824\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606870.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606870.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606870.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606870.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606870.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606870.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606870.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606870.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618824\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618824\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43793","name":"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260725","type":"Disease","symbol":"NEDCFSA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032790\"}","{\"db\":\"OMIM\",\"id\":\"618505\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"611577.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611577.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611577.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611577.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611577.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618505\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618505\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42239","name":"NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258281","type":"Disease","symbol":"ARLIAK","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032716\"}","{\"db\":\"OMIM\",\"id\":\"618384\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606411.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606411.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606411.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618384\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618384\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41580","name":"LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262873","type":"Disease","symbol":"SPGF41","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032863\"}","{\"db\":\"OMIM\",\"id\":\"618670\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618670\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618670\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43092","name":"SPERMATOGENIC FAILURE 41"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258280","type":"Disease","symbol":"FHEIG","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032714\"}","{\"db\":\"OMIM\",\"id\":\"618381\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"605720.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605720.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618381\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618381\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41579","name":"FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262178","type":"Disease","symbol":"IKSHD","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032798\"}","{\"db\":\"OMIM\",\"id\":\"618527\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"611813.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618527\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618527\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42302","name":"ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4014435","type":"Disease","symbol":"MRD26","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615834\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"352490\"}","{\"db\":\"OMIM\",\"id\":\"615834\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18793","name":"Mental retardation, autosomal dominant 26"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4722277","type":"Disease","symbol":"CHN2","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020765\"}","{\"db\":\"OMIM\",\"id\":\"618184\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618184\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40835","name":"Congenital hypomyelinating neuropathy 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748934","type":"Disease","symbol":"CONDCA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032650\"}","{\"db\":\"OMIM\",\"id\":\"618276\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606830.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606830.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606830.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606830.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606830.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606830.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606830.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606830.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618276\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618276\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40943","name":"NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748741","type":"Disease","symbol":"VETD","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032607\"}","{\"db\":\"OMIM\",\"id\":\"618223\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600747.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600747.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618223\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618223\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40860","name":"VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258295","type":"Disease","symbol":"COXPD39","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032726\"}","{\"db\":\"OMIM\",\"id\":\"618397\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606544.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606544.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606544.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606544.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606544.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606544.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618397\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618397\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41596","name":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263373","type":"Disease","symbol":"GUBS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032934\"}","{\"db\":\"OMIM\",\"id\":\"618820\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602021.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602021.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602021.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618820\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618820\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43778","name":"GENITOURINARY AND/OR BRAIN MALFORMATION SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3808920","type":"Disease","symbol":"AHMIO2","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615234\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"300298\"}","{\"db\":\"OMIM\",\"id\":\"615234\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17840","name":"Hypochromic microcytic anemia with iron overload 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258271","type":"Disease","symbol":"EIEE72","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032710\"}","{\"db\":\"OMIM\",\"id\":\"618374\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"601725.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601725.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618374\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618374\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41566","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748608","type":"Disease","symbol":"CHN3","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020766\"}","{\"db\":\"OMIM\",\"id\":\"618186\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618186\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40836","name":"Congenital hypomyelinating neuropathy 3"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263353","type":"Disease","symbol":"TKFCD","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032927\"}","{\"db\":\"OMIM\",\"id\":\"618805\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"615844.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615844.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618805\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618805\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43744","name":"TRIOKINASE AND FMN CYCLASE DEFICIENCY SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263062","type":"Disease","symbol":"NEDBAS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032877\"}","{\"db\":\"OMIM\",\"id\":\"618709\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606582.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618709\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618709\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43161","name":"NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258814","type":"Disease","symbol":"EIEE75","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032752\"}","{\"db\":\"OMIM\",\"id\":\"618437\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"612036.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612036.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612036.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612036.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612036.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612036.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612036.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618437\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618437\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41776","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748921","type":"Disease","symbol":"CAKUT3","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032646\"}","{\"db\":\"OMIM\",\"id\":\"618270\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618270\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618270\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40933","name":"CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 3"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262377","type":"Disease","symbol":"IDNADFS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032832\"}","{\"db\":\"OMIM\",\"id\":\"618608\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"604909.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604909.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618608\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618608\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42951","name":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH NASAL SPEECH, DYSMORPHIC FACIES, AND VARIABLE SKELETAL ANOMALIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263151","type":"Disease","symbol":"POBINDS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032889\"}","{\"db\":\"OMIM\",\"id\":\"618732\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"115441.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"115441.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"115441.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"115441.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"115441.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"115441.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"115441.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618732\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618732\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43281","name":"POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN259043","type":"Disease","symbol":"BDPLT22","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032765\"}","{\"db\":\"OMIM\",\"id\":\"618462\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618462\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618462\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41872","name":"BLEEDING DISORDER, PLATELET-TYPE, 22"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262441","type":"Disease","symbol":"NEDMABA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032838\"}","{\"db\":\"OMIM\",\"id\":\"618622\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"610457.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610457.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610457.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610457.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610457.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610457.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618622\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618622\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42987","name":"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"12271","medgen_id":"C0266464","type":"Finding","alternate_names":[],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002126\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0000087\"}","{\"db\":\"Orphanet\",\"id\":\"35981\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"12271\",\"ref_field\":\"gard_id\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002126\",\"ref_field\":\"name\"}"],"id":"18139","name":"Polymicrogyria"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0024145","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"Orphanet\",\"id\":\"90280\"}","{\"db\":\"Illumina Clinical Services Laboratory,Illumina\",\"id\":\"96824\",\"ref_field\":\"name\"}"],"id":"36533","name":"Chilblain Lupus"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4015635","type":"Disease","symbol":"CMT2T","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"617017\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"443950\"}","{\"db\":\"Orphanet\",\"id\":\"495274\"}","{\"db\":\"Orphanet\",\"id\":\"497757\"}","{\"db\":\"OMIM\",\"id\":\"617017\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"32742","name":"Charcot-Marie-Tooth disease, axonal, type 2T"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748579","type":"Disease","symbol":"DIAR10","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032586\"}","{\"db\":\"OMIM\",\"id\":\"618183\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"607647.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607647.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607647.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618183\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618183\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40815","name":"DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258232","type":"Disease","symbol":"IDDABS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032687\"}","{\"db\":\"OMIM\",\"id\":\"618342\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"616261.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616261.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616261.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616261.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616261.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618342\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618342\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41436","name":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262181","type":"Disease","symbol":"MTDPS16","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032799\"}","{\"db\":\"OMIM\",\"id\":\"618528\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618528\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618528\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42309","name":"MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE)"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN279277","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0018005\"}","{\"db\":\"Orphanet\",\"id\":\"329475\"}","{\"db\":\"NCBI for submitter\",\"id\":\"50519153\",\"ref_field\":\"name\"}"],"id":"42454","name":"Spastic paraplegia-Paget disease of bone syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258289","type":"Disease","symbol":"DFNY2","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0027048\"}","{\"db\":\"OMIM\",\"id\":\"400047\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"400047\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41584","name":"Deafness, Y-linked 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262226","type":"Disease","symbol":"EIEE79","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032813\"}","{\"db\":\"OMIM\",\"id\":\"618559\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"137142.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137142.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137142.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618559\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618559\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42881","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 79"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3808553","type":"Disease","symbol":"BMFS1","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614675\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"314399\"}","{\"db\":\"OMIM\",\"id\":\"614675\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17013","name":"Bone marrow failure syndrome 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262314","type":"Disease","symbol":"NDCAGF","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032817\"}","{\"db\":\"OMIM\",\"id\":\"618571\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"611345.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611345.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611345.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611345.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611345.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611345.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618571\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618571\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42920","name":"NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES"}
{"attribute_content":[],"alternate_symbols":["FFEVF"],"keywords":[],"gard_id":"13295","medgen_id":"C1858477","type":"Disease","symbol":"FPEVF","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020310\"}","{\"db\":\"OMIM\",\"id\":\"PS604364\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"98820\"}","{\"db\":\"OMIM\",\"id\":\"604364\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"FFEVF\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"13295\",\"ref_field\":\"gard_id\"}","{\"db\":\"NCBI for submitter\",\"id\":\"758764\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551668\",\"ref_field\":\"symbol\"}"],"id":"43259","name":"Familial focal epilepsy with variable foci"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3809753","type":"Disease","symbol":"MRT38","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615516\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"329195\"}","{\"db\":\"OMIM\",\"id\":\"615516\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18376","name":"Mental retardation, autosomal recessive 38"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748927","type":"Disease","symbol":"MCCCHCM","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032648\"}","{\"db\":\"OMIM\",\"id\":\"618273\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"612256.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612256.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612256.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612256.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618273\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618273\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40942","name":"MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C5193018","type":"Disease","symbol":"CRDHL1","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020778\"}","{\"db\":\"OMIM\",\"id\":\"617236\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"617236\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"36694","name":"Cone-rod dystrophy and hearing loss 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263138","type":"Disease","symbol":"LIWAS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032886\"}","{\"db\":\"OMIM\",\"id\":\"618729\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600150.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600150.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600150.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600150.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600150.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618729\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618729\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43263","name":"LIANG-WANG SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260589","type":"Disease","symbol":"PAPA10","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032785\"}","{\"db\":\"OMIM\",\"id\":\"618498\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"617266.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617266.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618498\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618498\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42206","name":"POLYDACTYLY, POSTAXIAL, TYPE A10"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN276908","type":"Disease","symbol":"RP87","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032873\"}","{\"db\":\"OMIM\",\"id\":\"618697\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"180069.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618697\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618697\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43125","name":"RETINITIS PIGMENTOSA 87 WITH CHOROIDAL INVOLVEMENT"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263245","type":"Disease","symbol":"JBTS36","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032902\"}","{\"db\":\"OMIM\",\"id\":\"618763\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618413.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618413.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618763\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618763\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43481","name":"JOUBERT SYNDROME 36"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262355","type":"Disease","symbol":"PCH13","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032831\"}","{\"db\":\"OMIM\",\"id\":\"618606\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"615738.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615738.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615738.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618606\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618606\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42949","name":"PONTOCEREBELLAR HYPOPLASIA, TYPE 13"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C5193070","type":"Disease","symbol":"SCAN3","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020770\"}","{\"db\":\"OMIM\",\"id\":\"618387\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618387\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41582","name":"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258377","type":"Disease","symbol":"DFNB100","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032740\"}","{\"db\":\"OMIM\",\"id\":\"618422\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"611648.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618422\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618422\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41620","name":"DEAFNESS, AUTOSOMAL RECESSIVE 100"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258254","type":"Disease","symbol":"SSASKS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032703\"}","{\"db\":\"OMIM\",\"id\":\"618363\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"611459.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611459.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611459.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611459.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611459.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618363\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618363\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41550","name":"SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN261027","type":"Disease","symbol":"CASVDD","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032788\"}","{\"db\":\"OMIM\",\"id\":\"618501\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"607082.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607082.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607082.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607082.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618501\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618501\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42249","name":"CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN279282","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0033211\"}","{\"db\":\"OMIM\",\"id\":\"PS251280\",\"type\":\"Phenotypic series\"}","{\"db\":\"OMIM\",\"id\":\"PS251280\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"],"id":"42507","name":"Diencephalic-mesencephalic junction dysplasia syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260174","type":"Disease","symbol":"NEDSSWI","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032775\"}","{\"db\":\"OMIM\",\"id\":\"618480\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600944.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600944.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600944.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600944.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618480\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618480\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42139","name":"NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262182","type":"Disease","symbol":"DFNA37","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032802\"}","{\"db\":\"OMIM\",\"id\":\"618533\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618533\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618533\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42310","name":"DEAFNESS, AUTOSOMAL DOMINANT 37"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263203","type":"Disease","symbol":"SPGF42","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032896\"}","{\"db\":\"OMIM\",\"id\":\"618745\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618735.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618735.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618735.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618735.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618735.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618735.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618745\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618745\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43436","name":"SPERMATOGENIC FAILURE 42"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262315","type":"Disease","symbol":"NEDCHS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032818\"}","{\"db\":\"OMIM\",\"id\":\"618572\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618572\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618572\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42921","name":"NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR HYPOPLASIA AND SPASTICITY"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301559\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1385\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C3151266","type":"Disease","symbol":"CMH19","alternate_names":[],"xrefs":["{\"db\":\"Genetic Alliance\",\"id\":\"Cardiomyopathy%2C+familial+hypertrophic%2C+19/7900\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613875\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"16024","name":"Familial hypertrophic cardiomyopathy 19"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"12357","medgen_id":"C4014722","type":"Disease","symbol":"SAVI","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615934\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"425120\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"12357\",\"ref_field\":\"gard_id\"}","{\"db\":\"OMIM\",\"id\":\"615934\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"21316","name":"Sting-associated vasculopathy, infantile-onset"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263394","type":"Disease","symbol":"MYOPMIL","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032937\"}","{\"db\":\"OMIM\",\"id\":\"618823\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618823\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618823\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43786","name":"MYOPATHY, CONGENITAL PROXIMAL, WITH MINICORE LESIONS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262195","type":"Disease","symbol":"TTD7","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032806\"}","{\"db\":\"OMIM\",\"id\":\"618546\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"187790.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"187790.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"187790.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618546\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618546\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42320","name":"TRICHOTHIODYSTROPHY 7, NONPHOTOSENSITIVE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258389","type":"Disease","symbol":"HYDM4","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032747\"}","{\"db\":\"OMIM\",\"id\":\"618432\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"616109.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616109.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618432\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618432\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41649","name":"HYDATIDIFORM MOLE, RECURRENT, 4"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263287","type":"Disease","symbol":"LQT16","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032915\"}","{\"db\":\"OMIM\",\"id\":\"618782\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"114183.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114183.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618782\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618782\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43647","name":"LONG QT SYNDROME 16"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301284\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1105\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C4759870","type":"Disease","symbol":"SCAN1","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"607250\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"607250\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5961","name":"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748536","type":"Disease","symbol":"RP83","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032577\"}","{\"db\":\"OMIM\",\"id\":\"618173\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618173\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40766","name":"Retinitis pigmentosa 83"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260095","type":"Disease","symbol":"IIAE9","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032742\"}","{\"db\":\"OMIM\",\"id\":\"618426\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"114350.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114350.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114350.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114350.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618426\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618426\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42028","name":"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3554657","type":"Disease","symbol":"LIS5","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615191\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"352682\"}","{\"db\":\"OMIM\",\"id\":\"615191\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17753","name":"Lissencephaly 5"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263233","type":"Disease","symbol":"NEDHAHM","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032900\"}","{\"db\":\"OMIM\",\"id\":\"618760\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618760\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618760\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43468","name":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258817","type":"Disease","symbol":"IDDSSA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032759\"}","{\"db\":\"OMIM\",\"id\":\"618453\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618453\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618453\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41783","name":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263107","type":"Disease","symbol":"SPGF39","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032845\"}","{\"db\":\"OMIM\",\"id\":\"618643\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"610063.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610063.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610063.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610063.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618643\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618643\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43033","name":"SPERMATOGENIC FAILURE 39"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748855","type":"Disease","symbol":"DFNB112","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032639\"}","{\"db\":\"OMIM\",\"id\":\"618257\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618257\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618257\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40915","name":"DEAFNESS, AUTOSOMAL RECESSIVE 112"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"23447832\",\"@Source\":\"PubMed\"},{\"$\":\"NBK121988\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C4748873","type":"Disease","symbol":"PCH12","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032643\"}","{\"db\":\"OMIM\",\"id\":\"618266\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"609855.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609855.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618266\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618266\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40938","name":"PONTOCEREBELLAR HYPOPLASIA, TYPE 12"}
{"attribute_content":[],"alternate_symbols":["CMAVM"],"keywords":[],"gard_id":"11904","medgen_id":"C1842180","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012016\"}","{\"db\":\"OMIM\",\"id\":\"PS608354\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"137667\"}","{\"db\":\"OMIM\",\"id\":\"608354\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CMAVM\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"11904\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Capillary+malformation-arteriovenous+malformation/7888\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS608354\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"],"id":"43207","name":"Capillary malformation-arteriovenous malformation"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262189","type":"Disease","symbol":"IMD64","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032803\"}","{\"db\":\"OMIM\",\"id\":\"618534\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603962.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603962.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603962.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603962.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603962.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618534\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618534\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42317","name":"IMMUNODEFICIENCY 64"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258393","type":"Disease","symbol":"DA2B3","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032751\"}","{\"db\":\"OMIM\",\"id\":\"618436\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"160720.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"160720.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"160720.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"160720.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"160720.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"160720.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618436\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618436\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41654","name":"ARTHROGRYPOSIS, DISTAL, TYPE 2B3"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748552","type":"Disease","symbol":"NPHS19","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032582\"}","{\"db\":\"OMIM\",\"id\":\"618178\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618178\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618178\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40813","name":"NEPHROTIC SYNDROME, TYPE 19"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4749042","type":"Disease","symbol":"EV4","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032666\"}","{\"db\":\"OMIM\",\"id\":\"618307\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618307\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618307\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41341","name":"EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258242","type":"Disease","symbol":"OOMD6","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032696\"}","{\"db\":\"OMIM\",\"id\":\"618353\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"182888.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"182888.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"182888.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618353\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618353\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41443","name":"OOCYTE MATURATION DEFECT 6"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN279271","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0017939\"}","{\"db\":\"Orphanet\",\"id\":\"324604\"}"],"id":"42300","name":"Classic multiminicore myopathy"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262329","type":"Disease","symbol":"NPHS21","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032826\"}","{\"db\":\"OMIM\",\"id\":\"618594\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"613397.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613397.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613397.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613397.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618594\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618594\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42940","name":"NEPHROTIC SYNDROME, TYPE 21"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262333","type":"Disease","symbol":"CHNG8","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0026731\"}","{\"db\":\"OMIM\",\"id\":\"301033\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"300196.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300196.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300196.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300196.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301033\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301033\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42944","name":"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 8"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258220","type":"Disease","symbol":"CDGF1","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020775\"}","{\"db\":\"OMIM\",\"id\":\"618005\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618005\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40079","name":"Congenital disorder of glycosylation with defective fucosylation 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263344","type":"Disease","symbol":"NEDHRIT","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032921\"}","{\"db\":\"OMIM\",\"id\":\"618797\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608884.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608884.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608884.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608884.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608884.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618797\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618797\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43738","name":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0342859","type":"Disease","symbol":"HARPO","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"618892\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618892\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"8718","name":"Harderoporphyria"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262311","type":"Disease","symbol":"NEDBAF","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032820\"}","{\"db\":\"OMIM\",\"id\":\"618577\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602050.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602050.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602050.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602050.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618577\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618577\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42917","name":"NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260593","type":"Disease","symbol":"AMCM","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032778\"}","{\"db\":\"OMIM\",\"id\":\"618484\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608441.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608441.0018\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608441.0019\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618484\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618484\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42209","name":"ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263110","type":"Disease","symbol":"WRCN","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032579\"}","{\"db\":\"OMIM\",\"id\":\"618175\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618175\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40733","name":"Warburg-Cinotti syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260592","type":"Disease","symbol":"NPHS20","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0026726\"}","{\"db\":\"OMIM\",\"id\":\"301028\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"301027.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301027.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301028\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301028\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42208","name":"NEPHROTIC SYNDROME, TYPE 20"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258820","type":"Disease","symbol":"IMD62","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032763\"}","{\"db\":\"OMIM\",\"id\":\"618459\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618459\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618459\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41787","name":"IMMUNODEFICIENCY 62"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748555","type":"Disease","symbol":"MCPH24","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032583\"}","{\"db\":\"OMIM\",\"id\":\"618179\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618179\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618179\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40814","name":"MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262278","type":"Disease","symbol":"CDG1CC","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0026729\"}","{\"db\":\"OMIM\",\"id\":\"301031\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"300715.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300715.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301031\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301031\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42907","name":"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Icc"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260585","type":"Disease","symbol":"LQT8","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032756\"}","{\"db\":\"OMIM\",\"id\":\"618447\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618447\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42204","name":"Long QT syndrome 8"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4014233","type":"Disease","symbol":"IMD22","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615758\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"280142\"}","{\"db\":\"OMIM\",\"id\":\"615758\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18717","name":"Immunodeficiency 22"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262217","type":"Disease","symbol":"FVH","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032809\"}","{\"db\":\"OMIM\",\"id\":\"618549\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618549\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618549\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42465","name":"HEPATITIS, FULMINANT VIRAL, SUSCEPTIBILITY TO"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262664","type":"Disease","symbol":"IDDILF","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032851\"}","{\"db\":\"OMIM\",\"id\":\"618653\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600326.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600326.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600326.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600326.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600326.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618653\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618653\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43054","name":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1835931","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"609889\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"231154\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Alpha-beta+T-cell+lymphopenia+with+gamma-delta+T-cell+expansion%2C+severe+cytomegalovirus+infection%2C+and+autoimmunity/7672\",\"ref_field\":\"name\"}"],"id":"107","name":"Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748984","type":"Disease","symbol":"MCIDDS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032656\"}","{\"db\":\"OMIM\",\"id\":\"618284\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618284\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618284\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40953","name":"MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263114","type":"Disease","symbol":"SEMDIST","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032885\"}","{\"db\":\"OMIM\",\"id\":\"618728\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"113703.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"113703.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"113703.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"113703.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618728\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618728\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43225","name":"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, ISIDOR-TOUTAIN TYPE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258275","type":"Disease","symbol":"COXPD38","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032712\"}","{\"db\":\"OMIM\",\"id\":\"618378\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618378\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618378\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41572","name":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748939","type":"Disease","symbol":"FINCA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032651\"}","{\"db\":\"OMIM\",\"id\":\"618278\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618277.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618277.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618278\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618278\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40947","name":"FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258383","type":"Disease","symbol":"MECREN","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032736\"}","{\"db\":\"OMIM\",\"id\":\"618416\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"610823.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610823.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618416\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618416\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41639","name":"METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262533","type":"Disease","symbol":"ILFS3","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032844\"}","{\"db\":\"OMIM\",\"id\":\"618641\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"610089.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610089.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610089.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610089.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610089.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618641\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618641\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43026","name":"INFANTILE LIVER FAILURE SYNDROME 3"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262874","type":"Disease","symbol":"NEDDFSA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032855\"}","{\"db\":\"OMIM\",\"id\":\"618659\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"607159.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607159.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607159.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607159.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607159.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607159.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618659\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618659\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43093","name":"NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258216","type":"Disease","symbol":"PEERB","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032681\"}","{\"db\":\"OMIM\",\"id\":\"618331\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"610970.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618331\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618331\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41421","name":"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258384","type":"Disease","symbol":"SPG80","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032737\"}","{\"db\":\"OMIM\",\"id\":\"618418\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"609787.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609787.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609787.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609787.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609787.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609787.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609787.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609787.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618418\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618418\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41640","name":"SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258217","type":"Disease","symbol":"MKHK1","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020763\"}","{\"db\":\"OMIM\",\"id\":\"618332\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618332\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41422","name":"Menke-Hennekam syndrome 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN261157","type":"Disease","symbol":"LCA19","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032794\"}","{\"db\":\"OMIM\",\"id\":\"618513\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618513\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618513\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42257","name":"LEBER CONGENITAL AMAUROSIS 19"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258223","type":"Disease","symbol":"CASGID","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032685\"}","{\"db\":\"OMIM\",\"id\":\"618339\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618339\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618339\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41425","name":"INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260165","type":"Disease","symbol":"IDDSSAD","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032770\"}","{\"db\":\"OMIM\",\"id\":\"618470\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"612458.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612458.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618470\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618470\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42119","name":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263293","type":"Disease","symbol":"DFNA76","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032917\"}","{\"db\":\"OMIM\",\"id\":\"618787\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602734.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602734.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602734.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602734.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618787\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618787\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43654","name":"DEAFNESS, AUTOSOMAL DOMINANT 76"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258437","type":"Disease","symbol":"DDVIBA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032745\"}","{\"db\":\"OMIM\",\"id\":\"618430\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603107.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603107.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603107.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603107.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603107.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603107.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603107.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603107.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603107.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618430\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618430\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41658","name":"DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4225379","type":"Disease","symbol":"LIPT1D","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"616299\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"401862\"}","{\"db\":\"OMIM\",\"id\":\"616299\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"33206","name":"Lipoyltransferase 1 deficiency"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4015624","type":"Disease","symbol":"VMCQA","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"616231\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"88635\"}","{\"db\":\"OMIM\",\"id\":\"616231\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"32737","name":"Myopathy, vacuolar, with casq1 aggregates"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262227","type":"Disease","symbol":"MTDPS17","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032815\"}","{\"db\":\"OMIM\",\"id\":\"618567\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606906.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618567\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618567\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42882","name":"MITOCHONDRIAL DNA DEPLETION SYNDROME 17"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN273084","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0018507\"}","{\"db\":\"Orphanet\",\"id\":\"423894\"}"],"id":"43632","name":"Microcephaly-complex motor and sensory axonal neuropathy syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748997","type":"Disease","symbol":"CMCU","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032659\"}","{\"db\":\"OMIM\",\"id\":\"618287\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618287\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618287\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41327","name":"MUCOCUTANEOUS ULCERATION, CHRONIC"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262902","type":"Disease","symbol":"CDCBM10","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032866\"}","{\"db\":\"OMIM\",\"id\":\"618677\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"612034.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612034.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612034.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612034.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618677\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618677\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43100","name":"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 10"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263214","type":"Disease","symbol":"SPGF43","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032898\"}","{\"db\":\"OMIM\",\"id\":\"618751\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"610172.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610172.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610172.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610172.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610172.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610172.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610172.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618751\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618751\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43448","name":"SPERMATOGENIC FAILURE 43"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748725","type":"Disease","symbol":"RP84","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032604\"}","{\"db\":\"OMIM\",\"id\":\"618220\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618220\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40858","name":"Retinitis pigmentosa 84"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4015146","type":"Disease","symbol":"RDGCA","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"616079\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"397758\"}","{\"db\":\"OMIM\",\"id\":\"616079\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"32194","name":"Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748540","type":"Disease","symbol":"CDCBM9","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032578\"}","{\"db\":\"OMIM\",\"id\":\"618174\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"114025.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114025.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114025.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618174\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618174\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40799","name":"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258266","type":"Disease","symbol":"SCAR27","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032706\"}","{\"db\":\"OMIM\",\"id\":\"618369\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618128.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618128.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618128.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618369\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618369\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41560","name":"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3281234","type":"Disease","symbol":"COXPD9","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614582\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"319509\"}","{\"db\":\"Genetic Alliance\",\"id\":\"COMBINED+OXIDATIVE+PHOSPHORYLATION+DEFICIENCY+9/8021\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614582\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"16882","name":"Combined oxidative phosphorylation deficiency 9"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262179","type":"Disease","symbol":"RRS2","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032800\"}","{\"db\":\"OMIM\",\"id\":\"618529\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"612895.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612895.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612895.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618529\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618529\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42303","name":"ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263070","type":"Disease","symbol":"MGBL","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032879\"}","{\"db\":\"OMIM\",\"id\":\"618719\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606127.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606127.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606127.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618719\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618719\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43175","name":"MEGABLADDER, CONGENITAL"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4014617","type":"Disease","symbol":"IMD24","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615897\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"420573\"}","{\"db\":\"OMIM\",\"id\":\"615897\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"21261","name":"Immunodeficiency 24"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1832216","type":"Disease","symbol":"BSAS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0019075\"}","{\"db\":\"Orphanet\",\"id\":\"69737\"}","{\"db\":\"OMIM\",\"id\":\"601536\",\"ref_field\":\"symbol\"}"],"id":"9161","name":"Bosley-Salih-Alorainy syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3554129","type":"Disease","symbol":"COXPD13","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614932\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"319514\"}","{\"db\":\"OMIM\",\"id\":\"614932\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17484","name":"Combined oxidative phosphorylation deficiency 13"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263124","type":"Disease","symbol":"NMOAS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032890\"}","{\"db\":\"OMIM\",\"id\":\"618733\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603405.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603405.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603405.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603405.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618733\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618733\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43258","name":"NEUROMUSCULAR DISEASE AND OCULAR OR AUDITORY ANOMALIES WITH OR WITHOUT SEIZURES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258244","type":"Disease","symbol":"GAMOS8","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032693\"}","{\"db\":\"OMIM\",\"id\":\"618349\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618349\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618349\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41445","name":"GALLOWAY-MOWAT SYNDROME 8"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258234","type":"Disease","symbol":"RP85","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032689\"}","{\"db\":\"OMIM\",\"id\":\"618345\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618345\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41438","name":"Retinitis pigmentosa 85"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258238","type":"Disease","symbol":"MCPH25","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032694\"}","{\"db\":\"OMIM\",\"id\":\"618351\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618351\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618351\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41440","name":"MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4225173","type":"Disease","symbol":"CVID13","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"616873\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"317473\"}","{\"db\":\"OMIM\",\"id\":\"616873\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"34886","name":"Immunodeficiency, common variable, 13"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263364","type":"Disease","symbol":"SCAR28","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032923\"}","{\"db\":\"OMIM\",\"id\":\"618800\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618800\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618802.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43761","name":"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 28"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263395","type":"Disease","symbol":"IDPOGSA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032930\"}","{\"db\":\"OMIM\",\"id\":\"618808\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618808\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618808\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43787","name":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258818","type":"Disease","symbol":"DFNB114","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032761\"}","{\"db\":\"OMIM\",\"id\":\"618456\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"604330.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618456\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618456\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41785","name":"DEAFNESS, AUTOSOMAL RECESSIVE 114"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262183","type":"Disease","symbol":"ECTD15","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032804\"}","{\"db\":\"OMIM\",\"id\":\"618535\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618535\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618535\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42311","name":"ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258816","type":"Disease","symbol":"NDCAMA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032758\"}","{\"db\":\"OMIM\",\"id\":\"618451\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618451\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618451\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41781","name":"NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258344","type":"Disease","symbol":"HLD18","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032730\"}","{\"db\":\"OMIM\",\"id\":\"618404\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"615843.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615843.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615843.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615843.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615843.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615843.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615843.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618404\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618404\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41605","name":"LEUKODYSTROPHY, HYPOMYELINATING, 18"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263069","type":"Disease","symbol":"NEDBASH","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032878\"}","{\"db\":\"OMIM\",\"id\":\"618718\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618689.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618689.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618689.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618689.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618689.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618689.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618718\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618718\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43174","name":"NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES, ABSENT SPEECH, AND HYPOTONIA"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4749043","type":"Disease","symbol":"EV5","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032667\"}","{\"db\":\"OMIM\",\"id\":\"618309\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618309\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618309\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41342","name":"EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 5"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260169","type":"Disease","symbol":"PGL6","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032767\"}","{\"db\":\"OMIM\",\"id\":\"618464\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"604165.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604165.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604165.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604165.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604165.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618464\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618464\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42136","name":"PARAGANGLIOMAS 6"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263169","type":"Disease","symbol":"PAMDDFS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032893\"}","{\"db\":\"OMIM\",\"id\":\"618737\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"617817.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617817.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617817.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618737\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618737\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43285","name":"PACHYGYRIA, MICROCEPHALY, DEVELOPMENTAL DELAY, AND DYSMORPHIC FACIES, WITH OR WITHOUT SEIZURES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1857682","type":"Disease","symbol":"COXPD4","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"610678\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"254925\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Combined+oxidative+phosphorylation+deficiency+4/8016\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610678\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1539","name":"Combined oxidative phosphorylation deficiency 4"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0268731","type":"Finding","alternate_names":[],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100820\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100820\",\"ref_field\":\"name\"}"],"id":"31570","name":"Glomerulopathy"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258375","type":"Disease","symbol":"SPGF36","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032739\"}","{\"db\":\"OMIM\",\"id\":\"618420\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"615902.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615902.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615902.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618420\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618420\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41617","name":"SPERMATOGENIC FAILURE 36"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258369","type":"Disease","symbol":"CTRCT48","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032735\"}","{\"db\":\"OMIM\",\"id\":\"618415\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"611282.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611282.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611282.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618415\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618415\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41611","name":"CATARACT 48"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262876","type":"Disease","symbol":"HYDCC1","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032862\"}","{\"db\":\"OMIM\",\"id\":\"618667\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618570.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618570.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618667\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618667\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43095","name":"HYDROCEPHALUS, CONGENITAL COMMUNICATING, 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262171","type":"Disease","symbol":"HIES4","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032796\"}","{\"db\":\"OMIM\",\"id\":\"618523\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600694.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600694.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618523\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618523\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42287","name":"HYPER-IgE RECURRENT INFECTION SYNDROME 4, AUTOSOMAL RECESSIVE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262700","type":"Disease","symbol":"ZLS3","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032854\"}","{\"db\":\"OMIM\",\"id\":\"618658\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602983.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602983.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602983.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618658\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618658\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43061","name":"ZIMMERMANN-LABAND SYNDROME 3"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258813","type":"Disease","symbol":"DFNB94","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032749\"}","{\"db\":\"OMIM\",\"id\":\"618434\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618434\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618434\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41775","name":"DEAFNESS, AUTOSOMAL RECESSIVE 94"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3149695","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"Orphanet\",\"id\":\"1879\"}"],"id":"8755","name":"Osteopoikilosis with melorheostosis"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748946","type":"Disease","symbol":"CUGS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032653\"}","{\"db\":\"OMIM\",\"id\":\"618280\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608329.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608329.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608329.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608329.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608329.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618280\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618280\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40944","name":"CARDIAC-UROGENITAL SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258218","type":"Disease","symbol":"MKHK2","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020769\"}","{\"db\":\"OMIM\",\"id\":\"618333\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618333\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41423","name":"Menke-Hennekam syndrome 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263276","type":"Disease","symbol":"SPG81","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032905\"}","{\"db\":\"OMIM\",\"id\":\"618768\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"607915.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607915.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618768\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618768\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43634","name":"SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263246","type":"Disease","symbol":"MECD2","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032904\"}","{\"db\":\"OMIM\",\"id\":\"618767\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618767\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43482","name":"Meesmann corneal dystrophy 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748418","type":"Disease","symbol":"EORVA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032565\"}","{\"db\":\"OMIM\",\"id\":\"618155\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"159990.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"159990.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618155\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618155\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40735","name":"OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263396","type":"Disease","symbol":"RP88","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032940\"}","{\"db\":\"OMIM\",\"id\":\"618826\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608581.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608581.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608581.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608581.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608581.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618826\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618826\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43788","name":"RETINITIS PIGMENTOSA 88"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748496","type":"Disease","symbol":"OCBMD","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032574\"}","{\"db\":\"OMIM\",\"id\":\"618167\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618167\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618167\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40745","name":"OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748549","type":"Disease","symbol":"NPHS18","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032581\"}","{\"db\":\"OMIM\",\"id\":\"618177\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"607613.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607613.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607613.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618177\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618177\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40812","name":"NEPHROTIC SYNDROME, TYPE 18"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748408","type":"Disease","symbol":"HKLLS3","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032564\"}","{\"db\":\"OMIM\",\"id\":\"618154\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"605011.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605011.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605011.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618154\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618154\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40734","name":"HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258385","type":"Disease","symbol":"NEDISHM","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032741\"}","{\"db\":\"OMIM\",\"id\":\"618425\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"604083.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604083.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604083.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604083.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604083.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604083.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618425\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618425\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41641","name":"NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263292","type":"Disease","symbol":"IMMAS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032916\"}","{\"db\":\"OMIM\",\"id\":\"618786\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606245.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606245.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606245.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606245.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606245.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618786\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618786\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43653","name":"IMAGAWA-MATSUMOTO SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262924","type":"Disease","symbol":"PFBMFT5","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032865\"}","{\"db\":\"OMIM\",\"id\":\"618674\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618674\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618674\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43109","name":"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 5"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262385","type":"Disease","symbol":"SEDN","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032835\"}","{\"db\":\"OMIM\",\"id\":\"618618\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"611894.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618618\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618618\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42960","name":"SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260594","type":"Disease","symbol":"NS11","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032786\"}","{\"db\":\"OMIM\",\"id\":\"618499\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608435.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608435.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608435.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618499\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618499\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42210","name":"NOONAN SYNDROME 11"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262376","type":"Disease","symbol":"RP86","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032834\"}","{\"db\":\"OMIM\",\"id\":\"618613\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"613344.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613344.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618613\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618613\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42950","name":"RETINITIS PIGMENTOSA 86"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258390","type":"Disease","symbol":"SPGF38","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032748\"}","{\"db\":\"OMIM\",\"id\":\"618433\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618424.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618424.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618424.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618424.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618424.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618433\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618433\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41650","name":"SPERMATOGENIC FAILURE 38"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4305072","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"Orphanet\",\"id\":\"163976\"}"],"id":"41651","name":"X-linked intellectual disability, Van Esch type"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN261026","type":"Disease","symbol":"HPE12","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032787\"}","{\"db\":\"OMIM\",\"id\":\"618500\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"604917.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618500\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42222","name":"HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0837178","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"Office of Rare Diseases\",\"id\":\"10447\",\"ref_field\":\"name\"}"],"id":"7720","name":"Cerebral palsy spastic quadriplegic"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258198","type":"Disease","symbol":"IBGC7","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032673\"}","{\"db\":\"OMIM\",\"id\":\"618317\",\"type\":\"MIM\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"primary-familial-brain-calcification\",\"ref_field\":\"ghr_links\"}","{\"db\":\"OMIM\",\"id\":\"618255.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618255.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618255.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618255.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618255.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618255.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618255.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618255.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618255.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618317\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618317\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41360","name":"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE","ghr_links":"primary familial brain calcification"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748517","type":"Disease","symbol":"DIAR9","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032575\"}","{\"db\":\"OMIM\",\"id\":\"618168\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"601968.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601968.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618168\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618168\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40765","name":"DIARRHEA 9"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263059","type":"Disease","symbol":"SSMGA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032875\"}","{\"db\":\"OMIM\",\"id\":\"618702\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618702\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618702\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43129","name":"SHORT STATURE AND MICROCEPHALY WITH GENITAL ANOMALIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263393","type":"Disease","symbol":"MYORIBF","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032936\"}","{\"db\":\"OMIM\",\"id\":\"618822\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618822\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618822\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43785","name":"MYOPATHY, CONGENITAL, WITH RESPIRATORY INSUFFICIENCY AND BONE FRACTURES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262378","type":"Disease","symbol":"LUTO","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032833\"}","{\"db\":\"OMIM\",\"id\":\"618612\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608669.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608669.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618612\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618612\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42952","name":"LOWER URINARY TRACT OBSTRUCTION, CONGENITAL"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C2675227","type":"Disease","symbol":"ECO","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"612651\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"199332\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Endocrine-cerebroosteodysplasia/8311\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612651\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1593","name":"Endocrine-cerebroosteodysplasia"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C5193051","type":"Disease","symbol":"CRDHL2","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020780\"}","{\"db\":\"OMIM\",\"id\":\"618358\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618358\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41544","name":"Cone-rod dystrophy and hearing loss 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748545","type":"Disease","symbol":"NPHS17","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032580\"}","{\"db\":\"OMIM\",\"id\":\"618176\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"170285.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"170285.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"170285.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"170285.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618176\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618176\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40811","name":"NEPHROTIC SYNDROME, TYPE 17"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4551515","type":"Disease","symbol":"CHBL","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0018827\"}","{\"db\":\"OMIM\",\"id\":\"PS610448\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"481662\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Chilblain+lupus+erythematosus/7966\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"238928005\",\"ref_field\":\"name\"}"],"id":"33007","name":"Chilblain lupus erythematosus"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258388","type":"Disease","symbol":"HYDM3","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032746\"}","{\"db\":\"OMIM\",\"id\":\"618431\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608797.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608797.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608797.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618431\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618431\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41646","name":"HYDATIDIFORM MOLE, RECURRENT, 3"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1835829","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"610798\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"90023\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Immunodeficiency+due+to+defect+in+mapbp-interacting+protein/8644\",\"ref_field\":\"name\"}"],"id":"1834","name":"Immunodeficiency due to defect in mapbp-interacting protein"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748602","type":"Disease","symbol":"PVNH8","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032588\"}","{\"db\":\"OMIM\",\"id\":\"618185\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"103180.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"103180.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"103180.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618185\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618185\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40817","name":"PERIVENTRICULAR NODULAR HETEROTOPIA 8"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262354","type":"Disease","symbol":"SNIBFIS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032830\"}","{\"db\":\"OMIM\",\"id\":\"618604\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602480.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602480.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602480.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602480.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602480.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602480.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618604\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618604\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42948","name":"SNIJDERS BLOK-FISHER SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258243","type":"Disease","symbol":"GAMOS7","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032692\"}","{\"db\":\"OMIM\",\"id\":\"618348\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"607617.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607617.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618348\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618348\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41444","name":"GALLOWAY-MOWAT SYNDROME 7"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748688","type":"Disease","symbol":"EIEE68","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032598\"}","{\"db\":\"OMIM\",\"id\":\"618201\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608112.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608112.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608112.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608112.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618201\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618201\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40840","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258246","type":"Disease","symbol":"NEDCPMD","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032698\"}","{\"db\":\"OMIM\",\"id\":\"618356\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"609145.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609145.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609145.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618356\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618356\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41540","name":"NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262920","type":"Disease","symbol":"PNCA5","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032867\"}","{\"db\":\"OMIM\",\"id\":\"618680\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618680\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618680\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43105","name":"PANCREATIC CANCER, SUSCEPTIBILITY TO, 5"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263286","type":"Disease","symbol":"CSS11","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032912\"}","{\"db\":\"OMIM\",\"id\":\"618779\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"601735.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601735.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601735.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601735.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601735.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618779\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618779\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43646","name":"COFFIN-SIRIS SYNDROME 11"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258240","type":"Disease","symbol":"MIGSB","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032690\"}","{\"db\":\"OMIM\",\"id\":\"618346\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"605924.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618346\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618346\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41441","name":"MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263123","type":"Disease","symbol":"NEDBAVC","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032888\"}","{\"db\":\"OMIM\",\"id\":\"618731\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618731\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618731\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43257","name":"NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES AND WITH OR WITHOUT VERTEBRAL OR CARDIAC ANOMALIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263349","type":"Disease","symbol":"BEFAHRS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032922\"}","{\"db\":\"OMIM\",\"id\":\"618798\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618798\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618798\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43740","name":"BECK-FAHRNER SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258374","type":"Disease","symbol":"GDRM","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032738\"}","{\"db\":\"OMIM\",\"id\":\"618419\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"615902.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615902.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615902.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618419\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618419\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41616","name":"GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258253","type":"Disease","symbol":"CSS8","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032702\"}","{\"db\":\"OMIM\",\"id\":\"618362\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"601734.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601734.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601734.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601734.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601734.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618362\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618362\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41549","name":"COFFIN-SIRIS SYNDROME 8"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0272324","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0015721\"}","{\"db\":\"Orphanet\",\"id\":\"169808\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0015721\",\"ref_field\":\"name\"}"],"id":"38731","name":"Mild hemophilia A"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262657","type":"Disease","symbol":"NOCGUS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032850\"}","{\"db\":\"OMIM\",\"id\":\"618652\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618586.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618586.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618586.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618586.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618652\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618652\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43044","name":"NEUROOCULOCARDIOGENITOURINARY SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260096","type":"Disease","symbol":"COFG","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032774\"}","{\"db\":\"OMIM\",\"id\":\"618479\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"601280.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601280.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601280.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601280.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601280.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618479\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618479\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42029","name":"CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN259075","type":"Disease","symbol":"DEDDFA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032760\"}","{\"db\":\"OMIM\",\"id\":\"618454\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618454\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618454\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41915","name":"DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258197","type":"Disease","symbol":"IDDCDF","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032672\"}","{\"db\":\"OMIM\",\"id\":\"618316\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618316\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41358","name":"Intellectual developmental disorder with cardiac defects and dysmorphic facies"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258233","type":"Disease","symbol":"PMGEDSV","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032688\"}","{\"db\":\"OMIM\",\"id\":\"618343\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618343\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618343\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41437","name":"POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260175","type":"Disease","symbol":"DFNB99","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032776\"}","{\"db\":\"OMIM\",\"id\":\"618481\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618481\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618481\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42140","name":"DEAFNESS, AUTOSOMAL RECESSIVE 99"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258225","type":"Disease","symbol":"SPGF35","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032686\"}","{\"db\":\"OMIM\",\"id\":\"618341\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618304.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618304.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618341\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618341\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41426","name":"SPERMATOGENIC FAILURE 35"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748898","type":"Disease","symbol":"THNS","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032645\"}","{\"db\":\"OMIM\",\"id\":\"618268\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618268\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40927","name":"Trichohepatoneurodevelopmental syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748158","type":"Disease","symbol":"SCA48","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032526\"}","{\"db\":\"OMIM\",\"id\":\"618093\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618093\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618093\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40802","name":"SPINOCEREBELLAR ATAXIA 48"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3554499","type":"Disease","symbol":"MCPH10","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615095\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"329228\"}","{\"db\":\"OMIM\",\"id\":\"615095\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17657","name":"Primary autosomal recessive microcephaly 10"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748560","type":"Disease","symbol":"ECTD14","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032584\"}","{\"db\":\"OMIM\",\"id\":\"618180\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618180\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618180\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40803","name":"ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258247","type":"Disease","symbol":"EIG15","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032699\"}","{\"db\":\"OMIM\",\"id\":\"618357\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618357\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41543","name":"Epilepsy, idiopathic generalized, susceptibility to, 15"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748969","type":"Disease","symbol":"HIES3","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032654\"}","{\"db\":\"OMIM\",\"id\":\"618282\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618269.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618269.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618269.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618269.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618269.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618282\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618282\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40951","name":"HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263352","type":"Disease","symbol":"SANDSTEF","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032926\"}","{\"db\":\"OMIM\",\"id\":\"618804\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"615587.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615587.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618804\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618804\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43743","name":"SANDESTIG-STEFANOVA SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4749014","type":"Disease","symbol":"NEDIDHA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032661\"}","{\"db\":\"OMIM\",\"id\":\"618292\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603123.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603123.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618292\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618292\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41328","name":"NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262218","type":"Disease","symbol":"OOMD7","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032810\"}","{\"db\":\"OMIM\",\"id\":\"618550\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608420.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608420.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608420.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608420.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618550\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618550\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42466","name":"OOCYTE MATURATION DEFECT 7"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN260597","type":"Disease","symbol":"CHEDDA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032781\"}","{\"db\":\"OMIM\",\"id\":\"618494\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"607462.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607462.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607462.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607462.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607462.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618494\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618494\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42212","name":"CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263282","type":"Disease","symbol":"DFNA75","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032911\"}","{\"db\":\"OMIM\",\"id\":\"618778\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618778\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618778\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43643","name":"DEAFNESS, AUTOSOMAL DOMINANT 75"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"type":"Disease","alternate_names":[],"xrefs":[],"id":"11142","name":"BCHE Newfoundland"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748488","type":"Disease","symbol":"BMFS5","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032573\"}","{\"db\":\"OMIM\",\"id\":\"618165\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"191170.0043\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"191170.0044\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618165\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618165\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40763","name":"BONE MARROW FAILURE SYNDROME 5"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262228","type":"Disease","symbol":"EIEE78","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032812\"}","{\"db\":\"OMIM\",\"id\":\"618557\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"137140.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137140.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137140.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137140.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137140.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618557\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618557\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42883","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 78"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1970211","type":"Disease","symbol":"DSMA4","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"611067\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"206580\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Distal+spinal+muscular+atrophy%2C+autosomal+recessive+4/8274\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611067\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4175","name":"Distal spinal muscular atrophy, autosomal recessive 4"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258209","type":"Disease","symbol":"LIS9","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032677\"}","{\"db\":\"OMIM\",\"id\":\"618325\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608271.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608271.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608271.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608271.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608271.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608271.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618325\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618325\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41410","name":"LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3809526","type":"Disease","symbol":"COXPD17","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615440\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"369913\"}","{\"db\":\"OMIM\",\"id\":\"615440\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18309","name":"Combined oxidative phosphorylation deficiency 17"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262279","type":"Disease","symbol":"NEDAHM","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032816\"}","{\"db\":\"OMIM\",\"id\":\"618569\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"617853.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617853.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618569\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618569\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42908","name":"NEURODEVELOPMENTAL DISORDER WITH ATAXIA, HYPOTONIA, AND MICROCEPHALY"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C0553730","type":"Finding","alternate_names":[],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000934\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0001314\"}","{\"db\":\"Orphanet\",\"id\":\"1416\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000934\",\"ref_field\":\"name\"}"],"id":"22042","name":"Chondrocalcinosis"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4749023","type":"Disease","symbol":"EIEE70","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032663\"}","{\"db\":\"OMIM\",\"id\":\"618298\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608723.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608723.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608723.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618298\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618298\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41329","name":"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"gard_id":"12978","medgen_id":"C3810285","type":"Disease","symbol":"MPXPS","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615673\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"401768\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"12978\",\"ref_field\":\"gard_id\"}","{\"db\":\"OMIM\",\"id\":\"615673\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18620","name":"Myopathy with extrapyramidal signs"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258241","type":"Disease","symbol":"GAMOS6","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032691\"}","{\"db\":\"OMIM\",\"id\":\"618347\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"605924.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605924.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605924.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605924.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605924.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618347\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618347\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41442","name":"GALLOWAY-MOWAT SYNDROME 6"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748978","type":"Disease","symbol":"VIPB","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032655\"}","{\"db\":\"OMIM\",\"id\":\"618283\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618283\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618283\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40952","name":"VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262666","type":"Disease","symbol":"MPD6","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032853\"}","{\"db\":\"OMIM\",\"id\":\"618655\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"102573.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"102573.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618655\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618655\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43056","name":"MYOPATHY, DISTAL, 6, ADULT-ONSET, AUTOSOMAL DOMINANT"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258343","type":"Disease","symbol":"DFNB113","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032732\"}","{\"db\":\"OMIM\",\"id\":\"618410\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"614591.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614591.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618410\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618410\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41604","name":"DEAFNESS, AUTOSOMAL RECESSIVE 113"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4024851","type":"Finding","alternate_names":[],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007530\",\"type\":\"primary\"}","{\"db\":\"Orphanet\",\"id\":\"307967\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007530\",\"ref_field\":\"name\"}"],"id":"26247","name":"Punctate palmoplantar hyperkeratosis"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN262921","type":"Disease","symbol":"LSKB","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032868\"}","{\"db\":\"OMIM\",\"id\":\"618681\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618681\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618681\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43106","name":"LESSEL-KUBISCH SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN258392","type":"Disease","symbol":"DA2B2","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032750\"}","{\"db\":\"OMIM\",\"id\":\"618435\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600692.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600692.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618435\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618435\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41653","name":"ARTHROGRYPOSIS, DISTAL, TYPE 2B2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN279272","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0016865\"}","{\"db\":\"Orphanet\",\"id\":\"261652\"}","{\"db\":\"NCBI for submitter\",\"id\":\"90830420\",\"ref_field\":\"name\"}"],"id":"42442","name":"Kleefstra syndrome due to a point mutation"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4748869","type":"Disease","symbol":"MRMV4","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032641\"}","{\"db\":\"OMIM\",\"id\":\"618264\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"601614.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601614.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601614.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618264\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618264\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40932","name":"MIRROR MOVEMENTS 4"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN263372","type":"Disease","symbol":"MTDPS18","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032932\"}","{\"db\":\"OMIM\",\"id\":\"618811\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618811\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618811\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"43777","name":"MITOCHONDRIAL DNA DEPLETION SYNDROME 18"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C1865371","type":"Disease","alternate_names":[],"xrefs":[],"id":"10090","name":"Severe combined immunodeficiency, athabascan-type"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301423\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1245\",\"@Source\":\"BookShelf\"}]}}","gard_id":"3995","medgen_id":"CN043584","public_definition":"X-linked congenital stationary night blindness (CSNB) is characterized by non-progressive retinal findings of reduced visual acuity ranging from 20/30 to 20/200; defective dark adaptation; refractive error, most typically myopia ranging from low (-0.25 diopters [D] to -4.75 D) to high (â¥-10.00 D) but occasionally hyperopia; nystagmus; strabismus; normal color vision; and normal fundus examination. Characteristic ERG findings can help distinguish between complete X-linked CSNB and incomplete X-linked CSNB.","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0044749\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3995\",\"ref_field\":\"gard_id\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1245\",\"ref_field\":\"public_definition\"}"],"id":"9475","name":"Congenital stationary night blindness, X-linked"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"24278995\",\"@Source\":\"PubMed\"},{\"$\":\"NBK169825\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C2749054","public_definition":"CASK disorders include a spectrum of phenotypes in both females and males. Two main types of clinical presentation are seen: Microcephaly with pontine and cerebellar hypoplasia (MICPCH), generally associated with pathogenic loss-of-function variants in CASK. X-linked intellectual disability (XLID) with or without nystagmus, generally associated with hypomorphic CASK pathogenic variants. MICPCH is typically seen in females with moderate-to-severe intellectual disability, progressive microcephaly with or without ophthalmologic anomalies, and sensorineural hearing loss. Most are able to sit independently; 20%-25% attain the ability to walk; language is nearly absent in most. Neurologic features may include axial hypotonia, hypertonia/spasticity of the extremities, and dystonia or other movement disorders. Nearly 40% have seizures by age ten years. Behaviors may include sleep disturbances, hand stereotypies, and self biting. MICPCH in males may occur with or without severe epileptic encephalopathy in addition to severe-to-profound developmental delay. When seizures are present they occur early and may be intractable. In individuals and families with milder (i.e., hypomorphic) pathogenic variants, the clinical phenotype is usually that of XLID with or without nystagmus and additional clinical features. Males have mild-to-severe intellectual disability, with or without nystagmus and other ocular features. Females typically have normal intelligence with some displaying mild-to-severe intellectual disability with or without ocular features.","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"Genetic Alliance\",\"id\":\"X-linked+mental+retardation%2C+CASK-related/9513\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK169825\",\"ref_field\":\"public_definition\"}"],"id":"9049","name":"Mental retardation, CASK-related, X-linked"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"21348050\",\"@Source\":\"PubMed\"},{\"$\":\"NBK52764\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C4748670","public_definition":"Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is characterized by the presence of multiple small (1-2 cm in diameter) capillary malformations mostly localized on the face and limbs. Some affected individuals also have associated arteriovenous malformations (AVMs) and/or arteriovenous fistulas (AFVs), fast-flow vascular anomalies that typically arise in the skin, muscle, bone, spine, and brain; life-threatening complications of these lesions can include bleeding, congestive heart failure, and/or neurologic consequences. Symptoms from intracranial AVMs/AVFs appear to occur early in life. Several individuals have Parkes Weber syndrome (multiple micro-AVFs associated with a cutaneous capillary stain and excessive soft-tissue and skeletal growth of an affected limb).","type":"Disease","symbol":"CMAVM2","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020785\"}","{\"db\":\"OMIM\",\"id\":\"618196\",\"type\":\"MIM\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK52764\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"618196\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"40832","name":"Capillary malformation-arteriovenous malformation 2"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"21348050\",\"@Source\":\"PubMed\"},{\"$\":\"NBK52764\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C4747394","public_definition":"Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is characterized by the presence of multiple small (1-2 cm in diameter) capillary malformations mostly localized on the face and limbs. Some affected individuals also have associated arteriovenous malformations (AVMs) and/or arteriovenous fistulas (AFVs), fast-flow vascular anomalies that typically arise in the skin, muscle, bone, spine, and brain; life-threatening complications of these lesions can include bleeding, congestive heart failure, and/or neurologic consequences. Symptoms from intracranial AVMs/AVFs appear to occur early in life. Several individuals have Parkes Weber syndrome (multiple micro-AVFs associated with a cutaneous capillary stain and excessive soft-tissue and skeletal growth of an affected limb).","type":"Disease","symbol":"CMAVM1","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020783\"}","{\"db\":\"OMIM\",\"id\":\"608354\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"137667\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK52764\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"608354\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"652","name":"Capillary malformation-arteriovenous malformation 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"24761742\",\"@Source\":\"PubMed\"},{\"$\":\"NBK196157\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C1867234","public_definition":"DICER1 tumor predisposition (DICER1) is characterized by an increased risk for pleuropulmonary blastoma (PPB), pulmonary cysts, thyroid gland neoplasia (multinodular goiter, adenomas, and/or thyroid cancer), ovarian tumors (Sertoli-Leydig cell tumor, gynandroblastoma, and sarcoma), and cystic nephroma. Less commonly observed tumors include ciliary body medulloepithelioma, nasal chondromesenchymal hamartoma, embryonal rhabdomyosarcoma, pituitary blastoma, pineoblastoma, central nervous system (CNS) sarcoma, other CNS tumors, and presacral malignant teratoid tumor. The majority of tumors occur in individuals younger than age 40 years. PPB typically presents in infants and children younger than age six years. Ovarian sex cord-stromal tumors are most often diagnosed before age 40 years. Cystic nephroma generally presents in young children but has also been reported in adolescents. Additional clinical features that may be seen include macrocephaly, ocular abnormalities, structural anomalies of the kidney and collecting system, and dental anomalies (bulbous crowns).","type":"Disease","symbol":"RMSE2","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"180295\",\"type\":\"MIM\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK196157\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"180295\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4104","name":"Rhabdomyosarcoma, embryonal, 2"}
{"attribute_content":[],"alternate_symbols":["PPB"],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"ASCO, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24493721\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"24761742\",\"@Source\":\"PubMed\"},{\"$\":\"NBK196157\",\"@Source\":\"BookShelf\"}]}]}","medgen_id":"C1266144","public_definition":"DICER1 tumor predisposition (DICER1) is characterized by an increased risk for pleuropulmonary blastoma (PPB), pulmonary cysts, thyroid gland neoplasia (multinodular goiter, adenomas, and/or thyroid cancer), ovarian tumors (Sertoli-Leydig cell tumor, gynandroblastoma, and sarcoma), and cystic nephroma. Less commonly observed tumors include ciliary body medulloepithelioma, nasal chondromesenchymal hamartoma, embryonal rhabdomyosarcoma, pituitary blastoma, pineoblastoma, central nervous system (CNS) sarcoma, other CNS tumors, and presacral malignant teratoid tumor. The majority of tumors occur in individuals younger than age 40 years. PPB typically presents in infants and children younger than age six years. Ovarian sex cord-stromal tumors are most often diagnosed before age 40 years. Cystic nephroma generally presents in young children but has also been reported in adolescents. Additional clinical features that may be seen include macrocephaly, ocular abnormalities, structural anomalies of the kidney and collecting system, and dental anomalies (bulbous crowns).","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100528\",\"type\":\"primary\"}","{\"db\":\"Orphanet\",\"id\":\"64741\"}","{\"db\":\"OMIM\",\"id\":\"601200\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PPB\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pleuropulmonary+blastoma/5804\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100528\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK196157\",\"ref_field\":\"public_definition\"}"],"id":"5772","name":"Pleuropulmonary blastoma"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"25834911\",\"@Source\":\"PubMed\"},{\"$\":\"NBK284774\",\"@Source\":\"BookShelf\"}]}}","gard_id":"13201","medgen_id":"C3810404","public_definition":"The four children with carbonic anhydrase VA (CA-VA) deficiency reported to date presented between day two of life and age 20 months with hyperammonemic encephalopathy (i.e., lethargy, feeding intolerance, weight loss, tachypnea, seizures, and coma). Data on long-term follow up are limited (the oldest known patient is age 7 years). Two of the four children showed normal psychomotor development and two showed mild learning difficulties and delayed motor skills. Seven additional children diagnosed with CA-VA deficiency (but not yet published) presented similarly.","type":"Disease","symbol":"CA5AD","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615751\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"401948\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"13201\",\"ref_field\":\"gard_id\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK284774\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"615751\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18709","name":"Carbonic anhydrase VA deficiency, hyperammonemia due to"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"31670927\",\"@Source\":\"PubMed\"},{\"$\":\"NBK549204\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"CN262386","public_definition":"Weiss-Kruszka syndrome is characterized by metopic ridging or synostosis, ptosis, nonspecific dysmorphic features, developmental delay, and autistic features. Brain imaging may identify abnormalities of the corpus callosum. Developmental delay can present as global delay, motor delay, or speech delay. Affected individuals may also have ear anomalies, feeding difficulties (sometimes requiring placement of a gastrostomy tube), and congenital heart defects. There is significant variability in the clinical features, even between affected members of the same family.","type":"Disease","symbol":"WSKA","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032836\"}","{\"db\":\"OMIM\",\"id\":\"618619\",\"type\":\"MIM\"}","{\"db\":\"GeneTests\",\"id\":\"320651\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617371.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617371.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617371.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617371.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617371.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617371.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617371.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618619\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK549204\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"618619\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"42963","name":"WEISS-KRUSZKA SYNDROME"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"ACMG, 2002\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3110944\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ACMG, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24651602\",\"@Source\":\"PubMed\"}}]}","gard_id":"1715","medgen_id":"CN043651","public_definition":"Nonsyndromic hearing loss is a partial or total loss of hearing that is not associated with other signs and symptoms. In contrast, syndromic hearing loss occurs with signs and symptoms affecting other parts of the body.Nonsyndromic hearing loss can be classified in several different ways. One common way is by the condition's pattern of inheritance: autosomal dominant (DFNA), autosomal recessive (DFNB), X-linked (DFNX), or mitochondrial (which does not have a special designation). Each of these types of hearing loss includes multiple subtypes. DFNA, DFNB, and DFNX subtypes are numbered in the order in which they were first described. For example, DFNA1 was the first type of autosomal dominant nonsyndromic hearing loss to be identified.The characteristics of nonsyndromic hearing loss vary among the different types. Hearing loss can affect one ear (unilateral) or both ears (bilateral). Degrees of hearing loss range from mild (difficulty understanding soft speech) to profound (inability to hear even very loud noises). The term \"deafness\" is often used to describe severe-to-profound hearing loss. Hearing loss can be stable, or it may be progressive, becoming more severe as a person gets older. Particular types of nonsyndromic hearing loss show distinctive patterns of hearing loss. For example, the loss may be more pronounced at high, middle, or low tones.Most forms of nonsyndromic hearing loss are described as sensorineural, which means they are associated with a permanent loss of hearing caused by damage to structures in the inner ear. The inner ear processes sound and sends the information to the brain in the form of electrical nerve impulses. Less commonly, nonsyndromic hearing loss is described as conductive, meaning it results from changes in the middle ear. The middle ear contains three tiny bones that help transfer sound from the eardrum to the inner ear. Some forms of nonsyndromic hearing loss, particularly a type called DFNX2, involve changes in both the inner ear and the middle ear. This combination is called mixed hearing loss.Depending on the type, nonsyndromic hearing loss can become apparent at any time from infancy to old age. Hearing loss that is present before a child learns to speak is classified as prelingual or congenital. Hearing loss that occurs after the development of speech is classified as postlingual.","type":"Disease","symbol":"DFNX","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"PS304500\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"90625\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1715\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Deafness%2C+X-Linked%2C+DFN/2162\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS304500\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"nonsyndromic-hearing-loss\",\"ref_field\":\"public_definition\"}"],"id":"9547","name":"Deafness, X-linked"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"30869852\",\"@Source\":\"PubMed\"},{\"$\":\"NBK538658\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C3554168","public_definition":"The spectrum of FARS2 deficiency ranges from the infantile-onset phenotype, characterized by epileptic encephalopathy with lactic acidosis and poor prognosis (70% of affected individuals), to the later-onset phenotype, characterized by spastic paraplegia, less severe neurologic manifestations, and longer survival (30% of affected individuals). To date FARS2 deficiency has been reported in 37 individuals from 25 families. Infantile-onset phenotype. Seizures are difficult to control and may progress quickly at an early age to intractable seizures with frequent status epilepticus; some children have hypsarrhythmia on EEG. All have developmental delay; most are nonverbal and unable to walk. Feeding difficulties are common. More than half of affected children die in early childhood. Later-onset phenotype. All affected individuals have spastic paraplegia manifested by weakness, spasticity, and exaggerated reflexes of the lower extremities associated with walking difficulties; some have developmental delay/intellectual disability; some have brief seizures that resolve over time.","type":"Disease","symbol":"COXPD14","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614946\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"319519\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK538658\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614946\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17497","name":"Combined oxidative phosphorylation deficiency 14"}
{"attribute_content":[],"alternate_symbols":["PSD"],"keywords":[],"disease_mechanism_id":"273","medgen_id":"C3281092","public_definition":"Autosomal recessive thrombophilia due to protein S deficiency is a very rare and severe hematologic disorder resulting in thrombosis and secondary hemorrhage usually beginning in early infancy. Some affected individuals develop neonatal purpura fulminans, multifocal thrombosis, or intracranial hemorrhage (Pung-amritt et al., 1999; Fischer et al., 2010), whereas others have recurrent thromboses later in childhood (Comp et al., 1984).\r\nSee also autosomal dominant thrombophilia due to protein S deficiency (THPH5; 612336), a less severe disorder caused by heterozygous mutation in the PROS1 gene.","type":"Disease","symbol":"THPH6","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0013791\"}","{\"db\":\"OMIM\",\"id\":\"614514\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"743\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000503187\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PSD\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000503187\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512307\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000576178\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"THROMBOPHILIA+DUE+TO+PROTEIN+S+DEFICIENCY%2C+AUTOSOMAL+RECESSIVE/9394\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614514\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614514\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"16844","disease_mechanism":"loss of function","name":"Thrombophilia due to protein S deficiency, autosomal recessive"}
{"attribute_content":[],"alternate_symbols":["TCS"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301704\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1532\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"CN119605","public_definition":"Treacher Collins syndrome (TCS) is characterized by bilateral and symmetric downslanting palpebral fissures, malar hypoplasia, micrognathia, and external ear abnormalities. Hypoplasia of the zygomatic bones and mandible can cause significant feeding and respiratory difficulties. About 40%-50% of individuals have conductive hearing loss attributed most commonly to malformation of the ossicles and hypoplasia of the middle ear cavities. Inner ear structures tend to be normal. Other, less common abnormalities include cleft palate and unilateral or bilateral choanal stenosis or atresia. Typically intellect is normal.","type":"Disease","symbol":"TCS1","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007944\"}","{\"db\":\"OMIM\",\"id\":\"154500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"861\"}","{\"db\":\"OMIM\",\"id\":\"154500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"TCS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Treacher+Collins+syndrome/7175\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1532\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"154500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"16740","name":"Treacher Collins syndrome 1"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN221543","public_definition":"Multiminicore disease is a disorder that primarily affects muscles used for movement (skeletal muscles). This condition causes muscle weakness and related health problems that range from mild to life-threatening.Researchers have identified at least four forms of multiminicore disease, which can be distinguished by their characteristic signs and symptoms. The forms of multiminicore disease are the classic form, the progressive form with hand involvement, the antenatal form with arthrogryposis, and the ophthalmoplegic form.The classic form accounts for about 75 percent of cases of multiminicore disease. This form causes muscle weakness beginning in infancy or early childhood. The muscles of the torso and neck (axial muscles) are most affected with arm and leg muscles less so. Muscle weakness causes affected infants to appear \"floppy\" (hypotonic) and they may have feeding problems early in life. Muscle weakness can delay the development of motor skills such as sitting, standing, and walking. In this form, the muscles of the ribcage and spine become stiff. In addition, the muscles needed for breathing are weak. This combination of muscle weakness and stiffness leads to severe or life-threatening respiratory problems. Almost all children with the classic form develop an abnormal curvature of the spine (scoliosis), which appears during childhood and steadily worsens over time.The progressive form with hand involvement causes muscle weakness and looseness of the joints (joint laxity) in the arms and hands. Individuals with this form may experience muscle pain (myalgia) or extreme fatigue in response to physical activity (exercise intolerance). This form accounts for about 10 percent of cases of multiminicore disease.The antenatal form with arthrogryposis is characterized by stiff, rigid joints throughout the body (arthrogryposis) and distinctive facial features. Weakness in the muscles needed for breathing can result in breathing problems for affected individuals. This form also accounts for about 10 percent of cases of multiminicore disease.The ophthalmoplegic form of multiminicore disease is characterized by paralysis of the eye muscles (external ophthalmoplegia). This can lead to abnormal eye movements and droopy eyelids (ptosis). This form of the condition can also cause weakness in the muscles close to the center of the body (proximal muscles), such as those of the upper arms and legs. The ophthalmoplegic form accounts for 5 to 10 percent of cases of multiminicore disease.Many people with multiminicore disease also have an increased risk of developing a severe reaction to certain drugs used during surgery and other invasive procedures. This reaction is called malignant hyperthermia. Malignant hyperthermia occurs in response to some anesthetic gases, which are used to block the sensation of pain, either given alone or in combination with a muscle relaxant that is used to temporarily paralyze a person during a surgical procedure. If given these drugs, people at risk of malignant hyperthermia may experience a rapid increase in heart rate (tachycardia) and body temperature (hyperthermia), abnormally fast breathing (tachypnea), muscle rigidity, breakdown of muscle fibers (rhabdomyolysis), and increased acid levels in the blood and other tissues (acidosis). The complications of malignant hyperthermia can be life-threatening unless they are treated promptly.Multiminicore disease gets its name from small, disorganized areas called minicores, which are found in skeletal muscle cells of many affected individuals. These abnormal regions can only been seen when muscle tissue is viewed under a microscope. Minicores are often present in cells with few or no mitochondria, which are the energy-producing centers within cells. Although the presence of minicores can help doctors diagnose multiminicore disease, it is unclear how they are related to muscle weakness and the other features of this condition.","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"Genetics Home Reference\",\"id\":\"multiminicore-disease\",\"ref_field\":\"public_definition\"}"],"id":"32318","name":"Multi-minicore disease and atypical periodic paralysis"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"CN221587","public_definition":"Multiminicore disease is a disorder that primarily affects muscles used for movement (skeletal muscles). This condition causes muscle weakness and related health problems that range from mild to life-threatening.Researchers have identified at least four forms of multiminicore disease, which can be distinguished by their characteristic signs and symptoms. The forms of multiminicore disease are the classic form, the progressive form with hand involvement, the antenatal form with arthrogryposis, and the ophthalmoplegic form.The classic form accounts for about 75 percent of cases of multiminicore disease. This form causes muscle weakness beginning in infancy or early childhood. The muscles of the torso and neck (axial muscles) are most affected with arm and leg muscles less so. Muscle weakness causes affected infants to appear \"floppy\" (hypotonic) and they may have feeding problems early in life. Muscle weakness can delay the development of motor skills such as sitting, standing, and walking. In this form, the muscles of the ribcage and spine become stiff. In addition, the muscles needed for breathing are weak. This combination of muscle weakness and stiffness leads to severe or life-threatening respiratory problems. Almost all children with the classic form develop an abnormal curvature of the spine (scoliosis), which appears during childhood and steadily worsens over time.The progressive form with hand involvement causes muscle weakness and looseness of the joints (joint laxity) in the arms and hands. Individuals with this form may experience muscle pain (myalgia) or extreme fatigue in response to physical activity (exercise intolerance). This form accounts for about 10 percent of cases of multiminicore disease.The antenatal form with arthrogryposis is characterized by stiff, rigid joints throughout the body (arthrogryposis) and distinctive facial features. Weakness in the muscles needed for breathing can result in breathing problems for affected individuals. This form also accounts for about 10 percent of cases of multiminicore disease.The ophthalmoplegic form of multiminicore disease is characterized by paralysis of the eye muscles (external ophthalmoplegia). This can lead to abnormal eye movements and droopy eyelids (ptosis). This form of the condition can also cause weakness in the muscles close to the center of the body (proximal muscles), such as those of the upper arms and legs. The ophthalmoplegic form accounts for 5 to 10 percent of cases of multiminicore disease.Many people with multiminicore disease also have an increased risk of developing a severe reaction to certain drugs used during surgery and other invasive procedures. This reaction is called malignant hyperthermia. Malignant hyperthermia occurs in response to some anesthetic gases, which are used to block the sensation of pain, either given alone or in combination with a muscle relaxant that is used to temporarily paralyze a person during a surgical procedure. If given these drugs, people at risk of malignant hyperthermia may experience a rapid increase in heart rate (tachycardia) and body temperature (hyperthermia), abnormally fast breathing (tachypnea), muscle rigidity, breakdown of muscle fibers (rhabdomyolysis), and increased acid levels in the blood and other tissues (acidosis). The complications of malignant hyperthermia can be life-threatening unless they are treated promptly.Multiminicore disease gets its name from small, disorganized areas called minicores, which are found in skeletal muscle cells of many affected individuals. These abnormal regions can only been seen when muscle tissue is viewed under a microscope. Minicores are often present in cells with few or no mitochondria, which are the energy-producing centers within cells. Although the presence of minicores can help doctors diagnose multiminicore disease, it is unclear how they are related to muscle weakness and the other features of this condition.","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"CSER _CC_NCGL, University of Washington\",\"id\":\"UWMG_7428375\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"multiminicore-disease\",\"ref_field\":\"public_definition\"}"],"id":"32362","name":"Multiminicore/minicore/multicore disease"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301543\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1369\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C3554367","public_definition":"Epidermolysis bullosa simplex (EBS) is characterized by fragility of the skin (and mucosal epithelia in some cases) that results in non-scarring blisters and erosions caused by minor mechanical trauma. The current classification of epidermolysis bullosa (EB) includes two major types and 17 minor subtypes of EBS; all share the common feature of blistering above the dermal-epidermal junction at the ultrastructural level. The four most common subtypes of EBS are the focus of this GeneReview: EBS, localized (EBS-loc; previously known as Weber-Cockayne type). EBS, generalized intermediate (EBS-gen intermed; previously known as Koebner type). EBS-with mottled pigmentation (EBS-MP). EBS, generalized severe (EBS-gen sev; previously known as Dowling-Meara type). The phenotypes for these subtypes range from relatively mild blistering of the hands and feet to more generalized blistering, which can be fatal. In EBS-loc, blisters are rarely present or minimal at birth and may occur on the knees and shins with crawling or on the feet at approximately age 18 months; some individuals manifest the disease in adolescence or early adulthood. Blisters are usually confined to the hands and feet, but can occur anywhere if trauma is significant. In EBS, gen intermed, blisters may be present at birth or develop within the first few months of life. Involvement is more widespread than in EBS-loc, but generally milder than in EBS-gen sev. In EBS-MP, skin fragility is evident at birth and clinically indistinguishable from EBS-gen sev; over time, progressive brown pigmentation interspersed with hypopigmented spots develops on the trunk and extremities, with the pigmentation disappearing in adult life. Focal palmar and plantar hyperkeratoses may occur. In EBS-gen sev, onset is usually at birth; severity varies greatly, both among and within families. Widespread and severe blistering and/or multiple grouped clumps of small blisters are typical and hemorrhagic blisters are common. Improvement occurs during mid- to late childhood. Progressive hyperkeratosis of the palms and soles begins in childhood and may be the major complaint of affected individuals in adult life. Nail dystrophy and milia are common. Both hyper- and hypopigmentation can occur. Mucosal involvement in EBS-gen sev may interfere with feeding, especially in neonates and infants. Blistering can be severe enough to result in neonatal or infant death.","type":"Disease","symbol":"EBNS","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615028\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"412189\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1369\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"615028\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17561","name":"Epidermolysis bullosa, nonspecific, autosomal recessive"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301650\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1477\",\"@Source\":\"BookShelf\"}]}}","gard_id":"6724","disease_mechanism_id":"274","medgen_id":"C0410529","public_definition":"Hypochondroplasia is a skeletal dysplasia characterized by short stature; stocky build; disproportionately short arms and legs; broad, short hands and feet; mild joint laxity; and macrocephaly. Radiologic features include shortening of long bones with mild metaphyseal flare; narrowing of the inferior lumbar interpedicular distances; short, broad femoral neck; and squared, shortened ilia. The skeletal features are very similar to those seen in achondroplasia but tend to be milder. Medical complications common to achondroplasia (e.g., spinal stenosis, tibial bowing, obstructive apnea) occur less frequently in hypochondroplasia but intellectual disability and epilepsy may be more prevalent. Children usually present as toddlers or at early school age with decreased growth velocity leading to short stature and limb disproportion. Other features also become more prominent over time.","type":"Disease","symbol":"HCH","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007793\"}","{\"db\":\"OMIM\",\"id\":\"146000\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"429\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500679\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6724\",\"ref_field\":\"gard_id\"}","{\"db\":\"GeneTests\",\"id\":\"2814\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hypochondroplasia/3635\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"205468002\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1477\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"146000\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5300","disease_mechanism":"gain of function","name":"Hypochondroplasia"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"28125198\",\"@Source\":\"PubMed\"},{\"$\":\"NBK410087\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C3553349","public_definition":"Primary coenzyme Q10 (CoQ10) deficiency is usually associated with multisystem involvement, including neurologic manifestations such as fatal neonatal encephalopathy with hypotonia; a late-onset slowly progressive multiple-system atrophy-like phenotype (neurodegeneration with autonomic failure and various combinations of parkinsonism and cerebellar ataxia, and pyramidal dysfunction); and dystonia, spasticity, seizures, and intellectual disability. Steroid-resistant nephrotic syndrome (SRNS), the hallmark renal manifestation, is often the initial manifestation either as isolated renal involvement that progresses to end-stage renal disease (ESRD), or associated with encephalopathy (seizures, stroke-like episodes, severe neurologic impairment) resulting in early death. Hypertrophic cardiomyopathy (HCM), retinopathy or optic atrophy, and sensorineural hearing loss can also be seen.","type":"Disease","symbol":"COQ10D6","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614650\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"280406\"}","{\"db\":\"Genetic Alliance\",\"id\":\"COENZYME+Q10+DEFICIENCY%2C+PRIMARY%2C+6/7997\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK410087\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614650\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"16993","name":"Coenzyme Q10 deficiency, primary, 6"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301773\",\"@Source\":\"PubMed\"},{\"$\":\"NBK9673\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C2676466","public_definition":"TSEN54 pontocerebellar hypoplasia (TSEN54-PCH) comprises three PCH phenotypes (PCH2, 4, and 5) that share characteristic neuroradiologic and neurologic findings. The three PCH phenotypes (which differ mainly in life expectancy) were considered to be distinct entities before their molecular basis was known. PCH2. Children usually succumb before age ten years (those with PCH4 and 5 usually succumb as neonates). Children with PCH2 have generalized clonus, uncoordinated sucking and swallowing, impaired cognitive development, lack of voluntary motor development, cortical blindness, and an increased risk for rhabdomyolysis during severe infections. Epilepsy is present in approximately 50%. PCH4. Neonates often have seizures, multiple joint contractures (\"arthrogryposis\"), generalized clonus, and central respiratory impairment. PCH5 resembles PCH4 and has been described in one family.","type":"Disease","symbol":"PCH2B","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012890\"}","{\"db\":\"OMIM\",\"id\":\"612389\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2524\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pontocerebellar+hypoplasia+type+2B/9134\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK9673\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"612389\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4004","name":"Pontocerebellar hypoplasia type 2B"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301773\",\"@Source\":\"PubMed\"},{\"$\":\"NBK9673\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C2676465","public_definition":"TSEN54 pontocerebellar hypoplasia (TSEN54-PCH) comprises three PCH phenotypes (PCH2, 4, and 5) that share characteristic neuroradiologic and neurologic findings. The three PCH phenotypes (which differ mainly in life expectancy) were considered to be distinct entities before their molecular basis was known. PCH2. Children usually succumb before age ten years (those with PCH4 and 5 usually succumb as neonates). Children with PCH2 have generalized clonus, uncoordinated sucking and swallowing, impaired cognitive development, lack of voluntary motor development, cortical blindness, and an increased risk for rhabdomyolysis during severe infections. Epilepsy is present in approximately 50%. PCH4. Neonates often have seizures, multiple joint contractures (\"arthrogryposis\"), generalized clonus, and central respiratory impairment. PCH5 resembles PCH4 and has been described in one family.","type":"Disease","symbol":"PCH2C","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012891\"}","{\"db\":\"OMIM\",\"id\":\"612390\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2524\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pontocerebellar+hypoplasia+type+2C/9135\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK9673\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"612390\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5785","name":"Pontocerebellar hypoplasia type 2C"}
{"attribute_content":[],"alternate_symbols":["VMD2"],"keywords":[],"medgen_id":"C0339510","public_definition":"Vitelliform macular dystrophy is a genetic eye disorder that can cause progressive vision loss. This disorder affects the retina, the specialized light-sensitive tissue that lines the back of the eye. Specifically, vitelliform macular dystrophy disrupts cells in a small area near the center of the retina called the macula. The macula is responsible for sharp central vision, which is needed for detailed tasks such as reading, driving, and recognizing faces.Vitelliform macular dystrophy causes a fatty yellow pigment (lipofuscin) to build up in cells underlying the macula. Over time, the abnormal accumulation of this substance can damage cells that are critical for clear central vision. As a result, people with this disorder often lose their central vision, and their eyesight may become blurry or distorted. Vitelliform macular dystrophy typically does not affect side (peripheral) vision or the ability to see at night.Researchers have described two forms of vitelliform macular dystrophy with similar features. The early-onset form (known as Best disease) usually appears in childhood; the onset of symptoms and the severity of vision loss vary widely. The adult-onset form begins later, usually in mid-adulthood, and tends to cause vision loss that worsens slowly over time. The two forms of vitelliform macular dystrophy each have characteristic changes in the macula that can be detected during an eye examination.","type":"Disease","symbol":"VMD","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0000390\"}","{\"db\":\"OMIM\",\"id\":\"PS153840\",\"type\":\"Phenotypic series\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000553865\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"VMD2\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"vitelliform-macular-dystrophy\",\"ref_field\":\"public_definition\"}"],"id":"33313","name":"Vitelliform macular dystrophy"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"25879134\",\"@Source\":\"PubMed\"},{\"$\":\"NBK285321\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C2675526","public_definition":"G6PC3 deficiency is characterized by severe congenital neutropenia which occurs in a phenotypic continuum that includes the following: Isolated severe congenital neutropenia (nonsyndromic). Classic G6PC3 deficiency (severe congenital neutropenia plus cardiovascular and/or urogenital abnormalities). Severe G6PC3 deficiency (classic G6PC3 deficiency plus involvement of non-myeloid hematopoietic cell lines, additional extra-hematologic features, and pulmonary hypertension; known as Dursun syndrome). Neutropenia usually presents with recurrent bacterial infections in the first few months of life. Intrauterine growth restriction (IUGR), failure to thrive (FTT), and poor postnatal growth are common. Other findings in classic and severe G6PC3 deficiency can include inflammatory bowel disease (IBD) resembling Crohn's disease, and endocrine disorders (growth hormone deficiency, hypogonadotropic hypogonadism, and delayed puberty).","type":"Disease","symbol":"SCN4","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"612541\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"331176\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Neutropenia%2C+severe+congenital%2C+4%2C+autosomal+recessive/9006\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK285321\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"612541\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3466","name":"Severe congenital neutropenia 4, autosomal recessive"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3553989","public_definition":"DSMA5 is an autosomal recessive neurologic disorder characterized by young adult onset of slowly progressive distal muscle weakness and atrophy resulting in gait impairment and loss of reflexes due to impaired function of motor nerves. Sensation and cognition are not impaired (summary by Blumen et al., 2012).\r\nFor a general phenotypic description and a discussion of genetic heterogeneity of distal SMA, see HMN1 (182960).","type":"Disease","symbol":"DSMA5","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614881\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"314485\"}","{\"db\":\"OMIM\",\"id\":\"614881\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614881\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17423","name":"Spinal muscular atrophy, distal, autosomal recessive, 5"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"Orphanet, 2013\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"Orphanet, Hemiplegic Migraine (HM), 2013\"},\"URL\":{\"$\":\"https://www.orpha.net/data/patho/Pro/en/Emergency_HemiplegicMigraine-enPro1031.pdf\"}}}","medgen_id":"C1832903","public_definition":"Sporadic hemiplegic migraine is a rare form of migraine headache. Migraines typically cause intense, throbbing pain in one area of the head. Some people with migraines also experience nausea, vomiting, and sensitivity to light and sound. These recurrent headaches typically begin in childhood or adolescence and can be triggered by certain foods, emotional stress, and minor head trauma. Each headache may last from a few hours to a few days.In sporadic hemiplegic migraine and some other types of migraine, a pattern of neurological symptoms called an aura occurs before onset of the headache. An aura commonly includes temporary visual changes such as blind spots (scotomas), flashing lights, zig-zagging lines, and double vision. In people with sporadic hemiplegic migraine, auras are also characterized by temporary numbness or weakness, often affecting one side of the body (hemiparesis). Additional features of an aura can include difficulty with speech, confusion, and drowsiness. An aura typically develops gradually over a few minutes and lasts about an hour.Some people with sporadic hemiplegic migraine experience unusually severe migraine episodes. These episodes can include fever, prolonged weakness, seizures, and coma. Although most people with sporadic hemiplegic migraine recover completely between episodes, neurological symptoms such as memory loss and problems with attention can last for weeks or months. Some affected individuals develop mild but permanent difficulty coordinating movements (ataxia), which may worsen with time, and rapid, involuntary eye movements called nystagmus. Mild to severe intellectual disability has been reported in some people with sporadic hemiplegic migraine.","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020757\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"sporadic-hemiplegic-migraine\",\"ref_field\":\"public_definition\"}"],"id":"8733","name":"Migraine, sporadic hemiplegic"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"32352694\",\"@Source\":\"PubMed\"},{\"$\":\"NBK556455\",\"@Source\":\"BookShelf\"}]}}","gard_id":"2375","medgen_id":"C0950122","public_definition":"WT1 disorder is characterized by congenital/infantile- or childhood-onset of a progressive glomerulopathy that does not respond to standard steroid therapy. Additional common findings can include disorders of testicular development (with or without abnormalities of the external genitalia and/or mÃ¼llerian structures) and Wilms tumor. Less common findings are congenital anomalies of the kidney and urinary tract (CAKUT) and gonadoblastoma. While various combinations of renal and other findings associated with a WT1 pathogenic variant were designated as certain syndromes in the past, those designations are now recognized to be part of a phenotypic continuum and are no longer clinically helpful.","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007635\"}","{\"db\":\"OMIM\",\"id\":\"136680\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"347\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2375\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Frasier+Syndrome/2919\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"frasier-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"445431000\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK556455\",\"ref_field\":\"public_definition\"}"],"id":"2150","name":"Frasier syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"32352694\",\"@Source\":\"PubMed\"},{\"$\":\"NBK556455\",\"@Source\":\"BookShelf\"}]}}","gard_id":"3432","medgen_id":"C1837026","public_definition":"WT1 disorder is characterized by congenital/infantile- or childhood-onset of a progressive glomerulopathy that does not respond to standard steroid therapy. Additional common findings can include disorders of testicular development (with or without abnormalities of the external genitalia and/or mÃ¼llerian structures) and Wilms tumor. Less common findings are congenital anomalies of the kidney and urinary tract (CAKUT) and gonadoblastoma. While various combinations of renal and other findings associated with a WT1 pathogenic variant were designated as certain syndromes in the past, those designations are now recognized to be part of a phenotypic continuum and are no longer clinically helpful.","type":"Disease","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012164\"}","{\"db\":\"OMIM\",\"id\":\"608978\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3097\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3432\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Meacham+syndrome/8792\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK556455\",\"ref_field\":\"public_definition\"}"],"id":"2831","name":"Meacham syndrome"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3280953","public_definition":"Transient infantile hypertriglyceridemia is an autosomal recessive disorder characterized by onset of moderate to severe transient hypertriglyceridemia in infancy that normalizes with age. The hypertriglyceridemia is associated with hepatomegaly, moderately elevated transaminases, persistent fatty liver, and the development of hepatic fibrosis. The long-term outcome of affected individuals is unclear (summary by Basel-Vanagaite et al., 2012).","type":"Disease","symbol":"HTGTI","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614480\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"300293\"}","{\"db\":\"Genetic Alliance\",\"id\":\"HYPERTRIGLYCERIDEMIA%2C+TRANSIENT+INFANTILE/8606\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614480\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614480\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"16825","name":"Hypertriglyceridemia, transient infantile"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C4014954","public_definition":"Severe congenital neutropenia is a condition that causes affected individuals to be prone to recurrent infections. People with this condition have a shortage (deficiency) of neutrophils, a type of white blood cell that plays a role in inflammation and in fighting infection. The deficiency of neutrophils, called neutropenia, is apparent at birth or soon afterward. It leads to recurrent infections beginning in infancy, including infections of the sinuses, lungs, and liver. Affected individuals can also develop fevers and inflammation of the gums (gingivitis) and skin. Approximately 40 percent of affected people have decreased bone density (osteopenia) and may develop osteoporosis, a condition that makes bones progressively more brittle and prone to fracture. In people with severe congenital neutropenia, these bone disorders can begin at any time from infancy through adulthood.Approximately 20 percent of people with severe congenital neutropenia develop certain cancerous conditions of the blood, particularly myelodysplastic syndrome or leukemia during adolescence.Some people with severe congenital neutropenia have additional health problems such as seizures, developmental delay, or heart and genital abnormalities.","type":"Disease","symbol":"SCN6","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"616022\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"423384\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"severe-congenital-neutropenia\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"616022\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"31878","name":"Severe congenital neutropenia 6, autosomal recessive"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"26131548\",\"@Source\":\"PubMed\"},{\"$\":\"NBK304142\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C3554398","public_definition":"CHCHD10-related disorders are characterized by a spectrum of adult-onset neurologic findings that can include: Mitochondrial myopathy (may also be early-onset): weakness, amyotrophy, exercise intolerance. Amyotrophic lateral sclerosis (ALS): progressive degeneration of upper motor neurons (UMNs) and lower motor neurons (LMNs). Frontotemporal dementia (FTD): slowly progressive behavioral changes, language disturbances, cognitive decline, extrapyramidal signs. Late-onset spinal motor neuronopathy (SMAJ): weakness, cramps, and/or fasciculations; areflexia. Cerebellar ataxia: gait ataxia, kinetic ataxia (progressive loss of coordination of lower- and upper-limb movements), dysarthria/dysphagia, nystagmus, cerebellar oculomotor disorder. Because of the recent discovery of CHCHD10-related disorders and the limited number of affected individuals reported to date, the natural history of these disorders (except for SMAJ caused by the p.Gly66Val pathogenic variant) is largely unknown.","type":"Disease","symbol":"SMAJ","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"615048\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"276435\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK304142\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"615048\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17579","name":"Spinal muscular atrophy, jokela type"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301684\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1511\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C4310725","public_definition":"MFN2 hereditary motor and sensory neuropathy (MFN2-HMSN) is a classic axonal peripheral sensorimotor neuropathy, inherited in either an autosomal dominant (AD) manner (~90%) or an autosomal recessive (AR) manner (~10%). MFN2-HMSN is characterized by more severe involvement of the lower extremities than the upper extremities, distal upper-extremity involvement as the neuropathy progresses, more prominent motor deficits than sensory deficits, and normal (\u003e42 m/s) or only slightly decreased nerve conduction velocities (NCVs). Postural tremor is common. Median onset is age 12 years in the AD form and age eight years in the AR form. The prevalence of optic atrophy is approximately 7% in the AD form and approximately 20% in the AR form.","type":"Disease","symbol":"CMT2A2B","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0014906\"}","{\"db\":\"OMIM\",\"id\":\"617087\",\"type\":\"MIM\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1511\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"617087\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"35863","name":"Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B"}
{"attribute_content":[],"alternate_symbols":["RPGRIP1L"],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21368913\",\"@Source\":\"PubMed\"}}}","medgen_id":"C1969052","public_definition":"Meckel syndrome is a disorder with severe signs and symptoms that affect many parts of the body. The most common features are enlarged kidneys with numerous fluid-filled cysts; an occipital encephalocele, which is a sac-like protrusion of the brain through an opening at the back of the skull; and the presence of extra fingers and toes (polydactyly). Most affected individuals also have a buildup of scar tissue (fibrosis) in the liver.Other signs and symptoms of Meckel syndrome vary widely among affected individuals. Numerous abnormalities of the brain and spinal cord (central nervous system) have been reported in people with Meckel syndrome, including a group of birth defects known as neural tube defects. These defects occur when a structure called the neural tube, a layer of cells that ultimately develops into the brain and spinal cord, fails to close completely during the first few weeks of embryonic development. Meckel syndrome can also cause problems with development of the eyes and other facial features, heart, bones, urinary system, and genitalia.Because of their serious health problems, most individuals with Meckel syndrome die before or shortly after birth. Most often, affected infants die of respiratory problems or kidney failure.","type":"Disease","symbol":"MKS5","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012695\"}","{\"db\":\"OMIM\",\"id\":\"611561\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"564\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012695\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"meckel-syndrome\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"611561\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2737","name":"Meckel syndrome, type 5"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"medgen_id":"C3553709","public_definition":"Centronuclear myopathy is a condition characterized by muscle weakness (myopathy) and wasting (atrophy) in the skeletal muscles, which are the muscles used for movement. The severity of centronuclear myopathy varies among affected individuals, even among members of the same family.People with centronuclear myopathy begin experiencing muscle weakness at any time from birth to early adulthood. The muscle weakness slowly worsens over time and can lead to delayed development of motor skills, such as crawling or walking; muscle pain during exercise; and difficulty walking. Some affected individuals may need wheelchair assistance as the muscles atrophy and weakness becomes more severe. In rare instances, the muscle weakness improves over time.Some people with centronuclear myopathy experience mild to severe breathing problems related to the weakness of muscles needed for breathing. People with centronuclear myopathy may have droopy eyelids (ptosis) and weakness in other facial muscles, including the muscles that control eye movement. People with this condition may also have foot abnormalities, a high arch in the roof of the mouth (high-arched palate), and abnormal side-to-side curvature of the spine (scoliosis). Rarely, individuals with centronuclear myopathy have a weakened heart muscle (cardiomyopathy), disturbances in nerve function (neuropathy), or intellectual disability.A key feature of centronuclear myopathy is the displacement of the nucleus in muscle cells, which can be viewed under a microscope. Normally the nucleus is found at the edges of the rod-shaped muscle cells, but in people with centronuclear myopathy the nucleus is located in the center of these cells. How the change in location of the nucleus affects muscle cell function is unknown.","type":"Disease","symbol":"CNM4","alternate_names":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614807\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"319160\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"centronuclear-myopathy\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614807\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17362","name":"Myopathy, centronuclear, 4"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"27336129\",\"@Source\":\"PubMed\"},{\"$\":\"NBK368475\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C3809320","public_definition":"The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-LÃ¸ken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).","type":"Disease","symbol":"NPHP16","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0014158\"}","{\"db\":\"OMIM\",\"id\":\"615382\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"655\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK368475\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"615382\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"18247","name":"Nephronophthisis 16"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301769\",\"@Source\":\"PubMed\"},{\"$\":\"NBK7047\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"CN258195","public_definition":"Diamond-Blackfan anemia (DBA) in its classic form is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, congenital malformations in up to 50% of affected individuals, and growth retardation in 30% of affected individuals. The hematologic complications occur in 90% of affected individuals during the first year of life. The phenotypic spectrum ranges from a mild form (e.g., mild anemia, no anemia with only subtle erythroid abnormalities, physical malformations without anemia) to a severe form of fetal anemia resulting in nonimmune hydrops fetalis. DBA is associated with an increased risk for acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), and solid tumors including osteogenic sarcoma.","type":"Disease","symbol":"DBA19","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032669\"}","{\"db\":\"OMIM\",\"id\":\"618312\",\"type\":\"MIM\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK7047\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"618312\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41356","name":"Diamond-Blackfan anemia 19"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301769\",\"@Source\":\"PubMed\"},{\"$\":\"NBK7047\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"CN258196","public_definition":"Diamond-Blackfan anemia (DBA) in its classic form is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, congenital malformations in up to 50% of affected individuals, and growth retardation in 30% of affected individuals. The hematologic complications occur in 90% of affected individuals during the first year of life. The phenotypic spectrum ranges from a mild form (e.g., mild anemia, no anemia with only subtle erythroid abnormalities, physical malformations without anemia) to a severe form of fetal anemia resulting in nonimmune hydrops fetalis. DBA is associated with an increased risk for acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), and solid tumors including osteogenic sarcoma.","type":"Disease","symbol":"DBA20","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032670\"}","{\"db\":\"OMIM\",\"id\":\"618313\",\"type\":\"MIM\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK7047\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"618313\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41357","name":"Diamond-Blackfan anemia 20"}
{"attribute_content":[],"alternate_symbols":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301769\",\"@Source\":\"PubMed\"},{\"$\":\"NBK7047\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"CN258194","public_definition":"Diamond-Blackfan anemia (DBA) in its classic form is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, congenital malformations in up to 50% of affected individuals, and growth retardation in 30% of affected individuals. The hematologic complications occur in 90% of affected individuals during the first year of life. The phenotypic spectrum ranges from a mild form (e.g., mild anemia, no anemia with only subtle erythroid abnormalities, physical malformations without anemia) to a severe form of fetal anemia resulting in nonimmune hydrops fetalis. DBA is associated with an increased risk for acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), and solid tumors including osteogenic sarcoma.","type":"Disease","symbol":"DBA18","alternate_names":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032668\"}","{\"db\":\"OMIM\",\"id\":\"618310\",\"type\":\"MIM\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK7047\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"618310\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"41355","name":"Diamond-Blackfan anemia 18"}
